{"text_format":"3","workbook":"xls","n_sheets":1,"sheets":["浙江省医保药品编码库变更"],"not_rendered":{"external_links":1,"defined_names":1},"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"浙江省医保药品编码库变更","index":0,"n_rows":1845,"n_cols":19,"rows_kept":1845,"merged":[[0,0,0,18]],"flags":["formulas_cached_only"]}
["浙江省医保药品编码库变更一览表"]
["序号","医保编码","分类","医保中文名称","医保文件剂型","备注","招标药品ID","招标药品通用名","商品名","剂型","规格","单位","转换比","包装材质","药品企业","支付标准","变更","变更原因","药品类型（供参考）"]
["1","XN05AHK094A010010181522","2","喹硫平","缓释控释剂型","","170127","富马酸喹硫平缓释片","无","缓释片","150mg","瓶","21","塑料瓶","植恩生物技术股份有限公司","57.12","修改（招标信息）","招采变更",""]
["2","XN05AHK094A010020181522","2","喹硫平","缓释控释剂型","","170123","富马酸喹硫平缓释片","无","缓释片","200mg","瓶","21","塑料瓶","植恩生物技术股份有限公司","71.19","修改（招标信息）","招采变更",""]
["3","XB01ABD056B002020200517","2","低分子肝素","注射剂","","100358","低分子肝素钙注射液","赛博利","注射液","1ml:5000AXaIU","支","1","西林瓶","广东三生制药有限公司","10.68","修改（企业名称）","招采变更",""]
["4","ZA15EAQ0244010205506","2","强力天麻杜仲丸（胶囊)","","","103216","强力天麻杜仲胶囊","无","胶囊剂","0.4g","盒","48","铝塑","贵州汉方药业有限公司","26.88","修改（招标信息）","招采变更",""]
["5","ZA02AAH0436010205506","1","藿香正气水（丸、片、胶囊、颗粒、口服液、软胶囊）","","","103225","藿香正气胶囊","无","胶囊剂","每粒装0.3g","盒","48","铝箔","贵州汉方药业有限公司","19.00","修改（招标信息）","招采变更",""]
["6","XA05BAF632B002010202503","2","复方甘草甜素（复方甘草酸苷）","注射剂","限AST或ALT大于120U/L的患者。","119764","复方甘草酸苷注射液","无","注射液","20ml:40mg","支","1","安瓿","西安利君制药有限责任公司","9.25","修改（医保和招标信息）","招采变更",""]
["7","XA02BCA081B001010102503","2","埃索美拉唑（艾司奥美拉唑）","注射剂","","168504","注射用艾司奥美拉唑钠","无","冻干粉针剂","40mg","瓶","1","玻璃瓶","西安利君制药有限责任公司","57.29","停用","招采国码变更",""]
["8","XA02BCA081B001010202503","2","埃索美拉唑（艾司奥美拉唑）","注射剂","","168504","注射用艾司奥美拉唑钠","无","冻干粉针剂","40mg","瓶","1","玻璃瓶","西安利君制药有限责任公司","57.29","启用","招采国码变更",""]
["9","XC01BCP099A001010100811","1","普罗帕酮","口服常释剂型","","171139","盐酸普罗帕酮片","悦复隆","片剂","150mg","盒","10","铝塑","上海雅培制药有限公司","17.30","修改（企业名称）","招采变更",""]
["10","ZA12BAL0035010107266","2","乐脉丸(片、胶囊、颗粒)","","","205767","乐脉胶囊","无","胶囊剂","每粒装0.45g","盒","36","铝塑泡罩包装","康普药业股份有限公司","15.78","修改（企业名称）","招采变更",""]
["11","XG02ADK026B002010178736","2","卡前列素氨丁三醇","注射剂","限生育保险","147403","卡前列素氨丁三醇注射液","欣母沛","注射剂","1ml:250μg","盒","10","空","Pharmacia and Upjohn Company LLC","4159.70","修改（招标信息）","招采变更",""]
["12","ZA02AAH0440010300960","1","藿香正气水（丸、片、胶囊、颗粒、口服液、软胶囊）","","","122067","藿香正气软胶囊","无","胶囊剂(软胶囊)","每粒装0.45g","盒","30","铝箔","津药达仁堂集团股份有限公司达仁堂制药厂","21.72","修改（招标信息）","招采变更",""]
["13","ZA02AAH0440010400960","1","藿香正气水（丸、片、胶囊、颗粒、口服液、软胶囊）","","","148581","藿香正气软胶囊","无","胶囊剂(软胶囊)","每粒装0.45g","盒","50","铝箔","津药达仁堂集团股份有限公司达仁堂制药厂","36.17","修改（招标信息）","招采变更",""]
["14","ZD01BAS0302010100960","1","少腹逐瘀丸（胶囊、颗粒）","","","152093","少腹逐瘀丸","无","丸剂(大蜜丸)","9g","盒","10","铝箔","津药达仁堂集团股份有限公司达仁堂制药厂","56.98","修改（招标信息）","招采变更",""]
["15","ZA06CAQ0331030100960","2","清肺消炎丸","","","148588","清肺消炎丸(人工牛黄)","无","丸剂(水丸)","每60丸重5g","盒","6","复合膜","津药达仁堂集团股份有限公司达仁堂制药厂","50.72","修改（招标信息）","招采变更",""]
["16","ZA06CCX0422010100960","2","小儿金丹（小儿金丹片）","","","166571","小儿金丹","无","丸剂(大蜜丸)","1.5g","盒","10","铝箔","津药达仁堂集团股份有限公司达仁堂制药厂","78.00","修改（招标信息）","招采变更",""]
["17","ZG02AAG0250010102969","2","骨刺宁片(胶囊)","","","200265","骨刺宁胶囊","无","胶囊剂","0.3g","盒","24","铝塑包装","重庆天致药业股份有限公司","48.00","修改（企业名称）","招采变更",""]
["18","XL03ABC097B002060104274","2","人干扰素α2b(重组人干扰素α-2b)","注射剂","限白血病、淋巴瘤、黑色素瘤、肾癌、多发性骨髓瘤、丙肝、慢性活动性乙肝。丙肝、慢性活动性乙肝连续使用6个月无效时停药，连续使用不超过12个月","137748","重组人干扰素α2b注射液","安达芬","注射液","600万IU","盒","1","预充式(预灌封)注射器","安徽安科生物工程(集团)股份有限公司","55.97","停用","招采国码变更",""]
["19","XL03ABR106B002010204274","2","人干扰素α2b(重组人干扰素α-2b)","注射剂","","137748","人干扰素α2b注射液","安达芬","注射液","600万IU/支","盒","1","预充式(预灌封)注射器","安徽安科生物工程(集团)股份有限公司","55.97","启用","招采国码变更",""]
["20","XL03ABC097B002040204274","2","人干扰素α2b(重组人干扰素α-2b)","注射剂","限白血病、淋巴瘤、黑色素瘤、肾癌、多发性骨髓瘤、丙肝、慢性活动性乙肝。丙肝、慢性活动性乙肝连续使用6个月无效时停药，连续使用不超过12个月","151139","重组人干扰素α2b注射液","安达芬","注射液","500万IU","盒","1","预充式(预灌封)注射器","安徽安科生物工程(集团)股份有限公司","48.16","停用","招采国码变更",""]
["21","XL03ABR106B002040204274","2","人干扰素α2b(重组人干扰素α-2b)","注射剂","","151139","人干扰素α2b注射液","安达芬","注射液","500万IU/支","盒","1","预充式(预灌封)注射器","安徽安科生物工程(集团)股份有限公司","48.16","启用","招采国码变更",""]
["22","ZD04AAX0210010105634","2","消结安胶囊","","","130193","消结安胶囊","无","胶囊剂","每粒装0.38g(相当于饮片2.5g)","盒","24","铝塑","云南神威施普瑞药业有限公司","33.93","修改（规格）","招采变更",""]
["23","ZA16FAS0058010205208","1","三金片（胶囊）","","","108325","三金片","无","薄膜衣片","每片重0.32g(相当于饮片3.5g)","盒","72","铝箔","桂林三金药业股份有限公司","44.46","修改（规格）","招采变更",""]
["24","ZA16FAS0058010105208","1","三金片（胶囊）","","","172494","三金片","无","薄膜衣片","每片重0.32g(相当于饮片3.5g)","盒","54","铝箔","桂林三金药业股份有限公司","33.70","修改（规格）","招采变更",""]
["25","XJ01MAZ083B002010100226","2","左氧氟沙星氯化钠","注射剂","","135523","左氧氟沙星氯化钠注射液","可乐必妥","注射液","100ml:左氧氟沙星0.5g与氯化钠0.9g","袋","1","多层共挤输液袋","北京吉洛华制药有限公司","84.06","修改（招标信息）","招采变更",""]
["26","XJ01MAZ074A001010200226","1","左氧氟沙星","口服常释剂型","","135664","左氧氟沙星片","可乐必妥","片剂","0.1g","盒","10","铝塑","北京吉洛华制药有限公司","23.36","修改（招标信息）","招采变更",""]
["27","XJ01MAZ074A001020100226","1","左氧氟沙星","口服常释剂型","","135665","左氧氟沙星片","可乐必妥","片剂","0.5g","盒","4","铝塑","北京吉洛华制药有限公司","33.12","修改（招标信息）","招采变更",""]
["28","XB03XAC103B002030104115","2","人促红素[重组人促红素（CHO细胞）]","注射剂","限肾性贫血、非骨髓恶性肿瘤化疗引起的贫血","140078","人促红素注射液","依普定","注射液","1ml:2000IU","支","1","西林瓶","科兴生物制药股份有限公司","19.07","停用","招采国码变更",""]
["29","XB03XAR103B002010404115","2","人促红素[重组人促红素（CHO细胞）]","注射剂","","140078","人促红素注射液","依普定","注射剂","2000IU","盒","1","西林瓶","科兴生物制药股份有限公司","19.07","启用","招采国码变更",""]
["30","XB03XAC103B002010104115","2","人促红素[重组人促红素（CHO细胞）]","注射剂","限肾性贫血、非骨髓恶性肿瘤化疗引起的贫血","148252","人促红素注射液","依普定","注射液","0.5ml:1万IU","支","1","预充式(预灌封)注射器","科兴生物制药股份有限公司","51.01","停用","招采国码变更",""]
["31","XB03XAR103B002050304115","2","人促红素[重组人促红素（CHO细胞）]","注射剂","","148252","人促红素注射液","依普定","注射剂","10000IU/0.5m/支(预灌封注射器)","盒","1","预充式(预灌封)注射器","科兴生物制药股份有限公司","51.01","启用","招采国码变更",""]
["32","XL03ABC094B014010100510","2","人干扰素α1b(重组人干扰素α-1b)","注射剂","限白血病、淋巴瘤、黑色素瘤、肾癌、多发性骨髓瘤、丙肝、慢性活动性乙肝。丙肝、慢性活动性乙肝连续使用6个月无效时停药，连续使用不超过12个月","144763","注射用人干扰素α1b","赛若金","冻干粉针剂","100万IU(10μg)","支","1","西林瓶","深圳科兴药业有限公司","14.65","停用","招采国码变更",""]
["33","XL03ABR105B014070100510","2","人干扰素α1b(重组人干扰素α-1b)","注射剂","","144763","注射用人干扰素α1b","赛若金","注射剂(冻干粉针剂)","10μg/支","盒","1","西林瓶","深圳科兴药业有限公司","14.65","启用","招采国码变更",""]
["34","XL03ABC094B014020100510","2","人干扰素α1b(重组人干扰素α-1b)","注射剂","限白血病、淋巴瘤、黑色素瘤、肾癌、多发性骨髓瘤、丙肝、慢性活动性乙肝。丙肝、慢性活动性乙肝连续使用6个月无效时停药，连续使用不超过12个月","144764","注射用人干扰素α1b","赛若金","冻干粉针剂","200万IU(20μg)","支","1","西林瓶","深圳科兴药业有限公司","24.06","停用","招采国码变更",""]
["35","XL03ABR105B014010200510","2","人干扰素α1b(重组人干扰素α-1b)","注射剂","","144764","注射用人干扰素α1b","赛若金","注射剂(冻干粉针剂)","20μg/支","盒","1","西林瓶","深圳科兴药业有限公司","24.06","启用","招采国码变更",""]
["36","XL03ABC094B014030100510","2","人干扰素α1b(重组人干扰素α-1b)","注射剂","限白血病、淋巴瘤、黑色素瘤、肾癌、多发性骨髓瘤、丙肝、慢性活动性乙肝。丙肝、慢性活动性乙肝连续使用6个月无效时停药，连续使用不超过12个月","144765","注射用人干扰素α1b","赛若金","冻干粉针剂","300万IU(30μg)","支","1","西林瓶","深圳科兴药业有限公司","32.82","停用","招采国码变更",""]
["37","XL03ABR105B014020200510","2","人干扰素α1b(重组人干扰素α-1b)","注射剂","","144765","注射用人干扰素α1b","赛若金","注射剂(冻干粉针剂)","30μg/支","盒","1","西林瓶","深圳科兴药业有限公司","32.82","启用","招采国码变更",""]
["38","XL03ABC094B014040100510","2","人干扰素α1b(重组人干扰素α-1b)","注射剂","限白血病、淋巴瘤、黑色素瘤、肾癌、多发性骨髓瘤、丙肝、慢性活动性乙肝。丙肝、慢性活动性乙肝连续使用6个月无效时停药，连续使用不超过12个月","144766","注射用人干扰素α1b","赛若金","冻干粉针剂","400万IU(40μg)","支","1","西林瓶","深圳科兴药业有限公司","43.60","停用","招采国码变更",""]
["39","XL03ABR105B014030200510","2","人干扰素α1b(重组人干扰素α-1b)","注射剂","","144766","注射用人干扰素α1b","赛若金","注射剂(冻干粉针剂)","40μg/支","盒","1","西林瓶","深圳科兴药业有限公司","43.60","启用","招采国码变更",""]
["40","XL03ABC094B014050100510","2","人干扰素α1b(重组人干扰素α-1b)","注射剂","限白血病、淋巴瘤、黑色素瘤、肾癌、多发性骨髓瘤、丙肝、慢性活动性乙肝。丙肝、慢性活动性乙肝连续使用6个月无效时停药，连续使用不超过12个月","144767","注射用人干扰素α1b","赛若金","冻干粉针剂","500万IU(50μg)","支","1","西林瓶","深圳科兴药业有限公司","53.39","停用","招采国码变更",""]
["41","XL03ABR105B014040200510","2","人干扰素α1b(重组人干扰素α-1b)","注射剂","","144767","注射用人干扰素α1b","赛若金","注射剂(冻干粉针剂)","50μg/支","盒","1","西林瓶","深圳科兴药业有限公司","53.39","启用","招采国码变更",""]
["42","XL03ABC094B014060100510","2","人干扰素α1b(重组人干扰素α-1b)","注射剂","限白血病、淋巴瘤、黑色素瘤、肾癌、多发性骨髓瘤、丙肝、慢性活动性乙肝。丙肝、慢性活动性乙肝连续使用6个月无效时停药，连续使用不超过12个月","144768","注射用人干扰素α1b","赛若金","冻干粉针剂","600万IU(60μg)","支","1","西林瓶","深圳科兴药业有限公司","62.35","停用","招采国码变更",""]
["43","XL03ABR105B014050200510","2","人干扰素α1b(重组人干扰素α-1b)","注射剂","","144768","注射用人干扰素α1b","赛若金","注射剂(冻干粉针剂)","60μg/支","盒","1","西林瓶","深圳科兴药业有限公司","62.35","启用","招采国码变更",""]
["44","XL01CXG054B002010104494","1","高三尖杉酯碱","注射剂","","135890","高三尖杉酯碱注射液","无","注射液","1ml:1.0mg","支","1","安瓿","杭州民生药业股份有限公司","","停用","招采国码变更","供应紧张药品"]
["45","XL01XXG054B002010104494","1","高三尖杉酯碱","注射剂","","135890","高三尖杉酯碱注射液","无","注射液","1ml:1mg","盒","1","安瓿","杭州民生药业股份有限公司","96.00","启用","招采国码变更",""]
["46","XB05BAA346B020010100952","2","氨基酸(15)腹膜透析液","","","310095","氨基酸（15）腹膜透析液","无","注射剂","2000ml ∶ 22.41g （总氨基酸）","袋","1","三层共挤输液用 膜（I） 制袋 、一次性使用腹膜透析引流袋、输液袋用聚碳酸酯加药塞、注射液用聚碳酸酯折断塞、输液袋用高密度聚乙烯非织造布袋装铁基吸氧剂、高阻隔外袋。","天津金耀药业有限公司","55.80","停用","招采国码变更","竞价药品"]
["47","XB05DAA346B020010100952","2","氨基酸(15)腹膜透析液","","","310095","氨基酸（15）腹膜透析液","无","注射剂","2000ml ∶ 22.41g （总氨基酸）","袋","1","三层共挤输液用 膜（I） 制袋 、一次性使用腹膜透析引流袋、输液袋用聚碳酸酯加药塞、注射液用聚碳酸酯折断塞、输液袋用高密度聚乙烯非织造布袋装铁基吸氧剂、高阻隔外袋。","天津金耀药业有限公司","55.80","启用","招采国码变更","竞价药品"]
["48","XV01AAC034X003010101415","2","肠内营养乳剂(SP)","","需经营养风险筛查，明确具有营养风险，且应为不能经饮食补充足够营养的住院患者方予支付。","175738","肠内营养乳剂(SP)","无","口服乳剂","500ml","袋","1","聚酯/聚酯-氧化硅/流延聚丙烯肠内营养乳剂用复合袋装","费森尤斯卡比华瑞制药有限公司","72.00","停用","招采国码变更","国谈药品"]
["49","XV01AAC173X003010101415","2","肠内营养乳剂(SP)","","需经营养风险筛查，明确具有营养风险，且应为不能经饮食补充足够营养的住院患者方予支付。","175738","肠内营养乳剂(SP)","无","口服乳剂","500ml","袋","1","聚酯/聚酯-氧化硅/流延聚丙烯肠内营养乳剂用复合袋装","费森尤斯卡比华瑞制药有限公司","72.00","启用","招采国码变更","国谈药品"]
["50","XA06ADL106P001010102166","2","磷酸钠盐散","","","310047","磷酸钠盐散","无","散剂","每袋含磷酸二氢钠(NaH2PO4·H2O)21.6g与磷酸氢二钠(Na2HPO4)4.3g","盒","2","聚酯/铝/聚乙烯药品包装用复合膜","四川健能制药有限公司","94.00","停用","招采国码变更","国谈药品"]
["51","XA06AGL394P001010102166","2","磷酸钠盐散","","","310047","磷酸钠盐散","无","散剂","每袋含磷酸二氢钠(NaH2PO4·H2O)21.6g与磷酸氢二钠(Na2HPO4)4.3g","盒","2","聚酯/铝/聚乙烯药品包装用复合膜","四川健能制药有限公司","94.00","启用","招采国码变更","国谈药品"]
["52","XL03AAC106B002020100552","2","人粒细胞刺激因子(重组人粒细胞刺激因子)","注射剂","限放化疗后的骨髓抑制","135802","人粒细胞刺激因子注射液","瑞血新","注射液","0.5ml:0.125mg","支","1","玻璃瓶","深圳未名新鹏生物医药有限公司","53.52","停用","招采国码变更",""]
["53","XL03AAR104B002030200552","2","人粒细胞刺激因子(重组人粒细胞刺激因子)","注射剂","","135802","人粒细胞刺激因子注射液","瑞血新","注射剂","125μg/0.5ml/支","支","1","玻璃瓶","深圳未名新鹏生物医药有限公司","53.52","启用","招采国码变更",""]
["54","XB03XAC103B002030100552","2","人促红素[重组人促红素（CHO细胞）]","注射剂","限肾性贫血、非骨髓恶性肿瘤化疗引起的贫血","135798","人促红素注射液","无","注射液","1ml:3000IU","支","1","玻璃瓶","深圳未名新鹏生物医药有限公司","18.90","停用","招采国码变更",""]
["55","XB03XAR103B002020200552","2","人促红素[重组人促红素（CHO细胞）]","注射剂","","135798","人促红素注射液","无","注射剂","3000IU/1.0ml/支","支","1","玻璃瓶","深圳未名新鹏生物医药有限公司","18.90","启用","招采国码变更",""]
["56","ZA06CAF0030010105478","1","肺力咳胶囊（合剂）","","","133403","肺力咳合剂","无","合剂(含口服液)","100ml(相当于饮片18.7g)","瓶","1","塑料瓶","贵州健兴药业有限公司","17.06","停用","招采国码变更",""]
["57","ZA06CAF0030020105478","1","肺力咳胶囊（合剂）","","","133403","肺力咳合剂","无","合剂","每瓶装100ml(每1ml相当于饮片0.187g)","瓶","1","塑料瓶","贵州健兴药业有限公司","17.06","启用","招采国码变更",""]
["58","XL03AAC106B002090204488","2","人粒细胞刺激因子(重组人粒细胞刺激因子)","注射剂","限放化疗后的骨髓抑制","145869","人粒细胞刺激因子注射液","吉粒芬","注射液","0.6ml:0.15mg","支","1","安瓿","杭州九源基因工程有限公司","67.12","停用","招采国码变更",""]
["59","XL03AAR104B002070104488","2","人粒细胞刺激因子(重组人粒细胞刺激因子)","注射剂","","145869","人粒细胞刺激因子注射液","吉粒芬","注射液","150μg(0.6ml: 1.2×10E7IU)/支(安瓿)","支","1","安瓿","杭州九源基因工程有限公司","67.12","启用","招采国码变更",""]
["60","XL03AAC106B002100204488","2","人粒细胞刺激因子(重组人粒细胞刺激因子)","注射剂","限放化疗后的骨髓抑制","145871","人粒细胞刺激因子注射液","吉粒芬","注射液","1.2ml:0.3mg","支","1","安瓿","杭州九源基因工程有限公司","108.85","停用","招采国码变更",""]
["61","XL03AAR104B002090104488","2","人粒细胞刺激因子(重组人粒细胞刺激因子)","注射剂","","145871","人粒细胞刺激因子注射液","吉粒芬","注射液","300μg(1.2ml: 2.4×10E7IU)/支(安瓿)","支","1","安瓿","杭州九源基因工程有限公司","108.85","启用","招采国码变更",""]
["62","XL03AAC106B002020204488","2","人粒细胞刺激因子(重组人粒细胞刺激因子)","注射剂","限放化疗后的骨髓抑制","145873","人粒细胞刺激因子注射液","吉粒芬","注射液","0.4ml:0.1mg","支","1","安瓿","杭州九源基因工程有限公司","45.54","停用","招采国码变更",""]
["63","XL03AAR104B002060104488","2","人粒细胞刺激因子(重组人粒细胞刺激因子)","注射剂","","145873","人粒细胞刺激因子注射液","吉粒芬","注射液","100μg(0.4ml: 8×10E6IU)/支(安瓿)","支","1","安瓿","杭州九源基因工程有限公司","45.54","启用","招采国码变更",""]
["64","XL03AAC106B002060204488","2","人粒细胞刺激因子(重组人粒细胞刺激因子)","注射剂","限放化疗后的骨髓抑制","145874","人粒细胞刺激因子注射液","吉粒芬","注射液","0.3ml:75μg","支","1","安瓿","杭州九源基因工程有限公司","36.79","停用","招采国码变更",""]
["65","XL03AAR104B002050104488","2","人粒细胞刺激因子(重组人粒细胞刺激因子)","注射剂","","145874","人粒细胞刺激因子注射液","吉粒芬","注射液","75μg(0.3ml: 6×10E6IU) /支(安瓿)","支","1","安瓿","杭州九源基因工程有限公司","36.79","启用","招采国码变更",""]
["66","XL03AAC106B002010304488","2","人粒细胞刺激因子(重组人粒细胞刺激因子)","注射剂","限放化疗后的骨髓抑制","145875","人粒细胞刺激因子注射液","吉粒芬","注射液","0.2ml:50μg","支","1","安瓿","杭州九源基因工程有限公司","27.32","停用","招采国码变更",""]
["67","XL03AAR104B002040104488","2","人粒细胞刺激因子(重组人粒细胞刺激因子)","注射剂","","145875","人粒细胞刺激因子注射液","吉粒芬","注射液","50μg(0.2ml: 4×10E6IU)/支(安瓿)","支","1","安瓿","杭州九源基因工程有限公司","27.32","启用","招采国码变更",""]
["68","XL03ACC084B001020104488","2","人白介素-11(重组人白介素-11)","注射剂","限放化疗引起的严重血小板减少患者","140112","注射用人白介素-11","吉巨芬","冻干粉针剂","2400万单位(3mg)","支","1","西林瓶","杭州九源基因工程有限公司","218.49","停用","招采国码变更",""]
["69","XL03ACR107B001010204488","2","人白介素-11(重组人白介素-11)","注射剂","","140112","注射用人白介素-11","无","注射剂","3mg(2400万U)/瓶","盒","5","西林瓶","杭州九源基因工程有限公司","1092.45","启用","招采国码变更",""]
["70","XL03ACC084B001030104488","2","人白介素-11(重组人白介素-11)","注射剂","限放化疗引起的严重血小板减少患者","140113","注射用人白介素-11","吉巨芬","冻干粉针剂","600万单位(0.75mg)","支","1","西林瓶","杭州九源基因工程有限公司","56.13","停用","招采国码变更",""]
["71","XL03ACR107B001020204488","2","人白介素-11(重组人白介素-11)","注射剂","","140113","注射用人白介素-11","无","注射剂","0.75mg(600万U)/瓶","盒","5","西林瓶","杭州九源基因工程有限公司","280.65","启用","招采国码变更",""]
["72","XB05XAL211B002010904346","1","氯化钠","注射剂","","156816","氯化钠注射液","无","注射液","100ml:0.9g(0.9%)","袋","1","直立式输液袋(聚丙烯共混)","安徽双鹤药业有限责任公司","1.63","停用","招采国码变更",""]
["73","XB05XAL211B002010604346","1","氯化钠","注射剂","","156816","氯化钠注射液","无","注射液","100ml:0.9g(0.9%)","袋","1","直立式输液袋(聚丙烯共混)","安徽双鹤药业有限责任公司","1.63","启用","招采国码变更",""]
["74","XB05XAL211B002020904346","1","氯化钠","注射剂","","156814","氯化钠注射液","无","注射液","250ml:2.25g(0.9%)","袋","1","直立式输液袋(聚丙烯共混)","安徽双鹤药业有限责任公司","1.85","停用","招采国码变更",""]
["75","XB05XAL211B002020604346","1","氯化钠","注射剂","","156814","氯化钠注射液","无","注射液","250ml:2.25g(0.9%)","袋","1","直立式输液袋(聚丙烯共混)","安徽双鹤药业有限责任公司","1.85","启用","招采国码变更",""]
["76","XB05XAL211B002030904346","1","氯化钠","注射剂","","156811","氯化钠注射液","无","注射液","500ml:4.5g(0.9%)","袋","1","直立式输液袋(聚丙烯共混)","安徽双鹤药业有限责任公司","2.26","停用","招采国码变更",""]
["77","XB05XAL211B002030604346","1","氯化钠","注射剂","","156811","氯化钠注射液","无","注射液","500ml:4.5g(0.9%)","袋","1","直立式输液袋(聚丙烯共混)","安徽双鹤药业有限责任公司","2.26","启用","招采国码变更",""]
["78","XB05BBP075B002010904346","1","葡萄糖氯化钠","注射剂","","156808","葡萄糖氯化钠注射液","无","注射液","100ml:5g:0.9g","袋","1","直立式输液袋(聚丙烯共混)","安徽双鹤药业有限责任公司","1.64","停用","招采国码变更",""]
["79","XB05BBP075B002010604346","1","葡萄糖氯化钠","注射剂","","156808","葡萄糖氯化钠注射液","无","注射液","100ml:5g:0.9g","袋","1","直立式输液袋(聚丙烯共混)","安徽双鹤药业有限责任公司","1.64","启用","招采国码变更",""]
["80","XB05BBP075B002030904346","1","葡萄糖氯化钠","注射剂","","156806","葡萄糖氯化钠注射液","无","注射液","250ml:12.5g:2.25g","袋","1","直立式输液袋(聚丙烯共混)","安徽双鹤药业有限责任公司","1.85","停用","招采国码变更",""]
["81","XB05BBP075B002030604346","1","葡萄糖氯化钠","注射剂","","156806","葡萄糖氯化钠注射液","无","注射液","250ml:12.5g:2.25g","袋","1","直立式输液袋(聚丙烯共混)","安徽双鹤药业有限责任公司","1.85","启用","招采国码变更",""]
["82","XB05BBP075B002040904346","1","葡萄糖氯化钠","注射剂","","156805","葡萄糖氯化钠注射液","无","注射液","500ml:25g:4.5g","袋","1","直立式输液袋(聚丙烯共混)","安徽双鹤药业有限责任公司","2.24","停用","招采国码变更",""]
["83","XB05BBP075B002040604346","1","葡萄糖氯化钠","注射剂","","156805","葡萄糖氯化钠注射液","无","注射液","500ml:25g:4.5g","袋","1","直立式输液袋(聚丙烯共混)","安徽双鹤药业有限责任公司","2.24","启用","招采国码变更",""]
["84","XB05BBP072B002010904346","1","葡萄糖","注射剂","","156797","葡萄糖注射液","无","注射液","100ml:10g(10%)","袋","1","直立式输液袋(聚丙烯共混)","安徽双鹤药业有限责任公司","1.64","停用","招采国码变更",""]
["85","XB05BBP072B002010604346","1","葡萄糖","注射剂","","156797","葡萄糖注射液","无","注射液","100ml:10g(10%)","袋","1","直立式输液袋(聚丙烯共混)","安徽双鹤药业有限责任公司","1.64","启用","招采国码变更",""]
["86","XB05BBP072B002020904346","1","葡萄糖","注射剂","","156804","葡萄糖注射液","无","注射液","100ml:5g(5%)","袋","1","直立式输液袋(聚丙烯共混)","安徽双鹤药业有限责任公司","1.64","停用","招采国码变更",""]
["87","XB05BBP072B002020604346","1","葡萄糖","注射剂","","156804","葡萄糖注射液","无","注射液","100ml:5g(5%)","袋","1","直立式输液袋(聚丙烯共混)","安徽双鹤药业有限责任公司","1.64","启用","招采国码变更",""]
["88","XB05BBP072B002030904346","1","葡萄糖","注射剂","","156801","葡萄糖注射液","无","注射液","250ml:12.5g(5%)","袋","1","直立式输液袋(聚丙烯共混)","安徽双鹤药业有限责任公司","1.85","停用","招采国码变更",""]
["89","XB05BBP072B002030604346","1","葡萄糖","注射剂","","156801","葡萄糖注射液","无","注射液","250ml:12.5g(5%)","袋","1","直立式输液袋(聚丙烯共混)","安徽双鹤药业有限责任公司","1.85","启用","招采国码变更",""]
["90","XB05BBP072B002040904346","1","葡萄糖","注射剂","","156794","葡萄糖注射液","无","注射液","250ml:25g(10%)","袋","1","直立式输液袋(聚丙烯共混)","安徽双鹤药业有限责任公司","1.85","停用","招采国码变更",""]
["91","XB05BBP072B002040604346","1","葡萄糖","注射剂","","156794","葡萄糖注射液","无","注射液","250ml:25g(10%)","袋","1","直立式输液袋(聚丙烯共混)","安徽双鹤药业有限责任公司","1.85","启用","招采国码变更",""]
["92","XB05BBP072B002050904346","1","葡萄糖","注射剂","","156799","葡萄糖注射液","无","注射液","500ml:25g(5%)","袋","1","直立式输液袋(聚丙烯共混)","安徽双鹤药业有限责任公司","2.24","停用","招采国码变更",""]
["93","XB05BBP072B002050604346","1","葡萄糖","注射剂","","156799","葡萄糖注射液","无","注射液","500ml:25g(5%)","袋","1","直立式输液袋(聚丙烯共混)","安徽双鹤药业有限责任公司","2.24","启用","招采国码变更",""]
["94","XB05BBP072B002060904346","1","葡萄糖","注射剂","","156792","葡萄糖注射液","无","注射液","500ml:50g(10%)","袋","1","直立式输液袋(聚丙烯共混)","安徽双鹤药业有限责任公司","2.24","停用","招采国码变更",""]
["95","XB05BBP072B002060604346","1","葡萄糖","注射剂","","156792","葡萄糖注射液","无","注射液","500ml:50g(10%)","袋","1","直立式输液袋(聚丙烯共混)","安徽双鹤药业有限责任公司","2.24","启用","招采国码变更",""]
["96","XB03XAC103B014030100713","2","人促红素[重组人促红素（CHO细胞）]","注射剂","限肾性贫血、非骨髓恶性肿瘤化疗引起的贫血","141293","注射用人促红素","怡宝","冻干粉针剂","3000IU","瓶","1","西林瓶","上海凯茂生物医药有限公司","19.08","停用","招采国码变更",""]
["97","XB03XAR103B014050200713","2","人促红素[重组人促红素（CHO细胞）]","注射剂","","141293","注射用人促红素","怡宝","冻干粉针剂","3000IU","盒","5","西林瓶","上海凯茂生物医药有限公司","95.40","启用","招采国码变更",""]
["98","XB03XAC103B014040100713","2","人促红素[重组人促红素（CHO细胞）]","注射剂","限肾性贫血、非骨髓恶性肿瘤化疗引起的贫血","141294","注射用人促红素","怡宝","冻干粉针剂","4000IU","瓶","1","西林瓶","上海凯茂生物医药有限公司","32.25","停用","招采国码变更",""]
["99","XB03XAR103B014060200713","2","人促红素[重组人促红素（CHO细胞）]","注射剂","","141294","注射用人促红素","怡宝","冻干粉针剂","4000IU","盒","5","西林瓶","上海凯茂生物医药有限公司","161.25","启用","招采国码变更",""]
["100","XC08CAX212A010010100044","1","硝苯地平/n硝苯地平Ⅰ/n硝苯地平Ⅱ/n硝苯地平Ⅲ/n硝苯地平Ⅳ","缓释控释剂型","","139564","硝苯地平控释片","无","缓释片","30mg","盒","7","双铝","北京红林制药有限公司","14.99","停用","招采国码变更",""]
["101","XC08CAX066A011010800044","1","硝苯地平/n硝苯地平Ⅰ/n硝苯地平Ⅱ/n硝苯地平Ⅲ/n硝苯地平Ⅳ","缓释控释剂型","","139564","硝苯地平控释片","无","片剂","30mg","盒","7","双铝","北京红林制药有限公司","14.99","启用","招采国码变更",""]
["102","XC08CAX212A010010200044","1","硝苯地平/n硝苯地平Ⅰ/n硝苯地平Ⅱ/n硝苯地平Ⅲ/n硝苯地平Ⅳ","缓释控释剂型","","139565","硝苯地平控释片","无","缓释片","30mg","盒","10","双铝","北京红林制药有限公司","20.88","停用","招采国码变更",""]
["103","XC08CAX066A011010900044","1","硝苯地平/n硝苯地平Ⅰ/n硝苯地平Ⅱ/n硝苯地平Ⅲ/n硝苯地平Ⅳ","缓释控释剂型","","139565","硝苯地平控释片","无","片剂","30mg","盒","10","双铝","北京红林制药有限公司","20.88","启用","招采国码变更",""]
["104","XC08CAX212A010010300044","1","硝苯地平/n硝苯地平Ⅰ/n硝苯地平Ⅱ/n硝苯地平Ⅲ/n硝苯地平Ⅳ","缓释控释剂型","","139566","硝苯地平控释片","无","缓释片","30mg","盒","14","双铝","北京红林制药有限公司","29.21","停用","招采国码变更",""]
["105","XC08CAX066A011011000044","1","硝苯地平/n硝苯地平Ⅰ/n硝苯地平Ⅱ/n硝苯地平Ⅲ/n硝苯地平Ⅳ","缓释控释剂型","","139566","硝苯地平控释片","无","片剂","30mg","盒","14","双铝","北京红林制药有限公司","29.21","启用","招采国码变更",""]
["106","XC08CAX212A010010500044","1","硝苯地平/n硝苯地平Ⅰ/n硝苯地平Ⅱ/n硝苯地平Ⅲ/n硝苯地平Ⅳ","缓释控释剂型","","173661","硝苯地平控释片","无","控释片","30mg","盒","21","铝箔","北京红林制药有限公司","43.20","停用","招采国码变更",""]
["107","XC08CAX066A011011100044","1","硝苯地平/n硝苯地平Ⅰ/n硝苯地平Ⅱ/n硝苯地平Ⅲ/n硝苯地平Ⅳ","缓释控释剂型","","173661","硝苯地平控释片","无","片剂","30mg","盒","21","铝箔","北京红林制药有限公司","43.20","启用","招采国码变更",""]
["108","XL01XCL075B002010100723","2","利妥昔单抗","注射剂","","101986","利妥昔单抗注射液","美罗华","注射液","10ml:0.1g","瓶","1","玻璃瓶","德国Roche Diagnostics GmbH","2294.44","停用","招采国码变更",""]
["109","XL01XCL075B002010179436","2","利妥昔单抗","注射剂","","101986","利妥昔单抗注射液","美罗华","注射剂","10ml:0.1g","盒","1","玻璃瓶","德国Roche Diagnostics GmbH","2294.44","启用","招采国码变更",""]
["110","XL01XCL075B002020100723","2","利妥昔单抗","注射剂","","101971","利妥昔单抗注射液","美罗华","注射液","50ml:0.5g","瓶","1","玻璃瓶","德国Roche Diagnostics GmbH","7866.26","停用","招采国码变更",""]
["111","XL01XCL075B002040179436","2","利妥昔单抗","注射剂","","101971","利妥昔单抗注射液","美罗华","注射液","500 mg/50 ml","盒","1","玻璃瓶","德国Roche Diagnostics GmbH","7866.26","启用","招采国码变更",""]
["112","XC01BDA201B002010180426","1","胺碘酮","注射剂","","147098","盐酸胺碘酮注射液","可达龙","注射液","3ml:0.15g","支","1","玻璃瓶","法国Sanofi Winthrop Industrie<赛诺菲(杭州)制药有限公司>分包装","23.93","停用","招采国码变更",""]
["113","XC01BDA201B002010478821","1","胺碘酮","注射剂","","147098","盐酸胺碘酮注射液","可达龙","注射液","3ml:0.15g","盒","6","玻璃瓶","法国Sanofi Winthrop Industrie","143.58","启用","招采国码变更",""]
["114","XB05BAZ087B002030178432","2","脂肪乳氨基酸葡萄糖","注射剂","需经营养风险筛查，明确具有营养风险，且不能经饮食或使用“肠内营养剂”补充足够营养的住院患者方予支付。","173460","脂肪乳氨基酸(17)葡萄糖(11%)注射液","无","注射液","1920ml(脂肪乳注射液(20%)340ml,复方氨基酸(17AA)注射液400ml,葡萄糖注射液(11%)1180ml)","袋","1","三层共挤三腔输液袋","费森尤斯卡比华瑞制药有限公司","85.88","停用","招采国码变更",""]
["115","XB05BAZ087B002040101415","2","脂肪乳氨基酸葡萄糖","注射剂","需经营养风险筛查，明确具有营养风险，且不能经饮食或使用“肠内营养剂”补充足够营养的住院患者方予支付。","173460","脂肪乳氨基酸(17)葡萄糖(11%)注射液","卡文","注射液","1920ml","袋","1","三层共挤三腔输液袋","费森尤斯卡比华瑞制药有限公司","85.88","启用","招采国码变更",""]
["116","XL01XEL369E001010104021","2","甲磺酸仑伐替尼胶囊","","","173767","甲磺酸仑伐替尼胶囊","无","胶囊剂","4mg(按C21H19ClN4O4计)","盒","30","铝塑枕式包装,加干燥剂","齐鲁制药有限公司","650.00","停用","招采国码变更",""]
["117","XL01EXL369E001010204021","2","甲磺酸仑伐替尼胶囊","","","173767","甲磺酸仑伐替尼胶囊","无","胶囊剂","4mg(按C21H19ClN4O4计)","瓶","30","口服固体药用高密度聚乙烯瓶和固体药用纸袋装硅胶干燥剂","齐鲁制药有限公司","650.00","启用","招采国码变更",""]
["118","XL04ABC082B001010100835","2","重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白","注射剂","","141273","注射用重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白","益赛普","注射剂","12.5mg","盒","1","西林瓶","三生国健药业（上海）股份有限公司","185.88","修改（医保和招标信息）","招采变更",""]
["119","XL04ABC082B001020100835","2","重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白","注射剂","","141274","注射用重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白","益赛普","注射剂","25mg","盒","1","西林瓶","三生国健药业(上海)股份有限公司","316.00","修改（医保和招标信息）","招采变更",""]
["120","XL04AAT194B001010180949","2","注射用泰它西普","","限与常规治疗联合，适用于在常规治疗基础上仍具有高疾病活动(例如：抗ds-DNA抗体阳性及低补体、SELENA-SLEDAI评分≥8)的活动性、自身抗体阳性的系统性红斑狼疮(SLE)成年患者。","172125","注射用泰它西普","泰爱","注射剂","80mg/支","盒","1","采用中硼硅玻璃管制注射剂瓶装,溴化丁基胶塞","荣昌生物制药（烟台）股份有限公司","777.86","修改（医保和招标信息）","招采变更","国谈药品"]
["121","XB01ABY273B002010104188","2","依诺肝素","注射剂","","176327","依诺肝素钠注射液","无","注射液","0.4ml:4000AxaIU","支","1","预充式(预灌封)注射器","山东新时代药业有限公司","22.90","启用","招采变更",""]
["122","ZD03AAA0043020402661","1","艾附暖宫丸","","","205611","艾附暖宫丸","无","大蜜丸","每丸重9g","盒","10","铝塑包装","河北唐威药业有限公司","55.00","启用","招采变更",""]
["123","ZA05BAX0143020104828","2","香砂理中丸","","","205628","香砂理中丸","无","丸剂(大蜜丸)","每丸重9g","盒","4","铝塑包装","福州海王金象中药制药有限公司","61.20","启用","招采变更",""]
["124","XN03AGB140B004020102044","2","丙戊酸钠","注射剂","","176332","丙戊酸钠注射用浓溶液","无","注射液","5ml:0.5g","支","1","安瓿","成都利尔药业有限公司","159.68","停用","招采变更",""]
["125","XJ01CRA042B003030102296","2","阿莫西林克拉维酸","注射剂","","200329","注射用阿莫西林钠克拉维酸钾","无","注射用无菌粉末","0.6g(0.5g:0.1g)","瓶","1","采用中硼硅玻璃模制注射剂瓶、注射用聚乙烯-四氟乙烯覆膜溴化丁基橡胶塞和抗生素瓶用铝塑组合盖包装。","四川制药制剂有限公司","44.50","停用","招采变更",""]
["126","XJ01CRA042B003040102296","2","阿莫西林克拉维酸","注射剂","","201970","注射用阿莫西林钠克拉维酸钾","无","注射用无菌粉末","1.2g(1.0g:0.2g)","瓶","1","采用中硼硅玻璃模制注射剂瓶、注射用聚乙烯-四氟乙烯覆膜溴化丁基橡胶塞和抗生素瓶用铝塑组合盖包装。","四川制药制剂有限公司","75.65","停用","招采变更",""]
["127","XJ01DCT102B013020104152","2","头孢西丁","注射剂","限有明确药敏试验证据或重症感染的患者","109615","注射用头孢西丁钠","无","粉针剂","2.0g","瓶","1","玻璃瓶","瑞阳制药股份有限公司","19.49","停用","招采变更",""]
["128","XJ01DCT102B003010102296","2","头孢西丁","注射剂","限有明确药敏试验证据或重症感染的患者","200590","注射用头孢西丁钠","无","注射剂(注射用无菌粉末)","1.0g","盒","1","钠钙玻璃模制注射剂瓶、注射用无菌粉末用卤化丁基橡胶塞包装","四川制药制剂有限公司","66.00","停用","招采变更",""]
["129","XJ01DCT102B003020102296","2","头孢西丁","注射剂","限有明确药敏试验证据或重症感染的患者","200607","注射用头孢西丁钠","无","注射剂(注射用无菌粉末)","2.0g","盒","1","钠钙玻璃模制注射剂瓶、注射用无菌粉末用卤化丁基橡胶塞包装","四川制药制剂有限公司","112.20","停用","招采变更",""]
["130","XB01AEA021B002020104188","2","阿加曲班","注射剂","","176662","阿加曲班注射液","无","注射剂","2ml:10mg","盒","1","中硼硅棕色安瓿","山东新时代药业有限公司","23.77","启用","招采变更",""]
["131","XB01AEA021B002010202763","2","阿加曲班","注射剂","","203300","阿加曲班注射液","无","注射剂","2ml:10mg","支","1","棕色中硼硅玻璃安瓿","石家庄四药有限公司","16.14","启用","招采变更",""]
["132","XB02AAA172B002010106725","1","氨甲环酸","注射剂","","203428","氨甲环酸注射液","无","注射液","5ml : 0.25g","支","1","中硼硅玻璃安瓿包装","广州市联瑞制药有限公司","2.88","启用","招采变更",""]
["133","XB02AAA172B002020179286","1","氨甲环酸","注射剂","","175211","氨甲环酸注射液","无","注射液","5ml:0.5g","支","1","中硼硅玻璃安瓿包装","湖南赛隆药业(长沙)有限公司","4.89","启用","招采变更",""]
["134","XB03BAJ038B002020203662","2","甲钴胺","注射剂","","202463","甲钴胺注射液","无","注射液","1ml:0.5mg","盒","10","棕色中硼硅玻璃安瓿","哈尔滨三联药业股份有限公司","26.10","启用","招采变更",""]
["135","XM01ABT149B002020101751","2","酮咯酸氨丁三醇","注射剂","","135944","酮咯酸氨丁三醇注射液","无","注射剂","1ml:30mg","支","1","中硼硅玻璃安瓿","德全药品(江苏)股份有限公司","4.38","启用","招采变更",""]
["136","XA05AAX163E001010200244","1","熊去氧胆酸","口服常释剂型","","176497","熊去氧胆酸胶囊","无","胶囊剂","250mg","盒","7","铝塑","安士制药(中山)有限公司","23.00","启用","招采变更",""]
["137","XA05AAX163E001010300244","1","熊去氧胆酸","口服常释剂型","","175246","熊去氧胆酸胶囊","无","胶囊剂","250mg","盒","12","铝塑","安士制药(中山)有限公司","38.66","启用","招采变更",""]
["138","XA05AAX163E001010100244","1","熊去氧胆酸","口服常释剂型","","173823","熊去氧胆酸胶囊","无","胶囊剂","250mg","盒","24","铝塑","安士制药(中山)有限公司","113.07","启用","招采变更",""]
["139","XJ01DFA194B001030100505","2","氨曲南","注射剂","","142442","注射用氨曲南","无","普通粉针","0.5g","盒","1","中性硼硅玻璃管制注射剂瓶(7ml)、注射用无菌粉末用卤化丁基橡胶塞(溴化)和抗生素瓶用铝塑组合盖包装","深圳华药南方制药有限公司","17.92","修改（医保和招标信息）","招采变更",""]
["140","XJ01DFA194B001020200505","2","氨曲南","注射剂","","142443","注射用氨曲南","无","普通粉针","1.0g","盒","1","中硼硅玻璃模制注射剂瓶(10ml)、注射用无菌粉末用卤化丁基橡胶塞(溴化)和抗生素瓶用铝塑组合盖包装","深圳华药南方制药有限公司","30.49","修改（医保和招标信息）","招采变更",""]
["141","XJ02ACF059B003020102087","2","伏立康唑","注射剂","","176798","注射用伏立康唑","无","注射剂","0.2g","盒","1","中硼硅玻璃管制注射剂瓶、冷冻干燥注射用局部覆聚四氟乙烯膜卤化丁基橡胶塞(溴化)","四川美大康华康药业有限公司","52.05","启用","招采变更",""]
["142","XJ02ACF059B001010201957","2","伏立康唑","注射剂","","203128","注射用伏立康唑","无","注射剂","0.2g","瓶","1","中硼硅玻璃管制注射剂瓶、覆膜氯化丁基橡胶塞和铝塑组合盖。","武汉启瑞药业有限公司","75.00","启用","招采变更",""]
["143","XB01AEA021B002010200148","2","阿加曲班","注射剂","1.用于发病48h内的缺血性脑梗死急性期病人的神经症状(运动麻痹)，日常活动(步行、起立、坐位保持、饮食)的改善；/n2.用于对慢性动脉闭塞症(血栓闭塞性脉管炎、闭塞性动脉硬化症)患者的四肢溃疡、静息痛及冷感等的改善。","200172","阿加曲班注射液","无","注射剂","2ml:10mg","盒","10","棕色中硼硅玻璃安瓿","北京双鹭药业股份有限公司","2330.00","停用","招采变更",""]
["144","XJ01XDA222B002010200148","2","奥硝唑","注射剂","","165239","奥硝唑注射液","无","注射液","3ml:0.5g","支","1","安瓿","北京双鹭药业股份有限公司","129.00","停用","招采变更",""]
["145","XJ01XDA222B002010102525","2","奥硝唑","注射剂","","176875","奥硝唑注射液","无","注射液","3ml:0.5g","支","1","安瓿","西安万隆制药股份有限公司","49.50","停用","招采变更",""]
["146","XJ01XDA222B002020200148","2","奥硝唑","注射剂","","165240","奥硝唑注射液","无","注射液","6ml:1.0g","支","1","安瓿","北京双鹭药业股份有限公司","258.00","停用","招采变更",""]
["147","XJ01XDJ185B002010101227","2","甲硝唑氯化钠","注射剂","","310006","甲硝唑氯化钠注射液","无","注射剂","100ml:甲硝唑0.5g与氯化钠0.8g","瓶","1","聚丙烯输液瓶装","辽宁民康制药有限公司","19.00","停用","招采变更",""]
["148","XJ01XDJ185B002010102180","2","甲硝唑氯化钠","注射剂","","108794","甲硝唑氯化钠注射液","无","注射液","100ml:0.5g:0.8g","袋","1","直立式输液袋(聚丙烯)","四川科伦药业股份有限公司","2.39","停用","招采变更",""]
["149","XJ01XDJ185B002010402763","2","甲硝唑氯化钠","注射剂","","163921","甲硝唑氯化钠注射液","无","注射液","100ml:0.5g:0.8g","袋","1","多层共挤输液袋(易折式)","石家庄四药有限公司","22.60","停用","招采变更",""]
["150","XJ01XDJ185B002020102763","2","甲硝唑氯化钠","注射剂","","152472","甲硝唑氯化钠注射液","无","注射液","250ml:1.25g:2.0g","袋","1","多层共挤输液袋","石家庄四药有限公司","46.07","停用","招采变更",""]
["151","XJ04ABL062E001020101292","1","利福平 利福平Ⅱ","口服常释剂型","","165565","利福平胶囊","无","硬胶囊剂","0.3g","瓶","50","塑料瓶","沈阳红旗制药有限公司","68.00","停用","招采变更",""]
["152","XC09DAL246A001010101650","2","氯沙坦氢氯噻嗪","口服常释剂型","","101485","氯沙坦钾氢氯噻嗪片","无","薄膜衣片","氯沙坦钾50mg,氢氯噻嗪12.5mg","盒","7","铝箔","苏州东瑞制药有限公司","14.0","停用","招采变更",""]
["153","XC09DAL246A001010201650","2","氯沙坦氢氯噻嗪","口服常释剂型","","101494","氯沙坦钾氢氯噻嗪片","无","薄膜衣片","氯沙坦钾50mg,氢氯噻嗪12.5mg","盒","14","铝箔","苏州东瑞制药有限公司","27.3","停用","招采变更",""]
["154","XC03CAT115B002010101556","2","托拉塞米","注射剂","限需迅速利尿或不能口服利尿剂的充血性心力衰竭患者","175730","托拉塞米注射液","无","注射液","2ml:10mg","支","1","安瓿","南京臣功制药股份有限公司","50.00","停用","招采变更",""]
["155","XH01CBS078B001020200526","2","生长抑素","注射剂","限胰腺手术，支付不超过5天；严重急性食道静脉曲张出血，支付不超过5天。","140056","注射用生长抑素","无","冻干粉针剂","2mg","支","1","西林瓶","深圳翰宇药业股份有限公司","54.41","停用","招采变更",""]
["156","XH01CBS078B001020100526","2","生长抑素","注射剂","限胰腺手术，支付不超过5天；严重急性食道静脉曲张出血，支付不超过5天。","146110","注射用生长抑素","无","冻干粉针剂","2mg","盒","1","预充式(预灌封)注射器","深圳翰宇药业股份有限公司","55.96","停用","招采变更",""]
["157","XJ01DCT102B013010104152","2","头孢西丁","注射剂","限有明确药敏试验证据或重症感染的患者","109610","注射用头孢西丁钠","无","无菌粉针","1.0g","盒","1","钠钙玻璃模制注射剂瓶/低硼硅玻璃管制注射剂瓶","瑞阳制药股份有限公司","7.32","停用","招采变更",""]
["158","XM04AAB117A001010601437","1","别嘌醇","口服常释剂型","","205312","别嘌醇片","无","片剂","0.1g","盒","12","铝塑包装","世贸天阶制药(江苏)有限责任公司","","启用","招采变更","供应紧张药品"]
["159","XA03BAA068B002030102601","1","阿托品","注射剂","","200916","硫酸阿托品注射液","无","注射液","1ml:0.5mg","支","1","玻璃安瓿","葵花药业集团（冀州）有限公司","","启用","招采变更","供应紧张药品"]
["160","XA03BAA068B002010102601","1","阿托品","注射剂","","200904","硫酸阿托品注射液","无","注射液","2ml:1mg","支","1","玻璃安瓿","葵花药业集团（冀州）有限公司","","启用","招采变更","供应紧张药品"]
["161","XA03BAA068B002020202601","1","阿托品","注射剂","","200913","硫酸阿托品注射液","无","注射液","1ml:5mg","支","1","玻璃安瓿","葵花药业集团（冀州）有限公司","","启用","招采变更","供应紧张药品"]
["162","XB02BDR012B001010102902","1","人凝血因子Ⅷ","注射剂","","200509","人凝血因子Ⅷ","无","注射剂","200IU/瓶","盒","1","西林瓶","山西康宝生物制品股份有限公司","","启用","招采变更","供应紧张药品"]
["163","XB02BDR011B001010102902","2","人凝血酶原复合物","注射剂","","170602","人凝血酶原复合物","无","注射剂","300IU","盒","1","中性硼硅玻璃模制注射剂瓶与注射用冷冻干燥用卤化丁基橡胶塞","山西康宝生物制品股份有限公司","","启用","招采变更","供应紧张药品"]
["164","XL01BAJ025B002010179465","1","甲氨蝶呤","注射剂","","205765","甲氨蝶呤注射液","无","注射剂","0.20ml:10mg","盒","1","预灌封注射器组合件和预灌封注射器用氯化丁基橡胶活塞包装","Oncotec Pharma Produktion GmbH","","启用","招采变更","供应紧张药品"]
["165","XJ01XDA222B002010304383","2","奥硝唑","注射剂","","166939","奥硝唑注射液","无","注射剂","3ml:0.5g","支","1","安瓿","国药集团国瑞药业有限公司","39.80","修改（招标信息）","招采变更",""]
["166","XB01ACB040A017020100156","2","贝前列素","口服常释剂型","限有慢性动脉闭塞的诊断且有明确的溃疡、间歇性跛行及严重疼痛体征的患者","115391","贝前列素钠片","无","片剂(薄膜衣片)","40ug","盒","10","铝塑","北京泰德制药股份有限公司","55.25","修改（招标信息）","招采变更",""]
["167","XB01ACB040A017020200156","2","贝前列素","口服常释剂型","限有慢性动脉闭塞的诊断且有明确的溃疡、间歇性跛行及严重疼痛体征的患者","172731","贝前列素钠片","无","片剂(薄膜衣片)","40ug","盒","30","铝塑","北京泰德制药股份有限公司","159.23","修改（招标信息）","招采变更",""]
["168","XH01CBA213B002010201088","2","奥曲肽","注射剂","","171731","醋酸奥曲肽注射液","无","注射剂","以C49H66N10O10S2计 1ml:0.1mg","支","1","安瓿","本溪恒康制药有限公司","16.77","修改（招标信息）","招采变更",""]
["169","XC01DAD024A010010100863","2","单硝酸异山梨酯/n单硝酸异山梨酯Ⅰ/n单硝酸异山梨酯Ⅱ/n单硝酸异山梨酯Ⅲ/n单硝酸异山梨酯Ⅳ","缓释控释剂型","","128747","单硝酸异山梨酯缓释片","索尼特","缓释片","60mg","盒","10","铝塑","瑞华(中山)制药有限公司","11.64","修改（支付标准）","招采变更",""]
["170","ZA01BAE0011030105377","2","儿感退热宁颗粒(口服液)","","","175349","儿感退热宁颗粒","无","颗粒剂","每1g相当于饮片2g","盒","6","复合膜包装","江西杏林白马药业股份有限公司","67.98","修改（支付标准）","招采变更",""]
["171","XA02BAF006B002010101723","1","法莫替丁","注射剂","","172687","法莫替丁注射液","无","注射液","2ml:20mg","支","1","安瓿","江苏朗欧药业有限公司","55.00","修改（支付标准）","招采变更",""]
["172","ZA12JAG0331010100651","2","瓜蒌皮注射液","","限二级及以上医疗机构的冠心病稳定型心绞痛患者。","132419","瓜蒌皮注射液","无","注射液","4ml","盒","1","安瓿","上海上药第一生化药业有限公司","74.35","修改（医保和招标信息）","招采变更",""]
["173","XC07ABM062A010010180279","2","美托洛尔/n美托洛尔Ⅱ","缓释控释剂型","","174675","琥珀酸美托洛尔缓释片","无","片剂","47.5mg","盒","14","铝箔","佛山德芮可制药有限公司","26.25","修改（招标信息）","招采变更",""]
["174","XC07ABM062A010020180279","2","美托洛尔/n美托洛尔Ⅱ","缓释控释剂型","","174676","琥珀酸美托洛尔缓释片","无","片剂","95mg","盒","14","铝箔","佛山德芮可制药有限公司","44.62","修改（招标信息）","招采变更",""]
["175","XN03AXJ019E001020100153","2","加巴喷丁","口服常释剂型","","175888","加巴喷丁胶囊","无","硬胶囊剂","0.3g","盒","20","铝箔","北京四环制药有限公司","73.46","修改（支付标准）","招采变更",""]
["176","XJ05AFL008A001010404960","2","拉米夫定","口服常释剂型","限有活动性乙型肝炎的明确诊断及检验证据或母婴乙肝传播阻断","162370","拉米夫定片","无","片剂","0.1g","盒","28","铝塑","湖南千金湘江药业股份有限公司","136.24","修改（招标信息）","招采变更",""]
["177","XB01AFL056A001030110104","2","利伐沙班","口服常释剂型","","171827","利伐沙班片","无","片剂","20mg","盒","7","铝塑","上海汇伦江苏药业有限公司","169.00","修改（招标信息）","招采变更",""]
["178","XB01AFL056A001010110104","2","利伐沙班","口服常释剂型","","171829","利伐沙班片","无","片剂","10mg","盒","10","铝塑","上海汇伦江苏药业有限公司","188.00","修改（招标信息）","招采变更",""]
["179","XB01AFL056A001020110104","2","利伐沙班","口服常释剂型","","171864","利伐沙班片","无","片剂","15mg","盒","10","铝塑","上海汇伦江苏药业有限公司","191.20","修改（招标信息）","招采变更",""]
["180","XB01AFL056A001020310104","2","利伐沙班","口服常释剂型","","204838","利伐沙班片","无","片剂","15mg","盒","20","铝塑泡罩","上海汇伦江苏药业有限公司","372.84","修改（支付标准）","招采变更",""]
["181","XB01AFL056A001010410104","2","利伐沙班","口服常释剂型","","204836","利伐沙班片","无","片剂","10mg","盒","20","铝塑泡罩","上海汇伦江苏药业有限公司","366.60","修改（支付标准）","招采变更",""]
["182","XB01AFL056A001030310104","2","利伐沙班","口服常释剂型","","204839","利伐沙班片","无","片剂","20mg","盒","14","铝塑泡罩","上海汇伦江苏药业有限公司","329.55","修改（支付标准）","招采变更",""]
["183","XA10BHL343A001010100638","2","利格列汀","口服常释剂型","","162672","利格列汀片","欧唐宁","片剂","5mg","盒","7","铝塑","德国勃林格殷格翰药业公司Boehringer Ingelheim Pharma GmbH & Co KG","56.00","修改（医保和招标信息）","招采变更",""]
["184","XA12CCL146B002020101447","1","硫酸镁","注射剂","","310126","硫酸镁注射液","无","注射剂","10ml:5g","支","1","中硼硅玻璃安瓿","江苏华阳制药有限公司","28.99","修改（支付标准）","招采变更",""]
["185","XA10XXL154B002010201478","2","硫辛酸","注射剂","","140173","硫辛酸注射液","无","注射液","12ml:0.3g","支","1","安瓿","江苏神龙药业有限公司","23.80","修改（支付标准）","招采变更",""]
["186","XC01CEM102B002040104383","2","米力农","注射剂","","169511","米力农注射液","无","注射剂","5ml:5mg","盒","1","安瓿","国药集团国瑞药业有限公司","33.49","修改（招标信息）","招采变更",""]
["187","XL01EXP125A001010100647","2","培唑帕尼片","","限晚期肾细胞癌患者的一线治疗和曾经接受过细胞因子治疗的晚期肾细胞癌的治疗。","205255","培唑帕尼片","无","薄膜衣片","0.2g( 按C？？H？？N？O？S计)","瓶","30","口服固体药用高密度聚乙烯热封垫片瓶","上海创诺制药有限公司","2495.00","修改（医保和招标信息）","招采变更",""]
["188","XA12AAP077B002010101495","1","葡萄糖酸钙","注射剂","","201346","葡萄糖酸钙注射液","无","注射液","10ml:1.0g","支","1","聚丙烯安瓿","江苏华阳制药有限公司","16.88","修改（支付标准）","招采变更",""]
["189","XS01BCP089G010010104094","2","普拉洛芬","滴眼剂","","100519","普拉洛芬滴眼液","无","眼用制剂","0.1%（5ml:5mg）","盒","1","塑料瓶","山东海山药业有限公司","20.78","修改（招标信息）","招采变更",""]
["190","XB01ACQ158B002010183439","2","曲前列尼尔注射液","","限肺动脉高压(PAH，WHO分类1)。","203866","曲前列尼尔注射液","无","注射剂","20ml:20mg","盒","1","中硼硅玻璃管制注射剂瓶,配有注射制剂用溴化丁基橡胶塞和抗生素瓶用铝塑组合盖","广东星昊药业有限公司","4080.00","修改（医保和招标信息）","招采变更",""]
["191","XR05CBY116L019010110349","2","乙酰半胱氨酸","吸入剂","","200540","吸入用乙酰半胱氨酸溶液","无","吸入用溶液剂","3ml:0.3g","支","1","中硼硅玻璃安瓿","河北仁合益康药业有限公司","11.79","修改（支付标准）","招采变更",""]
["192","XB05ZBX187B001010102053","2","血液滤过置换基础液","注射剂","","130586","血液滤过置换基础液","无","注射剂","4000ml","袋","1","PVC膜+双管双塞","成都青山利康药业股份有限公司","49.00","修改（招标信息）","招采变更",""]
["193","XC07AGA031A001010378991","2","阿罗洛尔","口服常释剂型","","146315","盐酸阿罗洛尔片","阿尔马尔","片剂","10mg","盒","10","铝箔","日本Kyoto Pharmaceutical Industries,Ltd.Osadano Plant","32.65","修改（招标信息）","招采变更",""]
["194","XR05CBA198X001010182068","2","氨溴索","口服液体剂","","203727","盐酸氨溴索口服溶液","无","口服溶液剂","100ml:0.3g","盒","1","钠钙玻璃模制药瓶和口服液体药用高密度聚乙烯揿压瓶盖。","江苏贝佳制药有限公司","29.30","修改（支付标准）","招采变更",""]
["195","XR05CBA198X001010182338","2","氨溴索","口服液体剂","","203681","盐酸氨溴索口服溶液","无","口服溶液剂","100ml:0.3g","盒","1","钠钙玻璃模制药瓶和儿童安全阻开盖。","成都倍特得诺药业有限公司","17.50","修改（支付标准）","招采变更",""]
["196","XR01ACA210A001010201503","2","奥洛他定","口服常释剂型","","203283","盐酸奥洛他定片","无","薄膜衣片","5mg","盒","24","药品包装用铝箔:聚氯乙烯固体药用硬片","江苏万高药业股份有限公司","56.83","修改（支付标准）","招采变更",""]
["197","XL01XEE006A001010200647","2","厄洛替尼","口服常释剂型","","166639","盐酸厄洛替尼片","无","片剂","0.15g","盒","7","铝塑","上海创诺制药有限公司","386.97","停用","招采国码变更",""]
["198","XL01EBE006A001010100647","2","厄洛替尼","口服常释剂型","","166639","盐酸厄洛替尼片","无","片剂","0.15g","盒","7","铝塑","上海创诺制药有限公司","350.00","启用","招采国码变更",""]
["199","XL01XEE006A001010100647","2","厄洛替尼","口服常释剂型","","166701","盐酸厄洛替尼片","无","片剂","0.15g","盒","14","铝塑","上海创诺制药有限公司","754.59","停用","招采国码变更",""]
["200","XL01EBE006A001010200647","2","厄洛替尼","口服常释剂型","","166701","盐酸厄洛替尼片","无","片剂","0.15g","盒","14","铝塑","上海创诺制药有限公司","682.50","启用","招采国码变更",""]
["201","XA02BAL050B002010201842","1","雷尼替丁","注射剂","","202521","盐酸雷尼替丁注射液","无","注射剂","2ml:50mg","支","1","玻璃安瓿","湖北天圣药业有限公司","18.20","修改（招标信息）","招采变更",""]
["202","XN01BBL265B002010103282","2","罗哌卡因","注射剂","","201250","盐酸罗哌卡因注射液","无","注射剂","10ml:75mg","支","1","中硼硅玻璃安瓿装","吉林四长制药有限公司","25.67","修改（支付标准）","招采变更",""]
["203","XN06DXM045E003010180923","2","盐酸美金刚缓释胶囊","","","175284","盐酸美金刚缓释胶囊","无","胶囊剂","7mg","瓶","30","口服固体药用高密度聚乙烯瓶","力品药业(厦门)股份有限公司","134.86","修改（支付标准）","招采变更",""]
["204","XN06DXM045E003020180923","2","盐酸美金刚缓释胶囊","","","175154","盐酸美金刚缓释胶囊","无","胶囊剂","28mg","瓶","30","口服固体药用高密度聚乙烯瓶","力品药业(厦门)股份有限公司","389.75","修改（支付标准）","招采变更",""]
["205","XA10XAY078A001010104077","2","依帕司他","口服常释剂型","","137377","依帕司他片","伊衡","片剂","50mg","盒","12","铝塑","山东达因海洋生物制药股份有限公司","36.00","修改（招标信息）","招采变更",""]
["206","ZA15BAZ0064010100716","2","珍菊降压片","","","110120","珍菊降压片","无","片剂","/","盒","24","铝箔","上海雷允上药业有限公司","8.26","修改（招标信息）","招采变更",""]
["207","XJ01CAP014B001020205006","1","哌拉西林","注射剂","","175406","注射用哌拉西林钠","无","注射剂","1.0g","瓶","1","玻璃瓶","湖南科伦制药有限公司","24.90","修改（招标信息）","招采变更",""]
["208","XJ01CRP018B001060101651","2","哌拉西林他唑巴坦","注射剂","","204907","注射用哌拉西林钠他唑巴坦钠","无","注射剂","4.5g(C23H27N5O7S 4.0g与C10H12N4O5S 0.5g)","盒","6","中硼硅玻璃模制注射剂瓶、注射用无菌粉末用卤化丁基橡胶塞(溴化)","山东二叶制药有限公司","228.36","修改（医保和招标信息）","招采变更",""]
["209","XJ01CRP018B001020105006","2","哌拉西林他唑巴坦","注射剂","","147776","注射用哌拉西林钠他唑巴坦钠","无","注射剂","2.25g(C23H27N5O7S 2.0g与C10H12N4O5S 0.25g)","盒","10","西林瓶","湖南科伦制药有限公司","159.80","修改（医保和招标信息）","招采变更",""]
["210","XA11HAY031B014010103283","2","烟酰胺","注射剂","","162525","注射用烟酰胺","普扶林","冻干粉针","0.1g","盒","10","玻璃瓶","吉林津升制药有限公司","739.20","修改（招标信息）","招采变更",""]
["211","XA11HAY031B014030103283","2","烟酰胺","注射剂","","162519","注射用烟酰胺","普扶林","冻干粉针","50mg","盒","10","玻璃瓶","吉林津升制药有限公司","434.80","修改（招标信息）","招采变更",""]
["212","XB06AAY099B014010100651","2","胰蛋白酶","注射剂","","163272","注射用胰蛋白酶","无","注射剂(冻干)","1.25万单位","盒","2","玻璃瓶","上海上药第一生化药业有限公司","160.60","修改（招标信息）","招采变更",""]
["213","XB06AAY099B014020100651","2","胰蛋白酶","注射剂","","163274","注射用胰蛋白酶","无","注射剂(冻干)","2.5万单位","盒","2","玻璃瓶","上海上药第一生化药业有限公司","273.00","修改（招标信息）","招采变更",""]
["214","XG04BXZ059X001010104649","2","左卡尼汀","口服液体剂","","200319","左卡尼汀口服溶液","无","口服溶液剂","10ml:1g","盒","6","钠钙玻璃管制口服液体瓶","浙江凯润药业股份有限公司","48.00","修改（医保和招标信息）","招采变更",""]
["215","XJ01MAZ083B002020100978","2","左氧氟沙星氯化钠","注射剂","","202494","左氧氟沙星氯化钠注射液","无","注射剂","50ml:左氧氟沙星(按C？？H？？FN？O？计)0.25g与氯化钠0.45g","袋","1","三层共挤输液用膜(I)制袋","西南药业股份有限公司","46.93","修改（支付标准）","招采变更",""]
["216","XM05BXD334B002010104021","2","地舒单抗注射液","","","206071","地舒单抗注射液","无","注射剂","60mg(1.0ml)/瓶","盒","1","中硼硅玻璃管制注射剂瓶","齐鲁制药有限公司","561.00","修改（医保和招标信息）","招采变更",""]
["217","XJ01CRP018B001040179252","2","哌拉西林他唑巴坦","注射剂","","205346","注射用哌拉西林钠他唑巴坦钠","无","注射剂","4.5g(4.0g/0.5g)","盒","1","玻璃瓶","海南通用三洋药业有限公司","27.54","启用","招采变更",""]
["218","XJ01CRP018B001020279252","2","哌拉西林他唑巴坦","注射剂","","205345","注射用哌拉西林钠他唑巴坦钠","无","注射剂","2.25g(2.0g/0.25g)","盒","1","玻璃瓶","海南通用三洋药业有限公司","16.18","启用","招采变更",""]
["219","XC02CAW069B002020209649","2","乌拉地尔","注射剂","","150287","盐酸乌拉地尔注射液","无","注射剂","5ml:25mg","支","1","中硼硅玻璃安瓿","河北一品制药股份有限公司","21.56","启用","招采变更",""]
["220","XA10BGB091A001010401142","2","吡格列酮","口服常释剂型","","110932","盐酸吡格列酮片","欧迪贝","片剂","15mg","盒","28","铝塑泡罩包装","石药集团远大(大连)制药有限公司","35.98","启用","招采变更",""]
["221","XC02CAW069B002010209649","2","乌拉地尔","注射剂","","150289","盐酸乌拉地尔注射液","无","注射剂","10ml:50mg","支","1","中硼硅玻璃安瓿","河北一品制药股份有限公司","36.66","启用","招采变更",""]
["222","XA10BFF058A001010202753","2","伏格列波糖","口服常释剂型","","166084","伏格列波糖片","无","片剂","0.2mg","盒","30","铝塑泡罩","石家庄市华新药业有限责任公司","37.70","启用","招采变更",""]
["223","XJ01FAA051B001020102092","2","阿奇霉素","注射剂","","205793","注射用阿奇霉素","无","冻干粉针剂","0.25g(按C38H72N2O12计)","瓶","1","中硼硅玻璃管制注射剂瓶、注射用冷冻干燥用溴化丁基胶塞","峨眉山通惠制药有限公司","28.82","启用","招采变更",""]
["224","XN05BED136A001020101436","1","丁螺环酮","口服常释剂型","","205846","盐酸丁螺环酮片","一舒","片剂","5mg","瓶","100","口服固体药用高密度聚乙烯瓶","江苏恩华药业股份有限公司","58.77","启用","招采变更",""]
["225","XM05BAZ079B002010102317","2","唑来膦酸","注射剂","","205358","唑来膦酸注射液","无","注射剂","100ml:5mg(按C？H？？N？O？P？计)","盒","1","环烯烃聚合物(COP)单层小瓶装,注射液用覆聚四氟乙烯/六氟丙烯的共聚物膜氯化丁基橡胶塞,抗生素瓶用铝塑组合盖","四川汇宇制药股份有限公司","363.00","启用","招采变更",""]
["226","XC08CXA188A001010183058","2","氨氯地平阿托伐他汀","口服常释剂型","","204413","氨氯地平阿托伐他汀钙片","无","片剂","5mg/10mg(以氨氯地平/阿托伐他汀计)","盒","14","铝箔泡罩","北京百奥药业有限责任公司","35.35","启用","招采变更",""]
["227","XN02BGP112E001010202987","2","普瑞巴林","口服常释剂型","","203954","普瑞巴林胶囊","无","胶囊剂","75mg","盒","32","铝塑(聚氯乙烯固体药用硬片/药用铝箔)包装","亚宝药业太原制药有限公司","74.69","启用","招采变更",""]
["228","XN06AXW067A010010104394","1","文拉法辛","缓释控释剂型","","203779","盐酸文拉法辛缓释片","无","片剂","75mg(按C？？H？？NO？计)","盒","14","聚氯乙烯/聚偏二氯乙烯固体药用复合硬片、药用铝箔包装","合肥立方制药股份有限公司","78.68","启用","招采变更",""]
["229","XN03AGB140X001010182338","2","丙戊酸钠","口服液体剂","","204715","丙戊酸钠口服溶液","无","口服溶液剂","300ml:12g","盒","1","钠钙玻璃模制药瓶及儿童安全阻开盖,配备口服液体药用聚丙烯量杯","成都倍特得诺药业有限公司","71.00","启用","招采变更",""]
["230","XA10BAE021A010010301021","2","二甲双胍/n二甲双胍Ⅱ","缓释控释剂型","","201126","盐酸二甲双胍缓释片","德艾欣","片剂(缓释)","0.5g","盒","30","药用铝箔、聚氯乙烯固体药用硬片包装。","重庆科瑞南海制药有限责任公司","21.00","启用","招采变更",""]
["231","XJ01MAZ074A001010102273","1","左氧氟沙星","口服常释剂型","","204734","左氧氟沙星片","无","片剂","0.5g(按C？？H？？FN？O？计)","盒","8","铝塑泡罩包装(聚氯乙烯/聚乙烯/聚偏二氯乙烯固体药用复合硬片、药用铝箔)","四川新斯顿制药股份有限公司","20.80","启用","招采变更",""]
["232","XC01AAD072B002010100816","1","地高辛","注射剂","","203631","地高辛注射液","无","注射剂","2ml:0.5mg","支","1","中硼硅玻璃安瓿","上海旭东海普药业有限公司","90.51","启用","招采变更",""]
["233","XV03ABS250B002010283339","2","舒更葡糖钠注射液","","","203400","舒更葡糖钠注射液","无","注射剂","按舒更葡糖钠活性实体与单-羟基舒更葡糖钠活性实体的总量计 2ml:200mg","支","1","中性硼硅玻璃安瓿","亚邦医药股份有限公司","225.00","启用","招采变更","竞价药品"]
["234","XV03ABS250B002020283339","2","舒更葡糖钠注射液","","","203403","舒更葡糖钠注射液","无","注射剂","按舒更葡糖钠活性实体与单-羟基舒更葡糖钠活性实体的总量计 5ml:500mg","支","1","中性硼硅玻璃安瓿","亚邦医药股份有限公司","453.75","启用","招采变更","竞价药品"]
["235","XV03ABW091B002010200816","2","戊乙奎醚","注射剂","","310153","盐酸戊乙奎醚注射液","无","注射剂","1ml:1mg","支","1","中硼硅玻璃安瓿","上海旭东海普药业有限公司","40.37","启用","招采变更",""]
["236","XC09CAE003A001010200601","2","厄贝沙坦","口服常释剂型","","204864","厄贝沙坦片","无","片剂","0.15g","盒","30","聚氯乙烯/聚偏二氯乙烯固体药用复合硬片和药用铝箔泡罩包装","珠海润都制药股份有限公司","63.23","启用","招采变更",""]
["237","XR05CBA198B002010202637","2","氨溴索","注射剂","","167529","盐酸氨溴索注射液","无","注射液","2ml:15mg","瓶","1","玻璃安瓿","石药集团欧意药业有限公司","3.57","启用","招采变更",""]
["238","XC08CAF017A010010101605","2","非洛地平/n非洛地平Ⅱ","缓释控释剂型","","130435","非洛地平缓释片","无","缓释制剂","5mg","盒","20","铝塑泡罩包装","南京易亨制药有限公司","8.35","修改（招标信息）","招采变更",""]
["239","XN01ABQ001L019020102120","2","七氟烷","吸入用溶液剂","","204440","吸入用七氟烷","无","吸入制剂","120ml","盒","1","钠钙玻璃模制药瓶、药用聚丙烯瓶盖","四川百利药业有限责任公司","662.00","启用","招采变更",""]
["240","XN01ABQ001L019010102120","2","七氟烷","吸入用溶液剂","","204437","吸入用七氟烷","无","吸入制剂","250ml","盒","1","钠钙玻璃模制药瓶、药用聚丙烯瓶盖","四川百利药业有限责任公司","1306.26","启用","招采变更",""]
["241","XM03ACB211B002010181456","2","苯磺顺阿曲库铵","注射剂","","205512","苯磺顺阿曲库铵注射液","无","注射剂","5ml:10mg(按C53H72N2O12计)","瓶","1","中硼硅玻璃管制注射剂瓶,注射液用覆聚四氟乙烯/六氟丙烯的共聚物膜氯化丁基橡胶塞,抗生素瓶用铝塑组合盖","上药东英(江苏)药业有限公司","87.00","启用","招采变更",""]
["242","XB01ACA056A012011002770","1","阿司匹林","口服常释剂型(不含分散片)","","169607","阿司匹林肠溶片","无","肠溶片","100mg","瓶","36","口服固体药用高密度聚乙烯瓶包装","石药集团欧意药业有限公司","17.80","启用","招采变更",""]
["243","XN05CMY189B002010201521","2","右美托咪定","注射剂","","203943","盐酸右美托咪定注射液","无","注射剂","2ml:0.2mg(以C？？H？？N？计)","支","1","中硼硅玻璃安瓿","江苏正大丰海制药有限公司","86.60","启用","招采变更",""]
["244","XN01ABQ001L019010100675","2","七氟烷","吸入用溶液剂","","203895","吸入用七氟烷","无","吸入制剂","120ml","盒","1","钠钙玻璃模制药瓶、药用聚丙烯瓶盖","上海恒瑞医药有限公司","664.03","启用","招采变更",""]
["245","XB01ACT038B004010102763","2","替罗非班","注射剂","限急性冠脉综合征的介入治疗","204726","盐酸替罗非班注射用浓溶液","无","注射剂","15ml:3.75mg(按C22H36N2O5S计)","支","1","中硼硅玻璃安瓿","石家庄四药有限公司","22.30","启用","招采变更",""]
["246","XB05DAD257B020010102053","1","腹膜透析液","注射剂","","205630","低钙腹膜透析液(乳酸盐-G1.5%)","无","注射剂","2000ml(含葡萄糖1.5%)","袋","1","本品的包装系统为三层共挤腹膜透析液用袋,由内袋、外袋、引流袋组成,配件有三层共挤输液用管、输液袋用聚碳酸酯注药组合盖、注射剂用聚碳酸酯折断塞。","成都青山利康药业股份有限公司","28.96","启用","招采变更",""]
["247","XB05DAD257B020020102053","1","腹膜透析液","注射剂","","205678","低钙腹膜透析液(乳酸盐-G2.5%)","无","注射剂","2000ml(含葡萄糖2.5%)","袋","1","本品的包装系统为三层共挤腹膜透析液用袋,由内袋、外袋、引流袋组成,配件有三层共挤输液用管、输液袋用聚碳酸酯注药组合盖、注射剂用聚碳酸酯折断塞。","成都青山利康药业股份有限公司","28.96","启用","招采变更",""]
["248","XS01BCX230G010010104127","2","溴芬酸钠","滴眼剂","限眼部手术后炎症","205862","溴芬酸钠滴眼液","无","滴眼剂","5ml:5mg(0.1%)","盒","1","聚丙烯药用滴眼剂瓶","山东辰欣佛都药业股份有限公司","49.69","启用","招采变更",""]
["249","XV08ABD113B002020102013","2","碘克沙醇","注射剂","","204680","碘克沙醇注射液","无","注射剂","100ml:32g(I)","盒","1","中硼硅玻璃输液瓶包装","成都倍特药业股份有限公司","347.90","启用","招采变更",""]
["250","XN03AGB140X001010180537","2","丙戊酸钠","口服液体剂","","205795","丙戊酸钠口服溶液","无","口服溶液剂","300ml:12g","盒","1","钠钙玻璃模制药瓶","南京海纳制药有限公司","70.85","启用","招采变更",""]
["251","XC09CAE003A001010600601","2","厄贝沙坦","口服常释剂型","","205642","厄贝沙坦片","无","片剂","0.15g","盒","28","聚氯乙烯/聚偏二氯乙烯固体药用复合硬片和药用铝箔泡罩包装","珠海润都制药股份有限公司","59.16","启用","招采变更",""]
["252","XJ01DBT074E001010301815","1","头孢拉定","口服常释剂型","","102051","头孢拉定胶囊","无","硬胶囊","0.25g","盒","24","聚氯乙烯固体药用硬片/药品包装用铝箔包装","华中药业股份有限公司","5.20","启用","招采变更",""]
["253","XC08CAF017A010010204942","2","非洛地平/n非洛地平Ⅱ","缓释控释剂型","","205634","非洛地平缓释片","无","片剂","5mg","盒","28","聚氯乙烯/聚偏二氯乙烯固体药用复合硬片、药品包装用铝箔","湖南九典制药股份有限公司","11.78","启用","招采变更",""]
["254","XJ05ABG075B001020301841","2","更昔洛韦","注射剂","","204912","注射用更昔洛韦","荷普欣","冻干粉针剂","0.25g","瓶","1","中硼硅玻璃管制注射剂瓶、冷冻干燥注射用局部覆聚四氟乙烯膜卤化丁基橡胶塞(溴化) 和抗生素瓶用铝塑组合盖包装","湖北潜龙药业有限公司","12.19","启用","招采变更",""]
["255","XN05AXP001A010020102770","2","帕利哌酮","缓释控释剂型","","204664","帕利哌酮缓释片","无","缓释片","6mg","瓶","30","口服固体药用高密度聚乙烯瓶包装","石药集团欧意药业有限公司","907.68","启用","招采变更",""]
["256","XN05AXP001A010010102770","2","帕利哌酮","缓释控释剂型","","204663","帕利哌酮缓释片","无","缓释片","3mg","瓶","30","口服固体药用高密度聚乙烯瓶包装","石药集团欧意药业有限公司","539.27","启用","招采变更",""]
["257","XJ01GBA034B002010201708","1","阿米卡星","注射剂","","202551","硫酸阿米卡星注射液","无","注射液","2ml:0.2g(20万单位))","支","1","中硼硅玻璃安瓿瓶","海南倍特药业有限公司","24.80","启用","招采变更",""]
["258","XJ01MAZ074B002010201599","1","左氧氟沙星","注射剂","","204879","左氧氟沙星注射液","无","注射剂","20ml:500mg","盒","2","中硼硅玻璃安瓿(棕色)","南京正科医药股份有限公司","58.75","启用","招采变更",""]
["259","XN02BGP112X001010100548","2","普瑞巴林口服溶液","","","204603","普瑞巴林口服溶液","无","口服溶液剂","200ml:4g","盒","1","口服液体药用高密度聚乙烯压旋式安全瓶","南京星银药业集团有限公司","152.00","启用","招采变更","竞价药品"]
["260","XA04AAP003B002020204948","2","帕洛诺司琼","注射剂","","205931","盐酸帕洛诺司琼注射液","无","注射剂","5ml:0.25mg(按C？？H？？N？O计)","盒","10","中硼硅玻璃管制注射剂瓶,注射液用覆聚四氟乙烯/六氟丙烯的共聚物膜氯化丁基橡胶塞及抗生素瓶用铝塑组合盖","湖南科伦制药有限公司","300.00","启用","招采变更",""]
["261","XC09CAE003A001010100523","2","厄贝沙坦","口服常释剂型","","203897","厄贝沙坦片","苏适","片剂","0.15g","盒","7","铝塑","深圳市海滨制药有限公司","13.92","启用","招采变更",""]
["262","XJ01XDJ185B002010103140","2","甲硝唑氯化钠","注射剂","","108762","甲硝唑氯化钠注射液","无","注射液","100ml:甲硝唑0.5g与氯化钠0.8g","袋","1","三层共挤输液用袋(双阀)","信合援生制药股份有限公司","6.72","启用","招采变更",""]
["263","XC09CAA257A001010183530","2","奥美沙坦酯","口服常释剂型","","205590","奥美沙坦酯片","无","片剂","20mg","盒","7","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片、药用铝箔包装","华润双鹤利民药业(济南)有限公司","28.42","启用","招采变更",""]
["264","XV08CAG172B002020104948","2","钆特醇注射液","","","202385","钆特醇注射液","无","注射剂","15ml:4.1895g","盒","1","中硼硅玻璃模制注射剂瓶包装","湖南科伦制药有限公司","142.00","启用","招采变更",""]
["265","XV08CAG172B002010104948","2","钆特醇注射液","","","202381","钆特醇注射液","无","注射剂","10ml:2.793g","盒","1","中硼硅玻璃模制注射剂瓶包装","湖南科伦制药有限公司","104.11","启用","招采变更",""]
["266","XC10AAA067A001010103216","2","阿托伐他汀","口服常释剂型","","203349","阿托伐他汀钙片","无","片剂","10mg","盒","7","铝/铝水泡眼包装,盒装","新乡市常乐制药有限责任公司","14.20","启用","招采变更",""]
["267","XC10AAA067A001010203216","2","阿托伐他汀","口服常释剂型","","203350","阿托伐他汀钙片","无","片剂","10mg","盒","14","铝/铝水泡眼包装,盒装","新乡市常乐制药有限责任公司","27.70","启用","招采变更",""]
["268","XC10AAA067A001010303216","2","阿托伐他汀","口服常释剂型","","203351","阿托伐他汀钙片","无","片剂","10mg","盒","28","铝/铝水泡眼包装,盒装","新乡市常乐制药有限责任公司","54.02","启用","招采变更",""]
["269","XD07ABD080F002010180999","2","地奈德","软膏剂","","205190","地奈德乳膏","无","乳膏剂","15g","盒","1","铝质药用软膏管","湖北人福成田药业有限公司","26.80","启用","招采变更",""]
["270","XM01AHS002E001020109542","2","塞来昔布","口服常释剂型","","203029","塞来昔布胶囊","无","胶囊剂","0.2g","盒","30","铝塑包装(聚三氟氯乙烯／聚氯乙烯固体药用复合硬片 、药用铝箔)","北京亚宝生物药业有限公司","16.50","启用","招采变更",""]
["271","XC08CAX066A011010904175","1","硝苯地平/n硝苯地平Ⅰ/n硝苯地平Ⅱ/n硝苯地平Ⅲ/n硝苯地平Ⅳ","缓释控释剂型","","205821","硝苯地平控释片","无","片剂","30mg","盒","20","铝塑泡罩包装","淄博万杰制药有限公司","58.43","启用","招采变更",""]
["272","XJ01FAA051B001010102092","2","阿奇霉素","注射剂","","205792","注射用阿奇霉素","无","冻干粉针剂","0.125g(按C38H72N2O12计)","瓶","1","中硼硅玻璃管制注射剂瓶、注射用冷冻干燥用溴化丁基胶塞","峨眉山通惠制药有限公司","16.95","启用","招采变更",""]
["273","XR01ACA210A001010301503","2","奥洛他定","口服常释剂型","","203284","盐酸奥洛他定片","无","薄膜衣片","5mg","盒","36","药品包装用铝箔:聚氯乙烯固体药用硬片","江苏万高药业股份有限公司","82.25","启用","招采变更",""]
["274","XR03DCM082N001010383521","2","孟鲁司特","颗粒剂","","204980","孟鲁司特钠颗粒","无","颗粒剂","4mg(以孟鲁司特计)","盒","8","铝塑复合袋包装","浙江诺得药业有限公司","45.28","启用","招采变更",""]
["275","XL04AAA362A001050102770","2","阿普米司特片","","限符合接受光疗或系统性治疗指征的中度至重度斑块状银屑病的成人患者。","205228","阿普米司特片","无","薄膜包衣片","10mg,20mg,30mg(10mg×4片/板、20mg×4片/板和30mg×4片/板、30mg×15片/板/盒)","盒","27","铝塑包装(聚氯乙烯固体药用硬片、药用铝箔)","石药集团欧意药业有限公司","353.83","启用","招采变更",""]
["276","XR05CBF100X001010182834","2","福多司坦口服溶液","","","206148","福多司坦口服溶液","无","口服溶液剂","100ml:8g","盒","1","钠钙玻璃药瓶和口服液体药用聚丙烯瓶盖","江苏欧歌制药有限公司","48.80","启用","招采变更",""]
["277","XL01EHN120A001010100647","2","马来酸奈拉替尼片","","限人类表皮生长因子受体2(HER2)阳性的早期乳腺癌成年患者，在接受含曲妥珠单抗辅助治疗之后的强化辅助治疗。","206139","马来酸奈拉替尼片","无","薄膜衣片","40mg(按C30H29ClN6O3计)","瓶","180","包装于带有儿童安全聚丙烯瓶盖的高密度聚乙烯瓶中,内装含1g硅胶的高密度聚乙烯干燥剂罐","上海创诺制药有限公司","5661.00","启用","招采变更","国谈药品"]
["278","XC02KXM170A001010101606","2","马昔腾坦片","","限WHO功能分级II级-III级的肺动脉高压(WHO第1组)的患者。","60019","马昔腾坦片","无","薄膜衣片","10mg","盒","30","聚氯乙烯/聚乙烯/聚偏二氯乙烯(PVC/PE/PVDC)固体药用复合硬片和药用铝箔包装","南京正大天晴制药有限公司","3960.00","启用","招采变更","国谈药品"]
["279","XL04ACS271B002040178679","2","司库奇尤单抗注射液","","限：1.银屑病：用于治疗符合系统治疗或光疗指征的中度至重度斑块状银屑病的成年及体重≥50kg的6岁及以上儿童患者；2.强直性脊柱炎：用于常规治疗疗效欠佳的强直性脊柱炎的成年患者。","203517","司库奇尤单抗注射液","可善挺","注射剂","0.5ml: 75mg","盒","1","预装式注射器","Novartis Pharma Stein AG","511.76","启用","招采变更","国谈药品"]
["280","XB02AAA171B002010203202","1","氨甲苯酸","注射剂","","205095","氨甲苯酸注射液","无","注射液","10ml:0.1g","支","1","低硼硅玻璃安瓿","上海现代哈森(商丘)药业有限公司","55.60","启用","招采变更",""]
["281","XB02AAA171B002020203202","1","氨甲苯酸","注射剂","","205094","氨甲苯酸注射液","无","注射液","5ml:50mg","支","1","低硼硅玻璃安瓿","上海现代哈森(商丘)药业有限公司","27.00","启用","招采变更",""]
["282","ZI01AAB0017010105934","2","八味沉香丸","","","167738","八味沉香丸","无","丸剂(水丸)","每丸重0.3g","盒","24","铝箔","金诃藏药股份有限公司","30.99","启用","招采变更",""]
["283","ZA04BAB0192010105313","2","板蓝根片(口服液)","","","203543","板蓝根片","无","薄膜衣片","每片重0.42g","盒","24","铝塑板包装","江西桔王药业有限公司","32.00","启用","招采变更",""]
["284","ZF02AAC0263010102281","2","苍耳子鼻炎滴丸(胶囊)","","","119108","苍耳子鼻炎胶囊","无","胶囊剂","0.4g","盒","24","药用PPT铝箔/药用PVC硬片","亚宝药业四川制药有限公司","26.80","启用","招采变更",""]
["285","XD07ABD085F002010104454","2","地塞米松","软膏剂","","151286","醋酸地塞米松乳膏","无","乳膏剂","10g:5mg","支","1","铝管","国药集团三益药业(芜湖)有限公司","16.00","启用","招采变更",""]
["286","ZE03AAD0086010200374","2","丹红化瘀口服液","","","170499","丹红化瘀口服液","无","合剂","10ml","盒","10","玻璃瓶","广州白云山和记黄埔中药有限公司","69.40","启用","招采变更",""]
["287","ZA16BAD0189020105377","2","当归拈痛丸(颗粒)","","","175777","当归拈痛颗粒","无","颗粒剂","6g(相当于饮片15g)","盒","9","镀铝膜","江西杏林白马药业股份有限公司","78.00","启用","招采变更",""]
["288","ZA12GAG0379020101285","1","冠心苏合丸(胶囊、软胶囊)","","","202985","冠心苏合软胶囊","无","软胶囊剂","每粒装0.5g","盒","18","铝塑泡罩包装","山西晋新双鹤药业有限责任公司","99.00","启用","招采变更",""]
["289","ZA16AAH0048010101089","2","寒湿痹片(胶囊、颗粒)","","","203251","寒湿痹颗粒","无","颗粒剂","每袋装5g","盒","12","药用复合膜袋装","辽宁上药好护士药业(集团)有限公司","88.20","启用","招采变更",""]
["290","ZA09DBJ0030020102826","1","济生肾气丸(片)","","","203276","济生肾气丸","无","丸剂（水蜜丸）","每10丸重2g","盒","180","口服固体药用高密度聚乙烯瓶","河北扁鹊制药有限公司","86.00","启用","招采变更",""]
["291","XJ01XDJ070B002020101924","1","甲硝唑","注射剂","","174991","甲硝唑注射液","无","注射剂","10ml:50mg","支","1","低硼硅玻璃安瓿","武汉爱民制药股份有限公司","36.70","启用","招采变更",""]
["292","XA05BAL080E001010101016","1","联苯双酯","口服常释剂型","","172816","联苯双酯胶囊","无","硬胶囊","25mg","盒","18","塑料瓶","重庆科瑞制药(集团)有限公司","59.80","启用","招采变更",""]
["293","ZE01AAM0147020103384","1","明目上清丸(片)","","","175653","明目上清片","无","素片","/","盒","24","铝塑","吉林巨仁堂药业股份有限公司","58.00","启用","招采变更",""]
["294","XR07ABN040B002020100137","1","尼可刹米","注射剂","","201420","尼可刹米注射液","无","注射液","1.5ml:0.375g","支","1","无色安瓿","北京市永康药业有限公司","38.00","启用","招采变更",""]
["295","ZA03AAS0044030104834","2","三黄膏(丸)","","","175325","三黄膏","无","膏药","10g/支","支","1","药用聚乙烯/铝/聚乙烯复合药用软膏管","威海人生药业有限公司","128.00","启用","招采变更",""]
["296","ZA16BAS0534020201089","2","湿热痹片(胶囊、颗粒)","","","203338","湿热痹颗粒","无","颗粒剂","每袋装3g","盒","12","药用复合膜袋装","辽宁上药好护士药业(集团)有限公司","79.80","启用","招采变更",""]
["297","ZF02AAX0688020100837","1","辛芩颗粒","","","175046","辛芩颗粒","无","颗粒剂(无糖型)","每袋装5g(无蔗糖)","盒","9","药用聚酯/铝/流延聚丙烯药用包装用复合膜","江西杏林白马药业股份有限公司","87.00","启用","招采变更",""]
["298","ZF02AAX0688010102294","1","辛芩颗粒","","","112532","辛芩颗粒","无","颗粒剂(无蔗糖)","每袋装5g","盒","9","药用复合膜","国药集团宜宾制药有限责任公司","29.85","启用","招采变更",""]
["299","ZA01BAX0750010100173","1","芎菊上清丸(片、颗粒)","","","200137","芎菊上清颗粒","无","颗粒剂","10g","盒","12","复合膜","北京同仁堂制药有限公司","79.40","启用","招采变更",""]
["300","XA02BAL050B002020103202","1","雷尼替丁","注射剂","","205096","盐酸雷尼替丁注射液","无","注射液","5ml:50mg","盒","5","低硼硅玻璃安瓿装","上海现代哈森(商丘)药业有限公司","399.00","启用","招采变更",""]
["301","ZA09FAY0106010305019","2","养心定悸胶囊(颗粒)","","","203856","养心定悸颗粒","无","颗粒剂","每袋装12g","盒","12","药品包装用复合膜袋","古汉中药有限公司","470.10","启用","招采变更",""]
["302","ZA06DAY0148020100124","1","养阴清肺丸(膏、颗粒、口服液、糖浆)","","","175195","养阴清肺丸","无","水蜜丸","6g/袋","盒","6","复合膜袋装","北京东升制药有限公司","66.00","启用","招采变更",""]
["303","ZA04CCY0246020103312","2","乙肝宁片(颗粒)","","","202986","乙肝宁片","无","薄膜衣片","每片重0.55g","盒","24","铝塑板包装","长春海外制药集团有限公司","89.80","启用","招采变更",""]
["304","ZG01AAY0663010304268","2","愈伤灵胶囊","","","202875","愈伤灵胶囊","无","胶囊剂","0.3g","盒","24","无","淄博亚大制药股份有限公司","43.00","启用","招采变更",""]
["305","ZA04BAZ0346010101016","2","肿节风片(胶囊、颗粒)","","","174884","肿节风胶囊","无","胶囊剂","每粒装0.35g","盒","24","药品包装用铝箔,聚氯乙烯固体药用硬片包装。","重庆科瑞制药(集团)有限公司","68.00","启用","招采变更",""]
["306","XJ01DBT074B001010202701","2","头孢拉定","注射剂","","203693","注射用头孢拉定","无","注射剂","0.5g","支","1","注射用无菌粉末用溴化丁基橡胶塞,钠钙玻璃管制注射剂瓶","华北制药河北华民药业有限责任公司","25.58","启用","招采变更",""]
["307","XJ05APA312A001010178633","2","艾尔巴韦格拉瑞韦","口服常释剂型","限本品用于治疗成人慢性丙型肝炎（CHC）感染。","165505","艾尔巴韦格拉瑞韦片","择必达","薄膜衣片","艾尔巴韦50mg,格拉瑞韦0.1g","盒","28","双铝","爱尔兰MSD International GmbH","2010.40","停用","医保发〔2023〕30号","国谈药品"]
["308","XS01LAA308G003010178269","2","阿柏西普眼内注射溶液","","限：1.50岁以上的湿性年龄相关性黄斑变性(AMD)；2.糖尿病性黄斑水肿(DME)引起的视力损害。/n应同时符合以下条件：1.需三级综合医院眼科或二级及以上眼科专科医院医师处方；2.首次处方时病眼基线矫正视力0.05-0.5；3.事前审查后方可用，初次申请需有血管造影或OCT(全身情况不允许的患者可以提供OCT血管成像)证据；4.每眼累计最多支付9支，第1年度最多支付5支。阿柏西普、雷珠单抗和康柏西普的药品支数合并计算。","163371","阿柏西普眼内注射溶液","艾力雅","注射液","0.1ml:4mg","盒","1","玻璃瓶(每盒附一个过滤针头)","德国Vetter Pharma-Fertigung GmbH & Co.KG","4100.00","修改（医保信息）","医保发〔2023〕30号",""]
["309","XC09CAA352A001010101445","2","阿齐沙坦片","","","173269","阿齐沙坦片","无","薄膜衣片","20mg","盒","10","铝箔","江苏恒瑞医药股份有限公司","18.70","修改（医保信息）","医保发〔2023〕30号",""]
["310","XC09CAA352A001010182502","2","阿齐沙坦片","","","310058","阿齐沙坦片","无","片剂","20mg","盒","28","聚氯乙烯固体药用硬片、药用铝箔包装","兆科药业(广州)有限公司","52.34","修改（医保信息）","医保发〔2023〕30号",""]
["311","XC09CAA352A001010283058","2","阿齐沙坦片","","","310059","阿齐沙坦片","无","片剂","20mg","盒","14","聚氯乙烯固体药用硬片和药品包装用铝箔包装。","北京百奥药业有限责任公司","26.17","修改（医保信息）","医保发〔2023〕30号",""]
["312","XC09CAA352A001020101445","2","阿齐沙坦片","","","173270","阿齐沙坦片","无","薄膜衣片","40mg","盒","10","铝箔","江苏恒瑞医药股份有限公司","31.80","修改（医保信息）","医保发〔2023〕30号",""]
["313","XC09CAA352A001020283058","2","阿齐沙坦片","","","310060","阿齐沙坦片","无","片剂","40mg","盒","14","聚氯乙烯固体药用硬片和药品包装用铝箔包装。","北京百奥药业有限责任公司","44.49","修改（医保信息）","医保发〔2023〕30号",""]
["314","XA10BJA085B002010106474","2","艾塞那肽注射液","","限2型糖尿病。","176942","艾塞那肽注射液","无","注射液","5μg(0.25mg/ml,1.2ml/支)","支","1","玻璃瓶","青海晨菲制药有限公司","239.90","修改（医保信息）","医保发〔2023〕30号",""]
["315","XA10BJA085B002010179096","2","艾塞那肽注射液","","限2型糖尿病。","147293","艾塞那肽注射液","百泌达","注射液","10μg(0.25mg/ml,2.4ml/支)","支","1","预充式(预灌封)注射器","美国Baxter Pharmaceutical Solutions LLC","408.00","修改（医保信息）","医保发〔2023〕30号",""]
["316","XA10BJA085B002020106474","2","艾塞那肽注射液","","限2型糖尿病。","176943","艾塞那肽注射液","无","注射液","10μg(0.25mg/ml,2.4ml/支)","支","1","玻璃瓶","青海晨菲制药有限公司","407.83","修改（医保信息）","医保发〔2023〕30号",""]
["317","XA10BJA085B002020179096","2","艾塞那肽注射液","","限2型糖尿病。","147292","艾塞那肽注射液","百泌达","注射液","5μg(0.25mg/ml,1.2ml/支)","支","1","预充式(预灌封)注射器","美国Baxter Pharmaceutical Solutions LLC","240.00","修改（医保信息）","医保发〔2023〕30号",""]
["318","XC02KXB144A001020178189","2","波生坦分散片","","限3-12岁特发性或先天性肺动脉高压患者。","166533","波生坦分散片","全可利","分散片","32mg","盒","56","铝塑","加拿大Patheon Inc.","1046.08","修改（医保信息）","医保发〔2023〕30号",""]
["319","XB06ACA361B002010183330","2","醋酸艾替班特注射液","","限成人、青少年和≥2 岁儿童的遗传性血管性水肿(HAE)急性发作。","174267","醋酸艾替班特注射液","无","注射液","3ml:30mg(按C59H89N19O13S计)","支","1","预灌封注射器组合件(带注射针)","德国Vetter Pharma-Fertigung GmbH & Co.KG","4330.00","修改（医保信息）","医保发〔2023〕30号",""]
["320","XJ04AKD325A001010104619","2","德拉马尼片","","限耐多药结核患者。","166611","德拉马尼片","德尔巴","薄膜衣片","50mg","盒","60","双铝PTP","Otsuka Pharmaceutical Co.,Ltd.Tokushima Itano Factory","5160.00","修改（医保和招标信息）","医保发〔2023〕30号",""]
["321","XJ05AFE013X001010101601","2","恩替卡韦口服溶液","","限慢性乙型肝炎成人患者或2岁至<18岁慢性HBV感染代偿性肝病的核苷初治儿童患者。","310029","恩替卡韦口服溶液","无","口服溶液剂","210ml:10.5mg","盒","1","口服液体药用高密度聚乙烯瓶,附刻度给药器。","南京星银药业集团有限公司","43.20","修改（医保信息）","医保发〔2023〕30号",""]
["322","XJ05AFE013X001010101747","2","恩替卡韦口服溶液","","限慢性乙型肝炎成人患者或2岁至<18岁慢性HBV感染代偿性肝病的核苷初治儿童患者。","171698","恩替卡韦口服溶液","无","口服溶液剂","210ml:10.5mg(0.005%)","瓶","1","塑料瓶","扬子江药业集团江苏制药股份有限公司","43.30","修改（医保信息）","医保发〔2023〕30号",""]
["323","XJ05AFE013X001010104360","2","恩替卡韦口服溶液","","限慢性乙型肝炎成人患者或2岁至<18岁慢性HBV感染代偿性肝病的核苷初治儿童患者。","176850","恩替卡韦口服溶液","无","口服溶液剂","210ml:10.5mg(0.005%)","瓶","1","高密度聚乙烯","安徽新世纪药业有限公司","43.20","修改（医保信息）","医保发〔2023〕30号",""]
["324","XJ05AFE013X001010181274","2","恩替卡韦口服溶液","","限慢性乙型肝炎成人患者或2岁至<18岁慢性HBV感染代偿性肝病的核苷初治儿童患者。","203379","恩替卡韦口服溶液","无","口服溶液剂","210ml:10.5mg","盒","1","口服液体药用聚丙烯瓶,液体药用塑料瓶盖(PE)","贝克诺顿(浙江)制药有限公司","43.20","修改（医保信息）","医保发〔2023〕30号",""]
["325","XA05BAG145B002010103282","2","甘草酸单铵半胱氨酸氯化钠注射液","","限肝功能衰竭或无法使用甘草酸口服制剂的患者。","152827","甘草酸单铵半胱氨酸氯化钠注射液","无","注射液","100ml","瓶","1","玻璃瓶","弘和制药有限公司","40.00","修改（医保信息）","医保发〔2023〕30号",""]
["326","XA05BAG145B002020103282","2","甘草酸单铵半胱氨酸氯化钠注射液","","限肝功能衰竭或无法使用甘草酸口服制剂的患者。","153761","甘草酸单铵半胱氨酸氯化钠注射液","无","注射液","250ml","瓶","1","玻璃瓶","弘和制药有限公司","81.16","修改（医保信息）","医保发〔2023〕30号",""]
["327","XL01XXA322B002010180081","2","甲磺酸艾立布林注射液","","限既往接受过至少两种化疗方案的局部晚期或转移性乳腺癌患者。既往的化疗方案应包含一种蒽环类和一种紫杉烷类药物。","203562","甲磺酸艾立布林注射液","无","注射剂","2ml:1mg","盒","1","中硼硅玻璃管制注射剂瓶装","无锡紫杉药业股份有限公司","699.88","修改（医保信息）","医保发〔2023〕30号",""]
["328","XL01XXA322B002010182465","2","甲磺酸艾立布林注射液","","限既往接受过至少两种化疗方案的局部晚期或转移性乳腺癌患者。既往的化疗方案应包含一种蒽环类和一种紫杉烷类药物。","166602","甲磺酸艾立布林注射液","无","注射液","2ml:1.0mg","支","1","玻璃瓶","意大利BSP Pharmaceuticals S.p.A.","726.00","修改（医保信息）","医保发〔2023〕30号",""]
["329","XA05BAJ212B002010106155","2","精氨酸谷氨酸注射液","","限肝性脑病。","166579","精氨酸谷氨酸注射液","思瑞雪","注射液","200ml:20g","袋","1","多层共挤输液袋","辽宁海思科制药有限公司","54.00","修改（医保信息）","医保发〔2023〕30号",""]
["330","XA05BAJ212B002010206155","2","精氨酸谷氨酸注射液","","限肝性脑病。","163219","精氨酸谷氨酸注射液","思瑞雪","注射液","200ml:20g","瓶","1","玻璃瓶","辽宁海思科制药有限公司","54.00","修改（医保信息）","医保发〔2023〕30号",""]
["331","XC02KXL363A001010178269","2","利奥西呱片","","限：1.术后持续性或复发性慢性血栓栓塞性肺动脉高压(CTEPH)或不能手术的CTEPH，且(WHO FC)为II-III的患者；2.动脉性肺动脉高压(PAH)且(WHO FC)为II-III患者的二线用药。","166628","利奥西呱片","安吉奥","薄膜衣片","0.5mg","盒","42","铝塑","德国Bayer AG","607.74","修改（医保信息）","医保发〔2023〕30号",""]
["332","XC02KXL363A001020178269","2","利奥西呱片","","限：1.术后持续性或复发性慢性血栓栓塞性肺动脉高压(CTEPH)或不能手术的CTEPH，且(WHO FC)为II-III的患者；2.动脉性肺动脉高压(PAH)且(WHO FC)为II-III患者的二线用药。","166629","利奥西呱片","安吉奥","薄膜衣片","1.0mg","盒","42","铝塑","德国Bayer AG","1033.20","修改（医保信息）","医保发〔2023〕30号",""]
["333","XC02KXL363A001030178269","2","利奥西呱片","","限：1.术后持续性或复发性慢性血栓栓塞性肺动脉高压(CTEPH)或不能手术的CTEPH，且(WHO FC)为II-III的患者；2.动脉性肺动脉高压(PAH)且(WHO FC)为II-III患者的二线用药。","166630","利奥西呱片","安吉奥","薄膜衣片","2.5mg","盒","84","铝塑","德国Bayer AG","4167.24","修改（医保信息）","医保发〔2023〕30号",""]
["334","XA10BJL326B002010107103","2","利拉鲁肽注射液","","限2型糖尿病。","129959","利拉鲁肽注射液","诺和力","注射液","3ml:18mg(预填充注射笔)","盒","1","笔芯由1型玻璃制成,内有一个活塞(溴丁基橡胶),并由一个橡胶塞(溴丁基 橡胶/聚异戊二烯橡胶)密封。 笔型注射器由聚烯烃和聚缩醛制成。","Novo Nordisk A/S","315.27","修改（医保和招标信息）","医保发〔2023〕30号",""]
["335","XA10BJL326B002020104520","2","利拉鲁肽注射液","","限2型糖尿病。","203101","利拉鲁肽注射液","利鲁平","注射剂","3ml:18mg(预填充注射笔)","盒","1","笔芯由硼硅玻璃套筒、溴化丁基橡胶活塞及铝盖组成。 笔型注射器由聚对苯二甲酸丁二醇酯、聚缩醛和聚丙烯制成。","杭州九源基因工程有限公司","283.70","修改（医保信息）","医保发〔2023〕30号",""]
["336","XA10BJL366B002010181708","2","利司那肽注射液","","限二甲双胍等口服降糖药或胰岛素控制效果不佳的BMI≥25的患者，首次处方时需由二级及以上医疗机构专科医师开具处方。","165315","利司那肽注射液","利时敏","注射液","10μg剂量注射笔(绿色):0.05mg/ml,3ml/支,单次注射药量10μg(0.2ml)","盒","1","Ⅰ型玻璃笔芯,溴丁基胶塞","Sanofi-Aventis Deutschland GmbH","157.65","修改（医保和招标信息）","医保发〔2023〕30号",""]
["337","XA10BJL366B002020181708","2","利司那肽注射液","","限二甲双胍等口服降糖药或胰岛素控制效果不佳的BMI≥25的患者，首次处方时需由二级及以上医疗机构专科医师开具处方。","165316","利司那肽注射液","利时敏","注射液","20μg剂量注射笔(深紫红色):0.10mg/ml,3ml/支,单次注射药量20μg(0.2ml)","盒","1","Ⅰ型玻璃笔芯,溴丁基胶塞","Sanofi-Aventis Deutschland GmbH","268.00","修改（医保信息）","医保发〔2023〕30号",""]
["338","XJ05AXM176A001010182682","2","玛巴洛沙韦片","","限成人和5岁及以上儿童单纯性甲型和乙型流感患者，或存在流感相关并发症高风险的成人和12岁及以上儿童流感患者。","173302","玛巴洛沙韦片","速福达","片剂","20mg","盒","2","铝塑包装","Shionogi Pharma Co.,Ltd.","222.36","修改（医保和招标信息）","医保发〔2023〕30号",""]
["339","XJ05AXM176A001020182682","2","玛巴洛沙韦片","","限成人和5岁及以上儿童单纯性甲型和乙型流感患者，或存在流感相关并发症高风险的成人和12岁及以上儿童流感患者。","174272","玛巴洛沙韦片","速福达","片剂","40mg","盒","1","铝塑包装","Shionogi Pharma Co.,Ltd.","189.00","修改（医保和招标信息）","医保发〔2023〕30号",""]
["340","XJ01XDM152B002010101444","2","吗啉硝唑氯化钠注射液","","限二线用药。","155907","吗啉硝唑氯化钠注射液","迈灵达","注射液","100ml:吗琳硝唑0.5与氯化钠0.9g","瓶","1","钠钙玻璃输液瓶灌装,加氯化丁基胶塞,铝盖封口包装","江苏豪森药业集团有限公司","97.00","修改（医保和招标信息）","医保发〔2023〕30号",""]
["341","XL01EAN092E001010104021","2","尼洛替尼胶囊","","限：1.新诊断的费城染色体阳性的慢性髓性白血病(Ph+CML)慢性期成人患者及2岁以上的儿童患者；2.既往治疗(包括伊马替尼)耐药或不耐受的费城染色体阳性的慢性髓性白血病(Ph+CML)慢性期或加速期成人患者以及慢性期2岁以上的儿童患者。","204558","尼洛替尼胶囊","无","胶囊剂","0.2g(按C？？H？？F？N？O计)","盒","40","口服固体药用高密度聚乙烯瓶","齐鲁制药有限公司","2928.96","修改（医保信息）","医保发〔2023〕30号",""]
["342","XL01EAN092E001020104021","2","尼洛替尼胶囊","","限：1.新诊断的费城染色体阳性的慢性髓性白血病(Ph+CML)慢性期成人患者及2岁以上的儿童患者；2.既往治疗(包括伊马替尼)耐药或不耐受的费城染色体阳性的慢性髓性白血病(Ph+CML)慢性期或加速期成人患者以及慢性期2岁以上的儿童患者。","204560","尼洛替尼胶囊","无","胶囊剂","0.15g(按C？？H？？F？N？O计)","盒","40","口服固体药用高密度聚乙烯瓶","齐鲁制药有限公司","2350.00","修改（医保信息）","医保发〔2023〕30号",""]
["343","XL01XEN092E001010210121","2","尼洛替尼胶囊","","限：1.新诊断的费城染色体阳性的慢性髓性白血病(Ph+CML)慢性期成人患者及2岁以上的儿童患者；2.既往治疗(包括伊马替尼)耐药或不耐受的费城染色体阳性的慢性髓性白血病(Ph+CML)慢性期或加速期成人患者以及慢性期2岁以上的儿童患者。","203564","尼洛替尼胶囊","无","胶囊剂","200mg(按尼洛替尼计)","盒","120","双层泡罩包装(聚氯乙烯/聚乙烯/聚偏二氯乙烯固体药用复合硬片、药用铝箔)","苏州特瑞药业股份有限公司","8786.88","修改（医保信息）","医保发〔2023〕30号",""]
["344","XL01XEN092E001010278679","2","尼洛替尼胶囊","","限：1.新诊断的费城染色体阳性的慢性髓性白血病(Ph+CML)慢性期成人患者及2岁以上的儿童患者；2.既往治疗(包括伊马替尼)耐药或不耐受的费城染色体阳性的慢性髓性白血病(Ph+CML)慢性期或加速期成人患者以及慢性期2岁以上的儿童患者。","153768","尼洛替尼胶囊","达希纳","胶囊剂","0.15g","盒","120","PVC/PVDC双层泡罩包装或PA/AL/PVC铝塑泡罩包装","Novartis Pharma Stein AG","8850.00","修改（医保和招标信息）","医保发〔2023〕30号",""]
["345","XL01XEN092E001020210121","2","尼洛替尼胶囊","","限：1.新诊断的费城染色体阳性的慢性髓性白血病(Ph+CML)慢性期成人患者及2岁以上的儿童患者；2.既往治疗(包括伊马替尼)耐药或不耐受的费城染色体阳性的慢性髓性白血病(Ph+CML)慢性期或加速期成人患者以及慢性期2岁以上的儿童患者。","203565","尼洛替尼胶囊","无","胶囊剂","150mg(按尼洛替尼计)","盒","120","双层泡罩包装(聚氯乙烯/聚乙烯/聚偏二氯乙烯固体药用复合硬片、药用铝箔)","苏州特瑞药业股份有限公司","7050.00","修改（医保信息）","医保发〔2023〕30号",""]
["346","XL01XEN092E001020278679","2","尼洛替尼胶囊","","限：1.新诊断的费城染色体阳性的慢性髓性白血病(Ph+CML)慢性期成人患者及2岁以上的儿童患者；2.既往治疗(包括伊马替尼)耐药或不耐受的费城染色体阳性的慢性髓性白血病(Ph+CML)慢性期或加速期成人患者以及慢性期2岁以上的儿童患者。","148383","尼洛替尼胶囊","达希纳","胶囊剂","200mg","盒","120","PVC/PVDC双层泡罩包装或PA/AL/PVC铝塑泡罩包装","Novartis Pharma Stein AG","11030.40","修改（医保和招标信息）","医保发〔2023〕30号",""]
["347","XL01XEN092E001020378679","2","尼洛替尼胶囊","","限：1.新诊断的费城染色体阳性的慢性髓性白血病(Ph+CML)慢性期成人患者及2岁以上的儿童患者；2.既往治疗(包括伊马替尼)耐药或不耐受的费城染色体阳性的慢性髓性白血病(Ph+CML)慢性期或加速期成人患者以及慢性期2岁以上的儿童患者。","141720","尼洛替尼胶囊","达希纳","胶囊剂","200mg","盒","112","PVC/PVDC双层泡罩包装或PA/AL/PVC铝塑泡罩包装","Novartis Pharma Stein AG","10295.04","修改（医保和招标信息）","医保发〔2023〕30号",""]
["348","XL01XEN092E001040178679","2","尼洛替尼胶囊","","限：1.新诊断的费城染色体阳性的慢性髓性白血病(Ph+CML)慢性期成人患者及2岁以上的儿童患者；2.既往治疗(包括伊马替尼)耐药或不耐受的费城染色体阳性的慢性髓性白血病(Ph+CML)慢性期或加速期成人患者以及慢性期2岁以上的儿童患者。","171674","尼洛替尼胶囊","达希纳","胶囊剂","50mg","盒","120","PVC/PVDC双层泡罩包装或PA/AL/PVC铝塑泡罩包装","Novartis Pharma Stein AG","3817.20","修改（医保和招标信息）","医保发〔2023〕30号",""]
["349","XL01XCP138B002010181735","2","帕妥珠单抗注射液","","限以下情况方可支付，且支付不超过12个月：1.HER2阳性的局部晚期、炎性或早期乳腺癌患者的新辅助治疗；2.具有高复发风险HER2阳性早期乳腺癌患者的辅助治疗。","165391","帕妥珠单抗注射液","帕捷特","注射剂","420mg(14ml)/瓶每个西林瓶含有14ml浓缩液,浓度为30 mg/mL,含420mg帕妥珠单抗","盒","1","西林瓶","Roche Diagnostics GmbH","4955.00","修改（医保和招标信息）","医保发〔2023〕30号",""]
["350","XJ01MBN102E001010107968","2","苹果酸奈诺沙星胶囊","","限二线用药。","162609","苹果酸奈诺沙星胶囊","太捷信","硬胶囊剂","0.25g","盒","6","铝塑","浙江医药股份有限公司新昌制药厂","97.20","修改（医保信息）","医保发〔2023〕30号",""]
["351","XJ02ACB206X002010104948","2","泊沙康唑口服混悬液","","限：1.预防移植后(干细胞及实体器官移植) 及恶性肿瘤患者有重度粒细胞缺乏的侵袭性曲霉菌和念球菌感染；2.伊曲康唑或氟康唑难治性口咽念珠菌病；3.接合菌纲类感染。","203545","泊沙康唑口服混悬液","无","口服混悬剂","40mg/ml(每瓶含泊沙康唑4.2g)(105ml)","盒","1","棕色钠钙玻璃模制药瓶装","湖南科伦制药有限公司","2180.00","修改（医保信息）","医保发〔2023〕30号",""]
["352","XJ02ACB206X002010180007","2","泊沙康唑口服混悬液","","限：1.预防移植后(干细胞及实体器官移植) 及恶性肿瘤患者有重度粒细胞缺乏的侵袭性曲霉菌和念球菌感染；2.伊曲康唑或氟康唑难治性口咽念珠菌病；3.接合菌纲类感染。","154667","泊沙康唑口服混悬液","诺科飞","口服混悬剂","105ml:4.2g","瓶","1","玻璃瓶","加拿大Patheon Inc.,Whitby Operations","2200.00","修改（医保信息）","医保发〔2023〕30号",""]
["353","XB02BDR100B001010102291","2","人凝血因子Ⅸ","","限凝血因子Ⅸ缺乏症(B型血友病)患者的出血治疗。","203621","人凝血因子IX","无","注射剂","500IU/瓶,复溶后体积10ml","盒","1","玻璃瓶、卤化丁基橡胶塞","四川远大蜀阳药业有限责任公司","880.00","修改（医保信息）","医保发〔2023〕30号",""]
["354","XB02BDR100B001010106396","2","人凝血因子Ⅸ","","限凝血因子Ⅸ缺乏症(B型血友病)患者的出血治疗。","172057","人凝血因子Ⅸ","无","冻干粉针剂","500IU","瓶","1","玻璃瓶","山东泰邦生物制品有限公司","888.00","修改（医保信息）","医保发〔2023〕30号",""]
["355","XJ05AXC169B002010181007","2","重组细胞因子基因衍生蛋白注射液","","限HBeAg阳性的慢性乙型肝炎患者。","164707","重组细胞因子基因衍生蛋白注射液","乐复能","注射液","1ml:10μg","盒","1","2ml中硼硅玻璃管制注射剂瓶","杰华生物技术(青岛)有限公司","325.00","修改（医保和招标信息）","医保发〔2023〕30号",""]
["356","XB01ADC148B003010206038","2","注射用重组人尿激酶原","","限急性心肌梗死发病12小时内使用。","147950","注射用重组人尿激酶原","普佑克","注射剂(无菌粉末)","5mg(50万IU)/支","支","1","中硼硅玻璃管制注射剂瓶装","天士力生物医药股份有限公司","508.00","修改（医保和招标信息）","医保发〔2023〕30号",""]
["357","XB01ADC119B001010104064","2","注射用重组人组织型纤溶酶原激酶衍生物","","限急性心肌梗死发病12小时内使用。","144310","注射用重组人组织型纤溶酶原激酶衍生物","瑞通立","冻干粉针剂","18mg/10ml/支","盒","1","玻璃瓶、丁基胶塞","华润昂德生物药业有限公司","1399.00","修改（医保和招标信息）","医保发〔2023〕30号",""]
["358","ZA06CAM0006010104336","2","麻芩消咳颗粒","","","149263","麻芩消咳颗粒","无","颗粒剂","8g","盒","6","复合膜","天长亿帆制药有限公司","28.74","修改（医保信息）","医保发〔2023〕30号",""]
["359","ZA06CAS0338010105762","2","射麻口服液","","","151341","射麻口服液","无","合剂(含口服液)","10ml(每1ml相当于饮片2.4g)","盒","6","玻璃瓶","海南中盛合美生物制药有限公司","23.88","修改（医保信息）","医保发〔2023〕30号",""]
["360","ZA06CAS0338020105762","2","射麻口服液","","","166697","射麻口服液","无","合剂(含口服液)","10ml(每1ml相当于饮片2.4g)","盒","12","玻璃瓶","海南中盛合美生物制药有限公司","47.76","修改（医保信息）","医保发〔2023〕30号",""]
["361","ZA06CAS0338020205762","2","射麻口服液","","","166696","射麻口服液","无","合剂(含口服液)","10ml(每1ml相当于饮片2.4g)","盒","9","玻璃瓶","海南中盛合美生物制药有限公司","35.82","修改（医保信息）","医保发〔2023〕30号",""]
["362","ZA09GAQ0627010102816","2","芪黄颗粒","","","153959","芪黄颗粒(无蔗糖)","无","颗粒剂","5g","盒","8","复合膜","药都制药集团股份有限公司","60.00","修改（医保信息）","医保发〔2023〕30号",""]
["363","ZA12AAB0505010201007","2","八味芪龙颗粒","","限中风病中经络(轻中度脑梗塞)恢复期患者。","166631","八味芪龙颗粒","无","颗粒剂","6g","盒","13","复合膜","重庆华森制药股份有限公司","38.09","修改（医保信息）","医保发〔2023〕30号",""]
["364","ZA12AAN0048010109623","2","脑心安胶囊","","限中重度脑梗塞、冠心病心绞痛患者。","166619","脑心安胶囊","无","硬胶囊剂","0.3g","盒","36","铝塑","吉林意达药业有限公司","49.68","修改（医保信息）","医保发〔2023〕30号",""]
["365","ZA12AAQ0061010107004","2","芪丹通络颗粒","","","166638","芪丹通络颗粒","无","颗粒剂","8g","盒","15","复合膜","河北中唐医药有限公司","62.40","修改（医保信息）","医保发〔2023〕30号",""]
["366","ZA12AAQ0061010207004","2","芪丹通络颗粒","","","166637","芪丹通络颗粒","无","颗粒剂","8g","盒","6","复合膜","河北中唐医药有限公司","24.96","修改（医保信息）","医保发〔2023〕30号",""]
["367","ZA12AAQ0061020107004","2","芪丹通络颗粒","","","310091","芪丹通络颗粒","无","颗粒剂","8g","盒","9","药用复合膜袋","河北中唐医药有限公司","37.44","修改（医保信息）","医保发〔2023〕30号",""]
["368","ZA12AAQ0614010103250","2","芪芎通络胶囊","","限中风病中经络(轻中度脑梗塞)恢复期患者。","122564","芪芎通络胶囊","无","硬胶囊剂","0.5g","盒","36","铝塑","吉林万通药业集团郑州万通复升药业股份有限公司","24.84","修改（医保信息）","医保发〔2023〕30号",""]
["369","ZA12HAY0759010106725","2","银杏内酯注射液","","限二级及以上医疗机构脑梗死恢复期患者，单次住院最多支付14天。","135849","银杏内酯注射液","无","注射液","2ml(含萜类内酯10mg)","支","1","安瓿","成都百裕制药股份有限公司","19.68","停用","招采国码变更","国谈药品"]
["370","ZA12HAY0759030106725","2","银杏内酯注射液","","限二级及以上医疗机构脑梗死恢复期患者，单次住院最多支付14天。","135849","银杏内酯注射液","无","注射剂","每支装2ml(含萜类内酯10mg)","支","1","中硼硅玻璃安瓿","成都百裕制药股份有限公司","19.68","启用","招采国码变更",""]
["371","ZA12HAY0771010101463","2","银杏二萜内酯葡胺注射液","","限二级及以上医疗机构脑梗死恢复期患者，单次住院最多支付14天。","148345","银杏二萜内酯葡胺注射液","无","注射液","5ml(含银杏二萜内酯25mg)","支","1","安瓿","江苏康缘药业股份有限公司","93.70","修改（医保信息）","医保发〔2023〕30号",""]
["372","ZC01AAS0667010102451","2","食道平散","","限中晚期食道癌所致食道狭窄梗阻的患者。","166351","食道平散","无","散剂","10g","盒","1","陶瓷瓶","陕西欧珂药业有限公司","163.00","修改（医保信息）","医保发〔2023〕30号",""]
["373","ZC02AAC0241010103490","2","参一胶囊","","限原发性肺癌、肝癌化疗期间使用。","102354","参一胶囊","无","硬胶囊剂","10mg","盒","16","铝塑","吉林亚泰制药股份有限公司","98.88","修改（医保信息）","医保发〔2023〕30号",""]
["374","ZA12GAX0006010104152","2","西红花总苷片","","限化疗产生心脏毒性引起的心绞痛患者。","163391","西红花总苷片","无","片剂","西红花总苷12mg(以西红花苷-1计)","盒","24","药品包装用铝箔聚氯乙烯固体药用硬片","瑞阳制药股份有限公司","396.00","修改（医保和招标信息）","医保发〔2023〕30号",""]
["375","XA02BCA348X006010180537","2","奥美拉唑碳酸氢钠干混悬剂(Ⅰ)","","限活动性十二指肠溃疡或胃食管反流病。","171970","奥美拉唑碳酸氢钠干混悬剂Ⅰ","无","口服混悬剂","每袋含奥美拉唑20mg和碳酸氢钠1680mg","盒","7","纸/铝/聚乙烯药用复合膜","南京海纳制药有限公司","16.73","修改（医保信息）","医保发〔2023〕30号",""]
["376","XA02BCA348X006010183183","2","奥美拉唑碳酸氢钠干混悬剂(Ⅰ)","","限活动性十二指肠溃疡或胃食管反流病。","310110","奥美拉唑碳酸氢钠干混悬剂Ⅰ","为长悦","干混悬剂","每袋含奥美拉唑20mg和碳酸氢钠1680mg","盒","30","聚酯/铝/聚乙烯药品包装用复合膜包装","济宁华能制药厂有限公司","71.70","修改（医保信息）","医保发〔2023〕30号",""]
["377","XA02BCA348X006010283183","2","奥美拉唑碳酸氢钠干混悬剂(Ⅰ)","","限活动性十二指肠溃疡或胃食管反流病。","310111","奥美拉唑碳酸氢钠干混悬剂Ⅰ","为长悦","干混悬剂","每袋含奥美拉唑20mg和碳酸氢钠1680mg","盒","7","聚酯/铝/聚乙烯药品包装用复合膜包装","济宁华能制药厂有限公司","16.73","修改（医保信息）","医保发〔2023〕30号",""]
["378","XA02BCA348X006010380537","2","奥美拉唑碳酸氢钠干混悬剂(Ⅰ)","","限活动性十二指肠溃疡或胃食管反流病。","310118","奥美拉唑碳酸氢钠干混悬剂(Ⅰ)","无","口服混悬剂","每袋含奥美拉唑20mg和碳酸氢钠1680mg","盒","14","纸/铝/聚乙烯药用复合膜","南京海纳制药有限公司","33.46","修改（医保信息）","医保发〔2023〕30号",""]
["379","XA02BCA348X006010383183","2","奥美拉唑碳酸氢钠干混悬剂(Ⅰ)","","限活动性十二指肠溃疡或胃食管反流病。","310114","奥美拉唑碳酸氢钠干混悬剂Ⅰ","为长悦","干混悬剂","每袋含奥美拉唑20mg和碳酸氢钠1680mg","盒","10","聚酯/铝/聚乙烯药品包装用复合膜包装","济宁华能制药厂有限公司","23.90","修改（医保信息）","医保发〔2023〕30号",""]
["380","XA02BCA348X006010483183","2","奥美拉唑碳酸氢钠干混悬剂(Ⅰ)","","限活动性十二指肠溃疡或胃食管反流病。","310112","奥美拉唑碳酸氢钠干混悬剂Ⅰ","为长悦","干混悬剂","每袋含奥美拉唑20mg和碳酸氢钠1680mg","盒","14","聚酯/铝/聚乙烯药品包装用复合膜包装","济宁华能制药厂有限公司","33.46","修改（医保信息）","医保发〔2023〕30号",""]
["381","XA02BCA348X006010583183","2","奥美拉唑碳酸氢钠干混悬剂(Ⅰ)","","限活动性十二指肠溃疡或胃食管反流病。","310113","奥美拉唑碳酸氢钠干混悬剂Ⅰ","为长悦","干混悬剂","每袋含奥美拉唑20mg和碳酸氢钠1680mg","盒","28","聚酯/铝/聚乙烯药品包装用复合膜包装","济宁华能制药厂有限公司","66.92","修改（医保信息）","医保发〔2023〕30号",""]
["382","XA02BCF721A001010110289","2","富马酸伏诺拉生片","","限反流性食管炎的患者。","169316","富马酸伏诺拉生片","沃克","薄膜衣片","20mg","盒","7","铝塑","日本Takeda Pharmaceutical Company Limited, Hikari Plant","69.30","修改（医保信息）","医保发〔2023〕30号",""]
["383","XA10BAE089A010010104023","2","盐酸二甲双胍缓释片(Ⅲ)","","","168466","盐酸二甲双胍缓释片(Ⅲ)","无","缓释片","0.5g","瓶","30","高密度聚乙烯瓶","青岛百洋制药有限公司","19.80","修改（医保信息）","医保发〔2023〕30号",""]
["384","XA10BAE089A010010204876","2","盐酸二甲双胍缓释片(Ⅲ)","","","310048","盐酸二甲双胍缓释片(Ⅲ)","无","缓释片","0.5g","瓶","28","口服固体药用高密度聚乙烯瓶","福建东瑞制药有限公司","18.48","修改（医保信息）","医保发〔2023〕30号",""]
["385","XA10BAE089A010010283802","2","盐酸二甲双胍缓释片(Ⅲ)","","","310049","盐酸二甲双胍缓释片(Ⅲ)","无","片剂","1.0g","瓶","30","高密度聚乙烯瓶","南通联亚药业股份有限公司","33.59","修改（医保信息）","医保发〔2023〕30号",""]
["386","XA10BAE089A010010304023","2","盐酸二甲双胍缓释片(Ⅲ)","","","310050","盐酸二甲双胍缓释片(Ⅲ)","无","缓释片","0.5g","瓶","60","高密度聚乙烯瓶","青岛百洋制药有限公司","39.60","修改（医保信息）","医保发〔2023〕30号",""]
["387","XA10BAE089A010020283802","2","盐酸二甲双胍缓释片(Ⅲ)","","","310051","盐酸二甲双胍缓释片(Ⅲ)","无","片剂","0.5g","瓶","30","高密度聚乙烯瓶","南通联亚药业股份有限公司","19.75","修改（医保信息）","医保发〔2023〕30号",""]
["388","XA11CCA351E002010179189","2","艾地骨化醇软胶囊","","限绝经后女性骨质疏松症。","205195","艾地骨化醇软胶囊","艾地罗","胶囊剂","0.5μg","盒","14","铝塑","Fujieda Plant of Chugai Pharma Manufacturing Co., Ltd","37.52","修改（医保信息）","医保发〔2023〕30号",""]
["389","XA11CCA351E002010203013","2","艾地骨化醇软胶囊","","限绝经后女性骨质疏松症。","310052","艾地骨化醇软胶囊","无","胶囊剂","0.75μg","盒","14","铝塑泡罩","河南泰丰生物科技有限公司","50.40","修改（医保信息）","医保发〔2023〕30号",""]
["390","XA11CCA351E002010280937","2","艾地骨化醇软胶囊","","限绝经后女性骨质疏松症。","310117","艾地骨化醇软胶囊","无","胶囊剂","0.75μg","盒","10","聚氯乙烯固体药用硬片/药用铝箔,外加聚酯/铝/聚乙烯药用复合膜、袋","四川国为制药有限公司","35.80","修改（医保信息）","医保发〔2023〕30号",""]
["391","XA11CCA351E002010304586","2","艾地骨化醇软胶囊","","限绝经后女性骨质疏松症。","203134","艾地骨化醇软胶囊","无","胶囊剂","0.75μg","盒","14","药用铝塑泡罩包装,外套复合袋","温州海鹤药业有限公司","50.68","修改（医保信息）","医保发〔2023〕30号",""]
["392","XA11CCA351E002020279189","2","艾地骨化醇软胶囊","","限绝经后女性骨质疏松症。","310053","艾地骨化醇软胶囊","艾地罗","胶囊剂","0.75μg","盒","14","铝塑","Fujieda Plant of Chugai Pharma Manufacturing Co., Ltd","51.24","修改（医保信息）","医保发〔2023〕30号",""]
["393","XB01ACL396A001010103094","2","氯吡格雷阿司匹林片","","","202585","氯吡格雷阿司匹林片","无","片剂","每片含硫酸氢氯吡格雷75mg(按氯吡格雷计)与阿司匹林100mg","盒","7","铝塑泡罩,装在带有干燥剂的铝袋包装中。","乐普药业股份有限公司","27.86","修改（医保信息）","医保发〔2023〕30号",""]
["394","XB01ACL396A001010283807","2","氯吡格雷阿司匹林片","","","176265","氯吡格雷阿司匹林片","无","片剂","每片含硫酸氢氯吡格雷75 mg（以氯吡格雷计）与阿司匹林100 mg","盒","28","铝塑泡罩,装在带有干燥剂的铝袋包装中","Sanofi Winthrop Industrie, Ambares Plant","114.80","修改（医保和招标信息）","医保发〔2023〕30号",""]
["395","XB01ACL396A001010403094","2","氯吡格雷阿司匹林片","","","310054","氯吡格雷阿司匹林片","无","片剂","每片含硫酸氢氯吡格雷75mg(按氯吡格雷计)与阿司匹林100mg","盒","14","铝塑泡罩,装在带有干燥剂的铝袋包装中。","乐普药业股份有限公司","55.72","修改（医保信息）","医保发〔2023〕30号",""]
["396","XB01ACQ158B002010104461","2","曲前列尼尔注射液","","限肺动脉高压(PAH，WHO分类1)。","169093","曲前列尼尔注射液","无","注射液","20ml:20mg","盒","1","中棚硅玻璃管制注射剂瓶","兆科药业(合肥)有限公司","4280.00","修改（医保信息）","医保发〔2023〕30号",""]
["397","XB01ACQ158B002020104461","2","曲前列尼尔注射液","","限肺动脉高压(PAH，WHO分类1)。","310055","曲前列尼尔注射液","无","注射剂","20ml:50mg","盒","1","中硼硅玻璃管制注射剂瓶，配有注射液用局部覆聚四氟乙烯膜溴化丁基橡胶塞和抗生素瓶用铝塑组合盖","兆科药业(合肥)有限公司","8631.39","修改（医保信息）","医保发〔2023〕30号",""]
["398","XB01AFA319A001010182561","2","甲苯磺酸艾多沙班片","","限华法林治疗控制不良或出血高危的非瓣膜性房颤、深静脉血栓、肺栓塞患者。","171761","甲苯磺酸艾多沙班片","里先安","薄膜衣片","15mg","盒","7","铝箔","德国Daiichi Sankyo Europe GmbH","43.82","修改（医保信息）","医保发〔2023〕30号",""]
["399","XB01AFA319A001020105849","2","甲苯磺酸艾多沙班片","","限华法林治疗控制不良或出血高危的非瓣膜性房颤、深静脉血栓、肺栓塞患者。","176918","甲苯磺酸艾多沙班片","无","薄膜衣片","30mg","盒","7","铝箔","海南先声药业有限公司","52.18","修改（医保信息）","医保发〔2023〕30号",""]
["400","XB01AFA319A001020182561","2","甲苯磺酸艾多沙班片","","限华法林治疗控制不良或出血高危的非瓣膜性房颤、深静脉血栓、肺栓塞患者。","169846","甲苯磺酸艾多沙班片","里先安","薄膜衣片","30mg","盒","7","铝箔","德国Daiichi Sankyo Europe GmbH","74.55","修改（医保信息）","医保发〔2023〕30号",""]
["401","XB01AFA319A001030182561","2","甲苯磺酸艾多沙班片","","限华法林治疗控制不良或出血高危的非瓣膜性房颤、深静脉血栓、肺栓塞患者。","169780","甲苯磺酸艾多沙班片","里先安","薄膜衣片","60mg","盒","7","铝箔","德国Daiichi Sankyo Europe GmbH","126.77","修改（医保信息）","医保发〔2023〕30号",""]
["402","XJ01DCT193B002010100108","2","注射用头孢美唑钠/氯化钠注射液","","","310160","注射用头孢美唑钠/氯化钠注射液","无","注射剂","粉体室: 按头孢美唑 ( C？？H？？N？O？S？) 计2.0g； 液体室: 氯化钠注射液100ml∶0.9g","袋","1","三层共挤输液用双室袋","北京锐业制药有限公司","66.65","修改（医保信息）","医保发〔2023〕30号",""]
["403","XJ01DCT193B002010182437","2","注射用头孢美唑钠/氯化钠注射液","","","171721","注射用头孢美唑钠/氯化钠注射液","无","即配型粉液双室袋注射剂","粉体室:按头孢美唑(C15H17N7O5S3)计1.0g；液体室:氯化钠注射液100ml:0.9g","袋","10","三层共挤(粉-液)输液用袋","苏州大冢制药有限公司","453.80","修改（医保信息）","医保发〔2023〕30号",""]
["404","XJ01DCT193B002010204948","2","注射用头孢美唑钠/氯化钠注射液","","","205209","注射用头孢美唑钠/氯化钠注射液","无","注射剂","粉体室:1.0g(按C？？H？？N？O？S3？计)；液体室:100ml:0.9g","袋","1","三层共挤(粉-液)输液用袋","湖南科伦制药有限公司","45.38","修改（医保信息）","医保发〔2023〕30号",""]
["405","XJ05AXF718A001010104641","2","法维拉韦片(又称:法匹拉韦片)","","限流感重症高危人群及重症患者的抗流感病毒治疗。","167280","法维拉韦片","无","薄膜衣片","0.2g","盒","20","铝塑","浙江海正药业股份有限公司","73.80","修改（医保信息）","医保发〔2023〕30号",""]
["406","XJ05AXF718A001010204641","2","法维拉韦片(又称:法匹拉韦片)","","限流感重症高危人群及重症患者的抗流感病毒治疗。","167281","法维拉韦片","无","薄膜衣片","0.2g","盒","40","铝塑","浙江海正药业股份有限公司","147.60","修改（医保信息）","医保发〔2023〕30号",""]
["407","XL01XER081A001010178262","2","瑞戈非尼片","","限：1.肝细胞癌二线治疗；2.转移性结直肠癌三线治疗；3.胃肠道间质瘤三线治疗。","164547","瑞戈非尼片","拜万戈","片剂","40mg","盒","28","HDPE瓶包装","Bayer AG","4829.44","修改（医保和招标信息）","医保发〔2023〕30号",""]
["408","XL01XEY299E001010182102","2","伊布替尼胶囊","","限：1.既往至少接受过一种治疗的套细胞淋巴瘤(MCL)患者的治疗；2.慢性淋巴细胞白血病/小淋巴细胞淋巴瘤(CLL/SLL)患者的治疗；3.华氏巨球蛋白血症患者的治疗，按说明书用药。","163066","伊布替尼胶囊","亿珂","硬胶囊","140mg","盒","90","白色HDPE瓶,带儿童安全盖","Catalent CTS LLC","14145.30","修改（医保和招标信息）","医保发〔2023〕30号",""]
["409","XL01XES267E001010178672","2","塞瑞替尼胶囊","","限间变性淋巴瘤激酶(ALK)阳性的局部晚期或转移性非小细胞肺癌(NSCLC)患者的治疗。","164545","塞瑞替尼胶囊","赞可达","胶囊剂","0.15g","盒","150","PCTFE/PVC 泡罩包装","Novartis Pharma Stein AG","16230.00","修改（医保和招标信息）","医保发〔2023〕30号",""]
["410","XL01XEP125A001010101606","2","培唑帕尼片","","限晚期肾细胞癌患者的一线治疗和曾经接受过细胞因子治疗的晚期肾细胞癌的治疗。","203553","培唑帕尼片","无","片剂","0.2g(按C？？H？？N？O？S计)","瓶","30","口服固体药用高密度聚乙烯瓶包装","南京正大天晴制药有限公司","2850.00","修改（医保信息）","医保发〔2023〕30号",""]
["411","XL01XEP125A001010104021","2","培唑帕尼片","","限晚期肾细胞癌患者的一线治疗和曾经接受过细胞因子治疗的晚期肾细胞癌的治疗。","203549","培唑帕尼片","无","片剂","0.2g(按C？？H？？N？O？S计)","瓶","30","口服固体药用高密度聚乙烯瓶","齐鲁制药有限公司","2495.00","修改（医保信息）","医保发〔2023〕30号",""]
["412","XL01XEP125A001010178679","2","培唑帕尼片","","限晚期肾细胞癌患者的一线治疗和曾经接受过细胞因子治疗的晚期肾细胞癌的治疗。","163083","培唑帕尼片","维全特","片剂","200mg(按培唑帕尼计)","瓶","30","带聚丙烯儿童安全盖的高密度聚乙烯瓶","Glaxo Operations UK Limited, (trading as Glaxo Wellcome Operations)","3660.00","修改（医保信息）","医保发〔2023〕30号",""]
["413","XL04AAA362A001010101522","2","阿普米司特片","","限符合接受光疗或系统性治疗指征的中度至重度斑块状银屑病的成人患者。","204749","阿普米司特片","无","片剂","30mg","盒","60","聚氯乙烯固体药用硬片及药用铝箔包装","江苏正大清江制药有限公司","849.80","修改（医保信息）","医保发〔2023〕30号",""]
["414","XL04AAA362A001010102770","2","阿普米司特片","","限符合接受光疗或系统性治疗指征的中度至重度斑块状银屑病的成人患者。","203366","阿普米司特片","无","薄膜包衣片","20mg","盒","4","铝塑包装(聚氯乙烯固体药用硬片、药用铝箔)","石药集团欧意药业有限公司","45.90","修改（医保信息）","医保发〔2023〕30号",""]
["415","XL04AAA362A001010104021","2","阿普米司特片","","限符合接受光疗或系统性治疗指征的中度至重度斑块状银屑病的成人患者。","204211","阿普米司特片","无","薄膜衣片","30mg","盒","60","口服固体药用高密度聚乙烯瓶","齐鲁制药有限公司","659.40","修改（医保信息）","医保发〔2023〕30号",""]
["416","XL04AAA362A001010104522","2","阿普米司特片","","限符合接受光疗或系统性治疗指征的中度至重度斑块状银屑病的成人患者。","205137","阿普米司特片","无","薄膜衣片","30mg","盒","28","本品包装为铝塑泡罩包装(PVC/Al),包装材料为聚氯乙烯固体药用硬片(PVC)、 药品铝箔(Al)。","杭州朱养心药业有限公司","362.88","修改（医保信息）","医保发〔2023〕30号",""]
["417","XL04AAA362A001010178217","2","阿普米司特片","","限符合接受光疗或系统性治疗指征的中度至重度斑块状银屑病的成人患者。","175876","阿普米司特片","欧泰乐","片剂","规格10mg,规格20mg,规格30mg由13片泡罩板和14片泡罩板组成；13片泡罩板含有4片10 mg、4片20 mg和5片30 mg片剂；14片泡罩板含有14片30mg片剂；共计27片。","盒","27","PVC泡罩＋铝箔包装。两周起始剂量包装。","Patheon Inc. (负责片剂生产及HDPE瓶包装)","371.42","修改（医保信息）","医保发〔2023〕30号",""]
["418","XL04AAA362A001010182502","2","阿普米司特片","","限符合接受光疗或系统性治疗指征的中度至重度斑块状银屑病的成人患者。","205126","阿普米司特片","无","薄膜衣片","10mg","盒","4","聚氯乙烯固体药用硬片、药品包装用铝箔包装","兆科药业(广州)有限公司","26.20","修改（医保信息）","医保发〔2023〕30号",""]
["419","XL04AAA362A001020101522","2","阿普米司特片","","限符合接受光疗或系统性治疗指征的中度至重度斑块状银屑病的成人患者。","204750","阿普米司特片","无","片剂","第1板:10mg规格4片,20mg规格4片；第2板:30mg规格20片。以上2板装1盒","盒","28","聚氯乙烯固体药用硬片及药用铝箔包装","江苏正大清江制药有限公司","356.80","修改（医保信息）","医保发〔2023〕30号",""]
["420","XL04AAA362A001020102770","2","阿普米司特片","","限符合接受光疗或系统性治疗指征的中度至重度斑块状银屑病的成人患者。","203368","阿普米司特片","无","薄膜包衣片","10mg","盒","4","铝塑包装(聚氯乙烯固体药用硬片、药用铝箔)","石药集团欧意药业有限公司","27.00","修改（医保信息）","医保发〔2023〕30号",""]
["421","XL04AAA362A001020104021","2","阿普米司特片","","限符合接受光疗或系统性治疗指征的中度至重度斑块状银屑病的成人患者。","204212","阿普米司特片","无","薄膜衣片","10mg","盒","12","铝塑包装(聚氯乙烯固体药用硬片、药用铝箔)","齐鲁制药有限公司","60.32","修改（医保信息）","医保发〔2023〕30号",""]
["422","XL04AAA362A001020178217","2","阿普米司特片","","限符合接受光疗或系统性治疗指征的中度至重度斑块状银屑病的成人患者。","175873","阿普米司特片","欧泰乐","片剂","30mg","瓶","60","HDPE瓶装","Patheon Inc. (负责片剂生产及HDPE瓶包装)","942.00","修改（医保信息）","医保发〔2023〕30号",""]
["423","XL04AAA362A001020182502","2","阿普米司特片","","限符合接受光疗或系统性治疗指征的中度至重度斑块状银屑病的成人患者。","205127","阿普米司特片","无","薄膜衣片","20mg","盒","4","聚氯乙烯固体药用硬片、药品包装用铝箔包装","兆科药业(广州)有限公司","44.52","修改（医保信息）","医保发〔2023〕30号",""]
["424","XL04AAA362A001030102770","2","阿普米司特片","","限符合接受光疗或系统性治疗指征的中度至重度斑块状银屑病的成人患者。","203347","阿普米司特片","无","薄膜包衣片","30mg","盒","56","铝塑包装(聚氯乙烯固体药用硬片、药用铝箔)","石药集团欧意药业有限公司","795.94","修改（医保信息）","医保发〔2023〕30号",""]
["425","XL04AAA362A001030182502","2","阿普米司特片","","限符合接受光疗或系统性治疗指征的中度至重度斑块状银屑病的成人患者。","205128","阿普米司特片","无","薄膜衣片","30mg","盒","20","聚氯乙烯固体药用硬片、药品包装用铝箔包装","兆科药业(广州)有限公司","286.40","修改（医保信息）","医保发〔2023〕30号",""]
["426","XL04AAA362A001040104522","2","阿普米司特片","","限符合接受光疗或系统性治疗指征的中度至重度斑块状银屑病的成人患者。","205138","阿普米司特片","无","薄膜衣片","组合包装:10mg×4 片/板×1 板,20mg×4 片/板×1 板,共8片","盒","8","本品包装为铝塑泡罩包装(PVC/Al),包装材料为聚氯乙烯固体药用硬片(PVC)、 药品铝箔(Al)。","杭州朱养心药业有限公司","64.81","修改（医保信息）","医保发〔2023〕30号",""]
["427","XR05CBF100X001010104610","2","福多司坦口服溶液","","","310085","福多司坦口服溶液","无","口服溶液剂","50ml:4g","盒","1","口服液体药用高密度聚乙烯瓶","浙江北生药业汉生制药有限公司","29.12","修改（医保信息）","医保发〔2023〕30号",""]
["428","XR05CBF100X001010182209","2","福多司坦口服溶液","","","175556","福多司坦口服溶液","无","口服溶液剂","100ml:8g","盒","1","口服液体药用聚酯瓶及口服药用高密度聚乙烯盖","北京诚济制药股份有限公司","49.50","修改（医保信息）","医保发〔2023〕30号",""]
["429","XV04CXL401L017010101523","2","吸入用氯醋甲胆碱","","","175249","吸入用氯醋甲胆碱","无","吸入制剂","100mg","盒","1","中硼硅玻璃管制注射剂瓶、注射用无菌粉末用聚对二甲苯镀膜溴化丁基橡胶塞和抗生素瓶用铝塑组合盖包装","正大天晴药业集团股份有限公司","157.80","修改（医保信息）","医保发〔2023〕30号",""]
["430","XV04CXL401L017010102918","2","吸入用氯醋甲胆碱","","","310086","吸入用氯醋甲胆碱","无","吸入制剂","100mg","盒","1","中硼硅玻璃管制注射剂瓶、注射用无菌粉末用覆聚酯膜溴化丁基橡胶塞和抗生素瓶用铝塑组合盖包装。","山西普德药业有限公司","157.79","修改（医保信息）","医保发〔2023〕30号",""]
["431","XV04CXL401L017010202918","2","吸入用氯醋甲胆碱","","","310087","吸入用氯醋甲胆碱","无","吸入制剂","100mg","盒","12","中硼硅玻璃管制注射剂瓶、注射用无菌粉末用覆聚酯膜溴化丁基橡胶塞和抗生素瓶用铝塑组合盖包装。","山西普德药业有限公司","1893.48","修改（医保信息）","医保发〔2023〕30号",""]
["432","XL01XXA316A001010179096","2","奥拉帕利片","","限：1.携带胚系或体细胞BRCA突变的(gBRCAm或sBRCAm)晚期上皮性卵巢癌、输卵管癌或原发性腹膜癌初治成人患者在一线含铂化疗达到完全缓解或部分缓解后的维持治疗；2.同源重组修复缺陷(HRD)阳性的晚期上皮性卵巢癌、输卵管癌或原发性腹膜癌成人患者在一线含铂化疗联合贝伐珠单抗治疗达到完全缓解或部分缓解后的维持治疗；3.铂敏感的复发性上皮性卵巢癌、输卵管癌或原发性腹膜癌成人患者在含铂化疗达到完全缓解或部分缓解后的维持治疗；4.携带胚系或体细胞BRCA突变(gBRCAm或sBRCAm)且既往治疗(包括一种新型内分泌药物)失败的转移性去势抵抗性前列腺癌成人患者的治疗。","165739","奥拉帕利片","利普卓","薄膜衣片","0.15g","盒","56","双铝","美国AbbVie Limited","5026.56","修改（医保信息）","医保发〔2023〕30号",""]
["433","XM05BXD334B002010178217","2","地舒单抗注射液","","","165853","地舒单抗注射液","安加维","注射液","120 mg(1.7 mL)/瓶","盒","1","西林瓶","Amgen Inc.","1060.00","修改（医保和招标信息）","医保发〔2023〕30号",""]
["434","XM05BXD334B002010182980","2","地舒单抗注射液","","","171132","地舒单抗注射液","普罗力","注射剂","60 mg(1.0 ml)/支(预充式注射器)","盒","1","预充式注射器","Amgen Manufacturing Limited","623.53","修改（医保和招标信息）","医保发〔2023〕30号",""]
["435","XM05BXD334B002010183013","2","地舒单抗注射液","","","177057","地舒单抗注射液","博优倍","注射液","1ml:60mg","支","1","预充式(预灌封)注射器","山东博安生物技术股份有限公司","615.00","修改（医保信息）","医保发〔2023〕30号",""]
["436","XM05BXD334B002010184517","2","地舒单抗注射液","","","203669","地舒单抗注射液","无","注射剂","60mg(1.0ml)/支(预充式注射器)","盒","1","预充式注射器","江苏泰康生物医药有限公司","613.80","修改（医保信息）","医保发〔2023〕30号",""]
["437","XR06AXD078K001030101442","2","地氯雷他定","口服液体剂","","169161","地氯雷他定糖浆","无","糖浆剂","120ml:60mg(50%)","盒","1","塑料瓶","江苏广承药业有限公司","50.66","修改（医保备注）","医保发〔2023〕30号",""]
["438","XR06AXD078K001030105848","2","地氯雷他定","口服液体剂","","126734","地氯雷他定糖浆","无","糖浆剂","100ml:50mg(50%)","瓶","1","玻璃瓶","万特制药(海南)有限公司","52.81","修改（医保备注）","医保发〔2023〕30号",""]
["439","XR06AXD078X001010100299","2","地氯雷他定","口服液体剂","","175929","地氯雷他定口服溶液","无","口服溶液剂","60ml:30mg","瓶","1","玻璃瓶","广东九明制药有限公司","112.68","修改（医保备注）","医保发〔2023〕30号",""]
["440","XR06AXD078X001010102753","2","地氯雷他定","口服液体剂","","203123","地氯雷他定口服溶液","无","口服溶液剂","100ml:50mg","盒","1","口服液体药用高密度聚乙烯瓶","石家庄市华新药业有限责任公司","98.00","修改（医保备注）","医保发〔2023〕30号",""]
["441","XR06AXD078X001010104610","2","地氯雷他定","口服液体剂","","202125","地氯雷他定口服溶液","无","口服溶液剂","100ml:50mg","盒","1","口服液体药用高密度聚乙烯瓶","浙江北生药业汉生制药有限公司","166.60","修改（医保备注）","医保发〔2023〕30号",""]
["442","XR06AXD078X001010105815","2","地氯雷他定","口服液体剂","","201579","地氯雷他定口服溶液","无","口服溶液剂","120ml:60mg","盒","1","口服液体药用聚酯瓶和口服液体药用聚酯瓶用盖包装","海南合瑞制药股份有限公司","198.00","修改（医保备注）","医保发〔2023〕30号",""]
["443","XR06AXD078X001010110237","2","地氯雷他定","口服液体剂","","174056","地氯雷他定口服溶液","无","口服溶液剂","50ml:25mg","盒","1","塑料瓶","合肥恩瑞特药业有限公司","98.00","修改（医保备注）","医保发〔2023〕30号",""]
["444","XR06AXD078X001010181654","2","地氯雷他定","口服液体剂","","202591","地氯雷他定口服溶液","无","口服溶液剂","10ml:5mg","盒","2","钠钙玻璃管制口服液体瓶和口服液瓶用铝塑组合盖","哈尔滨圣泰生物制药有限公司","48.40","修改（医保备注）","医保发〔2023〕30号",""]
["445","XR06AXD078X001010381654","2","地氯雷他定","口服液体剂","","202592","地氯雷他定口服溶液","无","口服溶液剂","10ml:5mg","盒","3","钠钙玻璃管制口服液体瓶和口服液瓶用铝塑组合盖","哈尔滨圣泰生物制药有限公司","72.60","修改（医保备注）","医保发〔2023〕30号",""]
["446","XR06AXD078X001010581654","2","地氯雷他定","口服液体剂","","202597","地氯雷他定口服溶液","无","口服溶液剂","10ml:5mg","盒","4","钠钙玻璃管制口服液体瓶和口服液瓶用铝塑组合盖","哈尔滨圣泰生物制药有限公司","96.80","修改（医保备注）","医保发〔2023〕30号",""]
["447","XR06AXD078X001020100299","2","地氯雷他定","口服液体剂","","176871","地氯雷他定口服溶液","无","口服溶液剂","30ml:15mg","瓶","1","玻璃瓶","广东九明制药有限公司","66.28","修改（医保备注）","医保发〔2023〕30号",""]
["448","XR06AXD078X001020104077","2","地氯雷他定","口服液体剂","","203203","地氯雷他定口服溶液","无","口服溶液剂","60ml/瓶","盒","1","口服液体药用聚酯瓶,口服药用高密度聚乙烯压旋盖","山东达因海洋生物制药股份有限公司","109.00","修改（医保备注）","医保发〔2023〕30号",""]
["449","XR06AXD078X006010505801","2","地氯雷他定","口服液体剂","","129663","地氯雷他定干混悬剂","芙必叮","干混悬剂","0.5g:2.5mg","盒","14","复合膜","海南普利制药股份有限公司","29.13","修改（医保备注）","医保发〔2023〕30号",""]
["450","XR06AXD078X006020305801","2","地氯雷他定","口服液体剂","","129673","地氯雷他定干混悬剂","芙必叮","干混悬剂","1g:5mg","盒","10","复合膜","海南普利制药股份有限公司","38.71","修改（医保备注）","医保发〔2023〕30号",""]
["451","XR06AEX017K001010104010","2","西替利嗪","口服液体剂","","130816","盐酸西替利嗪糖浆","贝分","糖浆剂","120ml:0.12g","瓶","1","塑料瓶","鲁南贝特制药有限公司","17.25","修改（医保备注）","医保发〔2023〕30号",""]
["452","XR06AEX017X001010100041","2","西替利嗪","口服液体剂","","121958","盐酸西替利嗪口服溶液","无","口服溶液剂","100ml:0.1g(0.1%)","瓶","1","塑料瓶","北京韩美药品有限公司","17.00","修改（医保备注）","医保发〔2023〕30号",""]
["453","XR06AEX017X001010100400","2","西替利嗪","口服液体剂","","121354","盐酸西替利嗪口服溶液","无","口服溶液剂","10ml:10mg(0.1%)","盒","5","玻璃瓶","广州康臣药业有限公司","18.07","修改（医保备注）","医保发〔2023〕30号",""]
["454","XR06AEX017X001010182338","2","西替利嗪","口服液体剂","","203217","盐酸西替利嗪口服溶液","无","口服溶液剂","100ml∶0.1g","盒","1","钠钙玻璃模制药瓶和儿童安全阻开盖","成都倍特得诺药业有限公司","36.00","修改（医保备注）","医保发〔2023〕30号",""]
["455","XR06AEX017X001020102166","2","西替利嗪","口服液体剂","","151862","盐酸西替利嗪口服溶液","无","口服溶液剂","60ml:60mg(0.1%)","瓶","1","塑料瓶","四川健能制药有限公司","14.45","修改（医保备注）","医保发〔2023〕30号",""]
["456","XR06AEX017X001020107800","2","西替利嗪","口服液体剂","","139980","盐酸西替利嗪口服溶液","无","口服溶液剂","150ml:0.15g(0.1%)","瓶","1","塑料瓶","广东众生药业股份有限公司","32.2","修改（医保备注）","医保发〔2023〕30号",""]
["457","XR06AEX017X004010102044","2","西替利嗪","口服液体剂","","202419","盐酸西替利嗪滴剂","无","滴剂","20ml:0.2g(10mg/ml)","盒","1","钠钙玻璃管制口服液体瓶,口服液体药用低密度聚乙烯滴塞及口服液体药用压旋瓶盖","成都利尔药业有限公司","74.10","修改（医保备注）","医保发〔2023〕30号",""]
["458","XR06AEX017X004010278928","2","西替利嗪","口服液体剂","","142015","盐酸西替利嗪滴剂","仙特明","滴剂","10mg/ml(10ml)","盒","1","玻璃瓶","意大利AESICA PHARMACEUTICALS S.r.l.","40.80","修改（医保备注）","医保发〔2023〕30号",""]
["459","XR06AEX017X004020179136","2","西替利嗪","口服液体剂","","132286","盐酸西替利嗪滴剂","无","滴剂","20ml:0.2g","瓶","1","玻璃瓶","香港澳美制药厂","22.67","修改（医保备注）","医保发〔2023〕30号",""]
["460","XR06AEX017X004030102044","2","西替利嗪","口服液体剂","","202424","盐酸西替利嗪滴剂","无","滴剂","10ml:0.1g(10mg/ml)","盒","1","钠钙玻璃管制口服液体瓶,口服液体药用低密度聚乙烯滴塞及口服液体药用压旋瓶盖","成都利尔药业有限公司","39.00","修改（医保备注）","医保发〔2023〕30号",""]
["461","XR06AEX017X004030179136","2","西替利嗪","口服液体剂","","127831","盐酸西替利嗪滴剂","无","滴剂","30ml:0.3g","瓶","1","玻璃瓶","香港澳美制药厂","33.00","修改（医保备注）","医保发〔2023〕30号",""]
["462","XR06AEZ066X001010100041","2","左西替利嗪","口服液体剂","","165884","盐酸左西替利嗪口服溶液","无","口服溶液剂","75ml:37.5mg","瓶","1","塑料瓶","北京韩美药品有限公司","36.00","修改（医保备注）","医保发〔2023〕30号",""]
["463","XR06AEZ066X001010101003","2","左西替利嗪","口服液体剂","","146159","盐酸左西替利嗪口服溶液","无","口服溶液剂","10ml(0.05%)","盒","6","玻璃瓶","重庆华邦制药有限公司","16.68","修改（医保备注）","医保发〔2023〕30号",""]
["464","XR06AEZ066X001010102132","2","左西替利嗪","口服液体剂","","170260","盐酸左西替利嗪口服溶液","无","口服溶液剂","150ml:75mg","盒","1","塑料瓶","四川大冢制药有限公司","168.00","修改（医保备注）","医保发〔2023〕30号",""]
["465","XR06AEZ066X001010201003","2","左西替利嗪","口服液体剂","","148433","盐酸左西替利嗪口服溶液","无","口服溶液剂","10ml(0.05%)","盒","10","玻璃瓶","重庆华邦制药有限公司","27.80","修改（医保备注）","医保发〔2023〕30号",""]
["466","XR06AEZ066X001010204828","2","左西替利嗪","口服液体剂","","171935","盐酸左西替利嗪口服溶液","无","口服溶液剂","75ml:37.5mg","盒","1","塑料瓶","福州海王金象中药制药有限公司","89.00","修改（医保备注）","医保发〔2023〕30号",""]
["467","XR06AEZ066X001020102132","2","左西替利嗪","口服液体剂","","176003","盐酸左西替利嗪口服溶液","无","口服溶液剂","75ml:37.5mg","瓶","1","塑料瓶","四川大冢制药有限公司","98.80","修改（医保备注）","医保发〔2023〕30号",""]
["468","XR06AEZ066X004010101012","2","左西替利嗪","口服液体剂","","173432","盐酸左西替利嗪口服滴剂","无","滴剂","20ml:0.1g","盒","1","玻璃瓶","广州一品红制药有限公司","49.80","修改（医保备注）","医保发〔2023〕30号",""]
["469","XR06AEZ066X004010104873","2","左西替利嗪","口服液体剂","","174197","盐酸左西替利嗪口服滴剂","无","滴剂","10ml:50mg","瓶","1","塑料瓶","国药控股星鲨制药(厦门)有限公司","43.00","修改（医保备注）","医保发〔2023〕30号",""]
["470","XR06AEZ066X004010110237","2","左西替利嗪","口服液体剂","","201521","盐酸左西替利嗪口服滴剂","无","口服溶液剂","10ml:50mg","盒","1","钠钙玻璃模制药瓶,口服药用聚丙烯压旋盖,药用低密度聚乙烯瓶塞包装。","合肥恩瑞特药业有限公司","58.00","修改（医保备注）","医保发〔2023〕30号",""]
["471","XR06AEZ066X004020104873","2","左西替利嗪","口服液体剂","","174101","盐酸左西替利嗪口服滴剂","无","滴剂","20ml:0.1g","瓶","1","塑料瓶","国药控股星鲨制药(厦门)有限公司","82.00","修改（医保备注）","医保发〔2023〕30号",""]
["472","XA10BHL343A001010106988","2","利格列汀","口服常释剂型","","171884","利格列汀片","无","片剂","5mg","盒","7","双铝包装","广东东阳光药业有限公司","44.80","修改（医保备注）","医保发〔2023〕30号",""]
["473","XA10BHX202A001010104495","2","西格列汀","口服常释剂型","","205707","磷酸西格列汀片","捷诺维","片剂","100mg","盒","7","铝塑","杭州默沙东制药有限公司","51.63","修改（医保备注）","医保发〔2023〕30号",""]
["474","XA10BHX202A001010178377","2","西格列汀","口服常释剂型","","203791","磷酸西格列汀片","无","薄膜衣片","100mg","瓶","30","瓶装,口服固体药用高密度聚乙烯瓶包装系统和口服固体药用高密度聚乙烯干燥剂罐","Dr.Reddy`s Laboratories Limited","197.40","修改（医保备注）","医保发〔2023〕30号",""]
["475","XA10BHX202A001010278642","2","西格列汀","口服常释剂型","","151168","磷酸西格列汀片","捷诺维","薄膜衣片","0.1g","盒","14","铝塑","英国Merck Sharp & Dohme Ltd.","103.26","修改（医保备注）","医保发〔2023〕30号",""]
["476","XA10BHX202A001010401523","2","西格列汀","口服常释剂型","","176229","磷酸西格列汀片","无","薄膜衣片","25mg","盒","28","铝塑","正大天晴药业集团股份有限公司","64.10","修改（医保备注）","医保发〔2023〕30号",""]
["477","XA10BHX202A001020301523","2","西格列汀","口服常释剂型","","176194","磷酸西格列汀片","无","薄膜衣片","0.1g","盒","14","铝塑","正大天晴药业集团股份有限公司","89.00","修改（医保备注）","医保发〔2023〕30号",""]
["478","XA10ABC161B002030100227","2","重组赖脯胰岛素","注射剂","","117180","赖脯胰岛素注射液","无","注射液","3ml:300单位","支","1","笔芯","甘李药业股份有限公司","23.98","修改（医保备注）","医保发〔2023〕30号",""]
["479","XA10BDL358A001010181737","2","利格列汀二甲双胍Ⅰ/n利格列汀二甲双胍Ⅱ","口服常释剂型","","166846","利格列汀二甲双胍片(Ⅱ)","无","薄膜衣片","利格列汀2.5mg,盐酸二甲双胍0.85g","盒","14","铝箔","德国勃林格殷格翰药业公司Boehringer Ingelheim Pharma GmbH & Co KG","79.77","修改（医保备注）","医保发〔2023〕30号",""]
["480","XA10BDX222A001010279533","2","西格列汀二甲双胍Ⅰ/n西格列汀二甲双胍Ⅱ","口服常释剂型","","163014","西格列汀二甲双胍片(I)","捷诺达","薄膜衣片","含磷酸西格列汀50mg(以西格列汀计),盐酸二甲双胍0.5g","盒","28","铝塑","美国Patheon Puerto Rico, Inc. (Manati)","135.84","修改（医保备注）","医保发〔2023〕30号",""]
["481","XA10BDX223A001010279533","2","西格列汀二甲双胍Ⅰ/n西格列汀二甲双胍Ⅱ","口服常释剂型","","163015","西格列汀二甲双胍片(II)","捷诺达","薄膜衣片","含磷酸西格列汀50mg(以西格列汀计),盐酸二甲双胍0.85g","盒","28","铝塑","美国Patheon Puerto Rico, Inc. (Manati)","136.68","修改（医保备注）","医保发〔2023〕30号",""]
["482","XA10BDS251A010010100177","2","沙格列汀二甲双胍Ⅰ/n沙格列汀二甲双胍Ⅱ/n沙格列汀二甲双胍Ⅲ","缓释控释剂型","","204884","沙格列汀二甲双胍缓释片(Ⅰ)","无","片剂","每片含沙格列汀5mg与盐酸二甲双胍1000mg","盒","7","铝塑包装外套复合膜袋","北京福元医药股份有限公司","62.77","修改（医保备注）","医保发〔2023〕30号",""]
["483","XA10BDS251A010010301359","2","沙格列汀二甲双胍Ⅰ/n沙格列汀二甲双胍Ⅱ/n沙格列汀二甲双胍Ⅲ","缓释控释剂型","","163113","沙格列汀二甲双胍缓释片(Ⅰ)","安立格","缓释片","沙格列汀5mg,盐酸二甲双胍1.0g","盒","14","铝塑","美国AstraZeneca Pharmaceuticals LP","136.00","修改（医保备注）","医保发〔2023〕30号",""]
["484","XA10BDS253A010010200177","2","沙格列汀二甲双胍Ⅰ/n沙格列汀二甲双胍Ⅱ/n沙格列汀二甲双胍Ⅲ","缓释控释剂型","","204885","沙格列汀二甲双胍缓释片(Ⅲ)","无","片剂","每片含沙格列汀2.5mg与盐酸二甲双胍1000mg","盒","14","铝塑包装外套复合膜袋","北京福元医药股份有限公司","72.00","修改（医保备注）","医保发〔2023〕30号",""]
["485","XA10BDS253A010010279096","2","沙格列汀二甲双胍Ⅰ/n沙格列汀二甲双胍Ⅱ/n沙格列汀二甲双胍Ⅲ","缓释控释剂型","","163114","沙格列汀二甲双胍缓释片(Ⅲ)","安立格","缓释片","沙格列汀2.5mg,盐酸二甲双胍1.0g","盒","14","铝塑","美国AstraZeneca Pharmaceuticals LP","80.00","修改（医保备注）","医保发〔2023〕30号",""]
["486","XA10BHA283A001010179133","2","阿格列汀","口服常释剂型","","154538","苯甲酸阿格列汀片","尼欣那","薄膜衣片","25mg","盒","10","铝塑","爱尔兰Takeda Ireland Limited","80.66","修改（医保备注）","医保发〔2023〕30号",""]
["487","XH01ACC113B001010103315","2","人生长激素(重组人生长激素)","注射剂","限生长激素缺乏症。","123858","注射用人生长激素","赛增(Jintropin)","冻干粉针剂","3.7mg(10IU)","瓶","1","玻璃瓶","长春金赛药业有限责任公司","87.00","修改（医保备注）","医保发〔2023〕30号",""]
["488","XH01ACC113B001030103315","2","人生长激素（重组人生长激素）","注射剂","限生长激素缺乏症。","123845","注射用人生长激素","赛增(Jintropin)","冻干粉针剂","0.85mg(2.5IU)","瓶","1","玻璃瓶","长春金赛药业有限责任公司","33.35","修改（医保备注）","医保发〔2023〕30号",""]
["489","XH01ACC113B001040103315","2","人生长激素（重组人生长激素）","注射剂","限生长激素缺乏症。","123848","注射用人生长激素","赛增(Jintropin)","冻干粉针剂","1.33mg(4IU)","瓶","1","玻璃瓶","长春金赛药业有限责任公司","43.41","修改（医保备注）","医保发〔2023〕30号",""]
["490","XH01ACC113B001050103315","2","人生长激素（重组人生长激素）","注射剂","限生长激素缺乏症。","123854","注射用人生长激素","赛增(Jintropin)","冻干粉针剂","1.7mg(4.5IU)","瓶","1","玻璃瓶","长春金赛药业有限责任公司","44.66","修改（医保备注）","医保发〔2023〕30号",""]
["491","XH01ACC113B002010103315","2","人生长激素（重组人生长激素）","注射剂","限生长激素缺乏症。","123863","重组人生长激素注射液","赛增(Jintropin)","注射液","3ml:5mg(15单位)","瓶","1","玻璃瓶","长春金赛药业有限责任公司","553.14","修改（医保备注）","医保发〔2023〕30号",""]
["492","XH01ACC113B002030103315","2","人生长激素（重组人生长激素）","注射剂","限生长激素缺乏症。","123866","重组人生长激素注射液","赛增（Jintropin）","注射液","3ml:10mg(30单位)","瓶","1","玻璃瓶","长春金赛药业有限责任公司","1023.38","修改（医保备注）","医保发〔2023〕30号",""]
["493","XH01ACC113B014020100719","2","人生长激素（重组人生长激素）","注射剂","限生长激素缺乏症。","141095","注射用人生长激素","珍怡","冻干粉针剂","1.0ml:1.33mg(4IU)","支","1","西林瓶","上海联合赛尔生物工程有限公司","58.97","修改（医保备注）","医保发〔2023〕30号",""]
["494","XH01ACC113B014020104274","2","人生长激素（重组人生长激素）","注射剂","限生长激素缺乏症。","136210","注射用人生长激素","安苏萌","冻干粉针剂","1.33mg(4IU)","支","1","玻璃瓶","安徽安科生物工程(集团)股份有限公司","57.16","修改（医保备注）","医保发〔2023〕30号",""]
["495","XH01ACC113B014030100719","2","人生长激素（重组人生长激素）","注射剂","限生长激素缺乏症。","141097","注射用人生长激素","珍怡","冻干粉针剂","1.0ml:2.0mg(6IU)","支","1","西林瓶","上海联合赛尔生物工程有限公司","80.43","修改（医保备注）","医保发〔2023〕30号",""]
["496","XH01ACC113B014030104274","2","人生长激素（重组人生长激素）","注射剂","限生长激素缺乏症。","136209","注射用人生长激素","安苏萌","冻干粉针剂","1.5mg(4.5IU)","支","1","玻璃瓶","安徽安科生物工程(集团)股份有限公司","72.45","修改（医保备注）","医保发〔2023〕30号",""]
["497","XH01CBS078B001010101749","2","生长抑素","注射剂","","101526","注射用生长抑素","无","冻干粉针剂","3mg","瓶","1","西林瓶","江苏海岸药业有限公司","15.80","修改（医保备注）","医保发〔2023〕30号",""]
["498","XH01CBS078B001010104188","2","生长抑素","注射剂","","131326","注射用生长抑素","无","冻干粉针剂","3mg","盒","1","玻璃瓶","山东新时代药业有限公司","29.16","修改（医保备注）","医保发〔2023〕30号",""]
["499","XH01CBS078B001010105589","2","生长抑素","注射剂","","115723","注射用生长抑素","无","冻干粉针剂","3mg","瓶","1","玻璃瓶","昆明积大制药股份有限公司","49.89","修改（医保备注）","医保发〔2023〕30号",""]
["500","XH01CBS078B001010105814","2","生长抑素","注射剂","","104773","注射用生长抑素","无","冻干粉针剂","3mg","瓶","1","西林瓶","海南双成药业股份有限公司","32.70","修改（医保备注）","医保发〔2023〕30号",""]
["501","XH01CBS078B001010107821","2","生长抑素","注射剂","","203786","注射用生长抑素","无","冻干粉针剂","3mg","盒","2","玻璃瓶","成都圣诺生物制药有限公司","15.76","修改（医保备注）","医保发〔2023〕30号",""]
["502","XH01CBS078B001010109554","2","生长抑素","注射剂","","204831","注射用生长抑素","无","注射剂","3mg","盒","10","中硼硅玻璃管制注射剂瓶、冷冻干燥注射用局部覆聚四氟乙烯膜卤化丁基橡胶塞(溴化)、抗生素瓶用铝塑组合盖","福安药业集团湖北人民制药有限公司","288.00","修改（医保备注）","医保发〔2023〕30号",""]
["503","XH01CBS078B001010179323","2","生长抑素","注射剂","","144466","注射用生长抑素","思他宁","注射剂","3mg","盒","1","安瓿","意大利Alfasigma   S.p.A","346.38","修改（医保备注）","医保发〔2023〕30号",""]
["504","XH01CBS078B001010205781","2","生长抑素","注射剂","","175609","注射用生长抑素","无","冻干粉针剂","3mg","盒","1","玻璃瓶","海南皇隆制药股份有限公司","29.07","修改（医保备注）","医保发〔2023〕30号",""]
["505","XH01CBS078B001010305781","2","生长抑素","注射剂","","204646","注射用生长抑素","无","注射剂","3mg","盒","10","中硼硅玻璃管制注射剂瓶,冷冻干燥注射用无菌粉末用溴化丁基橡胶塞","海南皇隆制药股份有限公司","290.70","修改（医保备注）","医保发〔2023〕30号",""]
["506","XH01CBS078B001020105842","2","生长抑素","注射剂","","111981","注射用生长抑素","无","注射剂","3mg","瓶","1","中硼硅玻璃管制注射剂瓶、冷冻干燥注射用局部覆聚四氟乙烯膜卤化丁基橡胶塞(溴化)和抗生素瓶用铝塑组合盖包装","海南中和药业股份有限公司","83.90","修改（医保备注）","医保发〔2023〕30号",""]
["507","XH01CBS078B001030600526","2","生长抑素","注射剂","","140057","注射用生长抑素","无","注射剂","3mg(按生长抑素计)","支","1","西林瓶","深圳翰宇药业股份有限公司","27.99","修改（医保备注）","医保发〔2023〕30号",""]
["508","XH01CBS078B001040105923","2","生长抑素","注射剂","","131989","注射用生长抑素","无","注射剂","3mg","支","1","玻璃瓶","上海华源药业(宁夏)沙赛制药有限公司","19.45","修改（医保备注）","医保发〔2023〕30号",""]
["509","XH01CBS078B003010102066","2","生长抑素","注射剂","","125624","注射用生长抑素","无","注射用无菌粉末","0.75mg","瓶","1","玻璃瓶","成都天台山制药股份有限公司","34.11","修改（医保备注）","医保发〔2023〕30号",""]
["510","XH01CBS078B003020102066","2","生长抑素","注射剂","","125632","注射用生长抑素","无","注射用无菌粉末","3mg","瓶","1","玻璃瓶","成都天台山制药股份有限公司","94.00","修改（医保备注）","医保发〔2023〕30号",""]
["511","XH01CBS078B014020104029","2","生长抑素","注射剂","","130512","注射用生长抑素","无","冻干粉针剂","3mg","支","1","西林瓶","青岛国大生物制药股份有限公司","58.05","修改（医保备注）","医保发〔2023〕30号",""]
["512","XH01CBS078B014020200148","2","生长抑素","注射剂","","146561","注射用生长抑素","无","冻干粉针剂","3mg","瓶","1","西林瓶","北京双鹭药业股份有限公司","8.99","修改（医保备注）","医保发〔2023〕30号",""]
["513","XB03XAC103B002010100152","2","人促红素[重组人促红素(CHO细胞)]","注射剂","","122138","人促红素注射液","环尔博","注射液","0.4ml:2000IU","盒","1","预充式(预灌封)注射器","北京四环生物制药有限公司","20.00","修改（医保备注）","医保发〔2023〕30号",""]
["514","XB03XAC103B002010101313","2","人促红素[重组人促红素(CHO细胞)]","注射剂","","103681","人促红素注射液","益比奥","注射液","1ml:1万IU","瓶","1","西林瓶","沈阳三生制药有限责任公司","80.06","修改（医保备注）","医保发〔2023〕30号",""]
["515","XB03XAC103B002010102954","2","人促红素[重组人促红素(CHO细胞)]","注射剂","","115346","人促红素注射液","宁红欣","注射液","1ml:4000IU","瓶","1","西林瓶","山西威奇达光明制药有限公司","31.53","修改（医保备注）","医保发〔2023〕30号",""]
["516","XB03XAC103B002020103708","2","人促红素[重组人促红素(CHO细胞)]","注射剂","","122925","人促红素注射液","无","注射液","1ml:3000IU","盒","1","预充式(预灌封)注射器","哈药集团生物工程有限公司","19.48","修改（医保备注）","医保发〔2023〕30号",""]
["517","XB03XAC103B002020200617","2","人促红素[重组人促红素(CHO细胞)]","注射剂","","137810","重组人促红素注射液(CHO细胞)","利血宝","注射液","2ml:3000IU","支","1","预充式(预灌封)注射器","日本Nichi-Iko Gifu Plant Co., Ltd.","109.91","修改（医保备注）","医保发〔2023〕30号",""]
["518","XB03XAC103B002030100152","2","人促红素[重组人促红素(CHO细胞)]","注射剂","","122148","人促红素注射液","环尔博","注射液","0.6ml:3000IU","盒","1","预充式(预灌封)注射器","北京四环生物制药有限公司","19.90","修改（医保备注）","医保发〔2023〕30号",""]
["519","XB03XAC103B002030102954","2","人促红素[重组人促红素(CHO细胞)]","注射剂","","115337","人促红素注射液","宁红欣","注射液","1ml:3000IU","瓶","1","西林瓶","山西威奇达光明制药有限公司","18.53","修改（医保备注）","医保发〔2023〕30号",""]
["520","XB03XAC103B002030103708","2","人促红素[重组人促红素(CHO细胞)]","注射剂","","122933","人促红素注射液","雪达升","注射液","1ml:4000IU","盒","1","预充式(预灌封)注射器","哈药集团生物工程有限公司","31.05","修改（医保备注）","医保发〔2023〕30号",""]
["521","XB03XAC103B002040100152","2","人促红素[重组人促红素(CHO细胞)]","注射剂","","122174","人促红素注射液","环尔博","注射液","0.6ml:6000IU","盒","1","预充式(预灌封)注射器","北京四环生物制药有限公司","43.41","修改（医保备注）","医保发〔2023〕30号",""]
["522","XB03XAC103B002040200617","2","人促红素[重组人促红素(CHO细胞)]","注射剂","","137811","重组人促红素注射液(CHO细胞)","利血宝","注射液","0.5ml:6000IU","支","1","预充式(预灌封)注射器","日本Nichi-Iko Gifu Plant Co., Ltd.","204.82","修改（医保备注）","医保发〔2023〕30号",""]
["523","XB03XAC103B002050100152","2","人促红素[重组人促红素(CHO细胞)]","注射剂","","122156","人促红素注射液","环尔博","注射液","0.8ml:4000IU","盒","1","预充式(预灌封)注射器","北京四环生物制药有限公司","25.76","修改（医保备注）","医保发〔2023〕30号",""]
["524","XB03XAC103B002050101313","2","人促红素[重组人促红素(CHO细胞)]","注射剂","","103658","人促红素注射液","益比奥","注射液","1ml:3000IU","瓶","1","西林瓶","沈阳三生制药有限责任公司","20.83","修改（医保备注）","医保发〔2023〕30号",""]
["525","XB03XAC103B002070101313","2","人促红素[重组人促红素(CHO细胞)]","注射剂","","103669","人促红素注射液","益比奥","注射液","1ml:4000IU","瓶","1","西林瓶","沈阳三生制药有限责任公司","35.75","修改（医保备注）","医保发〔2023〕30号",""]
["526","XB03XAC103B002090100152","2","人促红素[重组人促红素(CHO细胞)]","注射剂","","122124","人促红素注射液","环尔博","注射液","1ml:5000IU","瓶","1","西林瓶","北京四环生物制药有限公司","29.26","修改（医保备注）","医保发〔2023〕30号",""]
["527","XB03XAC103B002100200517","2","人促红素[重组人促红素(CHO细胞)]","注射剂","","100306","人促红素注射液","赛博尔","注射液","1ml:3000IU","支","1","西林瓶","深圳赛保尔生物药业有限公司","19.37","修改（医保备注）","医保发〔2023〕30号",""]
["528","XB03XAC103B002120200517","2","人促红素[重组人促红素(CHO细胞)]","注射剂","","100322","人促红素注射液","赛博尔","注射液","1ml:5000IU","支","1","西林瓶","深圳赛保尔生物药业有限公司","32.68","修改（医保备注）","医保发〔2023〕30号",""]
["529","XB03XAC103B003020102018","2","人促红素[重组人促红素(CHO细胞)]","注射剂","","143039","注射用人促红素","依倍","冻干粉针剂","3000IU","瓶","1","玻璃瓶","成都地奥九泓制药厂","24.00","修改（医保备注）","医保发〔2023〕30号",""]
["530","XB03XAR103B002020103708","2","人促红素[重组人促红素(CHO细胞)]","注射剂","","122919","人促红素注射液","雪达升","注射液","1ml:3000IU","支","1","玻璃瓶","哈药集团生物工程有限公司","19.48","修改（医保备注）","医保发〔2023〕30号",""]
["531","XB03XAR103B002090104064","2","人促红素[重组人促红素(CHO细胞)]","注射剂","","144311","人促红素注射液","佳林豪","注射剂","12000IU/1ml/支","盒","10","玻璃瓶","华润昂德生物药业有限公司","948.40","修改（医保备注）","医保发〔2023〕30号",""]
["532","XB03BAJ038B001010100487","2","甲钴胺","注射剂","","103129","注射用甲钴胺","爱昕保","冻干粉针剂","0.5mg","瓶","1","西林瓶","广东众生药业股份有限公司","8.35","修改（医保备注）","医保发〔2023〕30号",""]
["533","XB03BAJ038B001010102699","2","甲钴胺","注射剂","","101586","注射用甲钴胺","怡神保","冻干粉针剂","0.5mg","瓶","1","玻璃瓶","华北制药股份有限公司","9.87","修改（医保备注）","医保发〔2023〕30号",""]
["534","XB03BAJ038B002010100874","2","甲钴胺","注射剂","","126090","甲钴胺注射液","无","注射液","1ml:0.5mg","支","1","安瓿","天津金耀药业有限公司","3.24","修改（医保备注）","医保发〔2023〕30号",""]
["535","XB03BAJ038B002010101693","2","甲钴胺","注射剂","","163653","甲钴胺注射液","弥可保","注射剂","1ml:0.5mg","盒","10","安瓿","卫材(中国)药业有限公司","98.80","修改（医保备注）","医保发〔2023〕30号",""]
["536","XB03BAJ038B002010102611","2","甲钴胺","注射剂","","164340","甲钴胺注射液","无","注射剂","1ml:0.5mg","支","1","中硼硅玻璃安瓿(棕色)装","石家庄四药有限公司","0.98","修改（医保备注）","医保发〔2023〕30号",""]
["537","XB03BAJ038B002010102987","2","甲钴胺","注射剂","","119527","甲钴胺注射液","无","注射液","1ml:0.5mg","支","1","安瓿","亚宝药业集团股份有限公司","1.37","修改（医保备注）","医保发〔2023〕30号",""]
["538","XB03BAJ038B002010104127","2","甲钴胺","注射剂","","134160","甲钴胺注射液","无","注射液","1ml:0.5mg","盒","6","安瓿","辰欣药业股份有限公司","8.82","修改（医保备注）","医保发〔2023〕30号",""]
["539","XB03BAJ038B002010201749","2","甲钴胺","注射剂","","100359","甲钴胺注射液","奇信","注射液","1ml:0.5mg","支","1","安瓿","扬子江药业集团南京海陵药业有限公司","8.65","修改（医保备注）","医保发〔2023〕30号",""]
["540","XB03BAJ038B002010305816","2","甲钴胺","注射剂","","204699","甲钴胺注射液","无","注射液","1ml:0.5mg","盒","6","中硼硅玻璃安瓿","海南斯达制药有限公司","14.46","修改（医保备注）","医保发〔2023〕30号",""]
["541","XB03BAJ038B014010104152","2","甲钴胺","注射剂","","110647","注射用甲钴胺","托普优","冻干粉针剂","0.5mg","瓶","1","玻璃瓶","瑞阳制药股份有限公司","9.90","修改（医保备注）","医保发〔2023〕30号",""]
["542","XL03ABC094B001020100115","2","人干扰素α1b(重组人干扰素α-1b)","注射剂","","127842","注射用人干扰素α1b","运德素","注射剂","30μg/支","盒","1","西林瓶","北京三元基因药业股份有限公司","36.62","修改（医保备注）","医保发〔2023〕30号",""]
["543","XL03ABC094B002050100115","2","人干扰素α1b(重组人干扰素α-1b)","注射剂","","127820","人干扰素α1b注射液","运德素","注射液","1ml:300万IU(30μg)","支","1","西林瓶","北京三元基因药业股份有限公司","36.76","修改（医保备注）","医保发〔2023〕30号",""]
["544","XL03ABC094B002070100115","2","人干扰素α1b(重组人干扰素α-1b)","注射剂","","127828","人干扰素α1b注射液","运德素","注射液","1ml:500万IU(50μg)","支","1","西林瓶","北京三元基因药业股份有限公司","50.45","修改（医保备注）","医保发〔2023〕30号",""]
["545","XL03ABC095B002010101313","2","人干扰素α2a（重组人干扰素α-2a）","注射剂","","103776","人干扰素α2a注射液","因特芬","注射液","1ml:100万IU","瓶","1","西林瓶","沈阳三生制药有限责任公司","9.48","修改（医保备注）","医保发〔2023〕30号",""]
["546","XL03ABC095B002020101313","2","人干扰素α2a（重组人干扰素α-2a）","注射剂","","103783","人干扰素α2a注射液","因特芬","注射液","1ml:300万IU","瓶","1","西林瓶","沈阳三生制药有限责任公司","25.25","修改（医保备注）","医保发〔2023〕30号",""]
["547","XL03ABC095B002030101313","2","人干扰素α2a（重组人干扰素α-2a）","注射剂","","103786","人干扰素α2a注射液","因特芬","注射液","1ml:500万IU","瓶","1","西林瓶","沈阳三生制药有限责任公司","35.00","修改（医保备注）","医保发〔2023〕30号",""]
["548","XL03ABC095B014010103320","2","人干扰素α2a（重组人干扰素α-2a）","注射剂","","125956","注射用重组人干扰素α2a","无","冻干粉针剂","300万IU","瓶","1","西林瓶","长春生物制品研究所有限责任公司","21.83","修改（医保备注）","医保发〔2023〕30号",""]
["549","XL03ABC095B014020101313","2","人干扰素α2a（重组人干扰素α-2a）","注射剂","","103766","注射用人干扰素α2a","因特芬","冻干粉针剂","300万IU","瓶","1","西林瓶","沈阳三生制药有限责任公司","26.28","修改（医保备注）","医保发〔2023〕30号",""]
["550","XL03ABC095B014020103320","2","人干扰素α2a（重组人干扰素α-2a）","注射剂","","125961","注射用重组人干扰素α2a","无","冻干粉针剂","500万IU","瓶","1","西林瓶","长春生物制品研究所有限责任公司","38.30","修改（医保备注）","医保发〔2023〕30号",""]
["551","XL03ABC095B014030101313","2","人干扰素α2a（重组人干扰素α-2a）","注射剂","","103771","注射用人干扰素α2a","因特芬","冻干粉针剂","500万IU","瓶","1","西林瓶","沈阳三生制药有限责任公司","40.55","修改（医保备注）","医保发〔2023〕30号",""]
["552","XL03ABC097B002010103311","2","人干扰素α2b(重组人干扰素α-2b)","注射剂","","127876","人干扰素α2b注射液","无","注射液","0.3ml:300万IU","盒","1","西林瓶","长春海伯尔生物技术有限责任公司","22.41","修改（医保备注）","医保发〔2023〕30号",""]
["553","XL03ABC097B002020100070","2","人干扰素α2b(重组人干扰素α-2b)","注射剂","","137747","人干扰素α2b注射液","凯因益生","注射液","0.5ml:500万IU","盒","1","预充式(预灌封)注射器","北京凯因科技股份有限公司","40.94","修改（医保备注）","医保发〔2023〕30号",""]
["554","XL03ABC097B002020103311","2","人干扰素α2b(重组人干扰素α-2b)","注射剂","","127880","人干扰素α2b注射液","无","注射液","0.5ml:500万IU","支","1","西林瓶","长春海伯尔生物技术有限责任公司","33.13","修改（医保备注）","医保发〔2023〕30号",""]
["555","XL03ABC097B002030100070","2","人干扰素α2b(重组人干扰素α-2b)","注射剂","","137749","人干扰素α2b注射液","凯因益生","注射液","0.6ml:600万IU","盒","1","预充式(预灌封)注射器","北京凯因科技股份有限公司","50.00","修改（医保备注）","医保发〔2023〕30号",""]
["556","XL03ABC097B002030103311","2","人干扰素α2b(重组人干扰素α-2b)","注射剂","","127886","人干扰素α2b注射液","无","注射液","0.6ml:600万IU","支","1","西林瓶","长春海伯尔生物技术有限责任公司","46.30","修改（医保备注）","医保发〔2023〕30号",""]
["557","XL03ABC097B014010100214","2","人干扰素α2b(重组人干扰素α-2b)","注射剂","","131780","注射用重组人干扰素α2b(大肠杆菌)","远策素","冻干粉针剂","100万IU","瓶","1","玻璃瓶","北京远策药业有限责任公司","10.84","修改（医保备注）","医保发〔2023〕30号",""]
["558","XL03ABC097B014020100214","2","人干扰素α2b(重组人干扰素α-2b)","注射剂","","131783","注射用重组人干扰素α2b(大肠杆菌)","远策素","冻干粉针剂","300万IU","瓶","1","玻璃瓶","北京远策药业有限责任公司","25.13","修改（医保备注）","医保发〔2023〕30号",""]
["559","XL03ABC097B014020103320","2","人干扰素α2b(重组人干扰素α-2b)","注射剂","","125881","注射用重组人干扰素α2b(大肠杆菌)","长生扶康","冻干粉针剂","300万IU","瓶","1","西林瓶","长春生物制品研究所有限责任公司","32.95","修改（医保备注）","医保发〔2023〕30号",""]
["560","XL03ABC098B002020100868","2","人干扰素α2b[重组人干扰素α-2b（假单胞菌）]","注射剂","","140028","人干扰素α2b注射液","安福隆","注射液","1ml:300万IU","盒","1","预充式(预灌封)注射器","天津未名生物医药有限公司","35.53","修改（医保备注）","医保发〔2023〕30号",""]
["561","XL03ABC098B002030100868","2","人干扰素α2b[重组人干扰素α-2b（假单胞菌）]","注射剂","","140035","人干扰素α2b注射液","安福隆","注射液","1ml:500万IU","盒","1","预充式(预灌封)注射器","天津未名生物医药有限公司","52.29","修改（医保备注）","医保发〔2023〕30号",""]
["562","XL03AAC106B002010100152","2","人粒细胞刺激因子(重组人粒细胞刺激因子)","注射剂","","122182","人粒细胞刺激因子注射液","欣粒生","注射液","0.3ml:75μg","盒","1","预充式(预灌封)注射器","北京四环生物制药有限公司","49.77","修改（医保备注）","医保发〔2023〕30号",""]
["563","XL03AAC106B002010100617","2","人粒细胞刺激因子(重组人粒细胞刺激因子)","注射剂","","162171","人粒细胞刺激因子注射液","惠尔血","注射液","0.6ml:0.15mg","支","1","空","日本Nipro pharma Corporation Ise Plant","291.31","修改（医保备注）","医保发〔2023〕30号",""]
["564","XL03AAC106B002010103708","2","人粒细胞刺激因子(重组人粒细胞刺激因子)","注射剂","","129721","人粒细胞刺激因子注射液","里亚金","注射液","0.75ml:0.1mg","盒","1","预充式(预灌封)注射器","哈药集团生物工程有限公司","51.73","修改（医保备注）","医保发〔2023〕30号",""]
["565","XL03AAC106B002010104870","2","人粒细胞刺激因子(重组人粒细胞刺激因子)","注射剂","","136031","人粒细胞刺激因子注射液","特尔津","注射液","0.67ml:0.1mg","支","1","玻璃瓶","厦门特宝生物工程股份有限公司","42.31","修改（医保备注）","医保发〔2023〕30号",""]
["566","XL03AAC106B002020100152","2","人粒细胞刺激因子(重组人粒细胞刺激因子)","注射剂","","122194","人粒细胞刺激因子注射液","欣粒生","注射液","0.6ml:0.15mg","盒","1","预充式(预灌封)注射器","北京四环生物制药有限公司","65.19","修改（医保备注）","医保发〔2023〕30号",""]
["567","XL03AAC106B002020100617","2","人粒细胞刺激因子(重组人粒细胞刺激因子)","注射剂","","162172","人粒细胞刺激因子注射液","惠尔血","注射液","0.7ml:0.3mg","支","1","空","日本Nipro pharma Corporation Ise Plant","576.80","修改（医保备注）","医保发〔2023〕30号",""]
["568","XL03AAC106B002020103315","2","人粒细胞刺激因子(重组人粒细胞刺激因子)","注射剂","","123870","重组人粒细胞刺激因子注射液","金磊赛强","注射液","1ml:0.15mg","瓶","1","玻璃瓶","长春金赛药业有限责任公司","44.53","修改（医保备注）","医保发〔2023〕30号",""]
["569","XL03AAC106B002020103708","2","人粒细胞刺激因子(重组人粒细胞刺激因子)","注射剂","","129709","人粒细胞刺激因子注射液","里亚金","注射液","0.75ml:0.15mg","盒","1","预充式(预灌封)注射器","哈药集团生物工程有限公司","74.66","修改（医保备注）","医保发〔2023〕30号",""]
["570","XL03AAC106B002020203708","2","人粒细胞刺激因子(重组人粒细胞刺激因子)","注射剂","","129538","人粒细胞刺激因子注射液","里亚金","注射液","150μg","盒","5","玻璃瓶","哈药集团生物工程有限公司","332.35","修改（医保备注）","医保发〔2023〕30号",""]
["571","XL03AAC106B002030100617","2","人粒细胞刺激因子(重组人粒细胞刺激因子)","注射剂","","162170","人粒细胞刺激因子注射液","惠尔血","注射液","0.3ml:75μg","支","1","空","日本Nipro pharma Corporation Ise Plant","171.36","修改（医保备注）","医保发〔2023〕30号",""]
["572","XL03AAC106B002030103315","2","人粒细胞刺激因子(重组人粒细胞刺激因子)","注射剂","","123874","重组人粒细胞刺激因子注射液","金磊赛强","注射液","1ml:0.2mg","瓶","1","玻璃瓶","长春金赛药业有限责任公司","61.40","修改（医保备注）","医保发〔2023〕30号",""]
["573","XL03AAC106B002030103708","2","人粒细胞刺激因子(重组人粒细胞刺激因子)","注射剂","","129713","人粒细胞刺激因子注射液","里亚金","注射液","0.75ml:0.2mg","盒","1","预充式(预灌封)注射器","哈药集团生物工程有限公司","85.84","修改（医保备注）","医保发〔2023〕30号",""]
["574","XL03AAC106B002040100148","2","人粒细胞刺激因子(重组人粒细胞刺激因子)","注射剂","","142411","人粒细胞刺激因子注射液","立生素","注射液","0.2mg","瓶","1","西林瓶","北京双鹭药业股份有限公司","101.39","修改（医保备注）","医保发〔2023〕30号",""]
["575","XL03AAC106B002040103315","2","人粒细胞刺激因子(重组人粒细胞刺激因子)","注射剂","","123878","重组人粒细胞刺激因子注射液","金磊赛强","注射液","1ml:0.3mg","瓶","1","玻璃瓶","长春金赛药业有限责任公司","75.61","修改（医保备注）","医保发〔2023〕30号",""]
["576","XL03AAC106B002040104021","2","人粒细胞刺激因子(重组人粒细胞刺激因子)","注射剂","","113199","人粒细胞刺激因子注射液","瑞白","注射液","0.6ml:0.1mg","支","1","安瓿","齐鲁制药有限公司","72.45","修改（医保备注）","医保发〔2023〕30号",""]
["577","XL03AAC106B002060104021","2","人粒细胞刺激因子(重组人粒细胞刺激因子)","注射剂","","113206","人粒细胞刺激因子注射液","瑞白","注射液","0.9ml:0.15mg","支","1","安瓿","齐鲁制药有限公司","97.89","修改（医保备注）","医保发〔2023〕30号",""]
["578","XL03AAC146B001010279189","2","重组人粒细胞刺激因子（CHO细胞）","注射剂","","147344","注射用重组人粒细胞刺激因子(CHO细胞)","格拉诺赛特","冻干粉针剂","0.1mg","支","1","空","日本中外制药工业株式会社宇都宫工厂Utsunomiya Plant of Chugai Pharma Manufacturing Co.,Ltd.","260.74","修改（医保备注）","医保发〔2023〕30号",""]
["579","XL03AAC146B001020179189","2","重组人粒细胞刺激因子（CHO细胞）","注射剂","","147345","注射用重组人粒细胞刺激因子(CHO细胞)","格拉诺赛特","冻干粉针剂","0.25mg","支","1","空","日本中外制药工业株式会社宇都宫工厂Utsunomiya Plant of Chugai Pharma Manufacturing Co.,Ltd.","528.87","修改（医保备注）","医保发〔2023〕30号",""]
["580","XL03AAC146B001030279189","2","重组人粒细胞刺激因子（CHO细胞）","注射剂","","147343","注射用重组人粒细胞刺激因子(CHO细胞)","格拉诺赛特","冻干粉针剂","50μg","支","1","空","日本中外制药工业株式会社宇都宫工厂Utsunomiya Plant of Chugai Pharma Manufacturing Co.,Ltd.","152.47","修改（医保备注）","医保发〔2023〕30号",""]
["581","XL03AAC108B001010103708","2","人粒细胞巨噬细胞刺激因子（重组人粒细胞巨噬细胞刺激因子）","注射剂","","122888","注射用人粒细胞巨噬细胞刺激因子","里亚尔","冻干粉针剂","150μg","支","1","玻璃瓶","哈药集团生物工程有限公司","58.04","修改（医保备注）","医保发〔2023〕30号",""]
["582","XL03AAC108B001020103708","2","人粒细胞巨噬细胞刺激因子（重组人粒细胞巨噬细胞刺激因子）","注射剂","","122879","注射用人粒细胞巨噬细胞刺激因子","里亚尔","冻干粉针剂","75μg","支","1","玻璃瓶","哈药集团生物工程有限公司","34.14","修改（医保备注）","医保发〔2023〕30号",""]
["583","XL03AAC108B014010104870","2","人粒细胞巨噬细胞刺激因子（重组人粒细胞巨噬细胞刺激因子）","注射剂","","136201","注射用人粒细胞巨噬细胞刺激因子","特尔立","冻干粉针剂","100μg","支","1","玻璃瓶","厦门特宝生物工程股份有限公司","50.17","修改（医保备注）","医保发〔2023〕30号",""]
["584","XL03AAC108B014040104870","2","人粒细胞巨噬细胞刺激因子（重组人粒细胞巨噬细胞刺激因子）","注射剂","","136204","注射用人粒细胞巨噬细胞刺激因子","特尔立","冻干粉针剂","50μg","支","1","玻璃瓶","厦门特宝生物工程股份有限公司","37.00","修改（医保备注）","医保发〔2023〕30号",""]
["585","XL03ACC084B001010104021","2","人白介素-11(重组人白介素-11)","注射剂","","113226","注射用人白介素-11","巨和粒","冻干粉针剂","1200万单位(1.5mg)","支","1","西林瓶","齐鲁制药有限公司","113.31","修改（医保备注）","医保发〔2023〕30号",""]
["586","XL03ACC084B001020104021","2","人白介素-11(重组人白介素-11)","注射剂","","113232","注射用人白介素-11","巨和粒","冻干粉针剂","2400万单位(3mg)","支","1","西林瓶","齐鲁制药有限公司","213.44","修改（医保备注）","医保发〔2023〕30号",""]
["587","XL03ACC084B014010104870","2","人白介素-11(重组人白介素-11)","注射剂","","136195","注射用人白介素-11","特尔康","冻干粉针剂","1200万单位(1.5mg)","支","1","玻璃瓶","厦门特宝生物工程股份有限公司","92.12","修改（医保备注）","医保发〔2023〕30号",""]
["588","XL03ACC084B014020100148","2","人白介素-11(重组人白介素-11)","注射剂","","142421","注射用人白介素-11","迈格尔","冻干粉针剂","1200万单位(1.5mg)","瓶","1","西林瓶","北京双鹭药业股份有限公司","102.96","修改（医保备注）","医保发〔2023〕30号",""]
["589","XL03ACC084B014020104870","2","人白介素-11(重组人白介素-11)","注射剂","","135909","注射用人白介素-11","特尔康","冻干粉针剂","800万单位(1mg)","支","1","玻璃瓶","厦门特宝生物工程股份有限公司","81.27","修改（医保备注）","医保发〔2023〕30号",""]
["590","XL03ACC084B014030104870","2","人白介素-11(重组人白介素-11)","注射剂","","136196","注射用人白介素-11","特尔康","冻干粉针剂","1600万单位(2.0mg)","支","1","玻璃瓶","厦门特宝生物工程股份有限公司","127.97","修改（医保备注）","医保发〔2023〕30号",""]
["591","XL03ACC084B014040104870","2","人白介素-11(重组人白介素-11)","注射剂","","136197","注射用人白介素-11","特尔康","冻干粉针剂","2400万单位(3mg)","支","1","玻璃瓶","厦门特宝生物工程股份有限公司","174.55","修改（医保备注）","医保发〔2023〕30号",""]
["592","XL03ACC085B001010104064","2","重组人白介素-11（Ⅰ）","注射剂","","144172","注射用重组人白介素-11(Ⅰ)","百杰依","冻干粉针剂","1200万单位(1.5mg)","支","1","玻璃瓶","华润昂德生物药业有限公司","327.67","修改（医保备注）","医保发〔2023〕30号",""]
["593","XL03AAJ213B002010104021","2","聚乙二醇化人粒细胞刺激因子（聚乙二醇化重组人粒细胞刺激因子）","注射剂","限前次化疗曾发生重度中性粒细胞减少的患者。","162594","聚乙二醇化重组人粒细胞刺激因子注射液","无","注射液","1ml:3.0mg","盒","1","预充式(预灌封)注射器","齐鲁制药有限公司","1615.00","修改（医保备注）","医保发〔2023〕30号",""]
["594","XL03AAJ213B002010104089","2","聚乙二醇化人粒细胞刺激因子（聚乙二醇化重组人粒细胞刺激因子）","注射剂","限前次化疗曾发生重度中性粒细胞减少的患者。","128059","聚乙二醇化重组人粒细胞刺激因子注射液","津优力","注射液","1ml:3.0mg","支","1","玻璃瓶","石药集团百克(山东)生物制药股份有限公司","1600.00","修改（医保备注）","医保发〔2023〕30号",""]
["595","XL03AAJ213B002010204021","2","聚乙二醇化人粒细胞刺激因子（聚乙二醇化重组人粒细胞刺激因子）","注射剂","限前次化疗曾发生重度中性粒细胞减少的患者。","162593","聚乙二醇化重组人粒细胞刺激因子注射液","无","注射液","1ml:3.0mg","支","1","安瓿","齐鲁制药有限公司","1610.03","修改（医保备注）","医保发〔2023〕30号",""]
["596","XL03AAJ249B002010104188","2","聚乙二醇化人粒细胞刺激因子（聚乙二醇化重组人粒细胞刺激因子）","注射剂","限前次化疗曾发生重度中性粒细胞减少的患者。","172707","聚乙二醇化人粒细胞刺激因子注射液","无","注射液","1ml:3.0mg","瓶","1","玻璃瓶","山东新时代药业有限公司","1527.50","修改（医保备注）","医保发〔2023〕30号",""]
["597","XB03ABY199X001020203904","2","右旋糖酐铁","口服液体剂","","116232","右旋糖酐铁口服溶液","无","口服溶液剂","5ml:25mg(Fe)","盒","10","玻璃瓶","康臣药业(内蒙古)有限责任公司","25.33","修改（医保备注）","医保发〔2023〕30号",""]
["598","XB03ACZ012B002010102066","2","蔗糖铁","注射剂","","127045","蔗糖铁注射液","无","注射剂(注射液)","5ml:100mg铁与1600mg蔗糖","盒","5","安瓿","成都天台山制药股份有限公司","119.00","修改（医保备注）","医保发〔2023〕30号",""]
["599","XB03ACZ012B002010178941","2","蔗糖铁","注射剂","","142245","蔗糖铁注射液","维乐福","注射液","5ml:0.1g铁:1.6g蔗糖","支","1","安瓿","德国IDT Biologika GmbH","84.90","修改（医保备注）","医保发〔2023〕30号",""]
["600","XB03ACZ012B002020201565","2","蔗糖铁","注射剂","","132461","蔗糖铁注射液","无","注射液","5ml:0.1g铁","支","1","安瓿","南京恒生制药有限公司","29.18","修改（医保备注）","医保发〔2023〕30号",""]
["601","XB02BBR019B001010100538","2","人纤维蛋白原","注射剂","","165891","人纤维蛋白原","无","冻干粉针剂","0.5g","瓶","1","玻璃瓶","深圳市卫光生物制品股份有限公司","","修改（医保备注）","医保发〔2023〕30号","供应紧张药品"]
["602","XB02BBR019B001010100794","2","人纤维蛋白原","注射剂","","142235","人纤维蛋白原","无","冻干粉针剂","0.5g","瓶","1","玻璃瓶","上海新兴医药股份有限公司","","修改（医保备注）","医保发〔2023〕30号","供应紧张药品"]
["603","XB02BBR019B001010102291","2","人纤维蛋白原","注射剂","","175997","人纤维蛋白原","无","冻干粉针剂","0.5g","瓶","1","玻璃瓶","四川远大蜀阳药业有限责任公司","","修改（医保备注）","医保发〔2023〕30号","供应紧张药品"]
["604","XB02BBR019B001010102902","2","人纤维蛋白原","注射剂","","200452","人纤维蛋白原","无","注射剂","0.5g/瓶","盒","1","中硼硅玻璃模制注射剂瓶与注射用冷冻干燥用卤化丁基橡胶塞。","山西康宝生物制品股份有限公司","","修改（医保备注）","医保发〔2023〕30号","供应紧张药品"]
["605","XB02BBR019B001010103115","2","人纤维蛋白原","注射剂","","123188","人纤维蛋白原","无","冻干粉针剂","0.5g","盒","1","配溶媒","华兰生物工程股份有限公司","","修改（医保备注）","医保发〔2023〕30号","供应紧张药品"]
["606","XB02BBR019B001010103666","2","人纤维蛋白原","注射剂","","106746","人纤维蛋白原","无","冻干粉针剂","0.5g","瓶","1","玻璃瓶","哈尔滨派斯菲科生物制药有限公司","","修改（医保备注）","医保发〔2023〕30号","供应紧张药品"]
["607","XB02BBR019B001010104426","2","人纤维蛋白原","注射剂","","145649","人纤维蛋白原","无","冻干粉针剂","0.5g","瓶","1","玻璃瓶","绿十字(中国)生物制品有限公司","","修改（医保备注）","医保发〔2023〕30号","供应紧张药品"]
["608","XB02BBR019B001010105265","2","人纤维蛋白原","注射剂","","135814","人纤维蛋白原","无","冻干粉针剂","0.5g","瓶","1","玻璃瓶","华润博雅生物制药集团股份有限公司","","修改（医保备注）","医保发〔2023〕30号","供应紧张药品"]
["609","XB02BBR019B001010106396","2","人纤维蛋白原","注射剂","","163229","人纤维蛋白原","无","冻干粉针剂","0.5g","盒","1","配溶媒","山东泰邦生物制品有限公司","","修改（医保备注）","医保发〔2023〕30号","供应紧张药品"]
["610","XB02BBR019B014010100714","2","人纤维蛋白原","注射剂","","142051","人纤维蛋白原","无","冻干粉针剂","0.5g","瓶","1","玻璃瓶","上海莱士血液制品股份有限公司","","修改（医保备注）","医保发〔2023〕30号","供应紧张药品"]
["611","XB02BDR011B001010100348","2","人凝血酶原复合物","注射剂","","172603","人凝血酶原复合物","无","冻干粉针剂","300IU","瓶","1","玻璃瓶","广东卫伦生物制药有限公司","","修改（医保备注）","医保发〔2023〕30号","供应紧张药品"]
["612","XB02BDR011B001010100473","2","人凝血酶原复合物","注射剂","","204134","人凝血酶原复合物","无","注射剂","200IU/瓶(含Ⅸ因子200IU、Ⅱ因子200IU、Ⅶ因子80IU、Ⅹ因子200IU),复溶后体积为10ml。","瓶","1","丁基胶塞,玻璃瓶","广东双林生物制药有限公司","","修改（医保备注）","医保发〔2023〕30号","供应紧张药品"]
["613","XB02BDR011B001010102055","2","人凝血酶原复合物","注射剂","","173524","人凝血酶原复合物","无","冻干粉针剂","300IU","盒","1","玻璃瓶","成都蓉生药业有限责任公司","","修改（医保备注）","医保发〔2023〕30号","供应紧张药品"]
["614","XB02BDR011B001010102599","2","人凝血酶原复合物","注射剂","","171554","人凝血酶原复合物","无","冻干粉针剂","300IU","瓶","1","玻璃瓶","河北大安制药有限公司","","修改（医保备注）","医保发〔2023〕30号","供应紧张药品"]
["615","XB02BDR011B001010103115","2","人凝血酶原复合物","注射剂","","123183","人凝血酶原复合物","康舒宁","冻干粉针剂","200IU","盒","1","配溶媒","华兰生物工程股份有限公司","","修改（医保备注）","医保发〔2023〕30号","供应紧张药品"]
["616","XB02BDR011B001010104445","2","人凝血酶原复合物","注射剂","","174403","人凝血酶原复合物","无","冻干粉针剂","300IU","瓶","1","玻璃瓶","同路生物制药有限公司","","修改（医保备注）","医保发〔2023〕30号","供应紧张药品"]
["617","XB02BDR011B001010105265","2","人凝血酶原复合物","注射剂","","171652","人凝血酶原复合物","无","冻干粉针剂","400IU","瓶","1","玻璃瓶","华润博雅生物制药集团股份有限公司","","修改（医保备注）","医保发〔2023〕30号","供应紧张药品"]
["618","XB02BDR011B001010105417","2","人凝血酶原复合物","注射剂","","156586","人凝血酶原复合物","无","冻干粉针剂","300IU","瓶","1","玻璃瓶","贵州泰邦生物制品有限公司","","修改（医保备注）","医保发〔2023〕30号","供应紧张药品"]
["619","XB02BDR011B001010106396","2","人凝血酶原复合物","注射剂","","162225","人凝血酶原复合物","无","冻干粉针剂","300IU","盒","1","配溶媒","山东泰邦生物制品有限公司","","修改（医保备注）","医保发〔2023〕30号","供应紧张药品"]
["620","XB02BDR011B001010180825","2","人凝血酶原复合物","注射剂","","170923","人凝血酶原复合物","无","冻干粉针剂","300IU","瓶","1","玻璃瓶","南岳生物制药有限公司","","修改（医保备注）","医保发〔2023〕30号","供应紧张药品"]
["621","XB02BDR011B001010280825","2","人凝血酶原复合物","注射剂","","171094","人凝血酶原复合物","无","冻干粉针剂","200IU","瓶","1","玻璃瓶","南岳生物制药有限公司","","修改（医保备注）","医保发〔2023〕30号","供应紧张药品"]
["622","XB02BDR011B001020103115","2","人凝血酶原复合物","注射剂","","123177","人凝血酶原复合物","康舒宁","冻干粉针剂","300IU","盒","1","配溶媒","华兰生物工程股份有限公司","","修改（医保备注）","医保发〔2023〕30号","供应紧张药品"]
["623","XB02BDR011B001030103115","2","人凝血酶原复合物","注射剂","","162506","人凝血酶原复合物","康舒宁","冻干粉针剂","400IU","盒","1","配溶媒","华兰生物工程股份有限公司","","修改（医保备注）","医保发〔2023〕30号","供应紧张药品"]
["624","XB02BDR011B014030100714","2","人凝血酶原复合物","注射剂","","142047","人凝血酶原复合物","无","冻干粉针剂","200IU","瓶","1","玻璃瓶","上海莱士血液制品股份有限公司","","修改（医保备注）","医保发〔2023〕30号","供应紧张药品"]
["625","XB02BDR011B014040100714","2","人凝血酶原复合物","注射剂","","142234","人凝血酶原复合物","无","冻干粉针剂","300IU","瓶","1","玻璃瓶","上海莱士血液制品股份有限公司","","修改（医保备注）","医保发〔2023〕30号","供应紧张药品"]
["626","XB05BAD203B001010102918","2","多种维生素(12)","注射剂","","131262","注射用多种维生素(12)","无","冻干粉针剂","5ml","支","1","西林瓶","山西普德药业有限公司","83.63","修改（医保备注）","医保发〔2023〕30号",""]
["627","XB05BAD203B001010179365","2","多种维生素(12)","注射剂","","141721","注射用多种维生素(12)","施尼维他","冻干粉针剂","5ml","支","1","玻璃瓶","法国Pierre Fabre Medicament Production","83.83","修改（医保备注）","医保发〔2023〕30号",""]
["628","XA11CCA017X004010179051","2","阿法骨化醇","口服液体剂","","154364","阿法骨化醇滴剂","依安凡","滴剂","20ml:40μg","瓶","1","玻璃瓶","丹麦利奥制药有限公司LEO Pharmaceutical Products Ltd. A/S (LEO Pharma A/S)","411.00","修改（医保备注）","医保发〔2023〕30号",""]
["629","XA12AXX128N001010104929","2","小儿碳酸钙D3","颗粒剂","","165879","小儿碳酸钙D3颗粒","无","颗粒剂","碳酸钙0.75g(钙0.3g),维生素D3 100IU","盒","10","复合膜","湖南华纳大药厂股份有限公司","51.20","修改（医保备注）","医保发〔2023〕30号",""]
["630","XA12AXX128N001010105611","2","小儿碳酸钙D3","颗粒剂","","170102","小儿碳酸钙D3颗粒","无","颗粒剂","每袋含碳酸钙0.75克相当于钙0.3克,维生素D3100国际单位2.5微克","盒","15","复合膜","昆明源瑞制药有限公司","69.00","修改（医保备注）","医保发〔2023〕30号",""]
["631","XA12AXX128N001010204670","2","小儿碳酸钙D3","颗粒剂","","165579","小儿碳酸钙D3颗粒","无","颗粒剂","碳酸钙0.75g(钙0.3g),维生素D3 100IU","盒","10","复合膜","浙江康恩贝制药股份有限公司","59.60","修改（医保备注）","医保发〔2023〕30号",""]
["632","XA12AXX128N001010204929","2","小儿碳酸钙D3","颗粒剂","","165883","小儿碳酸钙D3颗粒","无","颗粒剂","碳酸钙0.75g(钙0.3g),维生素D3 100IU","盒","14","复合膜","湖南华纳大药厂股份有限公司","71.68","修改（医保备注）","医保发〔2023〕30号",""]
["633","XA12AXX128N001010301438","2","小儿碳酸钙D3","颗粒剂","","168637","小儿碳酸钙D3颗粒","无","颗粒剂","碳酸钙0.75g(钙0.3g),维生素D3 100IU","盒","16","复合膜","江苏福邦药业有限公司","58.20","修改（医保备注）","医保发〔2023〕30号",""]
["634","XA12AXX128N001010404670","2","小儿碳酸钙D3","颗粒剂","","165589","小儿碳酸钙D3颗粒","无","颗粒剂","碳酸钙0.75g(钙0.3g),维生素D3 100IU","盒","15","复合膜","浙江康恩贝制药股份有限公司","89.40","修改（医保备注）","医保发〔2023〕30号",""]
["635","XA12AXX128N001010604670","2","小儿碳酸钙D3","颗粒剂","","169562","小儿碳酸钙D3颗粒","无","颗粒剂","碳酸钙0.75g(钙0.3g),维生素D3 100IU","盒","6","复合膜","浙江康恩贝制药股份有限公司","35.76","修改（医保备注）","医保发〔2023〕30号",""]
["636","XA12AXX128N001010605611","2","小儿碳酸钙D3","颗粒剂","","205673","小儿碳酸钙D3颗粒","无","颗粒剂","每袋含碳酸钙0.75克相当于钙0.3克,维生素D3100国际单位2.5微克","盒","7","聚酯/铝/聚乙烯药品包装用复合膜袋密封包装后,装入纸盒","昆明源瑞制药有限公司","32.20","修改（医保备注）","医保发〔2023〕30号",""]
["637","XA12AXX128N001010704670","2","小儿碳酸钙D3","颗粒剂","","169563","小儿碳酸钙D3颗粒","无","颗粒剂","碳酸钙0.75g(钙0.3g),维生素D3 100IU","盒","30","复合膜","浙江康恩贝制药股份有限公司","178.80","修改（医保备注）","医保发〔2023〕30号",""]
["638","XA12AXX128N001010705611","2","小儿碳酸钙D3","颗粒剂","","205256","小儿碳酸钙D3颗粒","无","颗粒剂","每袋含碳酸钙0.75克相当于钙0.3克,维生素D3100国际单位2.5微克","盒","20","聚酯/铝/聚乙烯药品包装用复合膜袋密封包装后,装入纸盒","昆明源瑞制药有限公司","92.00","修改（医保备注）","医保发〔2023〕30号",""]
["639","XA12AXX128N001020104929","2","小儿碳酸钙D3","颗粒剂","","172716","小儿碳酸钙D3颗粒","无","颗粒剂","碳酸钙0.75g(钙0.3g),维生素D3 100IU","盒","7","复合膜","湖南华纳大药厂股份有限公司","35.84","修改（医保备注）","医保发〔2023〕30号",""]
["640","XA12AXX128N001020505611","2","小儿碳酸钙D3","颗粒剂","","205679","小儿碳酸钙D3颗粒","无","颗粒剂","每袋含碳酸钙0.75克(相当于钙0.3克),维生素D3100国际单位(2.5微克)","盒","21","聚酯/铝/聚乙烯药品包装用复合膜袋密封包装后,装入纸盒","昆明源瑞制药有限公司","96.60","修改（医保备注）","医保发〔2023〕30号",""]
["641","XA11CBW032X004010104052","2","维生素AD","口服液体剂","","149523","维生素AD滴剂(胶囊型)","无","滴剂","VA1500IU:VD500IU","盒","50","铝塑","青岛双鲸药业股份有限公司","18.38","修改（医保备注）","医保发〔2023〕30号",""]
["642","XA11CBW032X004010104636","2","维生素AD","口服液体剂","","139220","维生素AD滴剂(胶囊型)","贝特令","滴剂","VA1500IU:VD500IU","盒","24","铝塑","浙江仟源海力生制药有限公司","11.81","修改（医保备注）","医保发〔2023〕30号",""]
["643","XA11CBW032X004010204052","2","维生素AD","口服液体剂","","131594","维生素AD滴剂(胶囊型)","无","滴剂","VA1500IU:VD500IU","盒","30","铝塑","青岛双鲸药业股份有限公司","11.03","修改（医保备注）","医保发〔2023〕30号",""]
["644","XA11CBW032X004010204636","2","维生素AD","口服液体剂","","139221","维生素AD滴剂(胶囊型)","贝特令","滴剂","VA1500IU:VD500IU","盒","36","铝塑","浙江仟源海力生制药有限公司","17.46","修改（医保备注）","医保发〔2023〕30号",""]
["645","XA11CBW032X004010304077","2","维生素AD","口服液体剂","","137065","维生素AD滴剂(胶囊型)","伊可新","滴剂","VA1500IU:VD500IU","盒","40","铝塑","山东达因海洋生物制药股份有限公司","21.00","修改（医保备注）","医保发〔2023〕30号",""]
["646","XA11CBW032X004020104052","2","维生素AD","口服液体剂","","131602","维生素AD滴剂(胶囊型)","无","滴剂","VA2000IU:VD700IU","盒","30","铝塑","青岛双鲸药业股份有限公司","12.60","修改（医保备注）","医保发〔2023〕30号",""]
["647","XA11CBW032X004020104636","2","维生素AD","口服液体剂","","139214","维生素AD滴剂(胶囊型)","贝特令","滴剂","VA1800IU:VD600IU","盒","24","铝塑","浙江仟源海力生制药有限公司","10.80","修改（医保备注）","医保发〔2023〕30号",""]
["648","XA11CBW032X004020204052","2","维生素AD","口服液体剂","","149524","维生素AD滴剂(胶囊型)","无","滴剂","VA2000IU:VD700IU","盒","50","铝塑","青岛双鲸药业股份有限公司","21.00","修改（医保备注）","医保发〔2023〕30号",""]
["649","XA11CBW032X004020204636","2","维生素AD","口服液体剂","","139215","维生素AD滴剂(胶囊型)","贝特令","滴剂","VA1800IU:VD600IU","盒","36","铝塑","浙江仟源海力生制药有限公司","15.97","修改（医保备注）","医保发〔2023〕30号",""]
["650","XA11CBW032X004020204873","2","维生素AD","口服液体剂","","143958","维生素AD滴剂(胶囊型)","无","滴剂","VA1500IU:VD500IU","盒","30","铝塑","国药控股星鲨制药(厦门)有限公司","15.60","修改（医保备注）","医保发〔2023〕30号",""]
["651","XA11CBW032X004020304077","2","维生素AD","口服液体剂","","146144","维生素AD滴剂(胶囊型)","伊可新","滴剂","VA2000IU:VD700IU","盒","40","铝塑","山东达因海洋生物制药股份有限公司","21.20","修改（医保备注）","医保发〔2023〕30号",""]
["652","XA11CBW032X004020304873","2","维生素AD","口服液体剂","","148138","维生素AD滴剂(胶囊型)","无","滴剂","VA1500IU:VD500IU","盒","36","铝塑","国药控股星鲨制药(厦门)有限公司","18.60","修改（医保备注）","医保发〔2023〕30号",""]
["653","XA11CBW032X004030104636","2","维生素AD","口服液体剂","","139216","维生素AD滴剂(胶囊型)","贝特令","滴剂","VA2000IU:VD700IU","盒","24","铝塑","浙江仟源海力生制药有限公司","12.47","修改（医保备注）","医保发〔2023〕30号",""]
["654","XA11CBW032X004030204636","2","维生素AD","口服液体剂","","139217","维生素AD滴剂(胶囊型)","贝特令","滴剂","VA2000IU:VD700IU","盒","36","铝塑","浙江仟源海力生制药有限公司","18.43","修改（医保备注）","医保发〔2023〕30号",""]
["655","XA11CBW032X004030204873","2","维生素AD","口服液体剂","","143959","维生素AD滴剂(胶囊型)","无","滴剂","VA1800IU:VD600IU","盒","30","铝塑","国药控股星鲨制药(厦门)有限公司","18.60","修改（医保备注）","医保发〔2023〕30号",""]
["656","XA11CBW032X004030301564","2","维生素AD","口服液体剂","","106842","维生素AD滴剂(胶囊型)","无","滴剂","VA1500IU:VD500IU","盒","36","铝塑","南京海鲸药业股份有限公司","21.24","修改（医保备注）","医保发〔2023〕30号",""]
["657","XA11CBW032X004030304873","2","维生素AD","口服液体剂","","148164","维生素AD滴剂(胶囊型)","无","滴剂","VA1800IU:VD600IU","盒","48","铝塑","国药控股星鲨制药(厦门)有限公司","29.76","修改（医保备注）","医保发〔2023〕30号",""]
["658","XA11CBW032X004040104354","2","维生素AD","口服液体剂","","110954","维生素AD滴剂(胶囊型)","无","滴剂","VA1500IU:VD500IU","盒","20","铝塑","安徽威尔曼制药有限公司","29.47","修改（医保备注）","医保发〔2023〕30号",""]
["659","XA11CBW032X004040204354","2","维生素AD","口服液体剂","","161113","维生素AD滴剂(胶囊型)","无","滴剂","VA1500IU:VD500IU","盒","30","铝塑","安徽威尔曼制药有限公司","38.44","修改（医保备注）","医保发〔2023〕30号",""]
["660","XA11CBW032X004040204873","2","维生素AD","口服液体剂","","143961","维生素AD滴剂(胶囊型)","无","滴剂","VA2000IU:VD700IU","盒","30","铝塑","国药控股星鲨制药(厦门)有限公司","17.74","修改（医保备注）","医保发〔2023〕30号",""]
["661","XA11CBW032X004040304873","2","维生素AD","口服液体剂","","148137","维生素AD滴剂(胶囊型)","无","滴剂","VA2000IU:VD700IU","盒","36","铝塑","国药控股星鲨制药(厦门)有限公司","21.15","修改（医保备注）","医保发〔2023〕30号",""]
["662","XA11CBW032X004050104354","2","维生素AD","口服液体剂","","110957","维生素AD滴剂(胶囊型)","无","滴剂","VA2000IU:VD700IU","盒","20","铝塑","安徽威尔曼制药有限公司","29.47","修改（医保备注）","医保发〔2023〕30号",""]
["663","XA11CBW032X004050204354","2","维生素AD","口服液体剂","","161114","维生素AD滴剂(胶囊型)","无","滴剂","VA2000IU:VD700IU","盒","30","铝塑","安徽威尔曼制药有限公司","38.44","修改（医保备注）","医保发〔2023〕30号",""]
["664","XA11CCG111E002010103013","2","骨化三醇","口服常释剂型","","174732","骨化三醇软胶囊","无","软胶囊(胶丸)","0.5μg","盒","10","铝塑","河南泰丰生物科技有限公司","11.31","修改（医保备注）","医保发〔2023〕30号",""]
["665","XA11CCG111E002010104036","2","骨化三醇","口服常释剂型","","123262","骨化三醇软胶囊","盖三淳","软胶囊(胶丸)","0.25μg","盒","10","铝塑","正大制药(青岛)有限公司","30.60","修改（医保备注）","医保发〔2023〕30号",""]
["666","XA11CCG111E002010181812","2","骨化三醇","口服常释剂型","","204903","骨化三醇软胶囊","无","胶囊剂","0.5μg,10粒/板、3板/盒","盒","30","聚氯乙烯固体药用硬片/药用铝箔","安士制药(中山)有限公司","38.94","修改（医保备注）","医保发〔2023〕30号",""]
["667","XA11CCG111E002010204036","2","骨化三醇","口服常释剂型","","172575","骨化三醇软胶囊","盖三淳","软胶囊(胶丸)","0.25μg","盒","20","铝塑","正大制药(青岛)有限公司","59.67","修改（医保备注）","医保发〔2023〕30号",""]
["668","XA11CCG111E002010279436","2","骨化三醇","口服常释剂型","","204822","骨化三醇胶丸","罗盖全","软胶囊","0.25μg","盒","10","铝塑","德国Catalent Germany Eberbach GmbH","32.01","修改（医保备注）","医保发〔2023〕30号",""]
["669","XA11CCG111E002010280937","2","骨化三醇","口服常释剂型","","174747","骨化三醇软胶囊","无","软胶囊(胶丸)","0.25μg","盒","20","铝箔","四川国为制药有限公司","6.32","修改（医保备注）","医保发〔2023〕30号",""]
["670","XA11CCG111E002020182195","2","骨化三醇","口服常释剂型","","147452","骨化三醇软胶囊","海尼威","软胶囊(胶丸)","0.25μg","盒","10","铝塑","台湾井田国际医药厂股份有限公司","35.00","修改（医保备注）","医保发〔2023〕30号",""]
["671","XA11CCG111E002020203013","2","骨化三醇","口服常释剂型","","204010","骨化三醇软胶囊","无","软胶囊(胶丸)","0.25μg","盒","20","铝塑","河南泰丰生物科技有限公司","12.97","修改（医保备注）","医保发〔2023〕30号",""]
["672","XA11CCG111E002020482195","2","骨化三醇","口服常释剂型","","169325","骨化三醇软胶囊","海尼威","软胶囊(胶丸)","0.25μg","盒","20","铝塑","台湾井田国际医药厂股份有限公司","68.25","修改（医保备注）","医保发〔2023〕30号",""]
["673","XA12AAC067A001010101287","2","醋酸钙","口服常释剂型","限高磷血症。","169248","醋酸钙片","无","素片","0.667g","盒","20","铝塑","沈阳福宁药业有限公司","65.50","修改（医保备注）","医保发〔2023〕30号",""]
["674","XA12AAC067A001010105542","2","醋酸钙","口服常释剂型","限高磷血症。","100185","醋酸钙片","无","素片","0.667g","盒","12","空","贵州维康子帆药业股份有限公司","39.40","修改（医保备注）","医保发〔2023〕30号",""]
["675","XA12AAC067A001010182359","2","醋酸钙","口服常释剂型","限高磷血症。","165296","醋酸钙片","无","素片","0.667g","盒","24","铝塑","北京百美特生物制药有限公司","84.78","修改（医保备注）","医保发〔2023〕30号",""]
["676","XA12AAC067A001010183510","2","醋酸钙","口服常释剂型","限高磷血症。","176945","醋酸钙片","无","素片","0.667g","盒","24","铝箔","台湾Pei Li Pharmaceutical Ind.Co.,Ltd.","15.12","修改（医保备注）","医保发〔2023〕30号",""]
["677","XA12AAC067A001010205542","2","醋酸钙","口服常释剂型","限高磷血症。","173705","醋酸钙片","无","素片","0.667g","盒","24","铝管（铝塑）","贵州维康子帆药业股份有限公司","76.83","修改（医保备注）","医保发〔2023〕30号",""]
["678","XA12AAC067A001010205579","2","醋酸钙","口服常释剂型","限高磷血症。","121448","醋酸钙片","无","素片","0.667g","盒","24","铝塑","昆明邦宇制药有限公司","85.80","修改（医保备注）","医保发〔2023〕30号",""]
["679","XA12AAC067A001010205805","2","醋酸钙","口服常释剂型","限高磷血症。","163525","醋酸钙片","无","素片","0.667g","盒","24","铝塑","海南赛立克药业有限公司","76.95","修改（医保备注）","医保发〔2023〕30号",""]
["680","XA12AAC067A001020100548","2","醋酸钙","口服常释剂型","限高磷血症。","176889","醋酸钙片","无","素片","0.667g","盒","24","铝箔","广州大光制药有限公司","12.78","修改（医保备注）","医保发〔2023〕30号",""]
["681","XA12AAC067E001010205579","2","醋酸钙","口服常释剂型","限高磷血症。","168243","醋酸钙胶囊","无","硬胶囊剂","0.6g","瓶","15","塑料瓶","昆明邦宇制药有限公司","53.39","修改（医保备注）","医保发〔2023〕30号",""]
["682","XB05BAX104B002010100874","1","小儿复方氨基酸（18AA-Ⅰ）/小儿复方氨基酸（18AA-Ⅱ）","注射剂","需经营养风险筛查，明确具有营养风险，且不能经饮食或使用“肠内营养剂”补充足够营养的住院患者方予支付。","126139","小儿复方氨基酸注射液(18AA-Ⅰ)","爱咪特","注射液","20ml:1.348g(总氨基酸)","支","1","安瓿","天津金耀药业有限公司","15.00","修改（医保备注）","医保发〔2023〕30号",""]
["683","XB05BAX104B002010100933","1","小儿复方氨基酸（18AA-Ⅰ） 小儿复方氨基酸（18AA-Ⅱ）","注射剂","需经营养风险筛查，明确具有营养风险，且不能经饮食或使用“肠内营养剂”补充足够营养的住院患者方予支付。","131669","小儿复方氨基酸注射液(18AA-Ⅰ)","爱咪特","注射液","100ml:6.74g(总氨基酸)","瓶","1","玻璃瓶","天津金耀集团湖北天药药业股份有限公司","21.47","修改（医保备注）","医保发〔2023〕30号",""]
["684","XB05BAX104B002010104127","1","小儿复方氨基酸（18AA-Ⅰ） 小儿复方氨基酸（18AA-Ⅱ）","注射剂","需经营养风险筛查，明确具有营养风险，且不能经饮食或使用“肠内营养剂”补充足够营养的住院患者方予支付。","134524","小儿复方氨基酸注射液(18AA-Ⅰ)","无","注射液","100ml:6.74g(总氨基酸)","袋","1","多层共挤输液袋","辰欣药业股份有限公司","29.00","修改（医保备注）","医保发〔2023〕30号",""]
["685","XB05BAX104B002020304127","1","小儿复方氨基酸（18AA-Ⅰ） 小儿复方氨基酸（18AA-Ⅱ）","注射剂","需经营养风险筛查，明确具有营养风险，且不能经饮食或使用“肠内营养剂”补充足够营养的住院患者方予支付。","134274","小儿复方氨基酸注射液(18AA-Ⅰ)","无","注射液","20ml:1.348g(总氨基酸)","支","1","安瓿","辰欣药业股份有限公司","15.51","修改（医保备注）","医保发〔2023〕30号",""]
["686","XB05XBB120B001010105754","2","丙氨酰谷氨酰胺","注射剂","","125379","注射用丙氨酰谷氨酰胺","无","冻干粉针剂","10g","瓶","1","玻璃瓶","海南通用康力制药有限公司","43.68","修改（医保备注）","医保发〔2023〕30号",""]
["687","XB05XBB120B001010105793","2","丙氨酰谷氨酰胺","注射剂","","118302","注射用丙氨酰谷氨酰胺","欣坤畅","冻干粉针剂","10g","盒","1","配溶媒","海南灵康制药有限公司","59.28","修改（医保备注）","医保发〔2023〕30号",""]
["688","XB05XBB120B001010305765","2","丙氨酰谷氨酰胺","注射剂","","109020","注射用丙氨酰谷氨酰胺","培尔吉","粉针剂","10g","盒","1","配溶媒+复方氨基酸(18AA)+无菌导液针","海南全星制药有限公司","77.88","修改（医保备注）","医保发〔2023〕30号",""]
["689","XB05XBB120B001020105793","2","丙氨酰谷氨酰胺","注射剂","","118311","注射用丙氨酰谷氨酰胺","欣坤畅","冻干粉针剂","20g","盒","1","配溶媒","海南灵康制药有限公司","83.38","修改（医保备注）","医保发〔2023〕30号",""]
["690","XB05XBB120B002010101415","2","丙氨酰谷氨酰胺","注射剂","","134353","丙氨酰谷氨酰胺注射液","力太","注射液","100ml:20g","瓶","1","玻璃瓶","费森尤斯卡比华瑞制药有限公司","120.63","修改（医保备注）","医保发〔2023〕30号",""]
["691","XB05XBB120B002010101521","2","丙氨酰谷氨酰胺","注射剂","","137852","丙氨酰谷氨酰胺注射液","无","注射液","100ml:20g","瓶","1","钠钙玻璃输液瓶和注射液用卤化丁基橡胶塞(氯化)","江苏正大丰海制药有限公司","37.99","修改（医保备注）","医保发〔2023〕30号",""]
["692","XB05XBB120B002010101930","2","丙氨酰谷氨酰胺","注射剂","","201235","丙氨酰谷氨酰胺注射液","无","注射液","100ml:20g","瓶","1","钠钙玻璃输液瓶和注射液用卤化丁基橡胶塞装。","远大生命科学(武汉)有限公司","38.19","修改（医保备注）","医保发〔2023〕30号",""]
["693","XB05XBB120B002010103662","2","丙氨酰谷氨酰胺","注射剂","","106644","丙氨酰谷氨酰胺注射液","无","注射液","100ml:20g","瓶","1","玻璃瓶","哈尔滨三联药业股份有限公司","77.11","修改（医保备注）","医保发〔2023〕30号",""]
["694","XB05XBB120B002010103871","2","丙氨酰谷氨酰胺","注射剂","","173588","丙氨酰谷氨酰胺注射液","无","注射液","100ml:20g","瓶","1","玻璃瓶","赤峰源生药业有限公司","41.85","修改（医保备注）","医保发〔2023〕30号",""]
["695","XB05XBB120B002010104127","2","丙氨酰谷氨酰胺","注射剂","","134528","丙氨酰谷氨酰胺注射液","无","注射液","100ml:20g","袋","1","三层共挤输液袋包装","辰欣药业股份有限公司","27.90","修改（医保备注）","医保发〔2023〕30号",""]
["696","XB05XBB120B002010109550","2","丙氨酰谷氨酰胺","注射剂","","163956","丙氨酰谷氨酰胺注射液","无","注射液","100ml:20g","瓶","1","玻璃瓶","杭州民生药业股份有限公司","58.00","修改（医保备注）","医保发〔2023〕30号",""]
["697","XB05XBB120B002010202525","2","丙氨酰谷氨酰胺","注射剂","","132504","丙氨酰谷氨酰胺注射液","无","注射液","100ml:20g","盒","1","玻璃瓶","西安万隆制药股份有限公司","27.90","修改（医保备注）","医保发〔2023〕30号",""]
["698","XB05XBB120B002010282359","2","丙氨酰谷氨酰胺","注射剂","","204432","丙氨酰谷氨酰胺注射液","无","注射液","100ml:20g","袋","1","多层共挤输液袋","北京百美特生物制药有限公司","21.70","修改（医保备注）","医保发〔2023〕30号",""]
["699","XB05XBB120B002010302180","2","丙氨酰谷氨酰胺","注射剂","","108694","丙氨酰谷氨酰胺注射液","无","注射液","100ml:20g","瓶","1","玻璃瓶","四川科伦药业股份有限公司","11.66","修改（医保备注）","医保发〔2023〕30号",""]
["700","XB05XBB120B002010604127","2","丙氨酰谷氨酰胺","注射剂","","162200","丙氨酰谷氨酰胺注射液","无","注射液","100ml:20g","瓶","1","塑料瓶","辰欣药业股份有限公司","27.90","修改（医保备注）","医保发〔2023〕30号",""]
["701","XB05XBB120B002020101017","2","丙氨酰谷氨酰胺","注射剂","","126736","丙氨酰谷氨酰胺注射液","无","注射液","50ml:10g","瓶","1","玻璃瓶","重庆莱美药业股份有限公司","46.83","修改（医保备注）","医保发〔2023〕30号",""]
["702","XB05XBB120B002020101415","2","丙氨酰谷氨酰胺","注射剂","","146339","丙氨酰谷氨酰胺注射液","力太","注射液","50ml:10g","瓶","1","玻璃瓶","奥地利Fresenius Kabi Austria GmbH","70.96","修改（医保备注）","医保发〔2023〕30号",""]
["703","XB05XBB120B002020101521","2","丙氨酰谷氨酰胺","注射剂","","203942","丙氨酰谷氨酰胺注射液","无","注射剂","50ml:10g","瓶","1","钠钙玻璃输液瓶和注射液用卤化丁基橡胶塞(氯化)","江苏正大丰海制药有限公司","22.35","修改（医保备注）","医保发〔2023〕30号",""]
["704","XB05XBB120B002020101930","2","丙氨酰谷氨酰胺","注射剂","","201247","丙氨酰谷氨酰胺注射液","无","注射液","50ml:10g","瓶","1","钠钙玻璃输液瓶和注射液用卤化丁基橡胶塞装。","远大生命科学(武汉)有限公司","22.47","修改（医保备注）","医保发〔2023〕30号",""]
["705","XB05XBB120B002020103662","2","丙氨酰谷氨酰胺","注射剂","","106639","丙氨酰谷氨酰胺注射液","无","注射液","50ml:10g","瓶","1","玻璃瓶","哈尔滨三联药业股份有限公司","48.35","修改（医保备注）","医保发〔2023〕30号",""]
["706","XB05XBB120B002020104127","2","丙氨酰谷氨酰胺","注射剂","","134529","丙氨酰谷氨酰胺注射液","无","注射液","50ml:10g","袋","1","三层共挤输液袋包装","辰欣药业股份有限公司","16.41","修改（医保备注）","医保发〔2023〕30号",""]
["707","XB05XBB120B002020282359","2","丙氨酰谷氨酰胺","注射剂","","204431","丙氨酰谷氨酰胺注射液","无","注射液","50ml:10g","箱","1","多层共挤输液袋","北京百美特生物制药有限公司","12.77","修改（医保备注）","医保发〔2023〕30号",""]
["708","XB05XBB120B002020302180","2","丙氨酰谷氨酰胺","注射剂","","109432","丙氨酰谷氨酰胺注射液","无","注射液","50ml:10g","瓶","1","玻璃瓶","四川科伦药业股份有限公司","6.86","修改（医保备注）","医保发〔2023〕30号",""]
["709","XB05XBB120B002020604127","2","丙氨酰谷氨酰胺","注射剂","","134354","丙氨酰谷氨酰胺注射液","无","注射液","50ml:10g","瓶","1","玻璃瓶","辰欣药业股份有限公司","16.41","修改（医保备注）","医保发〔2023〕30号",""]
["710","XV01AAC031X010010101415","2","肠内营养剂(TPF-T)","乳剂","需经营养风险筛查，明确具有营养风险，且应为不能经饮食补充足够营养的患者方予支付。","146344","肠内营养乳剂(TPF-T)(水果味)","瑞能","口服乳液","200ml","瓶","1","玻璃瓶","费森尤斯卡比华瑞制药有限公司","42.81","修改（医保备注）","医保发〔2023〕30号",""]
["711","XV01AAC028X002010179366","2","肠内营养剂(TPF-D)","口服混悬剂","需经营养风险筛查，明确具有营养风险，且应为不能经饮食补充足够营养的患者方予支付。","147313","肠内营养混悬液(TPF-D)","伊力佳","口服混悬剂","500ml(1.01Kcal/ml)","瓶","1","塑料瓶","荷兰ABBOTT LABORATORIES.B.V.","82.17","修改（医保备注）","医保发〔2023〕30号",""]
["712","XV01AAC028X010010101415","2","肠内营养剂(TPF-D)","乳剂","需经营养风险筛查，明确具有营养风险，且应为不能经饮食补充足够营养的患者方予支付。","166357","肠内营养乳剂(TPF-D)","瑞代","口服乳液","500ml","袋","1","塑料袋","费森尤斯卡比华瑞制药有限公司","59.06","修改（医保备注）","医保发〔2023〕30号",""]
["713","XV01AAC029X002020201630","2","肠内营养剂(TPF-DM)","口服混悬剂","需经营养风险筛查，明确具有营养风险，且应为不能经饮食补充足够营养的患者方予支付。","130931","肠内营养混悬液(TPF-DM)","无","口服混悬剂","500ml(0.75kcal/ml)","瓶","1","玻璃瓶","纽迪希亚制药(无锡)有限公司","101.64","修改（医保备注）","医保发〔2023〕30号",""]
["714","XV01AAC025X002020201630","2","肠内营养剂(SP)","口服混悬剂","需经营养风险筛查，明确具有营养风险，且应为不能经饮食补充足够营养的患者方予支付。","130385","肠内营养混悬液(SP)","百普力","口服混悬剂","500ml(1Kcal/ml)","瓶","1","玻璃瓶","纽迪希亚制药(无锡)有限公司","78.14","修改（医保备注）","医保发〔2023〕30号",""]
["715","XV01AAC026P004010179366","2","肠内营养剂(TP)","口服粉剂","需经营养风险筛查，明确具有营养风险，且应为不能经饮食补充足够营养的患者方予支付。","141563","肠内营养粉剂(TP)","安素","粉剂","400g(1.06kcal/ml)","听","1","空","荷兰ABBOTT LABORATORIES.B.V.","54.60","修改（医保备注）","医保发〔2023〕30号",""]
["716","XV01AAC026X003010101415","2","肠内营养剂(TP)","口服乳剂","需经营养风险筛查，明确具有营养风险，且应为不能经饮食补充足够营养的患者方予支付。","166356","肠内营养乳剂(TP)","瑞素","口服乳液","500ml","袋","1","塑料袋","费森尤斯卡比华瑞制药有限公司","32.90","修改（医保备注）","医保发〔2023〕30号",""]
["717","XV01AAC027X002060201630","2","肠内营养剂(TPF)","口服混悬剂","需经营养风险筛查，明确具有营养风险，且应为不能经饮食补充足够营养的患者方予支付。","130356","肠内营养混悬液(TPF)","能全力","口服混悬剂","500ml(1.5kcal/ml)","瓶","1","玻璃瓶","纽迪希亚制药(无锡)有限公司","59.13","修改（医保备注）","医保发〔2023〕30号",""]
["718","XV01AAC027X002070201630","2","肠内营养剂(TPF)","口服混悬剂","需经营养风险筛查，明确具有营养风险，且应为不能经饮食补充足够营养的患者方予支付。","130349","肠内营养混悬液(TPF)","能全力","口服混悬剂","500ml(1kcal/ml)","瓶","1","玻璃瓶","纽迪希亚制药(无锡)有限公司","38.87","修改（医保备注）","医保发〔2023〕30号",""]
["719","XV01AAC027X010020101415","2","肠内营养剂(TPF)","乳剂","需经营养风险筛查，明确具有营养风险，且应为不能经饮食补充足够营养的患者方予支付。","134237","肠内营养乳剂(TPF)","瑞先","口服乳液","500ml","瓶","1","玻璃瓶","费森尤斯卡比华瑞制药有限公司","54.66","修改（医保备注）","医保发〔2023〕30号",""]
["720","XV01AAC030X002010179366","2","肠内营养剂(TPF-FOS)","口服混悬剂","需经营养风险筛查，明确具有营养风险，且应为不能经饮食补充足够营养的患者方予支付。","147314","肠内营养混悬液(TPF-FOS)","佳维体","口服混悬剂","500ml(1.07kcal/ml)","瓶","1","塑料瓶","荷兰ABBOTT LABORATORIES.B.V.","46.88","修改（医保备注）","医保发〔2023〕30号",""]
["721","XV01AAC032X010010101415","2","肠内营养剂(TP-HE)","乳剂","需经营养风险筛查，明确具有营养风险，且应为不能经饮食补充足够营养的患者方予支付。","166354","肠内营养乳剂(TP-HE)","瑞高","口服乳液","500ml","袋","1","塑料袋","费森尤斯卡比华瑞制药有限公司","61.09","修改（医保备注）","医保发〔2023〕30号",""]
["722","XV01AAC033X002020201630","2","肠内营养剂(TP-MCT)","口服混悬剂","需经营养风险筛查，明确具有营养风险，且应为不能经饮食补充足够营养的患者方予支付。","130390","肠内营养混悬液(TP-MCT)","无","口服混悬剂","500ml(1Kcal/ml)","瓶","1","玻璃瓶","纽迪希亚制药(无锡)有限公司","70.49","修改（医保备注）","医保发〔2023〕30号",""]
["723","XV01AAC037P004010100547","2","肠内营养粉(AA)","口服粉剂","需经营养风险筛查，明确具有营养风险，且应为不能经饮食补充足够营养的患者方予支付。","162842","肠内营养粉剂(AA)","无","散剂","80g","瓶","1","塑料瓶","日本EA制药株式会社福岛工厂EA Pharma Co.,Ltd.Fukushima Plant","68.58","修改（医保备注）","医保发〔2023〕30号",""]
["724","XV01AAD154P004010180083","2","短肽型肠内营养剂","口服粉剂","需经营养风险筛查，明确具有营养风险，且应为不能经饮食补充足够营养的患者方予支付。","147538","短肽型肠内营养剂","百普素","粉剂","125g(1kcal/ml)","袋","1","复合膜","德国Milupa GmbH","68.42","修改（医保备注）","医保发〔2023〕30号",""]
["725","XV01AAZ013P004010179067","2","整蛋白型肠内营养剂","口服粉剂","需经营养风险筛查，明确具有营养风险，且应为不能经饮食补充足够营养的患者方予支付。","147539","整蛋白型肠内营养剂","能全素","粉剂","320g(1kcal/ml)","听","1","空","德国Milupa GmbH","65.49","修改（医保备注）","医保发〔2023〕30号",""]
["726","XV01AAC154P004010180399","2","肠内营养粉(AA-PA)","口服粉剂","需经营养风险筛查，明确具有营养风险，且应为不能经饮食补充足够营养的患者方予支付。","171881","肠内营养粉剂(AA-PA)","无","散剂","400g","听","1","马口铁","英国SHS International Limited","458.0","修改（医保备注）","医保发〔2023〕30号",""]
["727","XN01BBZ055B002010101445","2","左布比卡因","注射剂","","135820","盐酸左布比卡因注射液","速卡","注射液","5ml:37.5mg","支","1","安瓿","江苏恒瑞医药股份有限公司","17.00","修改（医保备注）","医保发〔2023〕30号",""]
["728","XN01BBZ055B002010102000","2","左布比卡因","注射剂","","204069","盐酸左布比卡因注射液","无","注射液","5ml:37.5mg(按C18H28N2O计)","盒","5","玻璃瓶","宜昌人福药业有限责任公司","22.50","修改（医保备注）","医保发〔2023〕30号",""]
["729","XN01BBZ055B002010200601","2","左布比卡因","注射剂","","113912","盐酸左布比卡因注射液","伊捷卡","注射液","10ml:50mg","支","1","安瓿","珠海润都制药股份有限公司","23.68","修改（医保备注）","医保发〔2023〕30号",""]
["730","XN01BBZ055B002010404152","2","左布比卡因","注射剂","","175809","盐酸左布比卡因注射液","无","注射液","5ml:37.5mg","支","1","安瓿","瑞阳制药股份有限公司","9.72","修改（医保备注）","医保发〔2023〕30号",""]
["731","XN01BBZ055B002020102000","2","左布比卡因","注射剂","","204072","盐酸左布比卡因注射液","无","注射液","10ml:50mg(按C18H28N2O计)","盒","2","玻璃瓶","宜昌人福药业有限责任公司","11.20","修改（医保备注）","医保发〔2023〕30号",""]
["732","XN01BBZ055B002020104152","2","左布比卡因","注射剂","","175808","盐酸左布比卡因注射液","无","注射液","10ml:50mg","支","1","安瓿","瑞阳制药股份有限公司","12.10","修改（医保备注）","医保发〔2023〕30号",""]
["733","XN01BBZ055B002020200601","2","左布比卡因","注射剂","","113924","盐酸左布比卡因注射液","无","注射液","5ml:37.5mg","支","1","安瓿","珠海润都制药股份有限公司","19.00","修改（医保备注）","医保发〔2023〕30号",""]
["734","XN01BBZ055B002020201445","2","左布比卡因","注射剂","","202514","盐酸左布比卡因注射液","无","注射液","10ml:75mg(按C？？H？？N？O计)","盒","5","玻璃瓶","江苏恒瑞医药股份有限公司","45.00","修改（医保备注）","医保发〔2023〕30号",""]
["735","XN02ABF027V002010101389","2","芬太尼","贴剂","","","芬太尼透皮贴剂","无","透皮贴剂","2.5mg/贴","盒","2","复合膜","常州四药制药有限公司","","修改（医保备注）","医保发〔2023〕30号","毒麻精放类药品"]
["736","XN02ABF027V002010102529","2","芬太尼","贴剂","","","芬太尼透皮贴剂","多瑞吉","贴剂","25微克/小时,4.2mg/贴","盒","5","铝塑复合袋","JANSSEN-CILAG NV","","修改（医保备注）","医保发〔2023〕30号","毒麻精放类药品"]
["737","XN02ABF027V002010103050","2","芬太尼","贴剂","","","芬太尼透皮贴剂","无","贴剂","4.125mg/7.5cm2/贴","盒","1","聚酯/铝/聚乙烯药品包装复合膜袋包装","河南羚锐制药股份有限公司","","修改（医保备注）","医保发〔2023〕30号","毒麻精放类药品"]
["738","XN02ABF027V002010201389","2","芬太尼","贴剂","","","芬太尼透皮贴剂","无","透皮贴剂","2.5mg/贴","盒","5","复合膜","常州四药制药有限公司","","修改（医保备注）","医保发〔2023〕30号","毒麻精放类药品"]
["739","XN02ABF027V002010203050","2","芬太尼","贴剂","","","芬太尼透皮贴剂","无","贴剂","4.125mg/7.5cm2/贴","袋","5","无","河南羚锐制药股份有限公司","","修改（医保备注）","医保发〔2023〕30号","毒麻精放类药品"]
["740","XN02ABF027V002020101389","2","芬太尼","贴剂","","","芬太尼透皮贴剂","无","透皮贴剂","5mg/贴","盒","2","复合膜","常州四药制药有限公司","","修改（医保备注）","医保发〔2023〕30号","毒麻精放类药品"]
["741","XN02ABF027V002020102529","2","芬太尼","贴剂","","","芬太尼透皮贴剂","多瑞吉","贴剂","50微克/小时,8.4mg/贴","盒","5","铝塑复合袋","JANSSEN-CILAG NV","","修改（医保备注）","医保发〔2023〕30号","毒麻精放类药品"]
["742","XN02ABF027V002020103050","2","芬太尼","贴剂","","","芬太尼透皮贴剂","无","贴剂","8.250mg/15cm2/贴，50μg/h","盒","5","纸/铝/聚乙烯药品包装用复合膜袋","河南羚锐制药股份有限公司","","修改（医保备注）","医保发〔2023〕30号","毒麻精放类药品"]
["743","XN02ABF027V002020201389","2","芬太尼","贴剂","","","芬太尼透皮贴剂","无","透皮贴剂","5mg/贴","盒","5","复合膜","常州四药制药有限公司","","修改（医保备注）","医保发〔2023〕30号","毒麻精放类药品"]
["744","XN02AXD131V002010178655","2","丁丙诺啡","透皮贴剂","","","丁丙诺啡透皮贴剂","无","透皮贴剂","5mg","盒","2","含(从外到内)纸、低密度聚乙烯、铝和丙烯酸-乙烯共聚物","Mundipharma\u007fGmbH","","修改（医保备注）","医保发〔2023〕30号","毒麻精放类药品"]
["745","XN02AXD131V002010278655","2","丁丙诺啡","透皮贴剂","","","丁丙诺啡透皮贴剂","无","透皮贴剂","5mg","盒","1","含(从外到内)纸、低密度聚乙烯、铝和丙烯酸-乙烯共聚物","Mundipharma GmbH","","修改（医保备注）","医保发〔2023〕30号","毒麻精放类药品"]
["746","XN02AXD131V002010378655","2","丁丙诺啡","透皮贴剂","","","丁丙诺啡透皮贴剂","无","透皮贴剂","5mg","盒","1","含(从外到内)纸、低密度聚乙烯、铝和丙烯酸-乙烯共聚物","Mundipharma\u007fGmbH","","修改（医保备注）","医保发〔2023〕30号","毒麻精放类药品"]
["747","XN02AXD131V002010478655","2","丁丙诺啡","透皮贴剂","","","丁丙诺啡透皮贴剂","无","透皮贴剂","5mg","盒","2","含(从外到内)纸、低密度聚乙烯、铝和丙烯酸-乙烯共聚物","Mundipharma GmbH","","修改（医保备注）","医保发〔2023〕30号","毒麻精放类药品"]
["748","XN02AXD131V002010578655","2","丁丙诺啡","透皮贴剂","","","丁丙诺啡透皮贴剂","无","透皮贴剂","5mg","盒","4","含(从外到内)纸、低密度聚乙烯、铝和丙烯酸-乙烯共聚物","Mundipharma GmbH","","修改（医保备注）","医保发〔2023〕30号","毒麻精放类药品"]
["749","XN02AXD131V002010678655","2","丁丙诺啡","透皮贴剂","","","丁丙诺啡透皮贴剂","无","透皮贴剂","5mg","盒","4","含(从外到内)纸、低密度聚乙烯、铝和丙烯酸-乙烯共聚物","Mundipharma\u007fGmbH","","修改（医保备注）","医保发〔2023〕30号","毒麻精放类药品"]
["750","XN02AXD131V002010778655","2","丁丙诺啡","透皮贴剂","","","丁丙诺啡透皮贴剂","无","透皮贴剂","5mg","盒","20","含(从外到内)纸、低密度聚乙烯、铝和丙烯酸-乙烯共聚物","Mundipharma GmbH","","修改（医保备注）","医保发〔2023〕30号","毒麻精放类药品"]
["751","XN02AXD131V002020178655","2","丁丙诺啡","透皮贴剂","","","丁丙诺啡透皮贴剂","无","透皮贴剂","10mg","盒","1","含(从外到内)纸、低密度聚乙烯、铝和丙烯酸-乙烯共聚物","Mundipharma GmbH","","修改（医保备注）","医保发〔2023〕30号","毒麻精放类药品"]
["752","XN02AXD131V002020278655","2","丁丙诺啡","透皮贴剂","","","丁丙诺啡透皮贴剂","无","透皮贴剂","10mg","盒","1","含(从外到内)纸、低密度聚乙烯、铝和丙烯酸-乙烯共聚物","Mundipharma\u007fGmbH","","修改（医保备注）","医保发〔2023〕30号","毒麻精放类药品"]
["753","XN02AXD131V002020378655","2","丁丙诺啡","透皮贴剂","","","丁丙诺啡透皮贴剂","无","透皮贴剂","10mg","盒","2","含(从外到内)纸、低密度聚乙烯、铝和丙烯酸-乙烯共聚物","Mundipharma\u007fGmbH","","修改（医保备注）","医保发〔2023〕30号","毒麻精放类药品"]
["754","XN02AXD131V002020478655","2","丁丙诺啡","透皮贴剂","","","丁丙诺啡透皮贴剂","无","透皮贴剂","10mg","盒","2","含(从外到内)纸、低密度聚乙烯、铝和丙烯酸-乙烯共聚物","Mundipharma GmbH","","修改（医保备注）","医保发〔2023〕30号","毒麻精放类药品"]
["755","XN02AXD131V002020578655","2","丁丙诺啡","透皮贴剂","","","丁丙诺啡透皮贴剂","无","透皮贴剂","10mg","盒","4","含(从外到内)纸、低密度聚乙烯、铝和丙烯酸-乙烯共聚物","Mundipharma\u007fGmbH","","修改（医保备注）","医保发〔2023〕30号","毒麻精放类药品"]
["756","XN02AXD131V002020678655","2","丁丙诺啡","透皮贴剂","","","丁丙诺啡透皮贴剂","无","透皮贴剂","10mg","盒","4","含(从外到内)纸、低密度聚乙烯、铝和丙烯酸-乙烯共聚物","Mundipharma GmbH","","修改（医保备注）","医保发〔2023〕30号","毒麻精放类药品"]
["757","XN02AXD131V002020778655","2","丁丙诺啡","透皮贴剂","","","丁丙诺啡透皮贴剂","无","透皮贴剂","10mg","盒","20","含(从外到内)纸、低密度聚乙烯、铝和丙烯酸-乙烯共聚物","Mundipharma GmbH","","修改（医保备注）","医保发〔2023〕30号","毒麻精放类药品"]
["758","XN02AXD131V002030178655","2","丁丙诺啡","透皮贴剂","","","丁丙诺啡透皮贴剂","无","透皮贴剂","20mg","盒","1","含(从外到内)纸、低密度聚乙烯、铝和丙烯酸-乙烯共聚物","Mundipharma\u007fGmbH","","修改（医保备注）","医保发〔2023〕30号","毒麻精放类药品"]
["759","XN02AXD131V002030278655","2","丁丙诺啡","透皮贴剂","","","丁丙诺啡透皮贴剂","无","透皮贴剂","20mg","盒","1","含(从外到内)纸、低密度聚乙烯、铝和丙烯酸-乙烯共聚物","Mundipharma GmbH","","修改（医保备注）","医保发〔2023〕30号","毒麻精放类药品"]
["760","XN02AXD131V002030378655","2","丁丙诺啡","透皮贴剂","","","丁丙诺啡透皮贴剂","无","透皮贴剂","20mg","盒","2","含(从外到内)纸、低密度聚乙烯、铝和丙烯酸-乙烯共聚物","Mundipharma\u007fGmbH","","修改（医保备注）","医保发〔2023〕30号","毒麻精放类药品"]
["761","XN02AXD131V002030478655","2","丁丙诺啡","透皮贴剂","","","丁丙诺啡透皮贴剂","无","透皮贴剂","20mg","盒","2","含(从外到内)纸、低密度聚乙烯、铝和丙烯酸-乙烯共聚物","Mundipharma GmbH","","修改（医保备注）","医保发〔2023〕30号","毒麻精放类药品"]
["762","XN02AXD131V002030578655","2","丁丙诺啡","透皮贴剂","","","丁丙诺啡透皮贴剂","无","透皮贴剂","20mg","盒","4","含(从外到内)纸、低密度聚乙烯、铝和丙烯酸-乙烯共聚物","Mundipharma\u007fGmbH","","修改（医保备注）","医保发〔2023〕30号","毒麻精放类药品"]
["763","XN02AXD131V002030678655","2","丁丙诺啡","透皮贴剂","","","丁丙诺啡透皮贴剂","无","透皮贴剂","20mg","盒","4","含(从外到内)纸、低密度聚乙烯、铝和丙烯酸-乙烯共聚物","Mundipharma GmbH","","修改（医保备注）","医保发〔2023〕30号","毒麻精放类药品"]
["764","XN02AXD131V002030778655","2","丁丙诺啡","透皮贴剂","","","丁丙诺啡透皮贴剂","无","透皮贴剂","20mg","盒","20","含(从外到内)纸、低密度聚乙烯、铝和丙烯酸-乙烯共聚物","Mundipharma GmbH","","修改（医保备注）","医保发〔2023〕30号","毒麻精放类药品"]
["765","XN07XXT050B002010100239","2","天麻素","注射剂","支付不超过14天。","147048","天麻素注射液(肌内注射,静脉滴注)","无","注射液","1ml:0.1g","支","1","安瓿","悦康药业集团股份有限公司","6.18","修改（医保备注）","医保发〔2023〕30号",""]
["766","XN07XXT050B002010104982","2","天麻素","注射剂","支付不超过14天。","109243","天麻素注射液(肌内注射,静脉滴注)","无","注射液","1ml:0.1g","支","1","安瓿","湖南五洲通药业股份有限公司","5.54","修改（医保备注）","医保发〔2023〕30号",""]
["767","XN07XXT050B002010203973","2","天麻素","注射剂","支付不超过14天。","146683","天麻素注射液(肌内注射,静脉滴注)","无","注射液","1ml:0.1g","支","1","安瓿","华润双鹤利民药业（济南）有限公司","2.75","修改（医保备注）","医保发〔2023〕30号",""]
["768","XN07XXT050B002010204615","2","天麻素","注射剂","支付不超过14天。","130856","天麻素注射液(肌内注射)","无","注射液","2ml:0.2g","支","1","安瓿","浙江诚意药业股份有限公司","4.65","修改（医保备注）","医保发〔2023〕30号",""]
["769","XN07XXT050B002020100239","2","天麻素","注射剂","支付不超过14天。","147049","天麻素注射液(肌内注射,静脉滴注)","无","注射液","2ml:0.2g","支","1","安瓿","悦康药业集团股份有限公司","9.95","修改（医保备注）","医保发〔2023〕30号",""]
["770","XN07XXT050B002020100978","2","天麻素","注射剂","支付不超过14天。","129054","天麻素注射液(肌内注射,静脉滴注)","无","注射液","5ml:0.5g","支","1","安瓿","西南药业股份有限公司","23.26","修改（医保备注）","医保发〔2023〕30号",""]
["771","XN07XXT050B002020103973","2","天麻素","注射剂","支付不超过14天。","146680","天麻素注射液(肌内注射,静脉滴注)","无","注射液","2ml:0.2g","支","1","安瓿","华润双鹤利民药业(济南)有限公司","0.83","修改（医保备注）","医保发〔2023〕30号",""]
["772","XN07XXT050B002020105614","2","天麻素","注射剂","支付不超过14天。","122579","天麻素注射液(肌内注射,静脉滴注)","天眩清","注射液","2ml:0.2g","支","1","安瓿","昆药集团股份有限公司","15.56","修改（医保备注）","医保发〔2023〕30号",""]
["773","XN07XXT050B002030105290","2","天麻素","注射剂","支付不超过14天。","146048","天麻素注射液(肌内注射,静脉滴注)","无","注射液","2ml:0.2g","支","1","安瓿","江西国药有限责任公司","4.70","修改（医保备注）","医保发〔2023〕30号",""]
["774","XN07XXT050B002030200239","2","天麻素","注射剂","支付不超过14天。","147081","天麻素注射液(肌内注射,静脉滴注)","无","注射液","5ml:0.6g","支","1","安瓿","悦康药业集团股份有限公司","25.41","修改（医保备注）","医保发〔2023〕30号",""]
["775","XN02CCL077A001010101814","2","利扎曲普坦","口服常释剂型","","130815","苯甲酸利扎曲普坦片","欧立停","素片","5mg","盒","3","铝塑","湖北欧立制药有限公司","53.33","修改（医保备注）","医保发〔2023〕30号",""]
["776","XN02CCS094A001010105849","2","舒马普坦","口服常释剂型","","123391","琥珀酸舒马普坦片","尤舒","薄膜衣片","25mg","盒","2","复合膜","海南先声药业有限公司","9.80","修改（医保备注）","医保发〔2023〕30号",""]
["777","XN02CCS094A001010205849","2","舒马普坦","口服常释剂型","","162260","琥珀酸舒马普坦片","尤舒","薄膜衣片","25mg","盒","6","复合膜","海南先声药业有限公司","29.40","修改（医保备注）","医保发〔2023〕30号",""]
["778","XN02CCZ076A001010104065","2","佐米曲普坦","口服常释剂型","","106457","佐米曲普坦片","无","片剂","2.5mg","盒","6","铝塑包装","四川省旭晖制药有限公司","59.79","修改（医保备注）","医保发〔2023〕30号",""]
["779","XN02CCZ076A001010104489","2","佐米曲普坦","口服常释剂型","","142646","佐米曲普坦片","无","素片","2.5mg","盒","3","铝箔","杭州康恩贝制药有限公司","43.29","修改（医保备注）","医保发〔2023〕30号",""]
["780","XN02CCZ076A006010103010","2","佐米曲普坦","口服常释剂型","","125702","佐米曲普坦分散片","臻逹","分散片","2.5mg","盒","2","铝箔","辅仁药业集团有限公司","33.10","修改（医保备注）","医保发〔2023〕30号",""]
["781","XM01ABT149B002010102013","2","酮咯酸氨丁三醇","注射剂","","165681","酮咯酸氨丁三醇注射液","无","注射剂","1ml:15mg","盒","5","安瓿","成都倍特药业股份有限公司","177.05","修改（医保备注）","医保发〔2023〕30号",""]
["782","XM01ABT149B002010102189","2","酮咯酸氨丁三醇","注射剂","","164305","酮咯酸氨丁三醇注射液","无","注射液","1ml:30mg","支","1","安瓿","四川美大康佳乐药业有限公司","33.67","修改（医保备注）","医保发〔2023〕30号",""]
["783","XM01ABT149B002010104188","2","酮咯酸氨丁三醇","注射剂","","131271","酮咯酸氨丁三醇注射液","尼松","注射液","1ml:30mg","盒","1","安瓿","山东新时代药业有限公司","3.50","修改（医保备注）","医保发〔2023〕30号",""]
["784","XM01ABT149B002010204188","2","酮咯酸氨丁三醇","注射剂","","204039","酮咯酸氨丁三醇注射液","尼松","注射液","1ml:30mg","盒","10","塑料安瓿","山东华鲁制药有限公司","35.00","修改（医保备注）","医保发〔2023〕30号",""]
["785","XM01ABT149B002010381812","2","酮咯酸氨丁三醇","注射剂","","177165","酮咯酸氨丁三醇注射液","无","注射液","1ml:30mg","支","1","安瓿","南京海融制药有限公司","3.57","修改（医保备注）","医保发〔2023〕30号",""]
["786","XM01ABT149B002020102013","2","酮咯酸氨丁三醇","注射剂","","165669","酮咯酸氨丁三醇注射液","无","注射剂","1ml:30mg","盒","5","安瓿","成都倍特药业股份有限公司","301.00","修改（医保备注）","医保发〔2023〕30号",""]
["787","XB02BXB011B001010101190","2","白眉蛇毒血凝酶","注射剂","限手术患者或产后出血患者。","123513","注射用白眉蛇毒血凝酶","无","冻干粉针剂","0.5单位(KU)","支","1","玻璃瓶","锦州奥鸿药业有限责任公司","21.26","修改（医保备注）","医保发〔2023〕30号",""]
["788","XB02BXB011B001020101190","2","白眉蛇毒血凝酶","注射剂","限手术患者或产后出血患者。","123527","注射用白眉蛇毒血凝酶","邦亭","冻干粉针剂","1单位(KU)","支","1","玻璃瓶","锦州奥鸿药业有限责任公司","31.30","修改（医保备注）","医保发〔2023〕30号",""]
["789","XB02BXB011B001030101190","2","白眉蛇毒血凝酶","注射剂","限手术患者或产后出血患者。","123533","注射用白眉蛇毒血凝酶","无","冻干粉针剂","2单位(KU)","支","1","玻璃瓶","锦州奥鸿药业有限责任公司","56.26","修改（医保备注）","医保发〔2023〕30号",""]
["790","XB02BXM155B014010104069","2","矛头蝮蛇血凝酶","注射剂","限手术患者或产后出血患者。","111111","注射用矛头蝮蛇血凝酶","巴曲亭","冻干粉针剂","1单位","支","1","玻璃瓶","蓬莱诺康药业有限公司","36.19","修改（医保备注）","医保发〔2023〕30号",""]
["791","XB02BXM155B014020204017","2","矛头蝮蛇血凝酶","注射剂","限手术患者或产后出血患者。","146291","注射用矛头蝮蛇血凝酶","巴曲亭","冻干粉针剂","2单位","支","1","玻璃瓶","蓬莱诺康药业有限公司","61.52","修改（医保备注）","医保发〔2023〕30号",""]
["792","XB02BXS064B002010104461","2","蛇毒血凝酶","注射剂","限手术患者或产后出血患者。","135514","蛇毒血凝酶注射液","速乐涓","注射液","1ml:1单位","支","1","西林瓶","兆科药业(合肥)有限公司","30.30","修改（医保备注）","医保发〔2023〕30号",""]
["793","XA04AAG064B002010102210","2","格拉司琼","注射剂","","173854","盐酸格拉司琼注射液","无","注射液","3ml:3mg","支","1","安瓿","成都倍特药业股份有限公司","68.0","修改（医保备注）","医保发〔2023〕30号",""]
["794","XA04AAG064B002010104021","2","格拉司琼","注射剂","","113970","盐酸格拉司琼注射液","无","注射液","3ml:3mg","支","1","安瓿","齐鲁制药有限公司","9.60","修改（医保备注）","医保发〔2023〕30号",""]
["795","XA04AAG064B002010104561","2","格拉司琼","注射剂","","138059","盐酸格拉司琼注射液","枢星","注射液","3ml:3mg","支","1","安瓿","福安药业集团宁波天衡制药有限公司","37.43","修改（医保备注）","医保发〔2023〕30号",""]
["796","XA04AAG064B002010203973","2","格拉司琼","注射剂","","135985","盐酸格拉司琼注射液","无","注射液","3ml:3mg","支","1","安瓿","华润双鹤利民药业（济南）有限公司","8.60","修改（医保备注）","医保发〔2023〕30号",""]
["797","XA04AAG064B002010205783","2","格拉司琼","注射剂","","110197","盐酸格拉司琼注射液","无","注射液","1ml:1mg","支","1","安瓿","海南惠普森医药生物技术有限公司","6.80","修改（医保备注）","医保发〔2023〕30号",""]
["798","XA04AAG064B002010302298","2","格拉司琼","注射剂","","203877","盐酸格拉司琼注射液","无","注射液","3ml:3mg","支","1","中硼硅玻璃安瓿","成都市海通药业有限公司","67.80","修改（医保备注）","医保发〔2023〕30号",""]
["799","XA04AAG064B014010104141","2","格拉司琼","注射剂","","115830","注射用盐酸格拉司琼","佐坦","冻干粉针剂","3mg","瓶","1","玻璃瓶","山东罗欣药业集团股份有限公司","13.49","修改（医保备注）","医保发〔2023〕30号",""]
["800","XA04AAT122B001010103662","2","托烷司琼","注射剂","","106601","注射用盐酸托烷司琼","纾吉","冻干粉针剂","2mg(以托烷司琼计)","瓶","1","玻璃瓶","哈尔滨三联药业股份有限公司","23.54","修改（医保备注）","医保发〔2023〕30号",""]
["801","XA04AAT122B001010105793","2","托烷司琼","注射剂","","119549","注射用盐酸托烷司琼","瑞齐泰","冻干粉针剂","2mg(以托烷司琼计)","瓶","1","西林瓶","海南灵康制药有限公司","23.24","修改（医保备注）","医保发〔2023〕30号",""]
["802","XA04AAT122B001020103662","2","托烷司琼","注射剂","","106605","注射用盐酸托烷司琼","纾吉","冻干粉针剂","5mg(以托烷司琼计)","瓶","1","玻璃瓶","哈尔滨三联药业股份有限公司","45.00","修改（医保备注）","医保发〔2023〕30号",""]
["803","XA04AAT122B001020105793","2","托烷司琼","注射剂","","119557","注射用盐酸托烷司琼","瑞齐泰","冻干粉针剂","5mg(以托烷司琼计)","瓶","1","西林瓶","海南灵康制药有限公司","21.54","修改（医保备注）","医保发〔2023〕30号",""]
["804","XA04AAT122B002010101445","2","托烷司琼","注射剂","","135821","盐酸托烷司琼注射液","维瑞特","注射液","5ml:5mg(以托烷司琼计)","瓶","1","安瓿","江苏恒瑞医药股份有限公司","18.49","修改（医保备注）","医保发〔2023〕30号",""]
["805","XA04AAT122B002010101743","2","托烷司琼","注射剂","","102242","盐酸托烷司琼注射液","普洛林","注射液","5ml:5mg(以托烷司琼计)","支","1","安瓿","江苏联环药业股份有限公司","19.10","修改（医保备注）","医保发〔2023〕30号",""]
["806","XA04AAT122B002010102918","2","托烷司琼","注射剂","","130465","盐酸托烷司琼注射液","无","注射液","5ml:5mg(以托烷司琼计)","支","1","安瓿","山西普德药业有限公司","23.37","修改（医保备注）","医保发〔2023〕30号",""]
["807","XA04AAT122B002010104756","2","托烷司琼","注射剂","","131032","盐酸托烷司琼注射液","无","注射液","5ml:5mg(以托烷司琼计)","支","1","安瓿","浙江震元制药有限公司","19.03","修改（医保备注）","医保发〔2023〕30号",""]
["808","XA04AAT122B002010200978","2","托烷司琼","注射剂","","125587","盐酸托烷司琼注射液","赛格恩","注射液","2ml:2mg(以托烷司琼计)","支","1","安瓿","西南药业股份有限公司","33.89","修改（医保备注）","医保发〔2023〕30号",""]
["809","XA04AAT122B002010204021","2","托烷司琼","注射剂","","113956","盐酸托烷司琼注射液","欣贝","注射剂","1ml:5mg (以托烷司琼计)","支","1","安瓿","齐鲁制药有限公司","18.00","修改（医保备注）","医保发〔2023〕30号",""]
["810","XA04AAT122B002010304494","2","托烷司琼","注射剂","","135838","盐酸托烷司琼注射液","妥立士宁","注射液","5ml:5mg(以托烷司琼计)","支","1","安瓿","杭州民生药业股份有限公司","1.19","修改（医保备注）","医保发〔2023〕30号",""]
["811","XA04AAT122B002020200978","2","托烷司琼","注射剂","","125596","盐酸托烷司琼注射液","赛格恩","注射液","5ml:5mg(以托烷司琼计)","支","1","安瓿","西南药业股份有限公司","37.10","修改（医保备注）","医保发〔2023〕30号",""]
["812","XA04AAT122B014010104141","2","托烷司琼","注射剂","","115814","注射用盐酸托烷司琼","罗亭","冻干粉针剂","2mg(以托烷司琼计)","瓶","1","玻璃瓶","山东罗欣药业集团股份有限公司","24.48","修改（医保备注）","医保发〔2023〕30号",""]
["813","XA04AAT122B014010104152","2","托烷司琼","注射剂","","110020","注射用盐酸托烷司琼","无","冻干粉针剂","5mg(以托烷司琼计)","瓶","1","玻璃瓶","瑞阳制药股份有限公司","58.00","修改（医保备注）","医保发〔2023〕30号",""]
["814","XA04AAT122B014020104141","2","托烷司琼","注射剂","","115821","注射用盐酸托烷司琼","罗亭","冻干粉针剂","5mg(以托烷司琼计)","瓶","1","玻璃瓶","山东罗欣药业集团股份有限公司","47.20","修改（医保备注）","医保发〔2023〕30号",""]
["815","XA05BAY144B002010101523","2","异甘草酸镁","注射剂","限AST或ALT大于120U/L的患者。","118704","异甘草酸镁注射液","天晴甘美","注射液","10ml:50mg","支","1","安瓿","正大天晴药业集团股份有限公司","27.61","修改（医保备注）","医保发〔2023〕30号",""]
["816","XA05BAG105A001010101066","2","谷胱甘肽","口服常释剂型","限肝功能异常患者。","108040","谷胱甘肽片","阿拓莫兰","薄膜衣片","0.1g","瓶","24","空","重庆药友制药有限责任公司","40.06","修改（医保备注）","医保发〔2023〕30号",""]
["817","XA05BAG105A001010201066","2","谷胱甘肽","口服常释剂型","限肝功能异常患者。","108044","谷胱甘肽片","阿拓莫兰","薄膜衣片","0.1g","瓶","36","空","重庆药友制药有限责任公司","60.07","修改（医保备注）","医保发〔2023〕30号",""]
["818","XA05BAF632B001020102777","2","复方甘草甜素（复方甘草酸苷）","注射剂","限AST或ALT大于120U/L的患者。","114502","注射用复方甘草酸苷","无","冻干粉针剂","甘草酸苷40mg,甘氨酸0.4g,盐酸半胱氨酸20mg","瓶","1","西林瓶","石药集团欧意药业有限公司","10.98","修改（医保备注）","医保发〔2023〕30号",""]
["819","XA05BAF632B001030102049","2","复方甘草甜素（复方甘草酸苷）","注射剂","限AST或ALT大于120U/L的患者。","118202","注射用复方甘草酸苷","无","冻干粉针剂","甘草酸苷20mg,甘氨酸0.2g,盐酸半胱氨酸10mg","瓶","1","玻璃瓶","成都苑东生物制药股份有限公司","7.79","修改（医保备注）","医保发〔2023〕30号",""]
["820","XA05BAF632B002010102469","2","复方甘草甜素（复方甘草酸苷）","注射剂","限AST或ALT大于120U/L的患者。","117049","复方甘草酸苷注射液","无","注射液","20ml:甘草酸苷40mg,盐酸半胱氨酸20mg,甘氨酸0.4g","支","1","安瓿","西安远大德天药业股份有限公司","1.32","修改（医保备注）","医保发〔2023〕30号",""]
["821","XA05BAF632B002010102770","2","复方甘草甜素（复方甘草酸苷）","注射剂","限AST或ALT大于120U/L的患者。","110625","复方甘草酸苷注射液","无","注射液","20ml:甘草酸苷40mg,盐酸半胱氨酸20mg,甘氨酸0.4g","支","1","安瓿","石药集团欧意药业有限公司","6.95","修改（医保备注）","医保发〔2023〕30号",""]
["822","XA05BAF632B002010104127","2","复方甘草甜素（复方甘草酸苷）","注射剂","限AST或ALT大于120U/L的患者。","134217","复方甘草酸苷注射液","无","注射液","20ml:甘草酸苷40mg,盐酸半胱氨酸20mg,甘氨酸0.4g","支","1","安瓿","辰欣药业股份有限公司","6.30","修改（医保备注）","医保发〔2023〕30号",""]
["823","XA05BAF632B002010279084","2","复方甘草甜素（复方甘草酸苷）","注射剂","限AST或ALT大于120U/L的患者。","129537","复方甘草酸苷注射液","美能","注射液","20ml:甘草酸苷40mg,盐酸半胱氨酸20mg,甘氨酸0.4g","支","1","安瓿","日本Minophagen Pharmaceutical Co.,Ltd. Zama Factory<卫材(中国)药业有限公司>分包装","16.09","修改（医保备注）","医保发〔2023〕30号",""]
["824","XA05BAF632B014010204799","2","复方甘草甜素（复方甘草酸苷）","注射剂","限AST或ALT大于120U/L的患者。","136068","注射用复方甘草酸苷","无","冻干粉针剂","甘草酸苷40mg,甘氨酸0.4g,盐酸半胱氨酸20mg","瓶","1","玻璃瓶","福建省闽东力捷迅药业股份有限公司","11.69","修改（医保备注）","医保发〔2023〕30号",""]
["825","XA05BAF632B014020204799","2","复方甘草甜素（复方甘草酸苷）","注射剂","限AST或ALT大于120U/L的患者。","136069","注射用复方甘草酸苷","无","冻干粉针剂","甘草酸苷80mg,甘氨酸0.8g,盐酸半胱氨酸40mg","瓶","1","玻璃瓶","福建省闽东力捷迅药业股份有限公司","17.70","修改（医保备注）","医保发〔2023〕30号",""]
["826","XA05BAF632B014030104152","2","复方甘草甜素（复方甘草酸苷）","注射剂","限AST或ALT大于120U/L的患者。","110482","注射用复方甘草酸苷","无","冻干粉针剂","甘草酸苷80mg,甘氨酸0.8g,盐酸半胱氨酸40mg","瓶","1","玻璃瓶","瑞阳制药股份有限公司","19.66","修改（医保备注）","医保发〔2023〕30号",""]
["827","XA05BAM076B001020101957","2","门冬氨酸鸟氨酸","注射剂","限血氨升高或肝性脑病的患者。","127346","注射用门冬氨酸鸟氨酸","瑞甘","冻干粉针剂","2.5g","瓶","1","玻璃瓶","武汉启瑞药业有限公司","30.08","修改（医保备注）","医保发〔2023〕30号",""]
["828","XA05BAM076B002010178647","2","门冬氨酸鸟氨酸","注射剂","限血氨升高或肝性脑病的患者。","142191","门冬氨酸鸟氨酸注射液","雅博司","注射液","10ml:5.0g","支","1","安瓿","德国B.Braun Melsungen AG","41.37","修改（医保备注）","医保发〔2023〕30号",""]
["829","XA05BAM076B002010179286","2","门冬氨酸鸟氨酸","注射剂","限血氨升高或肝性脑病的患者。","169412","门冬氨酸鸟氨酸注射液","无","注射液","10ml:5g","盒","5","棕色中硼硅玻璃安瓿包装","湖南赛隆药业(长沙)有限公司","144.75","修改（医保备注）","医保发〔2023〕30号",""]
["830","XA05BAD195B002010102066","2","多烯磷脂酰胆碱","注射剂","限AST或ALT大于120U/L的患者。","126959","多烯磷脂酰胆碱注射液","无","注射剂(注射液)","5ml:232.5mg","盒","4","安瓿","成都天台山制药股份有限公司","76.44","修改（医保备注）","医保发〔2023〕30号",""]
["831","XA05BAG105B001020104141","2","还原型谷胱甘肽(谷胱甘肽)","注射剂","限AST或ALT大于120U/L的患者。","165959","注射用谷胱甘肽","无","冻干粉针剂","0.6g","盒","1","玻璃瓶","山东裕欣药业有限公司","5.10","修改（医保备注）","医保发〔2023〕30号",""]
["832","XA05BAG105B001040104141","2","还原型谷胱甘肽(谷胱甘肽)","注射剂","限AST或ALT大于120U/L的患者。","165967","注射用谷胱甘肽","无","冻干粉针剂","1.2g","盒","1","中硼硅玻璃管制注射剂瓶,冷冻干燥注射用无菌粉末用溴化丁基橡胶塞","山东罗欣药业集团股份有限公司","8.67","修改（医保备注）","医保发〔2023〕30号",""]
["833","XA05BAH032B001010100662","2","还原型谷胱甘肽（谷胱甘肽）","注射剂","限AST或ALT大于120U/L的患者。","138490","注射用谷胱甘肽","无","冻干粉针剂","0.3g","支","1","玻璃瓶","上海复旦复华药业有限公司","7.06","修改（医保备注）","医保发〔2023〕30号",""]
["834","XA05BAH032B001030100662","2","还原型谷胱甘肽（谷胱甘肽）","注射剂","限AST或ALT大于120U/L的患者。","138492","注射用谷胱甘肽","无","冻干粉针剂","0.9g","支","1","玻璃瓶","上海复旦复华药业有限公司","16.89","修改（医保备注）","医保发〔2023〕30号",""]
["835","XA05BAH032B001030101066","2","还原型谷胱甘肽（谷胱甘肽）","注射剂","限AST或ALT大于120U/L的患者。","108009","注射用谷胱甘肽","阿拓莫兰","冻干粉针剂","0.9g","瓶","1","玻璃瓶","重庆药友制药有限责任公司","17.28","修改（医保备注）","医保发〔2023〕30号",""]
["836","XA05BAH032B001050101066","2","还原型谷胱甘肽（谷胱甘肽）","注射剂","限AST或ALT大于120U/L的患者。","108018","注射用谷胱甘肽","阿拓莫兰","冻干粉针剂","1.2g","瓶","1","玻璃瓶","重庆药友制药有限责任公司","21.54","修改（医保备注）","医保发〔2023〕30号",""]
["837","XA05BAH032B001060101066","2","还原型谷胱甘肽（谷胱甘肽）","注射剂","限AST或ALT大于120U/L的患者。","108022","注射用谷胱甘肽","阿拓莫兰","冻干粉针剂","1.5g","瓶","1","玻璃瓶","重庆药友制药有限责任公司","25.56","修改（医保备注）","医保发〔2023〕30号",""]
["838","XA05BAH032B001070101066","2","还原型谷胱甘肽（谷胱甘肽）","注射剂","限AST或ALT大于120U/L的患者。","108028","注射用谷胱甘肽","阿拓莫兰","冻干粉针剂","1.8g","瓶","1","玻璃瓶","重庆药友制药有限责任公司","35.07","修改（医保备注）","医保发〔2023〕30号",""]
["839","XA05BAH032B014010104139","2","还原型谷胱甘肽（谷胱甘肽）","注射剂","限AST或ALT大于120U/L的患者。","136057","注射用谷胱甘肽","绿汀诺","冻干粉针剂","0.3g","瓶","1","玻璃瓶","山东绿叶制药有限公司","7.29","修改（医保备注）","医保发〔2023〕30号",""]
["840","XA05BAH032B014030104139","2","还原型谷胱甘肽（谷胱甘肽）","注射剂","限AST或ALT大于120U/L的患者。","136059","注射用谷胱甘肽","绿汀诺","冻干粉针剂","1.2g","瓶","1","玻璃瓶","山东绿叶制药有限公司","19.79","修改（医保备注）","医保发〔2023〕30号",""]
["841","XA05BAH032B014040104139","2","还原型谷胱甘肽（谷胱甘肽）","注射剂","限AST或ALT大于120U/L的患者。","136060","注射用谷胱甘肽","绿汀诺","冻干粉针剂","1.8g","瓶","1","玻璃瓶","山东绿叶制药有限公司","31.30","修改（医保备注）","医保发〔2023〕30号",""]
["842","XA05BAH112B001010101066","2","还原型谷胱甘肽（谷胱甘肽）","注射剂","限AST或ALT大于120U/L的患者。","107989","注射用谷胱甘肽","阿拓莫兰","冻干粉针剂","0.3g","瓶","1","玻璃瓶","重庆药友制药有限责任公司","8.67","修改（医保备注）","医保发〔2023〕30号",""]
["843","XA05BAH112B001010105589","2","还原型谷胱甘肽（谷胱甘肽）","注射剂","限AST或ALT大于120U/L的患者。","115619","注射用谷胱甘肽钠","松泰斯","注射剂","0.6g","盒","1","玻璃瓶","昆明积大制药股份有限公司","13.33","修改（医保备注）","医保发〔2023〕30号",""]
["844","XA05BAH112B001020101066","2","还原型谷胱甘肽（谷胱甘肽）","注射剂","限AST或ALT大于120U/L的患者。","108001","注射用谷胱甘肽","阿拓莫兰","冻干粉针剂","0.6g","瓶","1","玻璃瓶","重庆药友制药有限责任公司","12.67","修改（医保备注）","医保发〔2023〕30号",""]
["845","XA05BAG021B002010101523","2","甘草酸二铵","注射剂","限AST或ALT大于120U/L的患者。","118571","甘草酸二铵注射液","甘利欣","注射液","10ml:50mg","支","1","安瓿","正大天晴药业集团股份有限公司","3.08","修改（医保备注）","医保发〔2023〕30号",""]
["846","XA05BAG021B002010104718","2","甘草酸二铵","注射剂","限AST或ALT大于120U/L的患者。","132417","甘草酸二铵注射液","无","注射液","10ml:50mg","支","1","安瓿","浙江天瑞药业有限公司","0.65","修改（医保备注）","医保发〔2023〕30号",""]
["847","XA05BAG021B014010104141","2","甘草酸二铵","注射剂","限AST或ALT大于120U/L的患者。","115623","注射用甘草酸二铵","无","冻干粉针剂","0.15g","瓶","1","西林瓶","山东罗欣药业集团股份有限公司","4.20","修改（医保备注）","医保发〔2023〕30号",""]
["848","XA07BCM081X002040101554","2","蒙脱石","口服液体剂","","173044","蒙脱石混悬液","无","口服混悬剂","60ml:6g","瓶","1","塑料瓶","南京白敬宇制药有限责任公司","38.0","修改（医保备注）","医保发〔2023〕30号",""]
["849","XA07DAL281N001010101298","2","洛哌丁胺","颗粒剂","","172755","盐酸洛哌丁胺颗粒","雅邦","颗粒剂","1.0g:1.0mg","盒","12","复合膜","沈阳东星医药科技有限公司","56.0","修改（医保备注）","医保发〔2023〕30号",""]
["850","XA07DAL281N001010201298","2","洛哌丁胺","颗粒剂","","172753","盐酸洛哌丁胺颗粒","雅邦","颗粒剂","1.0g:1.0mg","盒","36","复合膜","沈阳东星医药科技有限公司","168.0","修改（医保备注）","医保发〔2023〕30号",""]
["851","XA16AAX051A012010180571","2","腺苷蛋氨酸","口服常释剂型","","147508","丁二磺酸腺苷蛋氨酸肠溶片","思美泰","肠溶片","0.5g","盒","10","铝塑","意大利ABBVIE S.R.L.","171.90","修改（医保备注）","医保发〔2023〕30号",""]
["852","XA16AAX051B001010100811","2","腺苷蛋氨酸","注射剂","","162527","注射用丁二磺酸腺苷蛋氨酸","思美泰","冻干粉针剂","0.5g","盒","1","配溶媒","法国DELPHARM SAINT REMY","49.68","修改（医保备注）","医保发〔2023〕30号",""]
["853","XA16AAX051B001010101523","2","腺苷蛋氨酸","注射剂","","310140","注射用丁二磺酸腺苷蛋氨酸","无","注射剂","0.5g(以腺苷蛋氨酸计)","盒","5","中硼硅玻璃管制瓶、注射用冷冻干燥用溴化丁基橡胶塞。中硼硅玻璃安瓿","正大天晴药业集团股份有限公司","225.80","修改（医保备注）","医保发〔2023〕30号",""]
["854","XA16AAX051B001010104641","2","腺苷蛋氨酸","注射剂","","144011","注射用丁二磺酸腺苷蛋氨酸","无","冻干粉针剂","0.5g","盒","1","配溶媒","浙江海正药业股份有限公司","48.25","修改（医保备注）","医保发〔2023〕30号",""]
["855","XC01CEA290B002010101323","2","盐酸奥普力农注射液","","","176069","盐酸奥普力农注射液","无","注射液","5ml:5mg","支","1","中硼硅玻璃安瓿装","沈阳双鼎制药有限公司","53.62","修改（医保备注）","医保发〔2023〕30号",""]
["856","XC01CEA290B002010101453","2","盐酸奥普力农注射液","","","176068","盐酸奥普力农注射液","无","注射液","5ml:5mg","支","1","安瓿","济川药业集团有限公司","17.60","修改（医保备注）","医保发〔2023〕30号",""]
["857","XC01CEA290B002010101751","2","盐酸奥普力农注射液","","","204038","盐酸奥普力农注射液","无","注射液","5ml:5mg","盒","10","安瓿","德全药品(江苏)股份有限公司","357.20","修改（医保备注）","医保发〔2023〕30号",""]
["858","XC01CEA290B002010102602","2","盐酸奥普力农注射液","","","162538","盐酸奥普力农注射液","爱尔辛泰","注射液","5ml:5mg","支","1","安瓿","河北爱尔海泰制药有限公司","198.00","修改（医保备注）","医保发〔2023〕30号",""]
["859","XC01CEA290B002010103282","2","盐酸奥普力农注射液","","","176264","盐酸奥普力农注射液","无","注射剂","5ml:5mg","支","1","中硼硅玻璃安瓿装","吉林四长制药有限公司","49.05","修改（医保备注）","医保发〔2023〕30号",""]
["860","XC01CEA290B002010104145","2","盐酸奥普力农注射液","","","200944","盐酸奥普力农注射液","无","注射剂","5ml:5mg","盒","1","中硼硅玻璃安瓿","山东齐都药业有限公司","158.40","修改（医保备注）","医保发〔2023〕30号",""]
["861","XC02ACK062V002010102924","2","可乐定","贴剂","","121829","可乐定透皮贴片","无","透皮贴剂","1mg,1.25cm2","盒","1","复合膜","国药集团山西瑞福莱药业有限公司","109.78","修改（医保备注）","医保发〔2023〕30号",""]
["862","XC03CAT115B001020101563","2","托拉塞米","注射剂","","141138","注射用托拉塞米","泽通","冻干粉针剂","20mg","瓶","1","西林瓶","南京海辰药业股份有限公司","30.96","修改（医保备注）","医保发〔2023〕30号",""]
["863","XC03CAT115B001020205816","2","托拉塞米","注射剂","","164479","注射用托拉塞米","无","冻干粉针剂","20mg","瓶","1","玻璃瓶","海南斯达制药有限公司","3.61","修改（医保备注）","医保发〔2023〕30号",""]
["864","XC03CAT115B002010105032","2","托拉塞米","注射剂","","176668","托拉塞米注射液","无","注射液","2ml:10mg","支","1","安瓿","康普药业股份有限公司","5.94","修改（医保备注）","医保发〔2023〕30号",""]
["865","XC03CAT115B002010202068","2","托拉塞米","注射剂","","203912","托拉塞米注射液","无","注射液","2ml:10mg","盒","10","玻璃瓶","成都市海通药业有限公司","38.60","修改（医保备注）","医保发〔2023〕30号",""]
["866","XC03CAT115B002010280729","2","托拉塞米","注射剂","","204029","托拉塞米注射液","无","注射液","2ml:10mg","支","1","安瓿","吉林天成制药有限公司","1.96","修改（医保备注）","医保发〔2023〕30号",""]
["867","XC03CAT115B002020101556","2","托拉塞米","注射剂","","204867","托拉塞米注射液","无","注射液","4ml:20mg","支","1","中硼硅玻璃安瓿","南京臣功制药股份有限公司","6.30","修改（医保备注）","医保发〔2023〕30号",""]
["868","XC03CAT115B002020104615","2","托拉塞米","注射剂","","130813","托拉塞米注射液","丽泉","注射液","2ml:10mg","支","1","安瓿","浙江诚意药业股份有限公司","5.76","修改（医保备注）","医保发〔2023〕30号",""]
["869","XC03CAT115B002020105032","2","托拉塞米","注射剂","","176667","托拉塞米注射液","无","注射液","4ml:20mg","支","1","安瓿","康普药业股份有限公司","10.09","修改（医保备注）","医保发〔2023〕30号",""]
["870","XC05CAQ005B001010101929","2","七叶皂苷","注射剂","支付不超过10天。","122976","注射用七叶皂苷钠","无","冻干粉针剂","10mg","瓶","1","玻璃瓶","湖北长联杜勒制药有限公司","14.85","修改（医保备注）","医保发〔2023〕30号",""]
["871","XC05CAQ005B001010204995","2","七叶皂苷","注射剂","支付不超过10天。","118697","注射用七叶皂苷钠","无","冻干粉针剂","10mg","瓶","1","玻璃瓶","湖南一格制药有限公司","3.39","修改（医保备注）","医保发〔2023〕30号",""]
["872","XC05CAQ005B001020201701","2","七叶皂苷","注射剂","支付不超过10天。","143427","注射用七叶皂苷钠","无","冻干粉针剂","15mg","瓶","1","玻璃瓶","无锡凯夫制药有限公司","10.88","修改（医保备注）","医保发〔2023〕30号",""]
["873","XC05CAQ005B001030101929","2","七叶皂苷","注射剂","支付不超过10天。","203624","注射用七叶皂苷钠","无","冻干粉针剂","10mg","盒","10","低硼硅玻璃管制注射剂瓶","湖北长联杜勒制药有限公司","39.50","修改（医保备注）","医保发〔2023〕30号",""]
["874","XC05CAQ005B014010103331","2","七叶皂苷","注射剂","支付不超过10天。","175438","注射用七叶皂苷钠","无","冻干粉针剂","10mg","瓶","1","西林瓶","广东星昊药业有限公司","5.20","修改（医保备注）","医保发〔2023〕30号",""]
["875","XC05CAQ005B014010204799","2","七叶皂苷","注射剂","支付不超过10天。","136264","注射用七叶皂苷钠","无","冻干粉针剂","10mg","瓶","1","玻璃瓶","福建省闽东力捷迅药业股份有限公司","3.86","修改（医保备注）","医保发〔2023〕30号",""]
["876","XC05CAQ005B014020104139","2","七叶皂苷","注射剂","支付不超过10天。","136266","注射用七叶皂苷钠","麦通纳","冻干粉针剂","15mg","瓶","1","玻璃瓶","山东绿叶制药有限公司","19.15","修改（医保备注）","医保发〔2023〕30号",""]
["877","XC09DAA212A001010100745","2","奥美沙坦酯氢氯噻嗪","口服常释剂型","","100113","奥美沙坦酯氢氯噻嗪片","无","薄膜衣片","奥美沙坦酯20mg,氢氯噻嗪12.5mg","盒","7","铝塑","第一三共制药(上海)有限公司","43.85","修改（医保备注）","医保发〔2023〕30号",""]
["878","XC09DAA212A001010101503","2","奥美沙坦酯氢氯噻嗪","口服常释剂型","","203614","奥美沙坦酯氢氯噻嗪片","无","片剂","每片含奥美沙坦酯20mg与氢氯噻嗪12.5mg。","盒","7","铝塑泡罩包装,外加复合膜袋","江苏万高药业股份有限公司","42.85","修改（医保备注）","医保发〔2023〕30号",""]
["879","XC09DAA212A001010183521","2","奥美沙坦酯氢氯噻嗪","口服常释剂型","","176254","奥美沙坦酯氢氯噻嗪片","无","薄膜衣片","奥美沙坦酯20mg和氢氯噻嗪12.5mg","盒","7","铝塑","浙江诺得药业有限公司","42.70","修改（医保备注）","医保发〔2023〕30号",""]
["880","XC09DAA212A001010200177","2","奥美沙坦酯氢氯噻嗪","口服常释剂型","","176419","奥美沙坦酯氢氯噻嗪片","无","薄膜衣片","奥美沙坦酯20mg和氢氯噻嗪12.5mg","盒","10","铝塑","北京福元医药股份有限公司","61.37","修改（医保备注）","医保发〔2023〕30号",""]
["881","XC09DAA212A001010204647","2","奥美沙坦酯氢氯噻嗪","口服常释剂型","","171661","奥美沙坦酯氢氯噻嗪片","无","薄膜衣片","奥美沙坦酯40mg和氢氯噻嗪12.5mg","盒","7","双铝","浙江华海药业股份有限公司","62.01","修改（医保备注）","医保发〔2023〕30号",""]
["882","XC09DAA212A001010283521","2","奥美沙坦酯氢氯噻嗪","口服常释剂型","","176255","奥美沙坦酯氢氯噻嗪片","无","薄膜衣片","奥美沙坦酯20mg和氢氯噻嗪12.5mg","盒","14","铝塑","浙江诺得药业有限公司","83.27","修改（医保备注）","医保发〔2023〕30号",""]
["883","XC09DAA212A001010304647","2","奥美沙坦酯氢氯噻嗪","口服常释剂型","","171644","奥美沙坦酯氢氯噻嗪片","无","薄膜衣片","奥美沙坦酯20mg,氢氯噻嗪12.5mg","盒","7","双铝","浙江华海药业股份有限公司","42.59","修改（医保备注）","医保发〔2023〕30号",""]
["884","XC09DAA212A001010504647","2","奥美沙坦酯氢氯噻嗪","口服常释剂型","","171660","奥美沙坦酯氢氯噻嗪片","无","片剂","每片含奥美沙坦酯20mg与氢氯噻嗪12.5mg","盒","14","双铝","浙江华海药业股份有限公司","83.77","修改（医保备注）","医保发〔2023〕30号",""]
["885","XC09DBA313A001010100745","2","奥美沙坦酯氨氯地平","口服常释剂型","","167809","奥美沙坦酯氨氯地平片","无","薄膜衣片","奥美沙坦酯20mg和苯磺酸氨氯地平5mg(以氨氯地平计)","盒","7","铝塑","第一三共制药(上海)有限公司","49.00","修改（医保备注）","医保发〔2023〕30号",""]
["886","XC09DBA313A001010101606","2","奥美沙坦酯氨氯地平","口服常释剂型","","171564","奥美沙坦酯氨氯地平片","无","薄膜衣片","奥美沙坦酯20mg和苯磺酸氨氯地平5mg(以氨氯地平计)","盒","14","铝箔","南京正大天晴制药有限公司","75.07","修改（医保备注）","医保发〔2023〕30号",""]
["887","XC09DBA313A001010105356","2","奥美沙坦酯氨氯地平","口服常释剂型","","203247","奥美沙坦酯氨氯地平片","无","片剂","每片含奥美沙坦酯20mg与苯磺酸氨氯地平(按氨氯地平计)5mg","盒","14","铝塑包装","江西施美药业股份有限公司","86.90","修改（医保备注）","医保发〔2023〕30号",""]
["888","XC09DBA313A001010109878","2","奥美沙坦酯氨氯地平","口服常释剂型","","201347","奥美沙坦酯氨氯地平片","无","片剂","每片含奥美沙坦酯20mg与苯磺酸氨氯地平5mg(按氨氯地平计)","盒","7","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片、药用铝箔包装","吉林省德商药业股份有限公司","48.50","修改（医保备注）","医保发〔2023〕30号",""]
["889","XC09DBA313A001010300745","2","奥美沙坦酯氨氯地平","口服常释剂型","","176458","奥美沙坦酯氨氯地平片","无","薄膜衣片","奥美沙坦酯20mg和苯磺酸氨氯地平5mg(以氨氯地平计)","盒","28","铝塑","第一三共制药(上海)有限公司","186.32","修改（医保备注）","医保发〔2023〕30号",""]
["890","XC09DBA313A001010301606","2","奥美沙坦酯氨氯地平","口服常释剂型","","171909","奥美沙坦酯氨氯地平片","无","薄膜衣片","奥美沙坦酯20mg和苯磺酸氨氯地平5mg(以氨氯地平计)","盒","7","铝箔","南京正大天晴制药有限公司","38.37","修改（医保备注）","医保发〔2023〕30号",""]
["891","XB01AEA021B002010100951","2","阿加曲班","注射剂","","125531","阿加曲班注射液","达贝","注射液","20ml:10mg","支","1","安瓿","天津药物研究院药业有限责任公司","120.10","修改（医保备注）","医保发〔2023〕30号",""]
["892","XB01AEA021B002010101495","2","阿加曲班","注射剂","","203574","阿加曲班注射液","无","注射液","2ml:10mg","支","1","玻璃瓶","江苏迪赛诺制药有限公司","13.98","修改（医保备注）","医保发〔2023〕30号",""]
["893","XB01AEA021B002010102964","2","阿加曲班","注射剂","","200639","阿加曲班注射液","无","注射液","2ml:10mg","支","1","中硼硅玻璃安瓿(棕色)","石药银湖制药有限公司","260.00","修改（医保备注）","医保发〔2023〕30号",""]
["894","XB01AEA021B002010104383","2","阿加曲班","注射剂","","204623","阿加曲班注射液","无","注射剂","2ml:10mg","支","1","中硼硅玻璃安瓿(棕色)","国药集团国瑞药业有限公司","15.85","修改（医保备注）","医保发〔2023〕30号",""]
["895","XB01AEA021B002010180081","2","阿加曲班","注射剂","","175452","阿加曲班注射液","无","注射液","2ml:10mg","支","1","安瓿","博瑞制药(苏州)有限公司","15.80","修改（医保备注）","医保发〔2023〕30号",""]
["896","XB01AEA021B002010200945","2","阿加曲班","注射剂","","147307","阿加曲班注射液","诺保思泰","注射液","2ml:10mg","支","1","安瓿","日本田边三菱制药工场株式会社 小野田工厂Mitsubishi Tanabe Pharma Factory Ltd., Onoda Plant","255.00","修改（医保备注）","医保发〔2023〕30号",""]
["897","XB01AEA021B002010202068","2","阿加曲班","注射剂","","203502","阿加曲班注射液","无","注射剂","2ml:10mg","盒","10","中硼硅玻璃安瓿","成都市海通药业有限公司","215.50","修改（医保备注）","医保发〔2023〕30号",""]
["898","XB01AEA021B002010279286","2","阿加曲班","注射剂","","167507","阿加曲班注射液","无","注射液","20ml:10mg","支","1","玻璃瓶","湖南赛隆药业有限公司","23.78","修改（医保备注）","医保发〔2023〕30号",""]
["899","XB01AEA021B002020279286","2","阿加曲班","注射剂","","204402","阿加曲班注射液","无","注射剂","2ml:10mg","盒","6","中硼硅玻璃安瓿(棕色)","湖南赛隆药业(长沙)有限公司","45.60","修改（医保备注）","医保发〔2023〕30号",""]
["900","XN07XXB220B002010104145","2","胞磷胆碱(胞二磷胆碱)","注射剂","","176733","胞磷胆碱注射液","无","注射剂","2ml:0.1g","支","1","中硼硅玻璃安瓿","山东齐都药业有限公司","99.00","修改（医保备注）","医保发〔2023〕30号",""]
["901","XN07XXB220B002010202763","2","胞磷胆碱(胞二磷胆碱)","注射剂","","204256","胞磷胆碱钠注射液","无","注射剂","4ml:0.5g(按C14H26N4O11P2计)","支","1","聚丙烯安瓿包装","石家庄四药有限公司","183.00","修改（医保备注）","医保发〔2023〕30号",""]
["902","XN07XXB220B002010202899","2","胞磷胆碱(胞二磷胆碱)","注射剂","","104138","胞磷胆碱钠注射液","无","注射液","2ml:0.25g","支","1","安瓿","山西晋新双鹤药业有限责任公司","0.74","修改（医保备注）","医保发〔2023〕30号",""]
["903","XN07XXB220B002010204145","2","胞磷胆碱(胞二磷胆碱)","注射剂","","176734","胞磷胆碱注射液","无","注射液","2ml:0.25g","支","1","玻璃瓶","山东齐都药业有限公司","199.00","修改（医保备注）","医保发〔2023〕30号",""]
["904","XN07XXB220B002010283128","2","胞磷胆碱(胞二磷胆碱)","注射剂","","203105","胞磷胆碱钠注射液","无","注射剂","4ml:0.5g(按C14H26N4O11P2计)","支","1","中硼硅玻璃安瓿包装","海南合瑞制药股份有限公司","187.00","修改（医保备注）","医保发〔2023〕30号",""]
["905","XN07XXB220B002010303304","2","胞磷胆碱(胞二磷胆碱)","注射剂","","202508","胞磷胆碱注射液","无","注射液","2ml:0.25g","瓶","1","低硼硅玻璃安瓿","吉林百年汉克制药有限公司","177.00","修改（医保备注）","医保发〔2023〕30号",""]
["906","XN07XXB220B002020103304","2","胞磷胆碱(胞二磷胆碱)","注射剂","","202509","胞磷胆碱注射液","无","注射液","2ml:0.1g","瓶","1","低硼硅玻璃安瓿","吉林百年汉克制药有限公司","87.00","修改（医保备注）","医保发〔2023〕30号",""]
["907","XN07XXB220B014020204799","2","胞磷胆碱(胞二磷胆碱)","注射剂","","136036","注射用胞磷胆碱钠","无","冻干粉针剂","0.5g","瓶","1","玻璃瓶","福建省闽东力捷迅药业股份有限公司","3.17","修改（医保备注）","医保发〔2023〕30号",""]
["908","XN06BXB181B002010404127","2","胞磷胆碱氯化钠","注射剂","","146358","胞磷胆碱钠氯化钠注射液","无","注射液","100ml:0.5g:0.9g","袋","1","非PVC膜+双管双塞","辰欣药业股份有限公司","7.65","修改（医保备注）","医保发〔2023〕30号",""]
["909","XG04BXZ059X001010201162","2","左卡尼汀","口服液体剂","","128125","左卡尼汀口服溶液","东维力","口服溶液剂","10ml:1.0g","盒","6","玻璃瓶","东北制药集团沈阳第一制药有限公司","48.01","修改（医保备注）","医保发〔2023〕30号",""]
["910","XG04BXZ059X001020182194","2","左卡尼汀","口服液体剂","","156091","左卡尼汀口服溶液","无","口服溶液剂","10ml:2.0g","盒","10","玻璃瓶","意大利Alfasigma.S.p.A","441.50","修改（医保备注）","医保发〔2023〕30号",""]
["911","XG04BXZ059B002010101162","2","左卡尼汀","注射剂","","113571","左卡尼汀注射液","无","注射液","5ml:1g","支","1","中硼硅玻璃安瓿(棕色)","东北制药集团沈阳第一制药有限公司","11.50","修改（医保备注）","医保发〔2023〕30号",""]
["912","XG04BXZ059B002010101376","2","左卡尼汀","注射剂","","135921","左卡尼汀注射液","雷卡","注射剂","5ml:1g","盒","5","安瓿","常州兰陵制药有限公司","66.00","修改（医保备注）","医保发〔2023〕30号",""]
["913","XG04BXZ059B002010103334","2","左卡尼汀","注射剂","","150952","左卡尼汀注射液","无","注射液","5ml:1.0g","盒","5","安瓿","长春翔通药业有限公司","91.50","修改（医保备注）","医保发〔2023〕30号",""]
["914","XG04BXZ059B002010106286","2","左卡尼汀","注射剂","","149604","左卡尼汀注射液","无","注射液","5ml:1.0g","支","1","安瓿","云南龙海天然植物药业有限公司","8.30","修改（医保备注）","医保发〔2023〕30号",""]
["915","XG04BXZ059B002010109910","2","左卡尼汀","注射剂","","202925","左卡尼汀注射液","无","注射剂","5ml∶1g","支","1","中硼硅玻璃安瓿(棕色)","华夏生生药业(北京)有限公司","17.40","修改（医保备注）","医保发〔2023〕30号",""]
["916","XG04BXZ059B002010182194","2","左卡尼汀","注射剂","","132232","左卡尼汀注射液","可益能","注射液","5ml:1.0g","瓶","1","玻璃瓶","ALFASIGMA S.p.A.","9.00","修改（医保备注）","医保发〔2023〕30号",""]
["917","XG04BXZ059B002010209510","2","左卡尼汀","注射剂","","119077","左卡尼汀注射液","无","注射液","5ml:1.0g","支","1","安瓿","哈尔滨誉衡制药有限公司","27.89","修改（医保备注）","医保发〔2023〕30号",""]
["918","XG04BXZ059B002010209910","2","左卡尼汀","注射剂","","205166","左卡尼汀注射液","无","注射剂","5ml∶1g","盒","5","中硼硅玻璃安瓿(棕色)","华夏生生药业(北京)有限公司","87.00","修改（医保备注）","医保发〔2023〕30号",""]
["919","XG04BXZ059B002010283267","2","左卡尼汀","注射剂","","204012","左卡尼汀注射液","无","注射液","5ml:1g","盒","5","安瓿","江苏九旭药业有限公司","42.75","修改（医保备注）","医保发〔2023〕30号",""]
["920","XG04BXZ059B002020104610","2","左卡尼汀","注射剂","","174551","左卡尼汀注射液","无","注射液","5ml:1.0g","支","1","安瓿","浙江北生药业汉生制药有限公司","47.00","修改（医保备注）","医保发〔2023〕30号",""]
["921","XG04BXZ059B002020106286","2","左卡尼汀","注射剂","","174892","左卡尼汀注射液","无","注射液","5ml:2.0g","支","1","中硼硅玻璃安瓿（棕色）","云南龙海天然植物药业有限公司","14.11","修改（医保备注）","医保发〔2023〕30号",""]
["922","XG04BXZ059B002020182194","2","左卡尼汀","注射剂","","169916","左卡尼汀注射液","可益能","注射液","5ml:2.0g","支","1","玻璃瓶","ALFASIGMA S.p.A.","15.30","修改（医保备注）","医保发〔2023〕30号",""]
["923","XG04BXZ059B014010101192","2","左卡尼汀","注射剂","","136182","注射用左卡尼汀","无","冻干粉针剂","0.5g","支","1","玻璃瓶","锦州九泰药业有限责任公司","11.19","修改（医保备注）","医保发〔2023〕30号",""]
["924","XJ01DHB084B001010100599","2","比阿培南","注射剂","","176477","注射用比阿培南","无","粉针剂","0.3g","瓶","1","玻璃瓶","珠海联邦制药股份有限公司","146.02","修改（医保备注）","医保发〔2023〕30号",""]
["925","XJ01DHB084B001010101523","2","比阿培南","注射剂","","118743","注射用比阿培南","天册","粉针剂","0.3g","瓶","1","玻璃瓶","正大天晴药业集团股份有限公司","12.58","修改（医保备注）","医保发〔2023〕30号",""]
["926","XJ01DHB084B001010101594","2","比阿培南","注射剂","","133584","注射用比阿培南","安信","注射剂","0.3g","盒","1","西林瓶","先声药业有限公司","40.00","修改（医保备注）","医保发〔2023〕30号",""]
["927","XJ01DHB084B001010102777","2","比阿培南","注射剂","","114481","注射用比阿培南","诺加南","注射剂","0.3g","瓶","1","西林瓶","石药集团欧意药业有限公司","105.60","修改（医保备注）","医保发〔2023〕30号",""]
["928","XJ01DHB084B001010104021","2","比阿培南","注射剂","","173154","注射用比阿培南","无","注射剂","0.3g","盒","1","玻璃瓶","齐鲁安替制药有限公司","20.00","修改（医保备注）","医保发〔2023〕30号",""]
["929","XJ01DHB084B001010204021","2","比阿培南","注射剂","","203969","注射用比阿培南","无","粉针剂","0.3g","盒","10","玻璃瓶","齐鲁制药有限公司,齐鲁安替制药有限公司","200.00","修改（医保备注）","医保发〔2023〕30号",""]
["930","XJ01FAL262N001010103202","2","罗红霉素","颗粒剂","","141892","罗红霉素颗粒","无","颗粒剂","50mg","盒","6","复合膜","上海现代哈森(商丘)药业有限公司","2.08","修改（医保备注）","医保发〔2023〕30号",""]
["931","XJ01FAL262N001010103205","2","罗红霉素","颗粒剂","","122827","罗红霉素颗粒","无","颗粒剂","25mg","盒","12","复合膜","国药集团容生制药有限公司","5.17","修改（医保备注）","医保发〔2023〕30号",""]
["932","XJ01FAL262N001010303202","2","罗红霉素","颗粒剂","","141891","罗红霉素颗粒","无","颗粒剂","50mg","盒","12","复合膜","上海现代哈森(商丘)药业有限公司","4.16","修改（医保备注）","医保发〔2023〕30号",""]
["933","XJ01DIF005N001010104929","2","法罗培南","颗粒剂","","152277","法罗培南钠颗粒","忾林","颗粒剂","0.1g","盒","6","复合膜","湖南华纳大药厂股份有限公司","130.00","修改（医保备注）","医保发〔2023〕30号",""]
["934","XJ01CRP018B001010101651","2","哌拉西林他唑巴坦","注射剂","","141214","注射用哌拉西林钠他唑巴坦钠(8:1)","无","冻干粉针剂","1.125g(1.0g/0.125g)","瓶","1","西林瓶","苏州二叶制药有限公司","8.88","修改（医保备注）","医保发〔2023〕30号",""]
["935","XJ01CRP018B001010102777","2","哌拉西林他唑巴坦","注射剂","","114539","注射用哌拉西林钠他唑巴坦钠(8:1)","无","冻干粉针剂","1.125g(1.0g/0.125g)","瓶","1","西林瓶","石药集团中诺药业(石家庄)有限公司","11.86","修改（医保备注）","医保发〔2023〕30号",""]
["936","XJ01CRP018B001010104129","2","哌拉西林他唑巴坦","注射剂","","113198","注射用哌拉西林钠他唑巴坦钠(8:1)","无","冻干粉针剂","1.125g(1.0g/0.125g)","支","1","玻璃瓶","山东鲁抗医药股份有限公司","9.09","修改（医保备注）","医保发〔2023〕30号",""]
["937","XJ01CRP018B001010104152","2","哌拉西林他唑巴坦","注射剂","","109433","注射用哌拉西林钠他唑巴坦钠(8:1)","无","冻干粉针剂","0.5625g(0.5g/62.5mg)","瓶","1","玻璃瓶","瑞阳制药股份有限公司","8.50","修改（医保备注）","医保发〔2023〕30号",""]
["938","XJ01CRP018B001010104606","2","哌拉西林他唑巴坦","注射剂","","134662","注射用哌拉西林钠他唑巴坦钠(4:1)","无","冻干粉针剂","1.25g(1.0g/0.25g)","瓶","1","玻璃瓶","浙江昂利康制药股份有限公司","49.00","修改（医保备注）","医保发〔2023〕30号",""]
["939","XJ01CRP018B001010105755","2","哌拉西林他唑巴坦","注射剂","","127448","注射用哌拉西林钠他唑巴坦钠(8:1)","无","冻干粉针剂","1.125g(1.0g/0.125g)","瓶","1","玻璃瓶","海口奇力制药股份有限公司","9.98","修改（医保备注）","医保发〔2023〕30号",""]
["940","XJ01CRP018B001010105821","2","哌拉西林他唑巴坦","注射剂","","127054","注射用哌拉西林钠他唑巴坦钠(8:1)","无","冻干粉针剂","0.5625g(0.5g/62.5mg)","瓶","1","玻璃瓶","海南通用三洋药业有限公司","6.78","修改（医保备注）","医保发〔2023〕30号",""]
["941","XJ01CRP018B001010109853","2","哌拉西林他唑巴坦","注射剂","","174894","注射用哌拉西林钠他唑巴坦钠(8:1)","无","注射剂","4.5g(C23H27N5O7S 4.0g与C10H12N4O5S 0.5g)","盒","1","玻璃瓶","瀚晖制药有限公司","96.55","修改（医保备注）","医保发〔2023〕30号",""]
["942","XJ01CRP018B001010181979","2","哌拉西林他唑巴坦","注射剂","","203224","注射用哌拉西林钠他唑巴坦钠","无","注射剂","2.25g( C？？H？？N？O？S 2.0g与 C？？H？？N？O？S 0.25g)","盒","10","中硼硅玻璃模制注射剂瓶、注射用无菌粉末用卤化丁基橡胶塞与抗生素瓶用铝塑组合盖","山东安信制药有限公司","227.50","修改（医保备注）","医保发〔2023〕30号",""]
["943","XJ01CRP018B001010204656","2","哌拉西林他唑巴坦","注射剂","","203666","注射用哌拉西林钠他唑巴坦钠","无","注射剂","1.125g(1.0g/0.125g)","盒","1","抗生素玻璃瓶","浙江金华康恩贝生物制药有限公司","14.61","修改（医保备注）","医保发〔2023〕30号",""]
["944","XJ01CRP018B001020101651","2","哌拉西林他唑巴坦","注射剂","","141207","注射用哌拉西林钠他唑巴坦钠(8:1)","无","冻干粉针剂","2.25g(2.0g/0.25g)","瓶","1","西林瓶","苏州二叶制药有限公司","13.45","修改（医保备注）","医保发〔2023〕30号",""]
["945","XJ01CRP018B001020102692","2","哌拉西林他唑巴坦","注射剂","","101446","注射用哌拉西林钠他唑巴坦钠(4:1)","无","粉针剂","1.25g(1.0g/0.25g)","瓶","1","玻璃瓶","华北制药股份有限公司","49.39","修改（医保备注）","医保发〔2023〕30号",""]
["946","XJ01CRP018B001020104129","2","哌拉西林他唑巴坦","注射剂","","113215","注射用哌拉西林钠他唑巴坦钠(8:1)","无","冻干粉针剂","2.25g(2.0g/0.25g)","支","1","玻璃瓶","山东鲁抗医药股份有限公司","16.18","修改（医保备注）","医保发〔2023〕30号",""]
["947","XJ01CRP018B001020105821","2","哌拉西林他唑巴坦","注射剂","","127062","注射用哌拉西林钠他唑巴坦钠","凯伦","注射剂","1.125g(C23H27N5O7S 1.0g与C10H12N4O5S 0.125g)","瓶","1","玻璃瓶","海南通用三洋药业有限公司","14.10","修改（医保备注）","医保发〔2023〕30号",""]
["948","XJ01CRP018B001020200792","2","哌拉西林他唑巴坦","注射剂","","134075","注射用哌拉西林钠他唑巴坦钠(8:1)","锋泰灵","冻干粉针剂","2.25g(2.0g/0.25g)","瓶","1","玻璃瓶","上海上药新亚药业有限公司","16.26","修改（医保备注）","医保发〔2023〕30号",""]
["949","XJ01CRP018B001030102692","2","哌拉西林他唑巴坦","注射剂","","101452","注射用哌拉西林钠他唑巴坦钠(4:1)","无","粉针剂","2.5g(2.0g/0.5g)","瓶","1","玻璃瓶","华北制药股份有限公司","83.41","修改（医保备注）","医保发〔2023〕30号",""]
["950","XJ01CRP018B001030181979","2","哌拉西林他唑巴坦","注射剂","","203225","注射用哌拉西林钠他唑巴坦钠","无","注射剂","4.5g( C？？H？？N？O？S 4.0g与 C？？H？？N？O？S 0.5g)","盒","10","中硼硅玻璃模制注射剂瓶、注射用无菌粉末用卤化丁基橡胶塞与抗生素瓶用铝塑组合盖","山东安信制药有限公司","386.70","修改（医保备注）","医保发〔2023〕30号",""]
["951","XJ01CRP018B001040101651","2","哌拉西林他唑巴坦","注射剂","","141197","注射用哌拉西林钠他唑巴坦钠(8:1)","无","冻干粉针剂","4.5g(4.0g/0.5g)","瓶","1","西林瓶","苏州二叶制药有限公司","28.80","修改（医保备注）","医保发〔2023〕30号",""]
["952","XJ01CRP018B001040105821","2","哌拉西林他唑巴坦","注射剂","","127073","注射用哌拉西林钠他唑巴坦钠(8:1)","凯伦","冻干粉针剂","2.25g(2.0g/0.25g)","瓶","1","玻璃瓶","海南通用三洋药业有限公司","18.22","修改（医保备注）","医保发〔2023〕30号",""]
["953","XJ01CRP018B001040201440","2","哌拉西林他唑巴坦","注射剂","","204512","注射用哌拉西林钠他唑巴坦钠","无","注射剂","2.25g(2.0g/0.25g)","盒","10","钠钙玻璃注射剂瓶、药用丁基橡胶塞、铝塑易拉盖","江苏海宏制药有限公司","246.40","修改（医保备注）","医保发〔2023〕30号",""]
["954","XJ01CRP018B001040202692","2","哌拉西林他唑巴坦","注射剂","","101465","注射用哌拉西林钠他唑巴坦钠(8:1)","无","冻干粉针剂","1.125g(1.0g/0.125g)","瓶","1","玻璃瓶","华北制药股份有限公司","8.43","修改（医保备注）","医保发〔2023〕30号",""]
["955","XJ01CRP018B001050101651","2","哌拉西林他唑巴坦","注射剂","","204905","注射用哌拉西林钠他唑巴坦钠","无","注射剂","2.25g(C23H27N5O7S 2.0g与C10H12N4O5S 0.25g)","盒","8","中硼硅玻璃模制注射剂瓶、注射用无菌粉末用卤化丁基橡胶塞(溴化)","山东二叶制药有限公司","195.60","修改（医保备注）","医保发〔2023〕30号",""]
["956","XJ01CRP018B001050202692","2","哌拉西林他唑巴坦","注射剂","","101471","注射用哌拉西林钠他唑巴坦钠(8:1)","无","注射剂","2.25g(2.0g/0.25g)","瓶","1","玻璃瓶","华北制药股份有限公司","23.44","修改（医保备注）","医保发〔2023〕30号",""]
["957","XJ01CRP018B001050404152","2","哌拉西林他唑巴坦","注射剂","","200957","注射用哌拉西林钠他唑巴坦钠","无","注射剂","2.25g(C23H27N5O7S2.0g与C10H12N4O5S0.25g)","瓶","1","钠钙玻璃模制注射剂瓶/低硼硅玻璃管制注射剂瓶","瑞阳制药股份有限公司","16.60","修改（医保备注）","医保发〔2023〕30号",""]
["958","XJ01CRP018B001060202692","2","哌拉西林他唑巴坦","注射剂","","101476","注射用哌拉西林钠他唑巴坦钠(8:1)","无","注射剂","4.5g(4.0g/0.5g)","瓶","1","玻璃瓶","华北制药股份有限公司","39.85","修改（医保备注）","医保发〔2023〕30号",""]
["959","XJ01CRP018B001070101440","2","哌拉西林他唑巴坦","注射剂","","310124","注射用哌拉西林钠他唑巴坦钠","无","注射剂","4.5g(C23H27N5O7S 4.0g和C10H12N4O5S 0.5g)","瓶","1","中硼硅玻璃模制注射剂瓶、注射用冷冻干燥用溴化丁基橡胶塞","江苏海宏制药有限公司","79.76","修改（医保备注）","医保发〔2023〕30号",""]
["960","XJ01CRP018B001070105821","2","哌拉西林他唑巴坦","注射剂","","127085","注射用哌拉西林钠他唑巴坦钠(8:1)","无","冻干粉针剂","4.5g(4.0g/0.5g)","瓶","1","玻璃瓶","海南通用三洋药业有限公司","29.39","修改（医保备注）","医保发〔2023〕30号",""]
["961","XJ01CRP018B001070404152","2","哌拉西林他唑巴坦","注射剂","","200961","注射用哌拉西林钠他唑巴坦钠","无","注射剂","3.375g(C23H27N5O7S3.0g与C10H12N4O5S0.375g)","瓶","1","钠钙玻璃模制注射剂瓶/低硼硅玻璃管制注射剂瓶","瑞阳制药股份有限公司","22.64","修改（医保备注）","医保发〔2023〕30号",""]
["962","XJ01CRP018B001080404152","2","哌拉西林他唑巴坦","注射剂","","200984","注射用哌拉西林钠他唑巴坦钠","无","注射剂","4.5g(C23H27N5O7S4.0g与C10H12N4O5S0.5g)","瓶","1","钠钙玻璃模制注射剂瓶/低硼硅玻璃管制注射剂瓶","瑞阳制药股份有限公司","28.22","修改（医保备注）","医保发〔2023〕30号",""]
["963","XJ01CRP018B014010204021","2","哌拉西林他唑巴坦","注射剂","","109862","注射用哌拉西林钠他唑巴坦钠(8:1)","邦达","冻干粉针","0.5625g(0.5g/62.5mg)","支","1","玻璃瓶","山东安信制药有限公司","8.25","修改（医保备注）","医保发〔2023〕30号",""]
["964","XJ01CRP018B014020200600","2","哌拉西林他唑巴坦","注射剂","","105838","注射用哌拉西林钠他唑巴坦钠(8:1)","无","冻干粉针剂","4.5g(4.0g/0.5g)","瓶","1","西林瓶","珠海联邦制药股份有限公司中山分公司","41.47","修改（医保备注）","医保发〔2023〕30号",""]
["965","XJ01CRP018B014050104021","2","哌拉西林他唑巴坦","注射剂","","151167","注射用哌拉西林钠他唑巴坦钠(8:1)","邦达","冻干粉针剂","4.5g(4.0g/0.5g)","支","5","玻璃瓶","山东安信制药有限公司","129.00","修改（医保备注）","医保发〔2023〕30号",""]
["966","XJ01CRP018B014060104021","2","哌拉西林他唑巴坦","注射剂","","169948","注射用哌拉西林钠他唑巴坦钠(8:1)","无","冻干粉针","2.25g(2.0g/0.25g)","支","1","玻璃瓶","山东安信制药有限公司","15.17","修改（医保备注）","医保发〔2023〕30号",""]
["967","XJ01DCT102B001010100450","2","头孢西丁","注射剂","","163290","注射用头孢西丁钠","无","粉针剂","1.0g","瓶","1","西林瓶","广东金城金素制药有限公司","46.46","修改（医保备注）","医保发〔2023〕30号",""]
["968","XJ01DCT102B001010100507","2","头孢西丁","注射剂","","200973","注射用头孢西丁钠","无","溶媒结晶粉针剂","1.0g(按C16H17N3O7S2计算)","瓶","1","中硼硅玻璃管制注射剂瓶、注射用无菌粉末用局部覆聚四氟乙烯膜氯化丁基橡胶塞、抗生素瓶用铝塑组合盖包装","深圳华润九新药业有限公司","35.68","修改（医保备注）","医保发〔2023〕30号",""]
["969","XJ01DCT102B001010100513","2","头孢西丁","注射剂","","155149","注射用头孢西丁钠","无","粉针剂","0.5g","瓶","1","玻璃瓶","深圳立健药业有限公司","12.87","修改（医保备注）","医保发〔2023〕30号",""]
["970","XJ01DCT102B001010100555","2","头孢西丁","注射剂","","124198","注射用头孢西丁钠","无","注射剂","0.5g","盒","10","玻璃瓶","国药集团致君(深圳)制药有限公司","40.50","修改（医保备注）","医保发〔2023〕30号",""]
["971","XJ01DCT102B001010101749","2","头孢西丁","注射剂","","101462","注射用头孢西丁钠","无","粉针剂","1.0g","瓶","1","玻璃瓶","扬子江药业集团有限公司","20.59","修改（医保备注）","医保发〔2023〕30号",""]
["972","XJ01DCT102B001010102690","2","头孢西丁","注射剂","","101746","注射用头孢西丁钠","无","注射剂","1.0g","盒","1","抗生素玻璃瓶,药用卤化丁基橡胶塞","华北制药河北华民药业有限责任公司","4.45","修改（医保备注）","医保发〔2023〕30号",""]
["973","XJ01DCT102B001010102946","2","头孢西丁","注射剂","","133656","注射用头孢西丁钠","无","粉针剂","3.0g","支","1","西林瓶","山西振东泰盛制药有限公司","51.01","修改（医保备注）","医保发〔2023〕30号",""]
["974","XJ01DCT102B001010103712","2","头孢西丁","注射剂","","119296","注射用头孢西丁钠","益丁欣","粉针剂","1.0g","支","1","玻璃瓶","哈药集团制药总厂","5.26","修改（医保备注）","医保发〔2023〕30号",""]
["975","XJ01DCT102B001010205758","2","头孢西丁","注射剂","","111213","注射用头孢西丁钠","无","粉针剂","0.5g","瓶","1","玻璃瓶","海口市制药厂有限公司","8.55","修改（医保备注）","医保发〔2023〕30号",""]
["976","XJ01DCT102B001020100450","2","头孢西丁","注射剂","","163291","注射用头孢西丁钠","无","粉针剂","2.0g","瓶","1","西林瓶","广东金城金素制药有限公司","78.98","修改（医保备注）","医保发〔2023〕30号",""]
["977","XJ01DCT102B001020100513","2","头孢西丁","注射剂","","141888","注射用头孢西丁钠","无","粉针剂","1.0g","瓶","1","玻璃瓶","深圳立健药业有限公司","19.30","修改（医保备注）","医保发〔2023〕30号",""]
["978","XJ01DCT102B001020101679","2","头孢西丁","注射剂","","144139","注射用头孢西丁钠","无","粉针剂","2.0g","瓶","1","玻璃瓶","苏州中化药品工业有限公司","16.95","修改（医保备注）","医保发〔2023〕30号",""]
["979","XJ01DCT102B001020200555","2","头孢西丁","注射剂","","124208","注射用头孢西丁钠","无","粉针剂","1.0g","瓶","1","玻璃瓶","国药集团致君(深圳)制药有限公司","6.88","修改（医保备注）","医保发〔2023〕30号",""]
["980","XJ01DCT102B001020205758","2","头孢西丁","注射剂","","200830","注射用头孢西丁钠","无","注射剂","1.0g","瓶","1","中硼硅玻璃模制注射剂瓶、注射用无菌粉末用溴化丁基橡胶塞和抗生素用铝塑组合盖包装。","海口市制药厂有限公司","21.22","修改（医保备注）","医保发〔2023〕30号",""]
["981","XJ01DCT102B001030205758","2","头孢西丁","注射剂","","200482","注射用头孢西丁钠","无","注射剂","2.0g","瓶","1","中硼硅玻璃模制注射剂瓶、注射用无菌粉末用溴化丁基橡胶塞和抗生素用铝塑组合盖包装。","海口市制药厂有限公司","36.07","修改（医保备注）","医保发〔2023〕30号",""]
["982","XJ01DCT102B001080100553","2","头孢西丁","注射剂","","138441","注射用头孢西丁钠","无","粉针剂","3.0g","支","1","玻璃瓶","深圳信立泰药业股份有限公司","32.34","修改（医保备注）","医保发〔2023〕30号",""]
["983","XJ01DCT102B013010104129","2","头孢西丁","注射剂","","113168","注射用头孢西丁钠","无","无菌粉针","1.0g","盒","1","抗生素玻璃瓶装","山东鲁抗医药股份有限公司","4.46","修改（医保备注）","医保发〔2023〕30号",""]
["984","XJ01DCT102B013010104141","2","头孢西丁","注射剂","","116620","注射用头孢西丁钠","无","溶媒结晶粉针剂","1.0g","盒","1","玻璃瓶","山东罗欣药业集团股份有限公司","4.50","修改（医保备注）","医保发〔2023〕30号",""]
["985","XJ01DCT102B013010204141","2","头孢西丁","注射剂","","203931","注射用头孢西丁钠","无","溶媒结晶粉针剂","1.0g(按C16H17N3O7S2计)","盒","10","玻璃瓶","山东罗欣药业集团股份有限公司","45.00","修改（医保备注）","医保发〔2023〕30号",""]
["986","XJ01DCT102B013020104129","2","头孢西丁","注射剂","","113175","注射用头孢西丁钠","无","无菌粉针","2.0g","盒","1","抗生素玻璃瓶装","山东鲁抗医药股份有限公司","7.58","修改（医保备注）","医保发〔2023〕30号",""]
["987","XJ01DCT102B013020104141","2","头孢西丁","注射剂","","116628","注射用头孢西丁钠","无","粉针剂","2.0g","瓶","1","玻璃瓶","山东罗欣药业集团股份有限公司","15.66","修改（医保备注）","医保发〔2023〕30号",""]
["988","XJ01DDT081B001010100513","2","头孢哌酮舒巴坦","注射剂","","142238","注射用头孢哌酮钠舒巴坦钠","无","注射剂","1.0g(C25H27N9O8S2 0.5g与C8H11NO5S 0.5g)","瓶","1","抗生素玻璃瓶","深圳立健药业有限公司","6.57","修改（医保备注）","医保发〔2023〕30号",""]
["989","XJ01DDT081B001010101187","2","头孢哌酮舒巴坦","注射剂","","101923","注射用头孢哌酮钠舒巴坦钠(1:1)","舒普深","粉针剂","1.0g(0.5g/0.5g)","瓶","1","玻璃瓶","辉瑞制药有限公司","48.16","修改（医保备注）","医保发〔2023〕30号",""]
["990","XJ01DDT081B001010105815","2","头孢哌酮舒巴坦","注射剂","","200561","注射用头孢哌酮钠舒巴坦钠","无","注射剂","1g(C25H27N9O8S2 0.5g与C8H11NO5S 0.5g)","瓶","1","中硼硅玻璃管制注射剂瓶、注射用无菌粉末用覆乙烯四氟乙烯共聚物膜氯化丁基橡胶塞和抗生素瓶用铝塑组合盖包装","海南合瑞制药股份有限公司","6.67","修改（医保备注）","医保发〔2023〕30号",""]
["991","XJ01DDT081B001010204744","2","头孢哌酮舒巴坦","注射剂","","139090","注射用头孢哌酮钠舒巴坦钠(1:1)","无","粉针剂","1.0g(0.5g/0.5g)","盒","1","配溶媒","浙江亚太药业股份有限公司","3.63","修改（医保备注）","医保发〔2023〕30号",""]
["992","XJ01DDT081B001010205006","2","头孢哌酮舒巴坦","注射剂","","203893","注射用头孢哌酮钠舒巴坦钠","无","注射剂","1.0g","瓶","1","中硼硅玻璃模制注射剂瓶、注射用无菌粉末用溴化丁基橡胶塞、抗生素瓶用铝塑组合盖包装","湖南科伦制药有限公司","5.94","修改（医保备注）","医保发〔2023〕30号",""]
["993","XJ01DDT081B001020100555","2","头孢哌酮舒巴坦","注射剂","","123588","注射用头孢哌酮钠舒巴坦钠(2:1)","无","粉针剂","1.5g(1.0g/0.5g)","瓶","1","玻璃瓶","国药集团致君(深圳)制药有限公司","2.50","修改（医保备注）","医保发〔2023〕30号",""]
["994","XJ01DDT081B001020101187","2","头孢哌酮舒巴坦","注射剂","","101934","注射用头孢哌酮钠舒巴坦钠","舒普深","粉针剂","1.5g(1.0g/0.5g)","瓶","1","玻璃瓶","辉瑞制药有限公司","53.38","修改（医保备注）","医保发〔2023〕30号",""]
["995","XJ01DDT081B001020104744","2","头孢哌酮舒巴坦","注射剂","","152145","注射用头孢哌酮钠舒巴坦钠(1:1)","无","粉针剂","2.0g(1.0g/1.0g)","盒","1","配溶媒","浙江亚太药业股份有限公司","6.03","修改（医保备注）","医保发〔2023〕30号",""]
["996","XJ01DDT081B001020105006","2","头孢哌酮舒巴坦","注射剂","","107319","注射用头孢哌酮钠舒巴坦钠","无","注射剂","2.0g","瓶","1","中硼硅玻璃模制注射剂瓶、注射用无菌粉末用溴化丁基橡胶塞、抗生素瓶用铝塑组合盖包装","湖南科伦制药有限公司","10.09","修改（医保备注）","医保发〔2023〕30号",""]
["997","XJ01DDT081B001020201650","2","头孢哌酮舒巴坦","注射剂","","203929","注射用头孢哌酮钠舒巴坦钠(1:1)","无","粉针剂","1.0g(C25H27N9O8S2 0.5g与C8H11NO5S 0.5g)","盒","10","西林瓶","苏州东瑞制药有限公司","32.90","修改（医保备注）","医保发〔2023〕30号",""]
["998","XJ01DDT081B001020201651","2","头孢哌酮舒巴坦","注射剂","","204908","注射用头孢哌酮钠舒巴坦钠","无","注射剂","1g(0.5g/0.5g)","盒","10","中硼硅玻璃模制注射剂瓶、注射用无菌粉末用覆聚四氟乙烯/六氟丙烯的共聚物膜氯化丁基橡胶塞与抗生素瓶用铝塑组合盖包装。","苏州二叶制药有限公司","73.00","修改（医保备注）","医保发〔2023〕30号",""]
["999","XJ01DDT081B001020201877","2","头孢哌酮舒巴坦","注射剂","","167436","注射用头孢哌酮钠舒巴坦钠","无","注射剂","1.0g(C25H27N9O8S2 0.5g与C8H11NO5S 0.5g)","盒","10","中硼硅玻璃管制注射剂瓶、注射用无菌粉末用卤化丁基橡胶塞(溴化)和抗生素瓶用铝塑组合盖包装","福安药业集团庆余堂制药有限公司","72.70","修改（医保备注）","医保发〔2023〕30号",""]
["1000","XJ01DDT081B001020204384","2","头孢哌酮舒巴坦","注射剂","","204709","注射用头孢哌酮钠舒巴坦钠","无","注射剂","0.5g(C？？H？？N？O？S？ 0.25g与C？H？？NO？S 0.25g)","瓶","1","中硼硅玻璃管制注射剂瓶、注射用无菌粉末用覆聚乙烯-四氟乙烯膜氯化丁基橡胶塞、抗生素瓶用铝塑组合盖包装","海南卫康制药(潜山)有限公司","21.17","修改（医保备注）","医保发〔2023〕30号",""]
["1001","XJ01DDT081B001030100513","2","头孢哌酮舒巴坦","注射剂","","142239","注射用头孢哌酮钠舒巴坦钠","无","注射剂","2.0g(C25H27N9O8S2 1.0g与C8H11NO5S 1.0g)","瓶","1","抗生素玻璃瓶","深圳立健药业有限公司","11.16","修改（医保备注）","医保发〔2023〕30号",""]
["1002","XJ01DDT081B001030101651","2","头孢哌酮舒巴坦","注射剂","","141124","注射用头孢哌酮钠舒巴坦钠","无","注射剂","2.0g(1.0g/1.0g)","盒","1","西林瓶","苏州二叶制药有限公司","12.40","修改（医保备注）","医保发〔2023〕30号",""]
["1003","XJ01DDT081B001030201877","2","头孢哌酮舒巴坦","注射剂","","167437","注射用头孢哌酮钠舒巴坦钠","无","注射剂","1.5g(C25H27N9O8S2 0.75g与C8H11NO5S 0.75g)","盒","10","中硼硅玻璃管制注射剂瓶、注射用无菌粉末用卤化丁基橡胶塞(溴化)和抗生素瓶用铝塑组合盖包装","福安药业集团庆余堂制药有限公司","99.10","修改（医保备注）","医保发〔2023〕30号",""]
["1004","XJ01DDT081B001030204384","2","头孢哌酮舒巴坦","注射剂","","204714","注射用头孢哌酮钠舒巴坦钠","无","注射剂","3.0g(C？？H？？N？O？S？ 2.0g与C？H？？NO？S 1.0g)","瓶","1","中硼硅玻璃管制注射剂瓶、注射用无菌粉末用覆聚乙烯-四氟乙烯膜氯化丁基橡胶塞、抗生素瓶用铝塑组合盖包装","海南卫康制药(潜山)有限公司","90.61","修改（医保备注）","医保发〔2023〕30号",""]
["1005","XJ01DDT081B001030301651","2","头孢哌酮舒巴坦","注射剂","","204909","注射用头孢哌酮钠舒巴坦钠","无","注射剂","2.0g(1.0g/1.0g)","盒","10","中硼硅玻璃模制注射剂瓶、注射用无菌粉末用覆聚四氟乙烯/六氟丙烯的共聚物膜氯化丁基橡胶塞与抗生素瓶用铝塑组合盖包装。","苏州二叶制药有限公司","124.00","修改（医保备注）","医保发〔2023〕30号",""]
["1006","XJ01DDT081B001040201651","2","头孢哌酮舒巴坦","注射剂","","204911","注射用头孢哌酮钠舒巴坦钠","无","注射剂","3.0g(1.5g/1.5g)","盒","10","中硼硅玻璃模制注射剂瓶、注射用无菌粉末用覆聚四氟乙烯/六氟丙烯的共聚物膜氯化丁基橡胶塞与抗生素瓶用铝塑组合盖包装。","苏州二叶制药有限公司","169.00","修改（医保备注）","医保发〔2023〕30号",""]
["1007","XJ01DDT081B001050104384","2","头孢哌酮舒巴坦","注射剂","","204713","注射用头孢哌酮钠舒巴坦钠","无","注射剂","1.5g(C25H27N9O8S2 1.0g与C8H11NO5S 0.5g)","瓶","1","中硼硅玻璃管制注射剂瓶、注射用无菌粉末用覆聚乙烯-四氟乙烯膜氯化丁基橡胶塞、抗生素瓶用铝塑组合盖包装","海南卫康制药(潜山)有限公司","53.30","修改（医保备注）","医保发〔2023〕30号",""]
["1008","XJ01DDT081B001050201877","2","头孢哌酮舒巴坦","注射剂","","167439","注射用头孢哌酮钠舒巴坦钠","无","注射剂","2.0g(C25H27N9O8S2 1.0g与C8H11NO5S 1.0g)","盒","10","中硼硅玻璃管制注射剂瓶、注射用无菌粉末用卤化丁基橡胶塞(溴化)和抗生素瓶用铝塑组合盖包装","福安药业集团庆余堂制药有限公司","123.60","修改（医保备注）","医保发〔2023〕30号",""]
["1009","XJ01DDT081B001060100450","2","头孢哌酮舒巴坦","注射剂","","203482","注射用头孢哌酮钠舒巴坦钠","无","注射剂","1.0g(C25H27N9O8S20.5g与C8H11NO5S0.5g)","盒","10","中硼硅玻璃模制注射剂瓶、注射用无菌粉末用覆乙烯四氟乙烯共聚物膜氯化丁基橡胶塞和抗生素瓶用铝塑组合盖包装","广东金城金素制药有限公司","35.00","修改（医保备注）","医保发〔2023〕30号",""]
["1010","XJ01DDT081B001070100450","2","头孢哌酮舒巴坦","注射剂","","203483","注射用头孢哌酮钠舒巴坦钠","无","注射剂","1.5g(C25H27N9O8S20.75g与C8H11NO5S0.75g)","盒","10","中硼硅玻璃模制注射剂瓶、注射用无菌粉末用覆乙烯四氟乙烯共聚物膜氯化丁基橡胶塞和抗生素瓶用铝塑组合盖包装","广东金城金素制药有限公司","47.70","修改（医保备注）","医保发〔2023〕30号",""]
["1011","XJ01DDT081B001080100450","2","头孢哌酮舒巴坦","注射剂","","203484","注射用头孢哌酮钠舒巴坦钠","无","注射剂","2.0g(C25H27N9O8S21.0g与C8H11NO5S1.0g)","盒","10","中硼硅玻璃模制注射剂瓶、注射用无菌粉末用覆乙烯四氟乙烯共聚物膜氯化丁基橡胶塞和抗生素瓶用铝塑组合盖包装","广东金城金素制药有限公司","59.50","修改（医保备注）","医保发〔2023〕30号",""]
["1012","XJ01DDT081B001080103712","2","头孢哌酮舒巴坦","注射剂","","119322","注射用头孢哌酮钠舒巴坦钠(2:1)","无","粉针剂","3.0g(2.0g/1.0g)","支","1","玻璃瓶","哈药集团制药总厂","13.05","修改（医保备注）","医保发〔2023〕30号",""]
["1013","XJ01DDT081B003010202673","2","头孢哌酮舒巴坦","注射剂","","175828","注射用头孢哌酮钠舒巴坦钠","无","注射剂(注射用无菌粉末)","1.0g(按C25H27N9O8S20.5g与C8H11NO5S0.5g计)","瓶","1","注射用无菌粉末用卤化丁基橡胶塞、钠钙玻璃模制注射剂瓶","成都倍特药业股份有限公司","5.55","修改（医保备注）","医保发〔2023〕30号",""]
["1014","XJ01DDT081B003030202673","2","头孢哌酮舒巴坦","注射剂","","175830","注射用头孢哌酮钠舒巴坦钠","无","注射剂(注射用无菌粉末)","2.0g(按C25H27N9O8S21.0g与C8H11NO5S1.0g计)","瓶","1","注射用无菌粉末用卤化丁基橡胶塞、钠钙玻璃模制注射剂瓶","成都倍特药业股份有限公司","9.43","修改（医保备注）","医保发〔2023〕30号",""]
["1015","XJ01DDT081B013010104021","2","头孢哌酮舒巴坦","注射剂","","204403","注射用头孢哌酮钠舒巴坦钠(1:1)","无","粉针剂","1.0g(C25H27N9O8S2 0.5g与C8H11NO5S 0.5g)","支","10","玻璃瓶","齐鲁安替制药有限公司,齐鲁制药有限公司","33.00","修改（医保备注）","医保发〔2023〕30号",""]
["1016","XJ01DDT081B013010204021","2","头孢哌酮舒巴坦","注射剂","","114340","注射用头孢哌酮钠舒巴坦钠","无","注射剂(无菌分装粉针剂)","1.0g(C25H27N9O8S2 0.5g与C8H11NO5S 0.5g)","盒","1","中硼硅玻璃模制注射剂瓶、注射用无菌粉末用聚全氟乙丙烯覆膜溴化丁基橡胶塞与抗生素瓶用铝塑组合盖","齐鲁安替制药有限公司","5.61","修改（医保备注）","医保发〔2023〕30号",""]
["1017","XJ01DDT081B013020100609","2","头孢哌酮舒巴坦","注射剂","","100071","注射用头孢哌酮钠舒巴坦钠(1:1)","无","注射剂(无菌分装)","1.0g(C25H27N9O8S2 0.5g与C8H11NO5S 0.5g)","瓶","1","西林瓶","山东润泽制药有限公司","5.50","修改（医保备注）","医保发〔2023〕30号",""]
["1018","XJ01DDT081B013020104021","2","头孢哌酮舒巴坦","注射剂","","204404","注射用头孢哌酮钠舒巴坦钠(1:1)","无","粉针剂","2.0g(C25H27N9O8S2 1.0g与C8H11NO5S 1.0g)","支","10","玻璃瓶","齐鲁安替制药有限公司,齐鲁制药有限公司","56.10","修改（医保备注）","医保发〔2023〕30号",""]
["1019","XJ01DDT081B013040100609","2","头孢哌酮舒巴坦","注射剂","","100074","注射用头孢哌酮钠舒巴坦钠(1:1)","无","注射剂","2.0g(C25H27N9O8S2 1.0g与C8H11NO5S 1.0g)","瓶","1","中硼硅玻璃管制注射剂瓶、注射用无菌粉末用局部覆聚四氟乙烯膜溴化丁基橡胶塞与抗生素瓶用铝塑组合盖包装","山东润泽制药有限公司","9.34","修改（医保备注）","医保发〔2023〕30号",""]
["1020","XJ01DFA194B001010104141","2","氨曲南","注射剂","","116898","注射用氨曲南","无","粉针剂","0.5g","瓶","1","西林瓶","山东罗欣药业集团股份有限公司","10.83","修改（医保备注）","医保发〔2023〕30号",""]
["1021","XJ01DFA194B001010105006","2","氨曲南","注射剂","","107921","注射用氨曲南","无","粉针剂","0.5g","瓶","1","西林瓶","湖南科伦制药有限公司","13.05","修改（医保备注）","医保发〔2023〕30号",""]
["1022","XJ01DFA194B001010105781","2","氨曲南","注射剂","","202786","注射用氨曲南","无","注射剂","0.5g","盒","10","西林瓶","海南皇隆制药股份有限公司","183.90","修改（医保备注）","医保发〔2023〕30号",""]
["1023","XJ01DFA194B001010105793","2","氨曲南","注射剂","","117651","注射用氨曲南","无","粉针剂","0.5g","瓶","1","玻璃瓶","海南灵康制药有限公司","9.48","修改（医保备注）","医保发〔2023〕30号",""]
["1024","XJ01DFA194B001010201041","2","氨曲南","注射剂","","200883","注射用氨曲南","无","注射剂","0.5g","盒","10","中硼硅玻璃管制注射剂瓶、注射用无菌粉末用局部覆聚四氟乙烯膜卤化丁基橡胶塞和抗生素瓶用铝塑组合盖包装","福安药业集团庆余堂制药有限公司","189.40","修改（医保备注）","医保发〔2023〕30号",""]
["1025","XJ01DFA194B001010202777","2","氨曲南","注射剂","","114441","注射用氨曲南","无","粉针剂","0.5g","支","1","玻璃瓶","石药集团欧意药业有限公司","14.23","修改（医保备注）","医保发〔2023〕30号",""]
["1026","XJ01DFA194B001010401034","2","氨曲南","注射剂","","204011","注射用氨曲南","无","粉针剂","0.5g","盒","10","西林瓶","重庆圣华曦药业股份有限公司","117.50","修改（医保备注）","医保发〔2023〕30号",""]
["1027","XJ01DFA194B001020101034","2","氨曲南","注射剂","","100468","注射用氨曲南","无","粉针剂","1.0g","瓶","1","玻璃瓶","重庆圣华曦药业股份有限公司","7.10","修改（医保备注）","医保发〔2023〕30号",""]
["1028","XJ01DFA194B001020104141","2","氨曲南","注射剂","","116904","注射用氨曲南","无","粉针剂","1.0g","瓶","1","西林瓶","山东罗欣药业集团股份有限公司","11.82","修改（医保备注）","医保发〔2023〕30号",""]
["1029","XJ01DFA194B001020104354","2","氨曲南","注射剂","","111180","注射用氨曲南","无","粉针剂","1.0g","瓶","1","玻璃瓶","安徽威尔曼制药有限公司","20.39","修改（医保备注）","医保发〔2023〕30号",""]
["1030","XJ01DFA194B001020105781","2","氨曲南","注射剂","","202787","注射用氨曲南","无","注射剂","1.0g","盒","10","西林瓶","海南皇隆制药股份有限公司","312.75","修改（医保备注）","医保发〔2023〕30号",""]
["1031","XJ01DFA194B001020105793","2","氨曲南","注射剂","","117666","注射用氨曲南","无","粉针剂","1.0g","瓶","1","玻璃瓶","海南灵康制药有限公司","15.11","修改（医保备注）","医保发〔2023〕30号",""]
["1032","XJ01DFA194B001020201041","2","氨曲南","注射剂","","200884","注射用氨曲南","无","注射剂","1.0g","盒","10","中硼硅玻璃管制注射剂瓶、注射用无菌粉末用局部覆聚四氟乙烯膜卤化丁基橡胶塞和抗生素瓶用铝塑组合盖包装","福安药业集团庆余堂制药有限公司","322.20","修改（医保备注）","医保发〔2023〕30号",""]
["1033","XJ01DFA194B001020202777","2","氨曲南","注射剂","","114453","注射用氨曲南","无","粉针剂","1.0g","瓶","1","玻璃瓶","石药集团欧意药业有限公司","24.19","修改（医保备注）","医保发〔2023〕30号",""]
["1034","XJ01DFA194B001020204141","2","氨曲南","注射剂","","203934","注射用氨曲南","无","粉针剂","1.0g","盒","10","玻璃瓶","山东罗欣药业集团股份有限公司","193.00","修改（医保备注）","医保发〔2023〕30号",""]
["1035","XJ01DFA194B001030101649","2","氨曲南","注射剂","","141262","注射用氨曲南","无","粉针剂","2.0g","瓶","1","西林瓶","苏州第壹制药有限公司","48.00","修改（医保备注）","医保发〔2023〕30号",""]
["1036","XJ01DFA194B001030104141","2","氨曲南","注射剂","","116913","注射用氨曲南","无","粉针剂","2.0g","瓶","1","西林瓶","山东罗欣药业集团股份有限公司","34.68","修改（医保备注）","医保发〔2023〕30号",""]
["1037","XJ01XXD215B001010100244","2","达托霉素","注射剂","","173200","注射用达托霉素","无","注射剂","0.5g","瓶","1","玻璃瓶","安士制药(中山)有限公司","247.00","修改（医保备注）","医保发〔2023〕30号",""]
["1038","XJ01XXD215B001010101445","2","达托霉素","注射剂","","162765","注射用达托霉素","无","冻干粉针剂","0.5g","瓶","1","玻璃瓶","江苏恒瑞医药股份有限公司","1066.40","修改（医保备注）","医保发〔2023〕30号",""]
["1039","XJ01XXD215B001010104495","2","达托霉素","注射剂","","173239","注射用达托霉素","克必信","冻干粉针剂","0.5g","瓶","1","西林瓶","意大利培森药厂Patheon Italia S.p.A","1675.00","修改（医保备注）","医保发〔2023〕30号",""]
["1040","XJ01XXD215B001010104520","2","达托霉素","注射剂","","162573","注射用达托霉素","无","冻干粉针剂","0.5g","瓶","1","玻璃瓶","杭州中美华东制药有限公司","1179.90","修改（医保备注）","医保发〔2023〕30号",""]
["1041","XJ01XXD215B001010104641","2","达托霉素","注射剂","","162575","注射用达托霉素","无","冻干粉针剂","0.5g","盒","1","中性硼硅玻璃管制镀聚二甲基硅氧烷膜注射剂瓶、冷冻干燥用溴化丁基橡胶塞","浙江海正药业股份有限公司","158.00","修改（医保备注）","医保发〔2023〕30号",""]
["1042","XJ01XXD215B001010105847","2","达托霉素","注射剂","","176963","注射用达托霉素","无","注射剂","0.5g","瓶","1","中硼硅玻璃管制注射剂瓶、冷冻干燥用溴化丁基橡胶塞6720GC。","齐鲁制药(海南)有限公司","112.00","修改（医保备注）","医保发〔2023〕30号",""]
["1043","XJ01XXD215B001020105801","2","达托霉素","注射剂","","204094","注射用达托霉素","无","注射剂","0.5g","盒","1","中硼硅玻璃管制注射剂瓶、注射制剂用溴化丁基橡胶塞","海南普利制药股份有限公司","247.00","修改（医保备注）","医保发〔2023〕30号",""]
["1044","XJ01DHM046B001010100523","2","美罗培南","注射剂","","105668","注射用美罗培南","倍能","粉针剂","0.25g","瓶","1","玻璃瓶","深圳市海滨制药有限公司","51.35","修改（医保备注）","医保发〔2023〕30号",""]
["1045","XJ01DHM046B001010102777","2","美罗培南","注射剂","","114525","注射用美罗培南","无","粉针剂","0.25g","支","1","西林瓶","石药集团欧意药业有限公司","50.00","修改（医保备注）","医保发〔2023〕30号",""]
["1046","XJ01DHM046B001010104641","2","美罗培南","注射剂","","144073","注射用美罗培南","海正美特","粉针剂","0.25g","瓶","1","玻璃瓶","瀚晖制药有限公司","39.34","修改（医保备注）","医保发〔2023〕30号",""]
["1047","XJ01DHM046B001010105758","2","美罗培南","注射剂","","111683","注射用美罗培南","无","粉针剂","0.25g","瓶","1","西林瓶","海口市制药厂有限公司","40.11","修改（医保备注）","医保发〔2023〕30号",""]
["1048","XJ01DHM046B001010180502","2","美罗培南","注射剂","","162969","注射用美罗培南","无","粉针剂","0.25g","瓶","1","玻璃瓶","山东罗欣药业集团股份有限公司","8.01","修改（医保备注）","医保发〔2023〕30号",""]
["1049","XJ01DHM046B001020100523","2","美罗培南","注射剂","","105672","注射用美罗培南","倍能","粉针剂","0.5g","瓶","1","玻璃瓶","深圳市海滨制药有限公司","81.07","修改（医保备注）","医保发〔2023〕30号",""]
["1050","XJ01DHM046B001020100976","2","美罗培南","注射剂","","101776","注射用美罗培南","无","粉针剂","0.5g","瓶","1","玻璃瓶","北大医药股份有限公司","9.33","修改（医保备注）","医保发〔2023〕30号",""]
["1051","XJ01DHM046B001020102777","2","美罗培南","注射剂","","114519","注射用美罗培南","无","粉针剂","0.5g","支","1","西林瓶","石药集团欧意药业有限公司","62.75","修改（医保备注）","医保发〔2023〕30号",""]
["1052","XJ01DHM046B001020104641","2","美罗培南","注射剂","","144074","注射用美罗培南","海正美特","粉针剂","0.5g","瓶","1","玻璃瓶","瀚晖制药有限公司","67.85","修改（医保备注）","医保发〔2023〕30号",""]
["1053","XJ01DHM046B001020105758","2","美罗培南","注射剂","","111688","注射用美罗培南","无","粉针剂","0.5g","瓶","1","西林瓶","海口市制药厂有限公司","57.46","修改（医保备注）","医保发〔2023〕30号",""]
["1054","XJ01DHM046B001020180502","2","美罗培南","注射剂","","162970","注射用美罗培南","无","粉针剂","0.5g","瓶","1","玻璃瓶","山东罗欣药业集团股份有限公司","13.61","修改（医保备注）","医保发〔2023〕30号",""]
["1055","XJ01DHM046B001020278991","2","美罗培南","注射剂","","146313","注射用美罗培南","美平","粉针剂","0.5g","瓶","1","西林瓶","日本Sumitomo Dainippon Pharma Co., Ltd. Oita Plant","109.45","修改（医保备注）","医保发〔2023〕30号",""]
["1056","XJ01DHM046B001030102777","2","美罗培南","注射剂","","148293","注射用美罗培南","无","粉针剂","1.0g","瓶","1","西林瓶","石药集团欧意药业有限公司","151.30","修改（医保备注）","医保发〔2023〕30号",""]
["1057","XJ01XXL070A001010100648","2","利奈唑胺","口服常释剂型","","171642","利奈唑胺片","无","薄膜衣片","0.6g","盒","10","铝箔","上海迪赛诺生物医药有限公司","78.00","修改（医保备注）","医保发〔2023〕30号",""]
["1058","XJ01XXL070A001010101003","2","利奈唑胺","口服常释剂型","","165814","利奈唑胺片","无","薄膜衣片","0.6g","盒","12","铝塑","重庆华邦制药有限公司","372.00","修改（医保备注）","医保发〔2023〕30号",""]
["1059","XJ01XXL070A001010101444","2","利奈唑胺","口服常释剂型","","167259","利奈唑胺片","无","薄膜衣片","0.6g","盒","6","铝塑","江苏豪森药业集团有限公司","190.77","修改（医保备注）","医保发〔2023〕30号",""]
["1060","XJ01XXL070A001010101523","2","利奈唑胺","口服常释剂型","","174742","利奈唑胺片","无","薄膜衣片","0.6g","盒","20","塑料瓶","正大天晴药业集团股份有限公司","609.37","修改（医保备注）","医保发〔2023〕30号",""]
["1061","XJ01XXL070A001010104641","2","利奈唑胺","口服常释剂型","","176189","利奈唑胺片","无","薄膜衣片","0.6g","盒","10","铝塑","浙江海正药业股份有限公司","308.80","修改（医保备注）","医保发〔2023〕30号",""]
["1062","XJ01XXL070A001010105206","2","利奈唑胺","口服常释剂型","","173583","利奈唑胺片","无","薄膜衣片","0.6g","盒","10","铝箔","桂林南药股份有限公司","310.00","修改（医保备注）","医保发〔2023〕30号",""]
["1063","XJ01XXL070A001010178736","2","利奈唑胺","口服常释剂型","","141997","利奈唑胺片","斯沃","薄膜衣片","0.6g","盒","10","空","美国Pfizer Pharmaceuticals LLC","312.50","修改（医保备注）","医保发〔2023〕30号",""]
["1064","XJ01XXL350B002010100978","2","利奈唑胺葡萄糖","注射剂","","166555","利奈唑胺葡萄糖注射液","无","注射液","100ml:利奈唑胺0.2g,无水葡萄糖4.6g","袋","1","多层共挤输液袋","西南药业股份有限公司","83.99","修改（医保备注）","医保发〔2023〕30号",""]
["1065","XJ01XXL350B002010101003","2","利奈唑胺葡萄糖","注射剂","","200999","利奈唑胺葡萄糖注射液","无","注射剂","100ml:利奈唑胺0.2g与葡萄糖(按C？H？？O？计)4.57g","袋","1","三层共挤输液外用袋,外套聚酯/铝/聚乙烯药用复合膜袋。","重庆华邦制药有限公司","28.02","修改（医保备注）","医保发〔2023〕30号",""]
["1066","XJ01XXL350B002010101444","2","利奈唑胺葡萄糖","注射剂","","164874","利奈唑胺葡萄糖注射液","无","注射剂","100ml:利奈唑胺200mg与葡萄糖4.57g(按C6H12O6计)","袋","1","五层共挤输液袋","江苏豪森药业集团有限公司","70.00","修改（医保备注）","医保发〔2023〕30号",""]
["1067","XJ01XXL350B002010101521","2","利奈唑胺葡萄糖","注射剂","","165498","利奈唑胺葡萄糖注射液","无","注射液","100ml:利奈唑胺0.2g,葡萄糖4.57g","袋","1","多层共挤输液袋","江苏正大丰海制药有限公司","23.58","修改（医保备注）","医保发〔2023〕30号",""]
["1068","XJ01XXL350B002010101523","2","利奈唑胺葡萄糖","注射剂","","162755","利奈唑胺葡萄糖注射液","无","注射液","100ml:利奈唑胺0.2g,葡萄糖4.57g","瓶","1","玻璃瓶","正大天晴药业集团股份有限公司","49.80","修改（医保备注）","医保发〔2023〕30号",""]
["1069","XJ01XXL350B002010102189","2","利奈唑胺葡萄糖","注射剂","","166162","利奈唑胺葡萄糖注射液","无","注射液","100ml:利奈唑胺0.2g,葡萄糖4.57g","袋","1","多层共挤输液袋","四川美大康佳乐药业有限公司","83.99","修改（医保备注）","医保发〔2023〕30号",""]
["1070","XJ01XXL350B002010102763","2","利奈唑胺葡萄糖","注射剂","","173348","利奈唑胺葡萄糖注射液","无","注射液","100ml:利奈唑胺0.2g,葡萄糖4.57g","袋","1","多层共挤输液袋","石家庄四药有限公司","106.76","修改（医保备注）","医保发〔2023〕30号",""]
["1071","XJ01XXL350B002010104948","2","利奈唑胺葡萄糖","注射剂","","167836","利奈唑胺葡萄糖注射液","无","注射液","100ml:利奈唑胺0.2g,葡萄糖4.57g","袋","1","直立式输液袋(聚丙烯)","湖南科伦制药有限公司","65.00","修改（医保备注）","医保发〔2023〕30号",""]
["1072","XJ01XXL350B002010107968","2","利奈唑胺葡萄糖","注射剂","","165472","利奈唑胺葡萄糖注射液","无","注射液","100ml:利奈唑胺0.2g,葡萄糖5g","袋","1","多层共挤输液袋","浙江医药股份有限公司新昌制药厂","62.68","修改（医保备注）","医保发〔2023〕30号",""]
["1073","XJ01XXL350B002010109910","2","利奈唑胺葡萄糖","注射剂","","200732","利奈唑胺葡萄糖注射液","无","注射剂","100ml∶利奈唑胺0.2g与葡萄糖(按C？H？？O？计)4.57g","袋","1","五层共挤输液用袋,外加铝箔袋包装","华夏生生药业(北京)有限公司","82.00","修改（医保备注）","医保发〔2023〕30号",""]
["1074","XJ01XXL350B002010201444","2","利奈唑胺葡萄糖","注射剂","","162457","利奈唑胺葡萄糖注射液","无","注射液","100ml:利奈唑胺0.2g,无水葡萄糖4.6g","瓶","1","玻璃瓶","江苏豪森药业集团有限公司","12.79","修改（医保备注）","医保发〔2023〕30号",""]
["1075","XJ01XXL350B002020100978","2","利奈唑胺葡萄糖","注射剂","","166556","利奈唑胺葡萄糖注射液","无","注射液","300ml:利奈唑胺0.6g,葡萄糖13.7g","袋","1","多层共挤输液袋","西南药业股份有限公司","200.80","修改（医保备注）","医保发〔2023〕30号",""]
["1076","XJ01XXL350B002020101003","2","利奈唑胺葡萄糖","注射剂","","201007","利奈唑胺葡萄糖注射液","无","注射剂","300ml:利奈唑胺0.6g与葡萄糖(按C？H？？O？计)13.7g","袋","1","三层共挤输液外用袋,外套聚酯/铝/聚乙烯药用复合膜袋。","重庆华邦制药有限公司","65.00","修改（医保备注）","医保发〔2023〕30号",""]
["1077","XJ01XXL350B002020101521","2","利奈唑胺葡萄糖","注射剂","","165497","利奈唑胺葡萄糖注射液","无","注射液","300ml:利奈唑胺0.6g,葡萄糖13.7g","袋","1","多层共挤输液袋","江苏正大丰海制药有限公司","54.68","修改（医保备注）","医保发〔2023〕30号",""]
["1078","XJ01XXL350B002020102189","2","利奈唑胺葡萄糖","注射剂","","166163","利奈唑胺葡萄糖注射液","无","注射液","300ml:利奈唑胺0.6g,葡萄糖13.7g","袋","1","多层共挤输液袋","四川美大康佳乐药业有限公司","245.60","修改（医保备注）","医保发〔2023〕30号",""]
["1079","XJ01XXL350B002020107968","2","利奈唑胺葡萄糖","注射剂","","165487","利奈唑胺葡萄糖注射液","无","注射液","300ml:利奈唑胺0.6g,葡萄糖13.7g","袋","1","多层共挤输液袋","浙江医药股份有限公司新昌制药厂","207.25","修改（医保备注）","医保发〔2023〕30号",""]
["1080","XJ01XXL350B002020109910","2","利奈唑胺葡萄糖","注射剂","","200739","利奈唑胺葡萄糖注射液","无","注射剂","300ml∶利奈唑胺0.6g与葡萄糖(按C？H？？O？计)13.7g","袋","1","五层共挤输液用袋,外加铝箔袋包装","华夏生生药业(北京)有限公司","198.00","修改（医保备注）","医保发〔2023〕30号",""]
["1081","XJ01XXL350B002030104948","2","利奈唑胺葡萄糖","注射剂","","167839","利奈唑胺葡萄糖注射液","无","注射液","300ml:利奈唑胺0.6g,葡萄糖13.7g","袋","1","直立式输液袋(聚丙烯)","湖南科伦制药有限公司","150.72","修改（医保备注）","医保发〔2023〕30号",""]
["1082","XJ01XXL350B002030179520","2","利奈唑胺葡萄糖","注射剂","","141806","利奈唑胺葡萄糖注射液","斯沃","注射液","300ml:利奈唑胺0.6g,葡萄糖15g","袋","1","塑料袋","挪威Fresenius Kabi Norge AS","249.89","修改（医保备注）","医保发〔2023〕30号",""]
["1083","XJ02ACF059B001010100453","2","伏立康唑","注射剂","","105374","注射用伏立康唑","无","粉针剂","0.1g","瓶","1","玻璃瓶","丽珠集团丽珠制药厂","161.13","修改（医保备注）","医保发〔2023〕30号",""]
["1084","XJ02ACF059B001010100611","2","伏立康唑","注射剂","","117596","注射用伏立康唑","无","冻干粉针剂","50mg","瓶","1","玻璃瓶","珠海亿邦制药有限责任公司","91.19","修改（医保备注）","医保发〔2023〕30号",""]
["1085","XJ02ACF059B001010102856","2","伏立康唑","注射剂","","100822","注射用伏立康唑","无","冻干粉针剂","0.2g","瓶","1","玻璃瓶","晋城海斯制药有限公司","286.00","修改（医保备注）","医保发〔2023〕30号",""]
["1086","XJ02ACF059B001010105791","2","伏立康唑","注射剂","","175500","注射用伏立康唑","无","冻干粉针剂","0.2g","瓶","1","玻璃瓶","海南倍特药业有限公司","69.00","修改（医保备注）","医保发〔2023〕30号",""]
["1087","XJ02ACF059B001010105801","2","伏立康唑","注射剂","","177154","注射用伏立康唑","无","粉针剂","0.2g","盒","1","玻璃瓶","海南普利制药股份有限公司","74.67","修改（医保备注）","医保发〔2023〕30号",""]
["1088","XJ02ACF059B001010105847","2","伏立康唑","注射剂","","176770","注射用伏立康唑","无","注射剂","0.2g","瓶","1","中硼硅玻璃管制注射剂瓶(30ml),冷冻干燥用溴化丁基橡胶塞6720GC,抗生素瓶用铝塑组合盖。","齐鲁制药(海南)有限公司","75.00","修改（医保备注）","医保发〔2023〕30号",""]
["1089","XJ02ACF059B001010178724","2","伏立康唑","注射剂","","132265","注射用伏立康唑","威凡","注射剂","0.2g","盒","1","玻璃瓶","美国Pharmacia & Upjohn Company","651.32","修改（医保备注）","医保发〔2023〕30号",""]
["1090","XJ02ACF059B001010204647","2","伏立康唑","注射剂","","203754","注射用伏立康唑","无","注射剂","0.2g","盒","10","中硼硅玻璃管制注射剂瓶、注射用冷冻干燥无菌粉末用覆聚四氟乙烯/乙烯共聚物膜氯化丁基橡胶塞和抗生素瓶用铝塑组合盖","杭州澳亚生物技术股份有限公司","750.00","修改（医保备注）","医保发〔2023〕30号",""]
["1091","XJ02ACF059B001010205847","2","伏立康唑","注射剂","","203972","注射用伏立康唑","无","冻干粉针剂","0.2g","盒","10","玻璃瓶","齐鲁制药(海南)有限公司","750.00","修改（医保备注）","医保发〔2023〕30号",""]
["1092","XJ02ACF059B003010102087","2","伏立康唑","注射剂","","107212","注射用伏立康唑","无","粉针剂","0.1g","瓶","1","西林瓶","四川美大康华康药业有限公司","140.15","修改（医保备注）","医保发〔2023〕30号",""]
["1093","XJ05AXA011A001010201645","2","阿比多尔","口服常释剂型","","200365","盐酸阿比多尔片","玛诺苏","片剂","0.1g","盒","12","铝塑包装","江苏吴中医药集团有限公司苏州制药厂","53.24","修改（医保备注）","医保发〔2023〕30号",""]
["1094","XJ05AXA011A006010205849","2","阿比多尔","口服常释剂型","","166726","盐酸阿比多尔分散片","再立克","分散片","0.1g","盒","12","复合膜","海南先声药业有限公司","72.00","修改（医保备注）","医保发〔2023〕30号",""]
["1095","XJ05AXA011E001010202763","2","阿比多尔","口服常释剂型","","122672","盐酸阿比多尔胶囊","无","硬胶囊剂","0.1g","盒","12","铝塑","石家庄四药有限公司","46.39","修改（医保备注）","医保发〔2023〕30号",""]
["1096","XJ05AHA218N001010101997","2","奥司他韦","颗粒剂","","109955","磷酸奥司他韦颗粒","可威","颗粒剂","15mg","盒","10","复合膜","宜昌东阳光长江药业股份有限公司","45.68","修改（医保备注）","医保发〔2023〕30号",""]
["1097","XJ05AHP119B002020100407","2","帕拉米韦氯化钠","注射剂","","149939","帕拉米韦氯化钠注射液","无","注射液","100ml:0.3g:0.9g","瓶","1","玻璃瓶","广州南新制药有限公司","195.82","修改（医保备注）","医保发〔2023〕30号",""]
["1098","XJ01FFK120X006010405777","2","克林霉素棕榈酸酯","口服液体剂","","129657","盐酸克林霉素棕榈酸酯干混悬剂","舍悦","干混悬剂","0.5g:37.5mg","盒","18","复合膜","海南海神同洲制药有限公司","21.63","修改（医保备注）","医保发〔2023〕30号",""]
["1099","XG02CXA070B002010100568","2","阿托西班","注射剂","","174858","醋酸阿托西班注射液","无","注射液","0.9ml:6.75mg(以阿托西班计)","瓶","1","玻璃瓶","扬子江药业集团广州海瑞药业有限公司","357.22","修改（医保备注）","医保发〔2023〕30号",""]
["1100","XG02CXA070B002010105842","2","阿托西班","注射剂","","150386","醋酸阿托西班注射液","无","注射液","0.9ml:6.75mg(以阿托西班计)","瓶","1","西林瓶","海南中和药业股份有限公司","260.00","修改（医保备注）","医保发〔2023〕30号",""]
["1101","XG02CXA070B002010107821","2","阿托西班","注射剂","","163661","醋酸阿托西班注射液","无","注射液","0.9ml:6.75mg(以阿托西班计)","瓶","1","西林瓶","成都圣诺生物制药有限公司","49.73","修改（医保备注）","医保发〔2023〕30号",""]
["1102","XG02CXA070B002010179252","2","阿托西班","注射剂","","176614","醋酸阿托西班注射液","无","注射液","0.9ml:6.75mg(以阿托西班计)","瓶","1","玻璃瓶","海南通用康力制药有限公司","49.78","修改（医保备注）","医保发〔2023〕30号",""]
["1103","XG02CXA070B002010179260","2","阿托西班","注射剂","","167337","醋酸阿托西班注射液","无","注射液","0.9ml:6.75mg(以阿托西班计)","盒","1","西林瓶","深圳翰宇药业股份有限公司","95.52","修改（医保备注）","医保发〔2023〕30号",""]
["1104","XG02CXA070B002010180537","2","阿托西班","注射剂","","172250","醋酸阿托西班注射液","无","注射液","0.9ml:6.75mg(以阿托西班计)","瓶","1","玻璃瓶","南京海纳制药有限公司","21.49","修改（医保备注）","医保发〔2023〕30号",""]
["1105","XG02CXA070B002020100568","2","阿托西班","注射剂","","174859","醋酸阿托西班注射液","无","注射液","5ml:37.5mg(以阿托西班计)","瓶","1","玻璃瓶","扬子江药业集团广州海瑞药业有限公司","1327.55","修改（医保备注）","医保发〔2023〕30号",""]
["1106","XG02CXA070B002020105842","2","阿托西班","注射剂","","163140","醋酸阿托西班注射液","无","注射液","5ml:37.5mg(以阿托西班计)","瓶","1","西林瓶","海南中和药业股份有限公司","966.25","修改（医保备注）","医保发〔2023〕30号",""]
["1107","XG02CXA070B002020107821","2","阿托西班","注射剂","","165880","醋酸阿托西班注射液","无","注射液","5ml:37.5mg(以阿托西班计)","瓶","1","西林瓶","成都圣诺生物制药有限公司","184.81","修改（医保备注）","医保发〔2023〕30号",""]
["1108","XG02CXA070B002020179252","2","阿托西班","注射剂","","176615","醋酸阿托西班注射液","无","注射液","5ml:37.5mg(以阿托西班计)","瓶","1","玻璃瓶","海南通用康力制药有限公司","185.00","修改（医保备注）","医保发〔2023〕30号",""]
["1109","XG02CXA070B002020179260","2","阿托西班","注射剂","","167338","醋酸阿托西班注射液","无","注射液","5ml:37.5mg(以阿托西班计)","盒","1","西林瓶","深圳翰宇药业股份有限公司","354.99","修改（医保备注）","医保发〔2023〕30号",""]
["1110","XG02CXA070B002020180537","2","阿托西班","注射剂","","172251","醋酸阿托西班注射液","无","注射液","5ml:37.5mg(以阿托西班计)","瓶","1","玻璃瓶","南京海纳制药有限公司","79.90","修改（医保备注）","医保发〔2023〕30号",""]
["1111","XG02CXA070B002030178422","2","阿托西班","注射剂","","141269","醋酸阿托西班注射液","依保","注射液","0.9ml:7.5mg/ml(以阿托西班计)","瓶","1","西林瓶","辉凌(德国)制药有限公司Ferring GmbH","264.16","修改（医保备注）","医保发〔2023〕30号",""]
["1112","XG02CXA070B002040178422","2","阿托西班","注射剂","","141270","醋酸阿托西班注射液","依保","注射液","5ml:7.5mg/ml(以阿托西班计)","瓶","1","西林瓶","辉凌(德国)制药有限公司Ferring GmbH","981.71","修改（医保备注）","医保发〔2023〕30号",""]
["1113","XR07AAN066B014010100143","2","牛肺表面活性剂","注射剂","","116814","注射用牛肺表面活性剂","珂立苏","冻干粉针剂","70mg","支","1","玻璃瓶","华润双鹤药业股份有限公司","2635.50","修改（医保备注）","医保发〔2023〕30号",""]
["1114","XR07AAZ038B002020178331","2","猪肺磷脂","注射剂","","142083","猪肺磷脂注射液","固尔苏","注射液","3ml:0.24g","瓶","1","玻璃瓶","意大利凯西制药公司Chiesi Farmaceutici S.p.A.","5547.10","修改（医保备注）","医保发〔2023〕30号",""]
["1115","XM01AEY191X002010106762","2","右旋布洛芬","口服液体剂","","150764","右旋布洛芬口服混悬液","无","口服混悬剂","100ml:2.0g","瓶","1","塑料瓶","湖北唯森制药有限公司","40.00","修改（医保备注）","医保发〔2023〕30号",""]
["1116","XL04ABC082B001020104641","2","重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白","注射剂","","162503","注射用重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白","无","冻干粉针剂","25mg","盒","1","西林瓶","海正生物制药有限公司","318.00","修改（医保备注）","医保发〔2023〕30号",""]
["1117","XL04ABC082B002010281272","2","重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白","注射剂","","203870","重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白注射液","无","注射剂","25mg(0.5ml)/支(预充式注射器)","盒","1","预灌封注射器(带注射针)","三生国健药业(上海)股份有限公司","314.75","修改（医保备注）","医保发〔2023〕30号",""]
["1118","XL04ABC082B003010109543","2","重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白","注射剂","","101591","注射用重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白","无","冻干粉针剂","25mg","瓶","1","西林瓶","上海赛金生物医药有限公司","316.00","修改（医保备注）","医保发〔2023〕30号",""]
["1119","XL04ABY179B001010181306","2","注射用英夫利西单抗","","","176244","注射用英夫利西单抗","佳佑健","粉针剂","0.1g","瓶","1","玻璃瓶","玉溪嘉和生物技术有限公司","1280.00","修改（医保备注）","医保发〔2023〕30号",""]
["1120","XL04ABY179B001010181463","2","注射用英夫利西单抗","","","173431","注射用英夫利西单抗","类停","粉针剂","0.1g","瓶","1","玻璃瓶","泰州迈博太科药业有限公司","1268.0","修改（医保备注）","医保发〔2023〕30号",""]
["1121","XL04ABY179B001010183502","2","注射用英夫利西单抗","","","173857","注射用英夫利西单抗","安佰特","粉针剂","0.1g","瓶","1","玻璃瓶","海正生物制药有限公司","1268.00","修改（医保备注）","医保发〔2023〕30号",""]
["1122","XL04ABY179B001010278323","2","注射用英夫利西单抗","","","131705","注射用英夫利西单抗","类克","注射剂","100mg/支","盒","1","玻璃瓶","瑞士Cilag AG","2006.80","修改（医保备注）","医保发〔2023〕30号",""]
["1123","XL04ABG180B002010178323","2","戈利木单抗","注射剂","限以下情况方可支付：1.诊断明确的类风湿关节炎经传统DMARDs治疗3-6个月疾病活动度下降低于50%者；2.诊断明确的强直性脊柱炎(不含放射学前期中轴性脊柱关节炎)NSAIDs充分治疗3个月疾病活动度下降低于50%者。","163340","戈利木单抗注射液","欣普尼","注射液","0.5ml:50mg","盒","1","预充式(预灌封)注射器","瑞士Cilag AG","4900.00","修改（医保备注）","医保发〔2023〕30号",""]
["1124","XM02AXH005B002010203141","2","汉防己甲素","注射剂","","115529","汉防己甲素注射液","无","注射液","2ml:30mg","支","1","安瓿","海南制药厂有限公司制药二厂","35.06","修改（医保备注）","医保发〔2023〕30号",""]
["1125","XM05BAP107B002010101606","2","帕米膦酸二钠葡萄糖","注射剂","","101818","帕米膦酸二钠葡萄糖注射液","仁怡","注射液","250ml:30mg:12.5g","袋","1","多层共挤输液袋","南京正大天晴制药有限公司","327.00","修改（医保备注）","医保发〔2023〕30号",""]
["1126","XM05BAY315B001020101802","2","因卡膦酸二钠（英卡膦酸二钠）","注射剂","","144170","注射用英卡膦酸二钠","茵福","冻干粉针剂","10mg","瓶","1","玻璃瓶","深圳市资福药业有限公司","1847.22","修改（医保备注）","医保发〔2023〕30号",""]
["1127","XM05BAA029A001010104494","2","阿仑膦酸","口服常释剂型","","170782","阿仑膦酸钠片","无","素片","70mg","盒","1","铝塑","杭州民生滨江制药有限公司","45.80","修改（医保备注）","医保发〔2023〕30号",""]
["1128","XM05BAA029A001010178639","2","阿仑膦酸","口服常释剂型","","146077","阿仑膦酸钠片","福善美","素片","70mg","盒","1","铝塑","意大利Savio Industrial S.r.L","58.46","修改（医保备注）","医保发〔2023〕30号",""]
["1129","XM05BAA029A001020100177","2","阿仑膦酸","口服常释剂型","","133791","阿仑膦酸钠片","无","素片","70mg","盒","1","铝塑","北京福元医药股份有限公司","10.26","修改（医保备注）","医保发〔2023〕30号",""]
["1130","XM05BAA029A001020102833","2","阿仑膦酸","口服常释剂型","","120743","阿仑膦酸钠片","无","素片","70mg","盒","2","铝塑","涿州东乐制药有限公司","13.99","修改（医保备注）","医保发〔2023〕30号",""]
["1131","XM05BAA029A001020200177","2","阿仑膦酸","口服常释剂型","","133792","阿仑膦酸钠片","无","素片","70mg","盒","4","铝塑","北京福元医药股份有限公司","38.99","修改（医保备注）","医保发〔2023〕30号",""]
["1132","XM05BAA029A012010102770","2","阿仑膦酸","口服常释剂型","","110164","阿仑膦酸钠肠溶片","无","肠溶片","70mg","盒","1","双铝","石药集团欧意药业有限公司","21.44","修改（医保备注）","医保发〔2023〕30号",""]
["1133","XM05BAA029A012010202770","2","阿仑膦酸","口服常释剂型","","110756","阿仑膦酸钠肠溶片","无","肠溶片","70mg","盒","4","双铝","石药集团欧意药业有限公司","81.60","修改（医保备注）","医保发〔2023〕30号",""]
["1134","XM05BAL072A001010100148","2","利塞膦酸","口服常释剂型","","142523","利塞膦酸钠片","无","薄膜衣片","5mg","盒","10","铝塑","北京双鹭药业股份有限公司","40.64","修改（医保备注）","医保发〔2023〕30号",""]
["1135","XM05BAL072A001010205589","2","利塞膦酸","口服常释剂型","","163647","利塞膦酸钠片","无","薄膜衣片","35mg","盒","4","铝箔","昆明积大制药股份有限公司","73.38","修改（医保备注）","医保发〔2023〕30号",""]
["1136","XM05BAL072A001020105589","2","利塞膦酸","口服常释剂型","","116389","利塞膦酸钠片","无","薄膜衣片","5mg","盒","12","双铝","昆明积大制药股份有限公司","49.63","修改（医保备注）","医保发〔2023〕30号",""]
["1137","XM05BAY053B002010102189","2","伊班膦酸","注射剂","","148868","伊班膦酸钠注射液","无","注射液","1ml:1.0mg","支","1","安瓿","四川美大康佳乐药业有限公司","107.77","修改（医保备注）","医保发〔2023〕30号",""]
["1138","XM05BAY053B002010102679","2","伊班膦酸","注射剂","","115785","伊班膦酸钠注射液","艾本","注射液","1ml:1mg","支","1","安瓿","石家庄凯达生物工程有限公司","267.64","修改（医保备注）","医保发〔2023〕30号",""]
["1139","XM05BAY053B002010179436","2","伊班膦酸","注射剂","","163206","伊班膦酸钠注射液","邦罗力","注射液","2ml:2.0mg","支","1","西林瓶","德国Roche Diagnostics GmbH","775.57","修改（医保备注）","医保发〔2023〕30号",""]
["1140","XM05BAY053B002010201565","2","伊班膦酸","注射剂","","132452","伊班膦酸钠注射液","佳诺顺","注射液","1ml:1.0mg","支","1","安瓿","南京恒生制药有限公司","267.64","修改（医保备注）","医保发〔2023〕30号",""]
["1141","XM05BAY053B002010204021","2","伊班膦酸","注射剂","","163374","伊班膦酸钠注射液","无","注射剂","1ml:1mg(以C9H23NO7P2计)","支","1","中硼硅玻璃安瓿","齐鲁制药有限公司","178.89","修改（医保备注）","医保发〔2023〕30号",""]
["1142","XM05BAY053B002020102189","2","伊班膦酸","注射剂","","148869","伊班膦酸钠注射液","无","注射液","2ml:2.0mg","支","1","安瓿","四川美大康佳乐药业有限公司","183.21","修改（医保备注）","医保发〔2023〕30号",""]
["1143","XM05BAY053B002020102679","2","伊班膦酸","注射剂","","115789","伊班膦酸钠注射液","艾本","注射液","2ml:2mg","支","1","安瓿","石家庄凯达生物工程有限公司","454.98","修改（医保备注）","医保发〔2023〕30号",""]
["1144","XM05BAY053B002020104021","2","伊班膦酸","注射剂","","163375","伊班膦酸钠注射液","无","注射剂","2ml:2mg(以C9H23NO7P2计)","盒","1","中硼硅玻璃安瓿","齐鲁制药有限公司","304.11","修改（医保备注）","医保发〔2023〕30号",""]
["1145","XM05BAY053B002020179436","2","伊班膦酸","注射剂","","150357","伊班膦酸钠注射液","邦罗力","注射液","6ml:6mg","支","1","西林瓶","德国Roche Diagnostics GmbH","1798.35","修改（医保备注）","医保发〔2023〕30号",""]
["1146","XM05BAY053B002020201565","2","伊班膦酸","注射剂","","132453","伊班膦酸钠注射液","佳诺顺","注射液","2ml:2.0mg","支","1","安瓿","南京恒生制药有限公司","631.00","修改（医保备注）","医保发〔2023〕30号",""]
["1147","XM05BAY053B002030102181","2","伊班膦酸","注射剂","","113269","伊班膦酸钠注射液","无","注射液","1ml:1.0mg","支","1","安瓿","成都苑东生物制药股份有限公司","47.90","修改（医保备注）","医保发〔2023〕30号",""]
["1148","XM05BAY053B002040102181","2","伊班膦酸","注射剂","","113273","伊班膦酸钠注射液","无","注射液","2ml:2.0mg","支","1","安瓿","成都苑东生物制药股份有限公司","81.43","修改（医保备注）","医保发〔2023〕30号",""]
["1149","XM05BAY053B002050102181","2","伊班膦酸","注射剂","","118903","伊班膦酸钠注射液","无","注射液","6ml:6mg","支","1","安瓿","成都苑东生物制药股份有限公司","1537.32","修改（医保备注）","医保发〔2023〕30号",""]
["1150","XM05BAP004B001010100553","2","帕米膦酸二钠","注射剂","","138387","注射用帕米膦酸二钠","无","冻干粉针剂","15mg","支","1","玻璃瓶","深圳信立泰药业股份有限公司","143.00","修改（医保备注）","医保发〔2023〕30号",""]
["1151","XM05BAP004B001010102066","2","帕米膦酸二钠","注射剂","","125768","注射用帕米膦酸二钠","无","注射剂","15mg","瓶","1","玻璃瓶","成都天台山制药股份有限公司","138.34","修改（医保备注）","医保发〔2023〕30号",""]
["1152","XM05BAP004B001010201669","2","帕米膦酸二钠","注射剂","","141208","注射用帕米膦酸二钠","无","冻干粉针剂","15mg","支","1","西林瓶","苏州天马医药集团天吉生物制药有限公司","113.00","修改（医保备注）","医保发〔2023〕30号",""]
["1153","XM05BAP004B001020101874","2","帕米膦酸二钠","注射剂","","104347","注射用帕米膦酸二钠","无","冻干粉针剂","30mg","瓶","1","玻璃瓶","湖北午时药业股份有限公司","202.58","修改（医保备注）","医保发〔2023〕30号",""]
["1154","XM05BAP004B001020102066","2","帕米膦酸二钠","注射剂","","125775","注射用帕米膦酸二钠","无","注射剂","30mg","瓶","1","玻璃瓶","成都天台山制药股份有限公司","249.89","修改（医保备注）","医保发〔2023〕30号",""]
["1155","XM05BAP004B002010201478","2","帕米膦酸二钠","注射剂","","140152","帕米膦酸二钠注射液","无","注射液","10ml:30mg","支","1","安瓿","江苏神龙药业有限公司","280.50","修改（医保备注）","医保发〔2023〕30号",""]
["1156","XM05BAP004B002010204608","2","帕米膦酸二钠","注射剂","","103601","帕米膦酸二钠注射液","无","注射液","5ml:15mg","支","1","安瓿","浙江奥托康制药集团股份有限公司","155.95","修改（医保备注）","医保发〔2023〕30号",""]
["1157","XM05BAP004B014010100503","2","帕米膦酸二钠","注射剂","","100293","注射用帕米膦酸二钠","博宁","冻干粉针剂","15mg","盒","1","配溶媒","深圳海王药业有限公司","131.84","修改（医保备注）","医保发〔2023〕30号",""]
["1158","XL01XXP031B002010101445","2","培门冬酶注射液","","","135513","培门冬酶注射液","无","注射液","5ml:3750IU","瓶","1","西林瓶","江苏恒瑞医药股份有限公司","2980.00","修改（医保备注）","医保发〔2023〕30号",""]
["1159","XL01BAL051B001010100198","2","雷替曲塞","注射剂","","174771","注射用雷替曲塞","无","冻干粉针剂","2.0mg","瓶","1","玻璃瓶","广东星昊药业有限公司","656.00","修改（医保备注）","医保发〔2023〕30号",""]
["1160","XL01BAL051B001010101606","2","雷替曲塞","注射剂","","101844","注射用雷替曲塞","无","冻干粉针剂","2.0mg","瓶","1","玻璃瓶","南京正大天晴制药有限公司","668.96","修改（医保备注）","医保发〔2023〕30号",""]
["1161","XL01BAL051B001010101749","2","雷替曲塞","注射剂","","171798","注射用雷替曲塞","无","冻干粉针剂","2.0mg","瓶","1","玻璃瓶","扬子江药业集团有限公司","668.99","修改（医保备注）","医保发〔2023〕30号",""]
["1162","XL01XEA291A001010178724","2","阿昔替尼片","","","163098","阿昔替尼片","英立达","薄膜衣片","1mg","盒","14","铝箔","德国Pfizer Manufacturing Deutschland GmbH, Betriebsstatte Freiburg","803.32","修改（医保备注）","医保发〔2023〕30号",""]
["1163","XL01XEA291A001020178724","2","阿昔替尼片","","","163097","阿昔替尼片","英立达","薄膜衣片","5mg","盒","28","铝箔","德国Pfizer Manufacturing Deutschland GmbH, Betriebsstatte Freiburg","5506.20","修改（医保备注）","医保发〔2023〕30号",""]
["1164","XL01BBF066B001010100310","2","氟达拉滨","注射剂","限接受过至少一个标准的含烷化剂方案治疗的B细胞性慢性淋巴细胞白血病(CLL)患者。","106195","注射用磷酸氟达拉滨","无","注射剂","50mg","盒","1","玻璃瓶","广东岭南制药有限公司","704.00","修改（医保备注）","医保发〔2023〕30号",""]
["1165","XL01BBF066B001010104641","2","氟达拉滨","注射剂","限接受过至少一个标准的含烷化剂方案治疗的B细胞性慢性淋巴细胞白血病(CLL)患者。","144057","注射用磷酸氟达拉滨","无","冻干粉针剂","50mg","瓶","1","玻璃瓶","瀚晖制药有限公司","851.28","修改（医保备注）","医保发〔2023〕30号",""]
["1166","XL01BBF066B001010179280","2","氟达拉滨","注射剂","限接受过至少一个标准的含烷化剂方案治疗的B细胞性慢性淋巴细胞白血病(CLL)患者。","148642","注射用磷酸氟达拉滨","无","冻干粉针剂","50mg","瓶","1","玻璃瓶","海南锦瑞制药有限公司","760.26","修改（医保备注）","医保发〔2023〕30号",""]
["1167","XL01XED246A001010101523","2","达沙替尼","口服常释剂型","","154952","达沙替尼片","无","薄膜衣片","20mg","盒","7","铝塑","正大天晴药业集团股份有限公司","186.99","修改（医保备注）","医保发〔2023〕30号",""]
["1168","XL01XED246A001010102770","2","达沙替尼","口服常释剂型","","173622","达沙替尼片","无","薄膜衣片","20mg","盒","7","铝箔","石药集团欧意药业有限公司","185.08","修改（医保备注）","医保发〔2023〕30号",""]
["1169","XL01XED246A001010179518","2","达沙替尼","口服常释剂型","","144547","达沙替尼片","施达赛","薄膜衣片","20mg","瓶","60","塑料瓶","美国AstraZeneca Pharmaceuticals LP","3607.00","修改（医保备注）","医保发〔2023〕30号",""]
["1170","XL01XED246A001020101523","2","达沙替尼","口服常释剂型","","154951","达沙替尼片","无","薄膜衣片","50mg","盒","7","铝塑","正大天晴药业集团股份有限公司","377.10","修改（医保备注）","医保发〔2023〕30号",""]
["1171","XL01XED246A001020102770","2","达沙替尼","口服常释剂型","","173623","达沙替尼片","无","薄膜衣片","50mg","盒","7","铝箔","石药集团欧意药业有限公司","373.25","修改（医保备注）","医保发〔2023〕30号",""]
["1172","XL01XED246A001020179518","2","达沙替尼","口服常释剂型","","144548","达沙替尼片","施达赛","薄膜衣片","50mg","盒","60","HDPE塑料瓶装","美国AstraZeneca Pharmaceuticals LP","7274.16","修改（医保备注）","医保发〔2023〕30号",""]
["1173","XL01DBY055B001010101420","2","伊达比星","注射剂","","164743","注射用盐酸伊达比星","善唯达","冻干粉针剂","10mg","瓶","1","玻璃瓶","辉瑞制药(无锡)有限公司","2990.00","修改（医保备注）","医保发〔2023〕30号",""]
["1174","XL01DBY055B001010101606","2","伊达比星","注射剂","","170882","注射用盐酸伊达比星","无","冻干粉针剂","5mg","瓶","1","玻璃瓶","南京正大天晴制药有限公司","1095.88","修改（医保备注）","医保发〔2023〕30号",""]
["1175","XL01DBY055B001010104641","2","伊达比星","注射剂","","144163","注射用盐酸伊达比星","艾诺宁","冻干粉针剂","10mg","瓶","1","玻璃瓶","瀚晖制药有限公司","1862.99","修改（医保备注）","医保发〔2023〕30号",""]
["1176","XL01DBY055B001020101606","2","伊达比星","注射剂","","170883","注射用盐酸伊达比星","无","冻干粉针剂","10mg","瓶","1","玻璃瓶","南京正大天晴制药有限公司","1863.00","修改（医保备注）","医保发〔2023〕30号",""]
["1177","XL01DBY055B001020104641","2","伊达比星","注射剂","","144164","注射用盐酸伊达比星","艾诺宁","冻干粉针剂","5mg","瓶","1","玻璃瓶","瀚晖制药有限公司","1095.88","修改（医保备注）","医保发〔2023〕30号",""]
["1178","XL01XXY306E001010179422","2","枸橼酸伊沙佐米胶囊","","限治疗已接受过至少一种既往治疗的多发性骨髓瘤成人患者。","163443","枸橼酸伊沙佐米胶囊","恩莱瑞","硬胶囊剂","2.3mg(按C14H19BCl2N2O4计)","盒","3","双铝","德国Haupt Pharma Amareg GmbH","9688.20","修改（医保备注）","医保发〔2023〕30号",""]
["1179","XL01XXY306E001020179422","2","枸橼酸伊沙佐米胶囊","","限治疗已接受过至少一种既往治疗的多发性骨髓瘤成人患者。","163444","枸橼酸伊沙佐米胶囊","恩莱瑞","硬胶囊剂","3mg(按C14H19BCl2N2O4计)","盒","3","双铝","德国Haupt Pharma Amareg GmbH","11873.70","修改（医保备注）","医保发〔2023〕30号",""]
["1180","XL01XXY306E001030179422","2","枸橼酸伊沙佐米胶囊","","限治疗已接受过至少一种既往治疗的多发性骨髓瘤成人患者。","163445","枸橼酸伊沙佐米胶囊","恩莱瑞","硬胶囊剂","4mg(按C14H19BCl2N2O4计)","盒","3","双铝","德国Haupt Pharma Amareg GmbH","14799.00","修改（医保备注）","医保发〔2023〕30号",""]
["1181","XL01FDQ110B001010182144","2","曲妥珠单抗","注射剂","","173944","注射用曲妥珠单抗","汉曲优","注射剂","60毫克/瓶","瓶","1","玻璃瓶","上海复宏汉霖生物医药有限公司","837.02","修改（医保备注）","医保发〔2023〕30号",""]
["1182","XL01FDQ110B001010282983","2","曲妥珠单抗","注射剂","","205224","注射用曲妥珠单抗","赛妥","注射剂","150mg/瓶","盒","1","中硼硅玻璃管制注射剂瓶、注射制剂用溴化丁基橡胶塞。","正大天晴药业集团南京顺欣制药有限公司","1587.00","修改（医保备注）","医保发〔2023〕30号",""]
["1183","XL01FDQ110B001020182144","2","曲妥珠单抗","注射剂","","171066","注射用曲妥珠单抗","汉曲优","注射剂","150毫克/瓶","瓶","1","空","上海复宏汉霖生物医药有限公司","1688.00","修改（医保备注）","医保发〔2023〕30号",""]
["1184","XL01XCQ110B001010100723","2","曲妥珠单抗","注射剂","","144497","注射用曲妥珠单抗","赫赛汀","冻干粉针剂","0.44g(20ml)","盒","1","配溶媒","美国Genentech Inc.","5500.00","修改（医保备注）","医保发〔2023〕30号",""]
["1185","XL01XCQ110B001010183502","2","曲妥珠单抗","注射剂","","203600","注射用曲妥珠单抗","安瑞泽","注射剂","150mg/瓶","盒","1","西林瓶","海正生物制药有限公司","1588.00","修改（医保备注）","医保发〔2023〕30号",""]
["1186","ZG03AAL0316050101946","2","龙牡壮骨颗粒","","","174937","龙牡壮骨颗粒(无糖型)","无","颗粒剂","3g","盒","18","复合膜","健民药业集团股份有限公司","66.60","修改（医保备注）","医保发〔2023〕30号",""]
["1187","ZA14BAH0245010305378","2","化积颗粒（口服液）","","","174616","化积颗粒","无","颗粒剂","2g","盒","4","复合膜","江西药都仁和制药有限公司","78.00","修改（医保备注）","医保发〔2023〕30号",""]
["1188","ZA14BAH0246020105271","2","化积颗粒（口服液）","","","175116","化积口服液","无","合剂(含口服液)","100ml","盒","1","玻璃瓶","江西诚志永丰药业有限责任公司","78.0","修改（医保备注）","医保发〔2023〕30号",""]
["1189","ZA14BAY0207010101928","2","一捻金、一捻金胶囊","","","148247","一捻金","无","散剂","1.2g","盒","10","复合膜","武汉钧安制药有限公司","22.32","修改（医保备注）","医保发〔2023〕30号",""]
["1190","ZA09BAF0284010204080","2","复方阿胶浆","","","200235","复方阿胶浆","无","合剂","每瓶装20ml","盒","9","玻璃瓶","东阿阿胶股份有限公司","56.00","修改（医保备注）","医保发〔2023〕30号",""]
["1191","ZC01AAZ0506010100963","2","紫龙金片","","","124825","紫龙金片","无","薄膜衣片","0.65g","盒","48","铝箔","津药达仁堂集团股份有限公司隆顺榕制药厂","138.06","修改（医保备注）","医保发〔2023〕30号",""]
["1192","ZC02AAK0038010205671","2","康力欣胶囊","","","133138","康力欣胶囊","无","硬胶囊剂","0.5g","盒","36","铝塑","云南名扬药业有限公司","205.67","修改（医保备注）","医保发〔2023〕30号",""]
["1193","ZC01AAY0003010101503","2","鸦胆子油软胶囊（口服乳液）","","","130616","鸦胆子油软胶囊","无","软胶囊(胶丸)","0.53g","盒","24","铝塑","江苏万高药业股份有限公司","73.92","修改（医保备注）","医保发〔2023〕30号",""]
["1194","ZC01AAY0003010105342","2","鸦胆子油软胶囊（口服乳液）","","","111117","鸦胆子油软胶囊","无","软胶囊(胶丸)","0.53g","盒","24","铝塑","华润三九(南昌)药业有限公司","90.60","修改（医保备注）","医保发〔2023〕30号",""]
["1195","ZC01AAY0003010204721","2","鸦胆子油软胶囊（口服乳液）","","","142914","鸦胆子油软胶囊","无","软胶囊(胶丸)","0.54g","盒","24","铝塑","浙江天一堂药业有限公司","90.88","修改（医保备注）","医保发〔2023〕30号",""]
["1196","ZC01AAY0003010205342","2","鸦胆子油软胶囊（口服乳液）","","","111124","鸦胆子油软胶囊","无","软胶囊(胶丸)","0.53g","瓶","48","铝塑","华润三九(南昌)药业有限公司","169.37","修改（医保备注）","医保发〔2023〕30号",""]
["1197","ZC01AAY0003010304721","2","鸦胆子油软胶囊（口服乳液）","","","142915","鸦胆子油软胶囊","无","软胶囊(胶丸)","0.54g","盒","36","铝塑","浙江天一堂药业有限公司","123.08","修改（医保备注）","医保发〔2023〕30号",""]
["1198","ZC01AAY0757020102539","2","鸦胆子油软胶囊（口服乳液）","","","100592","鸦胆子油口服乳液","无","口服乳液","20ml","盒","10","玻璃瓶","延安制药股份有限公司","91.20","修改（医保备注）","医保发〔2023〕30号",""]
["1199","ZC01AAY0757020103430","2","鸦胆子油软胶囊（口服乳液）","","","116850","鸦胆子油口服乳液","无","口服乳液","250ml","支","1","玻璃瓶","吉林省康福药业有限公司","111.50","修改（医保备注）","医保发〔2023〕30号",""]
["1200","ZC02AAS0475010109538","2","生白颗粒（口服液、合剂）","","限肿瘤患者。","140230","生白合剂","无","合剂(含口服液)","250ml","瓶","1","玻璃瓶","湖北梦阳药业股份有限公司","323.13","修改（医保备注）","医保发〔2023〕30号",""]
["1201","ZC02AAS0476010104670","2","生白颗粒（口服液、合剂）","","限肿瘤患者。","148375","生白颗粒","无","颗粒剂","9g","盒","6","铝塑","浙江康恩贝制药股份有限公司","433.99","修改（医保备注）","医保发〔2023〕30号",""]
["1202","ZC02AAS0477010109538","2","生白颗粒（口服液、合剂）","","限肿瘤患者。","146219","生白口服液","无","合剂(含口服液)","10ml","盒","6","玻璃瓶","湖北梦阳药业股份有限公司","116.71","修改（医保备注）","医保发〔2023〕30号",""]
["1203","ZC02AAS0477020109538","2","生白颗粒（口服液、合剂）","","限肿瘤患者。","140229","生白口服液","无","合剂(含口服液)","20ml","盒","6","玻璃瓶","湖北梦阳药业股份有限公司","195.00","修改（医保备注）","医保发〔2023〕30号",""]
["1204","ZC01AAF0428010101027","2","复方红豆杉胶囊","","","142494","复方红豆杉胶囊","无","硬胶囊剂","0.3g","盒","12","铝塑","重庆赛诺生物药业股份有限公司","223.88","修改（医保备注）","医保发〔2023〕30号",""]
["1205","ZC01AAF0428010201027","2","复方红豆杉胶囊","","","174811","复方红豆杉胶囊","无","硬胶囊剂","0.3g","盒","18","铝塑","重庆赛诺生物药业股份有限公司","385.69","修改（医保备注）","医保发〔2023〕30号",""]
["1206","ZC02AAQ0107010204553","2","芪珍胶囊","","","137756","芪珍胶囊","无","硬胶囊剂","0.3g","瓶","30","塑料瓶","宁波大昌药业有限公司","164.30","修改（医保备注）","医保发〔2023〕30号",""]
["1207","ZC02AAC0020010104140","2","参丹散结胶囊","","","100861","参丹散结胶囊","无","硬胶囊剂","0.4g","盒","48","铝塑","山东绿因药业有限公司","133.44","修改（医保备注）","医保发〔2023〕30号",""]
["1208","ZC01AAK0035010104672","2","康莱特软胶囊","","","135529","康莱特软胶囊","无","软胶囊(胶丸)","0.45g","瓶","72","塑料瓶","浙江康莱特药业有限公司","199.49","修改（医保备注）","医保发〔2023〕30号",""]
["1209","ZC02AAY0155010102537","2","养正合剂","","","116342","养正合剂","无","合剂(含口服液)","10ml","盒","10","玻璃瓶","陕西步长制药有限公司","79.80","修改（医保备注）","医保发〔2023〕30号",""]
["1210","ZC02AAA0046010105438","2","艾愈胶囊","","","115742","艾愈胶囊","无","硬胶囊剂","0.35g","盒","48","铝塑","贵州益佰女子大药厂有限责任公司","98.40","修改（医保备注）","医保发〔2023〕30号",""]
["1211","ZC02AAY0135010103355","2","养血饮口服液","","限肿瘤患者。","169625","养血饮口服液(低糖型)","无","合剂(含口服液)","100ml","盒","1","塑料瓶","吉林敖东集团力源制药股份有限公司","157.00","修改（医保备注）","医保发〔2023〕30号",""]
["1212","ZC02AAJ0142020301061","2","健脾益肾颗粒","","","166449","健脾益肾颗粒","无","颗粒剂","10g(相当于饮片8.68g)","盒","12","复合膜","重庆希尔安药业有限公司","63.28","修改（医保备注）","医保发〔2023〕30号",""]
["1213","ZC01AAH0362010202017","2","回生口服液","","","100978","回生口服液","无","合剂(含口服液)","10ml","盒","10","玻璃瓶","成都地奥集团天府药业股份有限公司","80.83","修改（医保备注）","医保发〔2023〕30号",""]
["1214","ZC01AAG0044010105032","2","肝复乐片（胶囊）","","","147087","肝复乐胶囊","无","硬胶囊剂","0.5g","瓶","60","塑料瓶","康普药业股份有限公司","98.00","修改（医保备注）","医保发〔2023〕30号",""]
["1215","ZC01AAG0045010205010","2","肝复乐片（胶囊）","","","103627","肝复乐片","无","薄膜衣片","0.5g(素片重)","瓶","60","塑料瓶","康哲(湖南)制药有限公司","115.18","修改（医保备注）","医保发〔2023〕30号",""]
["1216","ZC01AAJ0409010100057","2","金龙胶囊","","","130146","金龙胶囊","无","硬胶囊剂","0.25g","瓶","30","塑料瓶","北京建生药业有限公司","164.48","修改（医保备注）","医保发〔2023〕30号",""]
["1217","ZC02AAA0069010104295","2","安康欣胶囊","","","143533","安康欣胶囊","无","硬胶囊剂","0.5g","盒","45","铝塑","安徽高山药业有限公司","117.13","修改（医保备注）","医保发〔2023〕30号",""]
["1218","ZC01AAT0320010104670","2","消癌平丸、消癌平颗粒（通关藤颗粒）、消癌平片（通关藤片）、消癌平胶囊（通关藤胶囊）、消癌平口服液（通关藤口服液）","","限肿瘤患者。","145639","通关藤颗粒","无","颗粒剂","4g","盒","12","铝塑","浙江康恩贝制药股份有限公司","172.00","修改（医保备注）","医保发〔2023〕30号",""]
["1219","ZC01AAX0182010105859","2","消癌平丸、消癌平颗粒（通关藤颗粒）、消癌平片（通关藤片）、消癌平胶囊（通关藤胶囊）、消癌平口服液（通关藤口服液）","","限肿瘤患者。","106692","消癌平胶囊","无","硬胶囊剂","0.2g(相当于饮片3g)","盒","96","铝塑","陇药皇甫谧制药股份有限公司","73.20","修改（医保备注）","医保发〔2023〕30号",""]
["1220","ZC01AAX0185010102544","2","消癌平丸、消癌平颗粒（通关藤颗粒）、消癌平片（通关藤片）、消癌平胶囊（通关藤胶囊）、消癌平口服液（通关藤口服液）","","限肿瘤患者。","168326","通关藤口服液(无糖型)","无","合剂(含口服液)","10ml","盒","6","玻璃瓶","杨凌科森生物制药有限责任公司","191.20","修改（医保备注）","医保发〔2023〕30号",""]
["1221","ZC01AAX0185010103083","2","消癌平丸、消癌平颗粒（通关藤颗粒）、消癌平片（通关藤片）、消癌平胶囊（通关藤胶囊）、消癌平口服液（通关藤口服液）","","限肿瘤患者。","132775","消癌平口服液","无","合剂(含口服液)","10ml","盒","12","玻璃瓶","河南省新四方制药有限公司","81.27","修改（医保备注）","医保发〔2023〕30号",""]
["1222","ZC01AAX0185010103227","2","消癌平丸、消癌平颗粒（通关藤颗粒）、消癌平片（通关藤片）、消癌平胶囊（通关藤胶囊）、消癌平口服液（通关藤口服液）","","限肿瘤患者。","104148","通关藤口服液","无","合剂(含口服液)","10ml","盒","12","玻璃瓶","河南中杰药业有限公司","104.40","修改（医保备注）","医保发〔2023〕30号",""]
["1223","ZC01AAX0186010102384","2","消癌平丸、消癌平颗粒（通关藤颗粒）、消癌平片（通关藤片）、消癌平胶囊（通关藤胶囊）、消癌平口服液（通关藤口服液）","","限肿瘤患者。","133230","通关藤片","无","薄膜衣片","0.32g","盒","120","铝塑","陕西三正盛邦制药有限公司","49.32","修改（医保备注）","医保发〔2023〕30号",""]
["1224","ZC01AAX0186010104924","2","消癌平丸、消癌平颗粒（通关藤颗粒）、消癌平片（通关藤片）、消癌平胶囊（通关藤胶囊）、消癌平口服液（通关藤口服液）","","限肿瘤患者。","126448","通关藤片","无","薄膜衣片","0.5g(基片重)","盒","24","铝塑","湖南国华制药有限公司","24.68","修改（医保备注）","医保发〔2023〕30号",""]
["1225","ZC01AAX0186010104968","2","消癌平丸、消癌平颗粒（通关藤颗粒）、消癌平片（通关藤片）、消癌平胶囊（通关藤胶囊）、消癌平口服液（通关藤口服液）","","限肿瘤患者。","143564","通关藤片","无","薄膜衣片","0.63g","盒","36","铝箔","回春堂药业股份有限公司","32.96","修改（医保备注）","医保发〔2023〕30号",""]
["1226","ZC01AAX0186010204968","2","消癌平丸、消癌平颗粒（通关藤颗粒）、消癌平片（通关藤片）、消癌平胶囊（通关藤胶囊）、消癌平口服液（通关藤口服液）","","限肿瘤患者。","143565","通关藤片","无","薄膜衣片","0.63g","盒","48","铝塑","回春堂药业股份有限公司","47.66","修改（医保备注）","医保发〔2023〕30号",""]
["1227","ZC01AAC0061010202870","2","参莲胶囊（颗粒）","","","117994","参莲胶囊","无","硬胶囊剂","0.5g","盒","60","铝塑","山西澳迩药业有限公司","44.97","修改（医保备注）","医保发〔2023〕30号",""]
["1228","ZC01AAC0062010102870","2","参莲胶囊（颗粒）","","","166734","参莲颗粒","无","颗粒剂","4.5g","盒","12","复合膜","山西澳迩药业有限公司","321.99","修改（医保备注）","医保发〔2023〕30号",""]
["1229","ZC02AAY0156010202767","2","养正消积胶囊","","","114307","养正消积胶囊","无","硬胶囊剂","0.39g","盒","36","铝塑","石家庄以岭药业股份有限公司","37.77","修改（医保备注）","医保发〔2023〕30号",""]
["1230","ZC01AAW0048010100229","2","威麦宁胶囊","","","106893","威麦宁胶囊","无","硬胶囊剂","0.4g","瓶","60","塑料瓶","华颐药业有限公司","122.40","修改（医保备注）","医保发〔2023〕30号",""]
["1231","ZC01AAC0488020100036","2","慈丹胶囊","","","106131","慈丹胶囊","无","硬胶囊剂","0.27g","盒","60","铝塑","北京勃然制药有限公司","141.72","修改（医保备注）","医保发〔2023〕30号",""]
["1232","ZC02AAJ0329010105380","2","金复康口服液","","","153420","金复康口服液","无","合剂(含口服液)","30ml","盒","9","玻璃瓶","吉林三九金复康药业有限公司","169.51","修改（医保备注）","医保发〔2023〕30号",""]
["1233","ZC01AAA0120010203310","2","安替可胶囊","","","121808","安替可胶囊","无","硬胶囊剂","0.22g","盒","24","铝塑","长春雷允上药业有限公司","83.10","修改（医保备注）","医保发〔2023〕30号",""]
["1234","ZC02AAF0316010101199","2","复方蟾酥膏","","","166412","复方蟾酥膏","无","橡胶膏剂","7cm×10cm(含生药量1.05g)","盒","10","复合膜","锦州紫金药业有限公司","123.33","修改（医保备注）","医保发〔2023〕30号",""]
["1235","ZC02AAY0277010100960","2","益肺清化膏","","限肿瘤患者。","202527","益肺清化膏","无","煎膏剂(膏滋)","每瓶装120g","盒","2","药用塑料瓶包装","津药达仁堂集团股份有限公司达仁堂制药厂","680.00","修改（医保备注）","医保发〔2023〕30号",""]
["1236","ZA09FAJ0473010105300","2","金水宝片（胶囊)","","限慢性支气管炎、慢性肾功能不全的患者。","166562","金水宝片","无","薄膜衣片","0.42g(含发酵虫草菌粉0.25g)","盒","24","铝塑","江西济民可信药业有限公司","61.20","修改（医保备注）","医保发〔2023〕30号",""]
["1237","ZA09FAJ0473010205300","2","金水宝片（胶囊)","","限慢性支气管炎、慢性肾功能不全的患者。","166563","金水宝片","无","薄膜衣片","0.42g(含发酵虫草菌粉0.25g)","盒","36","铝塑","江西济民可信药业有限公司","91.80","修改（医保备注）","医保发〔2023〕30号",""]
["1238","ZA09FAJ0473010305300","2","金水宝片（胶囊)","","限慢性支气管炎、慢性肾功能不全的患者。","166564","金水宝片","无","薄膜衣片","0.42g(含发酵虫草菌粉0.25g)","盒","48","铝塑","江西济民可信药业有限公司","122.40","修改（医保备注）","医保发〔2023〕30号",""]
["1239","ZA09FAB0150010106297","2","百令片","","限慢性支气管炎、慢性肾功能不全的患者。","124658","百令片","无","薄膜衣片","0.45g(相当于发酵虫草菌粉0.2g)","盒","30","铝塑","青海珠峰冬虫夏草药业有限公司","25.50","修改（医保备注）","医保发〔2023〕30号",""]
["1240","ZA09FAB0150010306297","2","百令片","","限慢性支气管炎、慢性肾功能不全的患者。","124662","百令片","无","薄膜衣片","0.45g(相当于发酵虫草菌粉0.2g)","盒","60","铝塑","青海珠峰冬虫夏草药业有限公司","46.28","修改（医保备注）","医保发〔2023〕30号",""]
["1241","ZA09FAZ0266010304465","2","至灵胶囊","","限慢性支气管哮喘、慢性肾功能不全的患者。","144817","至灵胶囊","无","硬胶囊剂","0.25g","瓶","50","塑料瓶","长兴制药股份有限公司","16.52","修改（医保备注）","医保发〔2023〕30号",""]
["1242","ZA12HAS0775010102729","2","舒血宁注射液","","限二级及以上医疗机构缺血性心脑血管疾病的患者。","104469","舒血宁注射液","无","注射液","2ml","支","1","安瓿","神威药业集团有限公司","6.59","修改（医保备注）","医保发〔2023〕30号",""]
["1243","ZA12HAS0775020102729","2","舒血宁注射液","","限二级及以上医疗机构缺血性心脑血管疾病的患者。","104471","舒血宁注射液","无","注射液","5ml","支","1","安瓿","神威药业集团有限公司","14.18","修改（医保备注）","医保发〔2023〕30号",""]
["1244","ZA12HAS0775020103783","2","舒血宁注射液","","限二级及以上医疗机构缺血性心脑血管疾病的患者。","116791","舒血宁注射液","无","注射液","5ml","支","1","安瓿","黑龙江珍宝岛药业股份有限公司","13.41","修改（医保备注）","医保发〔2023〕30号",""]
["1245","ZA07AAX0718010103097","2","醒脑静注射液","","限二级及以上医疗机构并有中风昏迷、脑外伤昏迷或酒精中毒昏迷的患者。","109822","醒脑静注射液(人工麝香)","无","注射液","10ml","支","1","安瓿","河南天地药业股份有限公司","29.25","修改（医保备注）","医保发〔2023〕30号",""]
["1246","ZA07AAX0718010201697","2","醒脑静注射液","","限二级及以上医疗机构并有中风昏迷、脑外伤昏迷或酒精中毒昏迷的患者。","145733","醒脑静注射液","无","注射剂","每支装10ml（人工麝香）","盒","4","安瓿","无锡济煜山禾药业股份有限公司","78.56","修改（医保备注）","医保发〔2023〕30号",""]
["1247","ZA07AAX0718010205577","2","醒脑静注射液","","限二级及以上医疗机构并有中风昏迷、脑外伤昏迷或酒精中毒昏迷的患者。","111420","醒脑静注射液","无","注射剂","10ml（人工麝香）","盒","5","安瓿瓶","大理药业股份有限公司","75.89","修改（医保备注）","医保发〔2023〕30号",""]
["1248","ZA07AAX0718020103097","2","醒脑静注射液","","限二级及以上医疗机构并有中风昏迷、脑外伤昏迷或酒精中毒昏迷的患者。","109815","醒脑静注射液(人工麝香)","无","注射液","2ml","支","1","安瓿","河南天地药业股份有限公司","8.10","修改（医保备注）","医保发〔2023〕30号",""]
["1249","ZA07AAX0718020201697","2","醒脑静注射液","","限二级及以上医疗机构并有中风昏迷、脑外伤昏迷或酒精中毒昏迷的患者。","145754","醒脑静注射液","无","注射剂","每支装2ml（人工麝香）","盒","6","安瓿瓶","无锡济煜山禾药业股份有限公司","26.55","修改（医保备注）","医保发〔2023〕30号",""]
["1250","ZA07AAX0718020205577","2","醒脑静注射液","","限二级及以上医疗机构并有中风昏迷、脑外伤昏迷或酒精中毒昏迷的患者。","111446","醒脑静注射液","无","注射剂","2ml（人工麝香）","盒","10","安瓿瓶","大理药业股份有限公司","34.47","修改（医保备注）","医保发〔2023〕30号",""]
["1251","ZA07AAX0718030201697","2","醒脑静注射液","","限二级及以上医疗机构并有中风昏迷、脑外伤昏迷或酒精中毒昏迷的患者。","145734","醒脑静注射液","无","注射剂","每支装5ml（人工麝香）","盒","6","安瓿","无锡济煜山禾药业股份有限公司","58.14","修改（医保备注）","医保发〔2023〕30号",""]
["1252","ZA07AAX0718030205577","2","醒脑静注射液","","限二级及以上医疗机构并有中风昏迷、脑外伤昏迷或酒精中毒昏迷的患者。","111409","醒脑静注射液","无","注射剂","5ml（人工麝香）","盒","5","安瓿瓶","大理药业股份有限公司","37.70","修改（医保备注）","医保发〔2023〕30号",""]
["1253","ZA07AAX0718040105577","2","醒脑静注射液","","限二级及以上医疗机构并有中风昏迷、脑外伤昏迷或酒精中毒昏迷的患者。","205746","醒脑静注射液","无","注射液","2ml（人工麝香）","支","1","安瓿瓶","大理药业股份有限公司","3.45","修改（医保备注）","医保发〔2023〕30号",""]
["1254","ZA07AAX0718050105577","2","醒脑静注射液","","限二级及以上医疗机构并有中风昏迷、脑外伤昏迷或酒精中毒昏迷的患者。","205748","醒脑静注射液","无","注射液","5ml（人工麝香）","支","1","安瓿瓶","大理药业股份有限公司","7.54","修改（医保备注）","医保发〔2023〕30号",""]
["1255","ZA07AAX0718060105577","2","醒脑静注射液","","限二级及以上医疗机构并有中风昏迷、脑外伤昏迷或酒精中毒昏迷的患者。","205744","醒脑静注射液","无","注射液","10ml（人工麝香）","支","1","安瓿瓶","大理药业股份有限公司","15.18","修改（医保备注）","医保发〔2023〕30号",""]
["1256","ZC01AAY0002010100375","2","鸦胆子油乳注射液","","限二级及以上医疗机构癌症患者。","205839","鸦胆子油乳注射液","无","注射剂","每支装10ml","盒","5","无色安瓿","广州白云山明兴制药有限公司","45.00","修改（医保备注）","医保发〔2023〕30号",""]
["1257","ZC01AAY0002010101334","2","鸦胆子油乳注射液","","限二级及以上医疗机构癌症患者。","205719","鸦胆子油乳注射液","无","注射液","10ml","盒","10","安瓿","沈阳药大雷允上药业有限责任公司","189.00","修改（医保备注）","医保发〔2023〕30号",""]
["1258","ZC01AAY0002010200375","2","鸦胆子油乳注射液","","限二级及以上医疗机构癌症患者。","112169","鸦胆子油乳注射液","无","注射剂","10ml","支","1","无色安瓿","广州白云山明兴制药有限公司","9.00","修改（医保备注）","医保发〔2023〕30号",""]
["1259","ZC01AAY0002010201334","2","鸦胆子油乳注射液","","限二级及以上医疗机构癌症患者。","116378","鸦胆子油乳注射液","无","注射液","10ml","支","1","安瓿","沈阳药大雷允上药业有限责任公司","18.90","修改（医保备注）","医保发〔2023〕30号",""]
["1260","ZA09HAC0101010102210","1","参麦注射液","","限二级及以上医疗机构。","145668","参麦注射液","无","注射液","100ml","瓶","1","玻璃瓶","四川升和药业股份有限公司","70.46","修改（医保备注）","医保发〔2023〕30号",""]
["1261","ZA09HAC0101010102646","1","参麦注射液","","限二级及以上医疗机构。","119272","参麦注射液","无","注射液","100ml","瓶","1","玻璃瓶","河北神威药业有限公司","73.74","修改（医保备注）","医保发〔2023〕30号",""]
["1262","ZA09HAC0101010104762","1","参麦注射液","","限二级及以上医疗机构。","106315","参麦注射液","无","注射液","100ml","瓶","1","玻璃瓶","正大青春宝药业有限公司","95.91","修改（医保备注）","医保发〔2023〕30号",""]
["1263","ZA09HAC0101010105646","1","参麦注射液","","限二级及以上医疗机构。","131965","参麦注射液","无","注射液","10ml","支","1","安瓿","云南植物药业有限公司","2.25","修改（医保备注）","医保发〔2023〕30号",""]
["1264","ZA09HAC0101020102312","1","参麦注射液","","限二级及以上医疗机构。","131495","参麦注射液","无","注射液","10ml","支","1","安瓿","华润三九(雅安)药业有限公司","6.25","修改（医保备注）","医保发〔2023〕30号",""]
["1265","ZA09HAC0101030102129","1","参麦注射液","","限二级及以上医疗机构。","115845","参麦注射液","无","注射液","20ml","瓶","1","安瓿","四川川大华西药业股份有限公司","12.42","修改（医保备注）","医保发〔2023〕30号",""]
["1266","ZA09HAC0101030104762","1","参麦注射液","","限二级及以上医疗机构。","106296","参麦注射液","无","注射液","20ml","支","1","安瓿","正大青春宝药业有限公司","21.03","修改（医保备注）","医保发〔2023〕30号",""]
["1267","ZA09HAC0101030105577","1","参麦注射液","","限二级及以上医疗机构。","111351","参麦注射液","无","注射液","50ml","瓶","1","玻璃瓶","大理药业股份有限公司","27.82","修改（医保备注）","医保发〔2023〕30号",""]
["1268","ZA09HAC0101040102646","1","参麦注射液","","限二级及以上医疗机构。","119261","参麦注射液","无","注射液","50ml","瓶","1","玻璃瓶","河北神威药业有限公司","40.52","修改（医保备注）","医保发〔2023〕30号",""]
["1269","ZA09HAC0101040104762","1","参麦注射液","","限二级及以上医疗机构。","106306","参麦注射液","无","注射液","50ml","瓶","1","玻璃瓶","正大青春宝药业有限公司","45.06","修改（医保备注）","医保发〔2023〕30号",""]
["1270","ZA09HAC0101050102210","1","参麦注射液","","限二级及以上医疗机构。","145669","参麦注射液","无","注射液","50ml","瓶","1","玻璃瓶","四川升和药业股份有限公司","35.04","修改（医保备注）","医保发〔2023〕30号",""]
["1271","ZA04CCS0705010105505","2","舒肝宁注射液","","限肝炎患者。","167449","舒肝宁注射液","无","注射液","10ml","支","1","安瓿","贵州瑞和制药有限公司","160.87","修改（医保备注）","医保发〔2023〕30号",""]
["1272","ZA04BAR0001010101463","2","热毒宁注射液","","限二级及以上医疗机构。","110928","热毒宁注射液","无","注射液","10ml","支","1","安瓿","江苏康缘药业股份有限公司","33.15","修改（医保备注）","医保发〔2023〕30号",""]
["1273","ZA04CAT0019010100705","2","痰热清注射液","","限二级及以上医疗机构。","140075","痰热清注射液","无","注射液","10ml","支","1","西林瓶","上海凯宝药业股份有限公司","28.44","修改（医保备注）","医保发〔2023〕30号",""]
["1274","ZA12HAS0790010103827","2","疏血通注射液","","限二级及以上医疗机构缺血性心脑血管疾病的患者。","114373","疏血通注射液","无","注射液","2ml","支","1","安瓿","牡丹江友搏药业有限责任公司","33.37","修改（医保备注）","医保发〔2023〕30号",""]
["1275","ZC01AAF0479010102970","2","复方苦参注射液","","限二级及以上医疗机构癌症患者。","104391","复方苦参注射液","无","注射液","2ml","瓶","1","安瓿","山西振东制药股份有限公司","14.65","修改（医保备注）","医保发〔2023〕30号",""]
["1276","ZC01AAF0479020102970","2","复方苦参注射液","","限二级及以上医疗机构癌症患者。","104399","复方苦参注射液","无","注射液","5ml","瓶","1","安瓿","山西振东制药股份有限公司","32.00","修改（医保备注）","医保发〔2023〕30号",""]
["1277","ZC01AAA0042010305549","2","艾迪注射液","","限二级及以上医疗机构癌症患者。","114387","艾迪注射液","无","注射液","10ml","支","1","安瓿","贵州益佰制药股份有限公司","20.53","修改（医保备注）","医保发〔2023〕30号",""]
["1278","ZC02AAC0115010100454","2","参芪扶正注射液","","限二级及以上医疗机构癌症患者。","105890","参芪扶正注射液","无","注射液","250ml","瓶","1","玻璃瓶","丽珠集团利民制药厂","107.36","修改（医保备注）","医保发〔2023〕30号",""]
["1279","ZA12GAK0204010101323","2","苦碟子注射液","","限二级及以上医疗机构的冠心病、心绞痛、脑梗塞患者。","146271","苦碟子注射液","无","注射液","10ml","支","1","安瓿","沈阳双鼎制药有限公司","16.80","修改（医保备注）","医保发〔2023〕30号",""]
["1280","ZA12GAK0204020101323","2","苦碟子注射液","","限二级及以上医疗机构的冠心病、心绞痛、脑梗塞患者。","146272","苦碟子注射液","无","注射液","20ml","支","1","安瓿","沈阳双鼎制药有限公司","29.03","修改（医保备注）","医保发〔2023〕30号",""]
["1281","ZA05CAC0029040102312","1","参附注射液","","限二级及以上医疗机构。","170459","参附注射液","无","注射液","100ml","瓶","1","玻璃瓶","华润三九(雅安)药业有限公司","218.00","修改（医保备注）","医保发〔2023〕30号",""]
["1282","ZA12HAD0232010205682","2","灯盏细辛注射液","","限二级及以上医疗机构的缺血性心脑血管疾病患者。","204485","灯盏细辛注射液","无","注射剂","10ml","支","1","低硼硅玻璃安瓿","云南生物谷药业股份有限公司","17.32","修改（医保备注）","医保发〔2023〕30号",""]
["1283","ZA09HAS0507010101493","1","生脉注射液","","限二级及以上医疗机构。","138115","生脉注射液","无","注射液","10ml","支","1","安瓿","江苏苏中药业集团生物制药有限公司","11.04","修改（医保备注）","医保发〔2023〕30号",""]
["1284","ZA09HAS0507010102312","1","生脉注射液","","限二级及以上医疗机构。","131529","生脉注射液","无","注射液","10ml","支","1","安瓿","华润三九(雅安)药业有限公司","11.00","修改（医保备注）","医保发〔2023〕30号",""]
["1285","ZA09HAS0507020101363","1","生脉注射液","","限二级及以上医疗机构。","142045","生脉注射液","无","注射液","50ml","瓶","1","玻璃瓶","常熟雷允上制药有限公司","40.76","修改（医保备注）","医保发〔2023〕30号",""]
["1286","ZA09HAS0507020101493","1","生脉注射液","","限二级及以上医疗机构。","138116","生脉注射液","无","注射液","20ml","支","1","安瓿","江苏苏中药业集团生物制药有限公司","18.48","修改（医保备注）","医保发〔2023〕30号",""]
["1287","ZA09HAS0507030102312","1","生脉注射液","","限二级及以上医疗机构。","131543","生脉注射液","无","注射液","50ml","瓶","1","玻璃瓶","华润三九(雅安)药业有限公司","46.58","修改（医保备注）","医保发〔2023〕30号",""]
["1288","ZA12HAD0227010103388","2","灯盏花素注射液","","限二级及以上医疗机构的缺血性心脑血管疾病患者。","174060","灯盏花素注射液","无","注射液","5ml:20mg","支","1","安瓿","吉林龙泰制药股份有限公司","138.0","修改（医保备注）","医保发〔2023〕30号",""]
["1289","ZA12HAD0227010202729","2","灯盏花素注射液","","限二级及以上医疗机构的缺血性心脑血管疾病患者。","104628","灯盏花素注射液","无","注射液","5ml:20mg","支","1","安瓿","神威药业集团有限公司","11.87","修改（医保备注）","医保发〔2023〕30号",""]
["1290","ZA12HAD0227020102887","2","灯盏花素注射液","","限二级及以上医疗机构的缺血性心脑血管疾病患者。","173586","灯盏花素注射液","无","注射液","2ml:5mg","支","1","玻璃瓶","山西华卫药业有限公司","72.00","修改（医保备注）","医保发〔2023〕30号",""]
["1291","ZA06EAC0467010100397","2","喘可治注射液","","限二级及以上医疗机构的支气管炎哮喘患者。","103096","喘可治注射液","无","注射液","2ml","支","1","安瓿","广州万正药业有限公司","19.05","修改（医保备注）","医保发〔2023〕30号",""]
["1292","ZA12GAH0121010201833","2","红花注射液","","限二级及以上医疗机构。","204125","红花注射液","无","注射液","5ml","支","1","玻璃安瓿","湖北民康制药有限公司","21.80","修改（医保备注）","医保发〔2023〕30号",""]
["1293","ZA12GAH0121010302964","2","红花注射液","","限二级及以上医疗机构。","106863","红花注射液","奥克伦欣","注射剂","每支装5ml","支","1","玻璃安瓿","石药银湖制药有限公司","49.60","修改（医保备注）","医保发〔2023〕30号",""]
["1294","ZA01BAS0846010103776","2","双黄连注射液/n注射用双黄连(冻干)","","限二级及以上医疗机构。","205046","双黄连注射液","无","注射剂","每支装20ml","支","1","低硼硅玻璃安瓿装","黑龙江金九药业股份有限公司","296.00","修改（医保备注）","医保发〔2023〕30号",""]
["1295","ZA01BAS0846010103783","2","双黄连注射液/n注射用双黄连(冻干)","","限二级及以上医疗机构。","205117","双黄连注射液","无","注射液","每支装20ml","支","1","低硼硅玻璃安瓿","哈尔滨珍宝制药有限公司","69.00","修改（医保备注）","医保发〔2023〕30号",""]
["1296","ZA01BAZ0410030103714","2","双黄连注射液/n注射用双黄连(冻干)","","限二级及以上医疗机构。","121254","注射用双黄连","无","冻干粉针剂","0.6g","支","1","玻璃瓶","哈药集团中药二厂","69.80","修改（医保备注）","医保发〔2023〕30号",""]
["1297","ZA01BAZ0410040103714","2","双黄连注射液/n注射用双黄连(冻干)","","限二级及以上医疗机构。","121257","注射用双黄连","无","冻干粉针剂","1.2g","支","1","玻璃瓶","哈药集团中药二厂","118.66","修改（医保备注）","医保发〔2023〕30号",""]
["1298","ZC01AAH0225020104307","1","华蟾素注射液","","限肿瘤患者。","142769","华蟾素注射液","无","注射液","5ml","支","1","安瓿","安徽华润金蟾药业股份有限公司","19.50","修改（医保备注）","医保发〔2023〕30号",""]
["1299","ZA04BAX0048010105337","2","喜炎平注射液","","限二级及以上医疗机构。","142169","喜炎平注射液","无","注射液","2ml:50mg","支","1","安瓿","江西青峰药业有限公司","22.43","修改（医保备注）","医保发〔2023〕30号",""]
["1300","ZC01AAT0314010201583","2","通关藤注射液（消癌平注射液）","","限二级及以上医疗机构的肿瘤患者。","145975","通关藤注射液(静脉注射)","无","注射液","20ml","支","1","安瓿","南京圣和药业股份有限公司","200.79","修改（医保备注）","医保发〔2023〕30号",""]
["1301","ZD03AAD0318010103391","2","定坤丹（丸）","","","168379","定坤丹","无","大蜜丸","10.8g","盒","4","塑料壳","吉林市鹿王制药股份有限公司","33.20","修改（医保备注）","医保发〔2023〕30号",""]
["1302","ZD03AAD0318010103893","2","定坤丹（丸）","","","170537","定坤丹","无","大蜜丸","10.8g","盒","6","塑料壳","内蒙古京新药业有限公司","45.16","修改（医保备注）","医保发〔2023〕30号",""]
["1303","ZD03AAD0318010203391","2","定坤丹（丸）","","","161292","定坤丹","无","大蜜丸","10.8g","盒","6","塑料壳","吉林市鹿王制药股份有限公司","49.74","修改（医保备注）","医保发〔2023〕30号",""]
["1304","ZD03AAD0318060302884","2","定坤丹（丸）","","","114914","定坤丹","无","水蜜丸","7g","盒","6","塑料瓶","山西广誉远国药有限公司","55.66","修改（医保备注）","医保发〔2023〕30号",""]
["1305","ZA07AAA0061010104481","1","安宫牛黄丸","","限清热解毒，镇惊开窍。用于热病，邪入心包，高热惊厥，神昏谵语；中风昏迷及脑炎、脑膜炎、中毒性脑病、脑出血、败血症见上述证候者。","120674","安宫牛黄丸(体外培育牛黄、人工麝香)","无","大蜜丸","3g","盒","1","塑料壳","杭州胡庆余堂药业有限公司","87.52","修改（医保备注）","医保发〔2023〕30号",""]
["1306","ZA07AAA0061040102884","1","安宫牛黄丸","","限清热解毒，镇惊开窍。用于热病，邪入心包，高热惊厥，神昏谵语；中风昏迷及脑炎、脑膜炎、中毒性脑病、脑出血、败血症见上述证候者。","112335","安宫牛黄丸(体外培育牛黄、人工麝香)","无","大蜜丸","每丸重3g","盒","1","空","山西广誉远国药有限公司","","修改（医保备注）","医保发〔2023〕30号","供应紧张药品"]
["1307","ZA12HAZ0404010105595","2","注射用灯盏花素","","限二级及以上医疗机构的缺血性心脑血管疾病患者。","132784","注射用灯盏花素","无","冻干粉针剂","10mg","瓶","1","玻璃瓶","昆明龙津药业股份有限公司","8.35","修改（医保备注）","医保发〔2023〕30号",""]
["1308","ZA07AAA0085010103651","2","安脑丸（片）","","","148851","安脑片(人工牛黄)","无","薄膜衣片","0.5g","盒","8","铝塑","哈尔滨蒲公英药业有限公司","26.39","修改（医保备注）","医保发〔2023〕30号",""]
["1309","ZA07AAA0085010203651","2","安脑丸（片）","","","124925","安脑片(人工牛黄)","无","薄膜衣片","0.5g","盒","12","铝塑","哈尔滨蒲公英药业有限公司","36.54","修改（医保备注）","医保发〔2023〕30号",""]
["1310","ZA07AAA0085010303651","2","安脑丸（片）","","","124936","安脑片(人工牛黄)","无","薄膜衣片","0.5g","盒","24","铝塑","哈尔滨蒲公英药业有限公司","74.02","修改（医保备注）","医保发〔2023〕30号",""]
["1311","ZA07AAA0086020103651","2","安脑丸（片）","","","124912","安脑丸(人工牛黄)","无","小蜜丸","3g(3g/11粒)","盒","6","塑料壳","哈尔滨蒲公英药业有限公司","46.70","修改（医保备注）","医保发〔2023〕30号",""]
["1312","ZA07AAA0086020203651","2","安脑丸（片）","","","172667","安脑丸(人工牛黄)","无","小蜜丸","3g(3g/11粒)","盒","8","塑料壳","哈尔滨蒲公英药业有限公司","66.16","修改（医保备注）","医保发〔2023〕30号",""]
["1313","ZA07AAA0086030103651","2","安脑丸（片）","","","151856","安脑丸(人工牛黄)","无","小蜜丸","3g(3g/11粒)","盒","2","塑料壳","哈尔滨蒲公英药业有限公司","15.28","修改（医保备注）","医保发〔2023〕30号",""]
["1314","ZA07AAA0086030203651","2","安脑丸（片）","","","148848","安脑丸(人工牛黄)","无","小蜜丸","3g(3g/11粒)","盒","4","塑料壳","哈尔滨蒲公英药业有限公司","29.73","修改（医保备注）","医保发〔2023〕30号",""]
["1315","ZB01BAW0251010102959","2","五福化毒丸（片）","","","151884","五福化毒片","无","糖衣片","0.1g","盒","42","铝塑","亚宝药业集团股份有限公司","33.33","修改（医保备注）","医保发〔2023〕30号",""]
["1316","ZB01BAW0252010103460","2","五福化毒丸（片）","","","128448","五福化毒丸","无","水蜜丸","6g(10g/100粒)","盒","2","复合膜","吉林省银诺克药业有限公司","23.65","修改（医保备注）","医保发〔2023〕30号",""]
["1317","ZB01BAW0252020102816","2","五福化毒丸（片）","","","153995","五福化毒丸","无","小蜜丸","30g(20g/100粒)","瓶","1","塑料瓶","药都制药集团股份有限公司","34.05","修改（医保备注）","医保发〔2023〕30号",""]
["1318","ZB01BAW0252020202816","2","五福化毒丸（片）","","","172945","五福化毒丸","无","小蜜丸","30g(20g/100粒)","盒","2","塑料瓶","药都制药集团股份有限公司","68.10","修改（医保备注）","医保发〔2023〕30号",""]
["1319","ZA04BAY0746030103670","2","炎宁糖浆","","","163435","炎宁糖浆","无","糖浆剂","3ml","盒","6","玻璃瓶","哈尔滨市康隆药业有限责任公司","88.00","修改（医保备注）","医保发〔2023〕30号",""]
["1320","ZA04DAX0940010179250","2","小儿珠珀散（珠珀猴枣散）","","","166714","小儿珠珀散","无","散剂","0.3g","瓶","1","塑料瓶","香港保和堂制药有限公司","29.78","修改（医保备注）","医保发〔2023〕30号",""]
["1321","ZA06CAX0485010202402","2","小儿清热宣肺贴膏","","","171904","小儿清热宣肺贴膏","无","贴膏剂","6cm×8cm","盒","2","铝塑复合袋","陕西摩美得气血和制药有限公司","72.00","修改（医保备注）","医保发〔2023〕30号",""]
["1322","ZH01AAX0196010403503","2","消风止痒颗粒","","","109376","消风止痒颗粒","无","颗粒剂","15g","盒","30","复合膜","吉林紫鑫药业股份有限公司","32.71","修改（医保备注）","医保发〔2023〕30号",""]
["1323","ZA12AAM0056010100962","2","脉络通、脉络通片(胶囊、颗粒)","","","167131","脉络通片","无","糖衣片","0.4g","盒","24","铝塑","津药达仁堂集团股份有限公司乐仁堂制药厂","68.00","修改（医保备注）","医保发〔2023〕30号",""]
["1324","ZA12AAM0056010202451","2","脉络通、脉络通片(胶囊、颗粒)","","","175121","脉络通","无","片剂","0.4g","盒","24","铝塑泡罩包装","陕西欧珂药业有限公司","67.90","修改（医保备注）","医保发〔2023〕30号",""]
["1325","ZA12AAM0057010101748","2","脉络通、脉络通片(胶囊、颗粒)","","","100337","脉络通胶囊","无","硬胶囊剂","0.42g","盒","12","铝塑","扬子江药业集团南京海陵药业有限公司","36.00","修改（医保备注）","医保发〔2023〕30号",""]
["1326","ZA12AAM0058010101749","2","脉络通、脉络通片(胶囊、颗粒)","","","101293","脉络通颗粒","无","颗粒剂","6g","盒","3","复合膜","扬子江药业集团江苏龙凤堂中药有限公司","52.10","修改（医保备注）","医保发〔2023〕30号",""]
["1327","XL04AXL344E001010100148","2","来那度胺","口服常释剂型","限：1.与地塞米松合用，治疗此前未经治疗且不适合接受移植的多发性骨髓瘤成年患者；2.与地塞米松合用，治疗曾接受过至少一种疗法的多发性骨髓瘤的成年患者；3.与利妥昔单抗合用，治疗既往接受过治疗的滤泡性淋巴瘤(1-3a级)成年患者。","163161","来那度胺胶囊","无","硬胶囊剂","10mg","瓶","28","塑料瓶","北京双鹭药业股份有限公司","3657.92","修改（医保备注）","医保发〔2023〕30号",""]
["1328","XL04AXL344E001010101444","2","来那度胺","口服常释剂型","限：1.与地塞米松合用，治疗此前未经治疗且不适合接受移植的多发性骨髓瘤成年患者；2.与地塞米松合用，治疗曾接受过至少一种疗法的多发性骨髓瘤的成年患者；3.与利妥昔单抗合用，治疗既往接受过治疗的滤泡性淋巴瘤(1-3a级)成年患者。","172298","来那度胺胶囊","无","硬胶囊剂","25mg","盒","6","铝塑","江苏豪森药业集团有限公司","400.00","修改（医保备注）","医保发〔2023〕30号",""]
["1329","XL04AXL344E001010101523","2","来那度胺","口服常释剂型","限：1.与地塞米松合用，治疗此前未经治疗且不适合接受移植的多发性骨髓瘤成年患者；2.与地塞米松合用，治疗曾接受过至少一种疗法的多发性骨髓瘤的成年患者；3.与利妥昔单抗合用，治疗既往接受过治疗的滤泡性淋巴瘤(1-3a级)成年患者。","165230","来那度胺胶囊","无","硬胶囊剂","25mg","盒","21","双铝","正大天晴药业集团南京顺欣制药有限公司","3840.00","修改（医保备注）","医保发〔2023〕30号",""]
["1330","XL04AXL344E001010101749","2","来那度胺","口服常释剂型","限：1.与地塞米松合用，治疗此前未经治疗且不适合接受移植的多发性骨髓瘤成年患者；2.与地塞米松合用，治疗曾接受过至少一种疗法的多发性骨髓瘤的成年患者；3.与利妥昔单抗合用，治疗既往接受过治疗的滤泡性淋巴瘤(1-3a级)成年患者。","171162","来那度胺胶囊","无","硬胶囊剂","25mg","盒","21","铝箔","扬子江药业集团有限公司","3830.00","修改（医保备注）","医保发〔2023〕30号",""]
["1331","XL04AXL344E001010102770","2","来那度胺","口服常释剂型","限：1.与地塞米松合用，治疗此前未经治疗且不适合接受移植的多发性骨髓瘤成年患者；2.与地塞米松合用，治疗曾接受过至少一种疗法的多发性骨髓瘤的成年患者；3.与利妥昔单抗合用，治疗既往接受过治疗的滤泡性淋巴瘤(1-3a级)成年患者。","310122","来那度胺胶囊","无","胶囊剂","25mg(以C？？H？？N？O？计","盒","21","铝铝泡罩包装(聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片,药用铝箔)","石药集团欧意药业有限公司","2980.00","修改（医保备注）","医保发〔2023〕30号",""]
["1332","XL04AXL344E001010104021","2","来那度胺","口服常释剂型","限：1.与地塞米松合用，治疗此前未经治疗且不适合接受移植的多发性骨髓瘤成年患者；2.与地塞米松合用，治疗曾接受过至少一种疗法的多发性骨髓瘤的成年患者；3.与利妥昔单抗合用，治疗既往接受过治疗的滤泡性淋巴瘤(1-3a级)成年患者。","165580","来那度胺胶囊","无","硬胶囊剂","25mg","盒","21","铝塑","齐鲁制药有限公司","2515.00","修改（医保备注）","医保发〔2023〕30号",""]
["1333","XL04AXL344E001010201444","2","来那度胺","口服常释剂型","限：1.与地塞米松合用，治疗此前未经治疗且不适合接受移植的多发性骨髓瘤成年患者；2.与地塞米松合用，治疗曾接受过至少一种疗法的多发性骨髓瘤的成年患者；3.与利妥昔单抗合用，治疗既往接受过治疗的滤泡性淋巴瘤(1-3a级)成年患者。","176780","来那度胺胶囊","无","硬胶囊剂","25mg","盒","21","铝塑","江苏豪森药业集团有限公司","1337.38","修改（医保备注）","医保发〔2023〕30号",""]
["1334","XL04AXL344E001010278377","2","来那度胺","口服常释剂型","限：1.与地塞米松合用，治疗此前未经治疗且不适合接受移植的多发性骨髓瘤成年患者；2.与地塞米松合用，治疗曾接受过至少一种疗法的多发性骨髓瘤的成年患者；3.与利妥昔单抗合用，治疗既往接受过治疗的滤泡性淋巴瘤(1-3a级)成年患者。","175717","来那度胺胶囊","无","硬胶囊剂","10mg","瓶","28","高密度聚乙烯","印度Dr. Reddy`s Laboratories Limited","5250.00","修改（医保备注）","医保发〔2023〕30号",""]
["1335","XL04AXL344E001010279563","2","来那度胺","口服常释剂型","限：1.与地塞米松合用，治疗此前未经治疗且不适合接受移植的多发性骨髓瘤成年患者；2.与地塞米松合用，治疗曾接受过至少一种疗法的多发性骨髓瘤的成年患者；3.与利妥昔单抗合用，治疗既往接受过治疗的滤泡性淋巴瘤(1-3a级)成年患者。","149807","来那度胺胶囊","瑞复美","硬胶囊剂","10mg","盒","21","铝塑","瑞士Celgene International Sarl","17049.00","修改（医保备注）","医保发〔2023〕30号",""]
["1336","XL04AXL344E001020100148","2","来那度胺","口服常释剂型","限：1.与地塞米松合用，治疗此前未经治疗且不适合接受移植的多发性骨髓瘤成年患者；2.与地塞米松合用，治疗曾接受过至少一种疗法的多发性骨髓瘤的成年患者；3.与利妥昔单抗合用，治疗既往接受过治疗的滤泡性淋巴瘤(1-3a级)成年患者。","163162","来那度胺胶囊","无","硬胶囊剂","25mg","瓶","21","塑料瓶","北京双鹭药业股份有限公司","3840.00","修改（医保备注）","医保发〔2023〕30号",""]
["1337","XL04AXL344E001020101523","2","来那度胺","口服常释剂型","限：1.与地塞米松合用，治疗此前未经治疗且不适合接受移植的多发性骨髓瘤成年患者；2.与地塞米松合用，治疗曾接受过至少一种疗法的多发性骨髓瘤的成年患者；3.与利妥昔单抗合用，治疗既往接受过治疗的滤泡性淋巴瘤(1-3a级)成年患者。","166505","来那度胺胶囊","无","硬胶囊剂","10mg","盒","21","双铝","正大天晴药业集团南京顺欣制药有限公司","2625.00","修改（医保备注）","医保发〔2023〕30号",""]
["1338","XL04AXL344E001020101749","2","来那度胺","口服常释剂型","限：1.与地塞米松合用，治疗此前未经治疗且不适合接受移植的多发性骨髓瘤成年患者；2.与地塞米松合用，治疗曾接受过至少一种疗法的多发性骨髓瘤的成年患者；3.与利妥昔单抗合用，治疗既往接受过治疗的滤泡性淋巴瘤(1-3a级)成年患者。","173048","来那度胺胶囊","无","硬胶囊剂","10mg","盒","21","铝箔","扬子江药业集团有限公司","2700.0","修改（医保备注）","医保发〔2023〕30号",""]
["1339","XL04AXL344E001020278377","2","来那度胺","口服常释剂型","限：1.与地塞米松合用，治疗此前未经治疗且不适合接受移植的多发性骨髓瘤成年患者；2.与地塞米松合用，治疗曾接受过至少一种疗法的多发性骨髓瘤的成年患者；3.与利妥昔单抗合用，治疗既往接受过治疗的滤泡性淋巴瘤(1-3a级)成年患者。","175719","来那度胺胶囊","无","硬胶囊剂","25mg","瓶","21","高密度聚乙烯","印度Dr. Reddy`s Laboratories Limited","5752.50","修改（医保备注）","医保发〔2023〕30号",""]
["1340","XL04AXL344E001020279563","2","来那度胺","口服常释剂型","限：1.与地塞米松合用，治疗此前未经治疗且不适合接受移植的多发性骨髓瘤成年患者；2.与地塞米松合用，治疗曾接受过至少一种疗法的多发性骨髓瘤的成年患者；3.与利妥昔单抗合用，治疗既往接受过治疗的滤泡性淋巴瘤(1-3a级)成年患者。","149810","来那度胺胶囊","瑞复美","硬胶囊剂","25mg","盒","21","铝塑","瑞士Celgene International Sarl","21643.00","修改（医保备注）","医保发〔2023〕30号",""]
["1341","XL04AXL344E001020301397","2","来那度胺","口服常释剂型","限：1.与地塞米松合用，治疗此前未经治疗且不适合接受移植的多发性骨髓瘤成年患者；2.与地塞米松合用，治疗曾接受过至少一种疗法的多发性骨髓瘤的成年患者；3.与利妥昔单抗合用，治疗既往接受过治疗的滤泡性淋巴瘤(1-3a级)成年患者。","176174","来那度胺胶囊","无","硬胶囊剂","10mg","盒","21","铝塑","常州制药厂有限公司","2125.00","修改（医保备注）","医保发〔2023〕30号",""]
["1342","XL04AXL344E001030100148","2","来那度胺","口服常释剂型","限：1.与地塞米松合用，治疗此前未经治疗且不适合接受移植的多发性骨髓瘤成年患者；2.与地塞米松合用，治疗曾接受过至少一种疗法的多发性骨髓瘤的成年患者；3.与利妥昔单抗合用，治疗既往接受过治疗的滤泡性淋巴瘤(1-3a级)成年患者。","163163","来那度胺胶囊","无","硬胶囊剂","5mg","瓶","28","塑料瓶","北京双鹭药业股份有限公司","2857.96","修改（医保备注）","医保发〔2023〕30号",""]
["1343","XL04AXL344E001030101523","2","来那度胺","口服常释剂型","限：1.与地塞米松合用，治疗此前未经治疗且不适合接受移植的多发性骨髓瘤成年患者；2.与地塞米松合用，治疗曾接受过至少一种疗法的多发性骨髓瘤的成年患者；3.与利妥昔单抗合用，治疗既往接受过治疗的滤泡性淋巴瘤(1-3a级)成年患者。","166531","来那度胺胶囊","无","硬胶囊剂","5mg","盒","21","双铝","正大天晴药业集团南京顺欣制药有限公司","1120.07","修改（医保备注）","医保发〔2023〕30号",""]
["1344","XL04AXL344E001030104021","2","来那度胺","口服常释剂型","限：1.与地塞米松合用，治疗此前未经治疗且不适合接受移植的多发性骨髓瘤成年患者；2.与地塞米松合用，治疗曾接受过至少一种疗法的多发性骨髓瘤的成年患者；3.与利妥昔单抗合用，治疗既往接受过治疗的滤泡性淋巴瘤(1-3a级)成年患者。","169692","来那度胺胶囊","无","硬胶囊剂","10mg","盒","21","铝塑","齐鲁制药有限公司","2493.00","修改（医保备注）","医保发〔2023〕30号",""]
["1345","XL04AXL344E001030301397","2","来那度胺","口服常释剂型","限：1.与地塞米松合用，治疗此前未经治疗且不适合接受移植的多发性骨髓瘤成年患者；2.与地塞米松合用，治疗曾接受过至少一种疗法的多发性骨髓瘤的成年患者；3.与利妥昔单抗合用，治疗既往接受过治疗的滤泡性淋巴瘤(1-3a级)成年患者。","176175","来那度胺胶囊","无","硬胶囊剂","25mg","盒","21","铝塑","常州制药厂有限公司","3780.00","修改（医保备注）","医保发〔2023〕30号",""]
["1346","XL04AXL344E001040104021","2","来那度胺","口服常释剂型","限：1.与地塞米松合用，治疗此前未经治疗且不适合接受移植的多发性骨髓瘤成年患者；2.与地塞米松合用，治疗曾接受过至少一种疗法的多发性骨髓瘤的成年患者；3.与利妥昔单抗合用，治疗既往接受过治疗的滤泡性淋巴瘤(1-3a级)成年患者。","169820","来那度胺胶囊","无","硬胶囊剂","15mg","盒","21","铝塑","齐鲁制药有限公司","2597.16","修改（医保备注）","医保发〔2023〕30号",""]
["1347","XL01EXN112E002010104021","2","乙磺酸尼达尼布软胶囊","","限：1.特发性肺纤维化(IPF)；2.系统性硬化病相关间质性肺疾病(SSc-ILD)；3.具有进行性表型的慢性纤维化性间质性肺疾病。","204707","乙磺酸尼达尼布软胶囊","无","胶囊剂","150mg(按C？？H？？N？O？计)","盒","30","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药用铝箔","齐鲁制药有限公司","1450.00","修改（医保备注）","医保发〔2023〕30号",""]
["1348","XL01EXN112E002020104021","2","乙磺酸尼达尼布软胶囊","","限：1.特发性肺纤维化(IPF)；2.系统性硬化病相关间质性肺疾病(SSc-ILD)；3.具有进行性表型的慢性纤维化性间质性肺疾病。","204720","乙磺酸尼达尼布软胶囊","无","胶囊剂","100mg(按C？？H？？N？O？计)","盒","30","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药用铝箔","齐鲁制药有限公司","1063.08","修改（医保备注）","医保发〔2023〕30号",""]
["1349","XL01XEN112E002010102774","2","乙磺酸尼达尼布软胶囊","","限：1.特发性肺纤维化(IPF)；2.系统性硬化病相关间质性肺疾病(SSc-ILD)；3.具有进行性表型的慢性纤维化性间质性肺疾病。","174707","乙磺酸尼达尼布软胶囊","无","软胶囊(胶丸)","0.1g(按C31H33N5O4计)","瓶","30","高密度聚乙烯","石药集团恩必普药业有限公司","1098.0","修改（医保备注）","医保发〔2023〕30号",""]
["1350","XL01XEN112E002010180023","2","乙磺酸尼达尼布软胶囊","","限：1.特发性肺纤维化(IPF)；2.系统性硬化病相关间质性肺疾病(SSc-ILD)；3.具有进行性表型的慢性纤维化性间质性肺疾病。","163106","乙磺酸尼达尼布软胶囊","维加特","软胶囊(胶丸)","0.15g(按C31H33N5O4计)","盒","30","铝塑","德国Catalent Germany Eberbach GmbH","3800.40","修改（医保备注）","医保发〔2023〕30号",""]
["1351","XL01XEN112E002020102774","2","乙磺酸尼达尼布软胶囊","","限：1.特发性肺纤维化(IPF)；2.系统性硬化病相关间质性肺疾病(SSc-ILD)；3.具有进行性表型的慢性纤维化性间质性肺疾病。","174708","乙磺酸尼达尼布软胶囊","无","软胶囊(胶丸)","0.15g(按C31H33N5O4计)","瓶","30","高密度聚乙烯","石药集团恩必普药业有限公司","1498.2","修改（医保备注）","医保发〔2023〕30号",""]
["1352","XL01XEN112E002020180023","2","乙磺酸尼达尼布软胶囊","","限：1.特发性肺纤维化(IPF)；2.系统性硬化病相关间质性肺疾病(SSc-ILD)；3.具有进行性表型的慢性纤维化性间质性肺疾病。","163105","乙磺酸尼达尼布软胶囊","维加特","软胶囊(胶丸)","0.1g(按C31H33N5O4计)","盒","30","铝塑","德国Catalent Germany Eberbach GmbH","2786.28","修改（医保备注）","医保发〔2023〕30号",""]
["1353","XL01XEA343A001010178403","2","阿贝西利片","","限：1.联合内分泌治疗(他莫昔芬或芳香化酶抑制剂)用于激素受体(HR)阳性、人表皮生长因子受体2(HER2)阴性、淋巴结阳性，高复发风险且Ki-67≥20%的早期乳腺癌成人患者的辅助治疗。2.激素受体(HR)阳性、人表皮生长因子受体2(HER2)阴性的局部晚期或转移性乳腺癌：与芳香化酶抑制剂联合使用作为绝经后女性患者的初始内分泌治疗；与氟维司群联合用于既往曾接受内分泌治疗后出现疾病进展的患者。","171958","阿贝西利片","唯择","薄膜衣片","50mg","盒","14","铝箔","波多黎各Lilly del Caribe, Inc.","421.40","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1354","XL01XEA343A001020178403","2","阿贝西利片","","限：1.联合内分泌治疗(他莫昔芬或芳香化酶抑制剂)用于激素受体(HR)阳性、人表皮生长因子受体2(HER2)阴性、淋巴结阳性，高复发风险且Ki-67≥20%的早期乳腺癌成人患者的辅助治疗。2.激素受体(HR)阳性、人表皮生长因子受体2(HER2)阴性的局部晚期或转移性乳腺癌：与芳香化酶抑制剂联合使用作为绝经后女性患者的初始内分泌治疗；与氟维司群联合用于既往曾接受内分泌治疗后出现疾病进展的患者。","171960","阿贝西利片","唯择","薄膜衣片","0.1g","盒","14","铝箔","波多黎各Lilly del Caribe, Inc.","716.38","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1355","XL01XEA343A001030178403","2","阿贝西利片","","限：1.联合内分泌治疗(他莫昔芬或芳香化酶抑制剂)用于激素受体(HR)阳性、人表皮生长因子受体2(HER2)阴性、淋巴结阳性，高复发风险且Ki-67≥20%的早期乳腺癌成人患者的辅助治疗。2.激素受体(HR)阳性、人表皮生长因子受体2(HER2)阴性的局部晚期或转移性乳腺癌：与芳香化酶抑制剂联合使用作为绝经后女性患者的初始内分泌治疗；与氟维司群联合用于既往曾接受内分泌治疗后出现疾病进展的患者。","171959","阿贝西利片","唯择","薄膜衣片","0.15g","盒","14","铝箔","波多黎各Lilly del Caribe, Inc.","977.06","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1356","XA16ABA345B004010183140","2","阿加糖酶α注射用浓溶液","","限法布雷病(α-半乳糖苷酶A缺乏症)患者的长期酶替代治疗，适用于成人、儿童和青少年。尚未确定本品在0-6岁儿童中的安全性和有效性。","172336","阿加糖酶α注射用浓溶液","瑞普佳","注射液","3.5ml:3.5mg","瓶","1","玻璃瓶","德国Vetter Pharma-Fertigung GmbH & Co.KG","3100.00","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1357","XC09CAA284A001010100553","2","阿利沙坦酯片","","限轻、中度原发性高血压。","154693","阿利沙坦酯片","信立坦","薄膜衣片","0.24g","盒","7","铝箔","深圳信立泰药业股份有限公司","29.05","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1358","XC09CAA284A001010200553","2","阿利沙坦酯片","","限轻、中度原发性高血压。","172033","阿利沙坦酯片","信立坦","薄膜衣片","0.24g","盒","14","铝箔","深圳信立泰药业股份有限公司","58.10","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1359","XC09CAA284A001010300553","2","阿利沙坦酯片","","限轻、中度原发性高血压。","177066","阿利沙坦酯片","信立坦","薄膜衣片","0.24g","盒","28","铝箔","深圳信立泰药业股份有限公司","116.20","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1360","XC09CAA284A001020100553","2","阿利沙坦酯片","","限轻、中度原发性高血压。","154692","阿利沙坦酯片","信立坦","薄膜衣片","80mg","盒","14","铝箔","深圳信立泰药业股份有限公司","25.06","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1361","XC10AXA333B002010182507","2","阿利西尤单抗注射液","","限：1.心血管事件预防。在确诊为动脉粥样硬化性心血管疾病的成人患者中，降低心肌梗死、卒中、需要住院的不稳定性心绞痛的风险。通过：与最大耐受剂量的他汀类药物联合用药，伴随或不伴随其他降脂疗法，或者在他汀类药物不耐受或禁忌使用的患者中，单独用药或与其他降脂疗法联合用药；2.原发性高胆固醇血症(包括杂合子型家族性和非家族性)和混合型血脂异常：可作为饮食的辅助疗法，用于成人原发性高胆固醇血症(杂合子型家族性和非家族性)或混合型血脂异常患者的治疗，以降低低密度脂蛋白胆固醇(LDL-C)水平。在接受最大耐受剂量的他汀类药物治疗仍无法达到LDL-C目标的患者中，与他汀类药物、或者与他汀类药物及其他降脂疗法联合用药，或者在他汀类药物不耐受或禁忌使用的患者中，单独用药或与其他降脂疗法联合用药。","168899","阿利西尤单抗注射液","波立达","注射液","1.0ml:75mg","支","1","玻璃瓶","法国Sanofi Winthrop Industrie","290.70","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1362","XC10AXA333B002010282507","2","阿利西尤单抗注射液","","限：1.心血管事件预防。在确诊为动脉粥样硬化性心血管疾病的成人患者中，降低心肌梗死、卒中、需要住院的不稳定性心绞痛的风险。通过：与最大耐受剂量的他汀类药物联合用药，伴随或不伴随其他降脂疗法，或者在他汀类药物不耐受或禁忌使用的患者中，单独用药或与其他降脂疗法联合用药；2.原发性高胆固醇血症(包括杂合子型家族性和非家族性)和混合型血脂异常：可作为饮食的辅助疗法，用于成人原发性高胆固醇血症(杂合子型家族性和非家族性)或混合型血脂异常患者的治疗，以降低低密度脂蛋白胆固醇(LDL-C)水平。在接受最大耐受剂量的他汀类药物治疗仍无法达到LDL-C目标的患者中，与他汀类药物、或者与他汀类药物及其他降脂疗法联合用药，或者在他汀类药物不耐受或禁忌使用的患者中，单独用药或与其他降脂疗法联合用药。","205766","阿利西尤单抗注射液","波立达","注射剂","1.0mL:75mg 预填充式注射笔","盒","2","1ml溶液装于1型硅化透明玻璃注射器中,预充式注射笔","SANOFI WINTHROP INDUSTRIE","581.40","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1363","XL02BBA326A001020178537","2","阿帕他胺片","","限：1.转移性内分泌治疗敏感性前列腺癌(mHSPC)成年患者；2.有高危转移风险的非转移性去势抵抗性前列腺癌(NM-CRPC)成年患者。","166375","阿帕他胺片","安森珂","片剂","60mg","盒","120","高密度聚乙烯（HDPE）瓶","Janssen Ortho, LLC","5808.00","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1364","XL02BBA326A001020278537","2","阿帕他胺片","","限：1.转移性内分泌治疗敏感性前列腺癌(mHSPC)成年患者；2.有高危转移风险的非转移性去势抵抗性前列腺癌(NM-CRPC)成年患者。","174169","阿帕他胺片","安森珂","片剂","60mg","盒","120","160ml高密度聚乙烯(HDPE)瓶","Janssen Ortho, LLC","5808.00","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1365","XJ05ARA315A001010178451","2","艾考恩丙替片","","限艾滋病病毒感染。","165463","艾考恩丙替片","捷扶康","薄膜衣片","艾维雷韦0.15g,考比司他0.15g,恩曲他滨0.2g,丙酚替诺福韦10mg","瓶","30","塑料瓶","加拿大Patheon Inc.","1026.00","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1366","XJ05AFA353A001010183096","2","艾米替诺福韦片","","限慢性乙型肝炎成人患者。","173273","艾米替诺福韦片","恒沐","素片","25mg","盒","30","高密度聚乙烯","常州恒邦药业有限公司","456.00","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1367","XJ05AFA353A001010283096","2","艾米替诺福韦片","","限慢性乙型肝炎成人患者。","310068","艾米替诺福韦片","恒沐","片剂","25mg(按C22H31N6O5P计)","盒","28","铝塑包装","江苏豪森药业集团有限公司","425.60","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1368","XJ05AGA354A001010181452","2","艾诺韦林片","","限艾滋病病毒感染。","173689","艾诺韦林片","无","素片","75mg","瓶","60","高密度聚乙烯","江苏艾迪药业股份有限公司","514.80","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1369","XB02BXA307A001010178679","2","艾曲泊帕乙醇胺片","","限：1.既往对糖皮质激素、免疫球蛋白等治疗反应不佳的成人和6岁及以上儿童慢性免疫性(特发性)血小板减少症(ITP)患者；2.既往对免疫抑制治疗缓解不充分的重型再生障碍性贫血(SAA)患者。","167212","艾曲泊帕乙醇胺片","瑞弗兰","薄膜衣片","25mg","盒","14","铝塑","Siegfried Barbera, S.L.","1890.00","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1370","XB02BXA307A001010278679","2","艾曲泊帕乙醇胺片","","限：1.既往对糖皮质激素、免疫球蛋白等治疗反应不佳的成人和6岁及以上儿童慢性免疫性(特发性)血小板减少症(ITP)患者；2.既往对免疫抑制治疗缓解不充分的重型再生障碍性贫血(SAA)患者。","165604","艾曲泊帕乙醇胺片","瑞弗兰","薄膜衣片","25mg","盒","28","铝塑","Siegfried Barbera, S.L.","3780.00","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1371","XN07XXA364A010010283283","2","氨吡啶缓释片","","限多发性硬化合并步行障碍(EDSS评分4-7分)的成年患者。","174288","氨吡啶缓释片","无","缓释片","10mg","盒","56","铝箔","爱尔兰Alkermes Pharma Ireland Ltd.","901.60","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1372","XC08CAA321A001010179306","2","氨氯地平叶酸片(Ⅱ)","","限伴有血浆同型半胱氨酸水平升高的原发性高血压。","165354","氨氯地平叶酸片(Ⅱ)","无","素片","苯磺酸氨氯地平5mg(以氨氯地平计),叶酸0.8mg","盒","7","铝塑","深圳奥萨制药有限公司","11.06","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1373","XC08CAA321A001010279306","2","氨氯地平叶酸片(Ⅱ)","","限伴有血浆同型半胱氨酸水平升高的原发性高血压。","165355","氨氯地平叶酸片(Ⅱ)","无","素片","苯磺酸氨氯地平5mg(以氨氯地平计),叶酸0.8mg","盒","14","铝塑","深圳奥萨制药有限公司","22.12","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1374","XC08CAA321A001010379306","2","氨氯地平叶酸片(Ⅱ)","","限伴有血浆同型半胱氨酸水平升高的原发性高血压。","174539","氨氯地平叶酸片(Ⅱ)","无","素片","苯磺酸氨氯地平5mg(以氨氯地平计),叶酸0.8mg","盒","28","铝塑","深圳奥萨制药有限公司","44.24","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1375","XL01XEA342A001010181490","2","奥布替尼片","","限：1.既往至少接受过一种治疗的成人套细胞淋巴瘤(MCL)患者；2.既往至少接受过一种治疗的成人慢性淋巴细胞白血病(CLL)/小淋巴细胞淋巴瘤(SLL)患者；3.既往至少接受过一种治疗的成人边缘区淋巴瘤(MZL)患者。","171751","奥布替尼片","宜诺凯","素片","50mg","盒","30","空","北京诺诚健华医药科技有限公司","3560.40","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1376","XL01XCA356B002010181735","2","奥妥珠单抗注射液","","限与化疗联合，用于初治的 II 期伴有巨大肿块、III 期或 IV 期滤泡性淋巴瘤成人患者，达到至少部分缓解的患者随后用奥妥珠单抗维持治疗。","173439","奥妥珠单抗注射液","佳罗华","注射液","40ml:1.0g","瓶","1","西林瓶","德国Roche Diagnostics GmbH","9369.00","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1377","XR01ACB241L025010100123","2","苯环喹溴铵鼻喷雾剂","","限变应性鼻炎。","169628","苯环喹溴铵鼻喷雾剂","必立汀","鼻用喷雾剂","5ml:5mg(90μg/喷,50喷)","盒","1","高密度聚乙烯","银谷制药有限责任公司","24.31","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1378","XR01ACB241L025020100123","2","苯环喹溴铵鼻喷雾剂","","限变应性鼻炎。","169627","苯环喹溴铵鼻喷雾剂","必立汀","鼻用喷雾剂","10ml:10mg(90μg/喷,100喷)","盒","1","高密度聚乙烯","银谷制药有限责任公司","41.33","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1379","XJ05ARB236A001010182157","2","比克恩丙诺片","","限艾滋病病毒感染。","167849","比克恩丙诺片","必妥维","薄膜衣片","比克替拉韦钠(以比克替拉韦计)50mg,恩曲他滨0.2g,富马酸丙酚替诺福韦(以丙酚替诺福韦计)25mg","瓶","30","塑料瓶","爱尔兰Gilead Sciences Ireland UC","933.90","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1380","XL01XED333A001010378724","2","达可替尼片","","限表皮生长因子受体(EGFR)19号外显子缺失突变或21号外显子L858R置换突变的局部晚期或转移性非小细胞肺癌(NSCLC)患者的一线治疗。","165890","达可替尼片","多泽润","薄膜衣片","15mg","瓶","30","塑料瓶","德国Pfizer Manufacturing Deutschland GMBH","931.50","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1381","XL01XCD337B002010178537","2","达雷妥尤单抗注射液","","限：1.与来那度胺和地塞米松联合用药或与硼替佐米、美法仑和泼尼松联合用药治疗不适合自体干细胞移植的新诊断的多发性骨髓瘤成年患者；2.与来那度胺和地塞米松联合用药或与硼替佐米和地塞米松联合用药治疗既往至少接受过一线治疗的多发性骨髓瘤成年患者；3.单药治疗复发和难治性多发性骨髓瘤成年患者，患者既往接受过包括蛋白酶体抑制剂和免疫调节剂的治疗且最后一次治疗时出现疾病进展。","165898","达雷妥尤单抗注射液","兆珂","注射液","5ml:0.1g","瓶","1","玻璃瓶","瑞士Cilag AG","1279.61","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1382","XL01XCD337B002020178537","2","达雷妥尤单抗注射液","","限：1.与来那度胺和地塞米松联合用药或与硼替佐米、美法仑和泼尼松联合用药治疗不适合自体干细胞移植的新诊断的多发性骨髓瘤成年患者；2.与来那度胺和地塞米松联合用药或与硼替佐米和地塞米松联合用药治疗既往至少接受过一线治疗的多发性骨髓瘤成年患者；3.单药治疗复发和难治性多发性骨髓瘤成年患者，患者既往接受过包括蛋白酶体抑制剂和免疫调节剂的治疗且最后一次治疗时出现疾病进展。","165899","达雷妥尤单抗注射液","兆珂","注射液","20ml:0.4g","瓶","1","玻璃瓶","瑞士Cilag AG","3698.07","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1383","XL02BBD348A001010183396","2","达罗他胺片","","限：1.治疗有高危转移风险的非转移性去势抵抗性前列腺癌(NM-CRPC)成年患者；2.联合多西他赛治疗转移性激素敏感性前列腺癌(mHSPC)成年患者。","174255","达罗他胺片","诺倍戈","薄膜衣片","0.3g","盒","120","塑料瓶","德国Bayer HealthCare Pharmaceuticals Inc.","5913.60","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1384","XJ05APD326A001010181008","2","达诺瑞韦钠片","","限与盐酸拉维达韦片等联合用于治疗初治的非肝硬化的基因1b型慢性丙型肝炎成人患者。","163441","达诺瑞韦钠片","戈诺卫","薄膜衣片","0.1g","瓶","28","塑料瓶","歌礼药业(浙江)有限公司","232.40","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1385","XS01BAD085J005010178976","2","地塞米松玻璃体内植入剂","","限：1.视网膜静脉阻塞(RVO)的黄斑水肿；2.糖尿病性黄斑水肿(DME)。/n应同时符合以下条件：1.需三级综合医院眼科或二级及以上眼科专科医院医师处方；2.首次处方时病眼基线矫正视力0.05-0.5；3.事前审查后方可用，初次申请需有血管造影或OCT(全身情况不允许的患者可以提供OCT血管成像)证据；4.每眼累计最多支付5支，每个年度最多支付2支。","163136","地塞米松玻璃体内植入剂","傲迪适","植入剂","0.7mg","支","1","铝箔","艾尔建爱尔兰制药公司Allergan Pharmaceuticals Ireland","3800.00","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1386","XB05BAD252B002010101415","2","多种油脂肪乳注射液(C6～24)","","需经营养风险筛查，明确具有营养风险，且不能经饮食或“肠内营养剂”补充足够营养的住院患者方予支付。","163073","多种油脂肪乳注射液(C6-24)","无","注射液","100ml:6g(精制大豆油):6g(中链甘油三酸酯):5g(精制橄榄油):3g(纯化鱼油)","瓶","1","玻璃瓶","奥地利Fresenius Kabi Austria GmbH(<费森尤斯卡比华瑞制药有限公司>分包装)","42.81","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1387","XB05BAD252B002020101415","2","多种油脂肪乳注射液(C6～24)","","需经营养风险筛查，明确具有营养风险，且不能经饮食或“肠内营养剂”补充足够营养的住院患者方予支付。","154314","多种油脂肪乳注射液(C6-24)","无","注射液","250ml:15g(精制大豆油):15g(中链甘油三酸酯):12.5g(精制橄榄油):7.5g(纯化鱼油)","瓶","1","玻璃瓶","奥地利Fresenius Kabi Austria GmbH(<费森尤斯卡比华瑞制药有限公司>分包装)","100.00","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1388","XA10BDE082A001010204520","2","二甲双胍恩格列净片(Ⅰ)","","","174275","二甲双胍恩格列净片(Ⅰ)","无","薄膜衣片","盐酸二甲双胍0.5g与恩格列净5mg","盒","30","铝箔","杭州中美华东制药有限公司","30.90","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1389","XA10BDE082A001010304520","2","二甲双胍恩格列净片(Ⅰ)","","","174330","二甲双胍恩格列净片(Ⅰ)","无","薄膜衣片","盐酸二甲双胍0.5g与恩格列净5mg","盒","60","铝箔","杭州中美华东制药有限公司","61.80","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1390","XL01XXF723E001010101445","2","氟唑帕利胶囊","","限：1.既往经过二线及以上化疗的伴有胚系BRCA突变(gBRCAm)的铂敏感复发性卵巢癌、输卵管癌或原发性腹膜癌的患者；2.铂敏感的复发性上皮性卵巢癌、输卵管癌或原发性腹膜癌成人患者在含铂化疗达到完全缓解或部分缓解后的维持治疗。","171697","氟唑帕利胶囊","艾瑞颐","硬胶囊剂","50mg","盒","36","铝箔","江苏恒瑞医药股份有限公司","1928.16","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1391","XB05BAF703B002010101927","2","复方氨基酸注射液(14AA-SF)","","需经营养风险筛查，明确具有营养风险，且不能经饮食或“肠内营养剂”补充足够营养的住院患者方予支付。","171767","复方氨基酸注射液(14AA-SF)","无","注射液","250ml:21.2g(总氨基酸)","瓶","1","玻璃瓶","湖北一半天制药有限公司","102.98","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1392","XB05BAF703B002010106932","2","复方氨基酸注射液(14AA-SF)","","需经营养风险筛查，明确具有营养风险，且不能经饮食或“肠内营养剂”补充足够营养的住院患者方予支付。","165717","复方氨基酸注射液(14AA-SF)","无","注射液","50ml:4.2g(总氨基酸)","瓶","1","玻璃瓶","湖北一半天制药有限公司","29.82","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1393","XB05BAF705B002010102001","2","复方氨基酸注射液(18AA-Ⅴ-SF)","","需经营养风险筛查，明确具有营养风险，且不能经饮食或“肠内营养剂”补充足够营养的住院患者方予支付。","165720","复方氨基酸注射液(18AA-Ⅴ-SF)","无","注射液","100ml:3.224g(总氨基酸)＋5g(木糖醇)","瓶","1","玻璃瓶","湖北一半天制药有限公司","20.90","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1394","XB05BAF705B002010106932","2","复方氨基酸注射液(18AA-Ⅴ-SF)","","需经营养风险筛查，明确具有营养风险，且不能经饮食或“肠内营养剂”补充足够营养的住院患者方予支付。","165718","复方氨基酸注射液(18AA-Ⅴ-SF)","立命","注射液","250ml:8.06g(总氨基酸)＋12.5g(木糖醇)","瓶","1","玻璃瓶","湖北一半天制药有限公司","42.15","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1395","XB05BAF705B002020102001","2","复方氨基酸注射液(18AA-Ⅴ-SF)","","需经营养风险筛查，明确具有营养风险，且不能经饮食或“肠内营养剂”补充足够营养的住院患者方予支付。","165719","复方氨基酸注射液(18AA-Ⅴ-SF)","无","注射液","500ml:16.12g(总氨基酸)＋25g(木糖醇)","瓶","1","玻璃瓶","湖北一半天制药有限公司","71.65","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1396","XN06DXG184E001010100722","2","甘露特钠胶囊","","限轻度至中度阿尔茨海默病。","166589","甘露特钠胶囊","九期一","硬胶囊剂","0.15g","盒","42","铝塑","上海绿谷制药有限公司","296.10","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1397","XC10AXH118A001010104641","2","海博麦布片","","限饮食控制以外的辅助治疗，可单独或与HMG-CoA还原酶抑制剂(他汀类)联合用于治疗原发性(杂合子家族性或非家族性)高胆固醇血症。","173416","海博麦布片","赛斯美","素片","10mg","盒","20","铝塑","浙江海正药业股份有限公司","127.40","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1398","XC10AXH118A001010204641","2","海博麦布片","","限饮食控制以外的辅助治疗，可单独或与HMG-CoA还原酶抑制剂(他汀类)联合用于治疗原发性(杂合子家族性或非家族性)高胆固醇血症。","173833","海博麦布片","赛斯美","素片","10mg","盒","14","铝塑","浙江海正药业股份有限公司","89.18","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1399","XC10AXH118A001010304641","2","海博麦布片","","限饮食控制以外的辅助治疗，可单独或与HMG-CoA还原酶抑制剂(他汀类)联合用于治疗原发性(杂合子家族性或非家族性)高胆固醇血症。","310061","海博麦布片","赛斯美","片剂","10mg","盒","7","铝塑泡罩包装,外加聚酯/铝/聚乙烯药用复合袋,复合袋内加固体药用纸袋装硅胶干燥剂","浙江海正药业股份有限公司","44.59","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1400","XC10AXH118A001020104641","2","海博麦布片","","限饮食控制以外的辅助治疗，可单独或与HMG-CoA还原酶抑制剂(他汀类)联合用于治疗原发性(杂合子家族性或非家族性)高胆固醇血症。","173417","海博麦布片","赛斯美","素片","20mg","盒","14","铝塑","浙江海正药业股份有限公司","151.48","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1401","XB02BXH117A001010101445","2","海曲泊帕乙醇胺片","","限：1.既往对糖皮质激素、免疫球蛋白等治疗反应不佳的慢性原发免疫性血小板减少症(ITP)成人患者；2.对免疫抑制治疗(IST)疗效不佳的重型再生障碍性贫血(SAA)成人患者。","173268","海曲泊帕乙醇胺片","恒曲","薄膜衣片","2.5mg(按C25H22N4O5计)","盒","14","铝箔","江苏恒瑞医药股份有限公司","1631.98","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1402","XB02BXH117A001020101445","2","海曲泊帕乙醇胺片","","限：1.既往对糖皮质激素、免疫球蛋白等治疗反应不佳的慢性原发免疫性血小板减少症(ITP)成人患者；2.对免疫抑制治疗(IST)疗效不佳的重型再生障碍性贫血(SAA)成人患者。","173267","海曲泊帕乙醇胺片","恒曲","薄膜衣片","3.75mg(按C25H22N4O5计)","盒","14","铝箔","江苏恒瑞医药股份有限公司","2226.00","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1403","XB02BXH117A001030101445","2","海曲泊帕乙醇胺片","","限：1.既往对糖皮质激素、免疫球蛋白等治疗反应不佳的慢性原发免疫性血小板减少症(ITP)成人患者；2.对免疫抑制治疗(IST)疗效不佳的重型再生障碍性贫血(SAA)成人患者。","173266","海曲泊帕乙醇胺片","恒曲","薄膜衣片","5mg(按C25H22N4O5计)","盒","14","铝箔","江苏恒瑞医药股份有限公司","2774.38","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1404","XS01XAH114G010010101322","2","环孢素滴眼液(Ⅱ)","","限干眼症。","170473","环孢素滴眼液(Ⅱ)","无","滴眼剂","0.4ml:0.2mg(0.05%)","盒","30","塑料瓶","沈阳兴齐眼药股份有限公司","165.00","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1405","XV03AEH113P001010179096","2","环硅酸锆钠散","","限成人高钾血症。","174276","环硅酸锆钠散","利倍卓","散剂","5g","盒","30","复合膜","美国AndersonBrecon, Inc.","855.90","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1406","XV03AEH113P001010279096","2","环硅酸锆钠散","","限成人高钾血症。","168759","环硅酸锆钠散","利倍卓","散剂","5g","盒","3","复合膜","美国AndersonBrecon, Inc.","85.59","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1407","XV03AEH113P001010379096","2","环硅酸锆钠散","","限成人高钾血症。","171582","环硅酸锆钠散","利倍卓","散剂","5g","盒","11","铝塑","美国AndersonBrecon, Inc.","313.83","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1408","XV03AEH113P001020179096","2","环硅酸锆钠散","","限成人高钾血症。","168758","环硅酸锆钠散","利倍卓","散剂","10g","盒","3","复合膜","美国AndersonBrecon, Inc.","145.50","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1409","XV03AEH113P001020279096","2","环硅酸锆钠散","","限成人高钾血症。","174283","环硅酸锆钠散","利倍卓","散剂","10g","盒","30","铝塑","美国AndersonBrecon,Inc","1455.00","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1410","XV03AEH113P001020379096","2","环硅酸锆钠散","","限成人高钾血症。","171583","环硅酸锆钠散","利倍卓","散剂","10g","盒","11","铝塑","美国AndersonBrecon, Inc.","533.50","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1411","XN01AXH115B002010206155","2","环泊酚注射液","","限：1.非气管插管的手术/操作中的镇静和麻醉；2.全身麻醉诱导和维持；3.重症监护期间机械通气时的镇静。","171601","环泊酚注射液","思舒宁","注射液","20ml:50mg","支","1","安瓿","辽宁海思科制药有限公司","83.00","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1412","XN01AXH115B002020106155","2","环泊酚注射液","","限：1.非气管插管的手术/操作中的镇静和麻醉；2.全身麻醉诱导和维持；3.重症监护期间机械通气时的镇静。","172085","环泊酚注射液","无","注射液","5ml:50mg","支","1","安瓿","辽宁海思科制药有限公司","83.00","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1413","XL01EXD351A001010181829","2","甲苯磺酸多纳非尼片","","限：1.既往未接受过全身系统性治疗的不可切除肝细胞癌患者；2.进展性、局部晚期或转移性放射性碘难治性分化型甲状腺癌患者。","173304","甲苯磺酸多纳非尼片","泽普生","片剂","0.1g(按C21H13D3CIF3N4O3计)","盒","40","铝箔","苏州泽璟生物制药股份有限公司","2592.00","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1414","XL01XKN118E001010182136","2","甲苯磺酸尼拉帕利胶囊","","限：1.晚期上皮性卵巢癌、输卵管癌或原发性腹膜癌成人患者对一线含铂化疗达到完全缓解或部分缓解后的维持治疗；2.铂敏感的复发性上皮性卵巢癌、输卵管癌或原发性腹膜癌成人患者在含铂化疗达到完全缓解或部分缓解后的维持治疗。","166873","甲苯磺酸尼拉帕利胶囊","则乐","胶囊剂","100mg按C19H20N4O计","盒","30","铝塑","再鼎医药(苏州)有限公司","4368.00","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1415","XL01XEA288A001010101445","2","甲磺酸阿帕替尼片","","限：1.既往至少接受过2 种系统化疗后进展或复发的晚期胃腺癌或胃-食管结合部腺癌患者；2.既往接受过至少一线系统性治疗后失败或不可耐受的晚期肝细胞癌患者；3.不可切除或转移性肝细胞癌患者的一线治疗。","162587","甲磺酸阿帕替尼片","艾坦","薄膜衣片","0.25g","盒","10","双铝","江苏恒瑞医药股份有限公司","1046.80","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1416","XL01XEA288A001010301445","2","甲磺酸阿帕替尼片","","限：1.既往至少接受过2 种系统化疗后进展或复发的晚期胃腺癌或胃-食管结合部腺癌患者；2.既往接受过至少一线系统性治疗后失败或不可耐受的晚期肝细胞癌患者；3.不可切除或转移性肝细胞癌患者的一线治疗。","164414","甲磺酸阿帕替尼片","艾坦","薄膜衣片","0.25g","盒","30","双铝","江苏恒瑞医药股份有限公司","3140.40","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1417","XL01XEA288A001020101445","2","甲磺酸阿帕替尼片","","限：1.既往至少接受过2 种系统化疗后进展或复发的晚期胃腺癌或胃-食管结合部腺癌患者；2.既往接受过至少一线系统性治疗后失败或不可耐受的晚期肝细胞癌患者；3.不可切除或转移性肝细胞癌患者的一线治疗。","162914","甲磺酸阿帕替尼片","艾坦","薄膜衣片","0.375g","盒","10","双铝","江苏恒瑞医药股份有限公司","1427.80","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1418","XL01XEA288A001030201445","2","甲磺酸阿帕替尼片","","限：1.既往至少接受过2 种系统化疗后进展或复发的晚期胃腺癌或胃-食管结合部腺癌患者；2.既往接受过至少一线系统性治疗后失败或不可耐受的晚期肝细胞癌患者；3.不可切除或转移性肝细胞癌患者的一线治疗。","162691","甲磺酸阿帕替尼片","艾坦","薄膜衣片","0.425g","盒","14","铝箔","江苏恒瑞医药股份有限公司","2199.96","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1419","XS01LAK119B023010109681","2","康柏西普眼用注射液","","限:1.50岁以上的湿性年龄相关性黄斑变性(AMD)；2.糖尿病性黄斑水肿(DME)引起的视力损害；3.脉络膜新生血管(CNV)导致的视力损害；4.继发于视网膜静脉阻塞(RVO)(视网膜分支静脉阻塞(BRVO)或视网膜中央静脉阻塞(CRVO)的黄斑水肿引起的视力损伤。/n应同时符合以下条件：1.需三级综合医院眼科或二级及以上眼科专科医院医师处方；2.首次处方时病眼基线矫正视力0.05-0.5；3.事前审查后方可用，初次申请需有血管造影或OCT(全身情况不允许的患者可以提供OCT血管成像)证据；4.每眼累计最多支付9支，第1年度最多支付5支。阿柏西普、雷珠单抗和康柏西普的药品支数合并计算。","155169","康柏西普眼用注射液","朗沐","注射液","0.2ml:2.0mg","支","1","玻璃瓶","成都康弘生物科技有限公司","3452.80","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1420","XS01LAK119B023020109681","2","康柏西普眼用注射液","","限:1.50岁以上的湿性年龄相关性黄斑变性(AMD)；2.糖尿病性黄斑水肿(DME)引起的视力损害；3.脉络膜新生血管(CNV)导致的视力损害；4.继发于视网膜静脉阻塞(RVO)(视网膜分支静脉阻塞(BRVO)或视网膜中央静脉阻塞(CRVO)的黄斑水肿引起的视力损伤。/n应同时符合以下条件：1.需三级综合医院眼科或二级及以上眼科专科医院医师处方；2.首次处方时病眼基线矫正视力0.05-0.5；3.事前审查后方可用，初次申请需有血管造影或OCT(全身情况不允许的患者可以提供OCT血管成像)证据；4.每眼累计最多支付9支，第1年度最多支付5支。阿柏西普、雷珠单抗和康柏西普的药品支数合并计算。","310116","康柏西普眼用注射液","朗沐","眼用注射液","10mg/ml,0.05ml/支(预充式)","盒","1","一次性预充式注射器包装","成都康弘生物科技有限公司","3452.80","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1421","XJ01XXK140A001010104647","2","康替唑胺片","","限对本品敏感的金黄色葡萄球菌(甲氧西林敏感和耐药的菌株)、化脓性链球菌或无乳链球菌引起的复杂性皮肤和软组织感染。","174271","康替唑胺片","优喜泰","薄膜衣片","0.4g","盒","12","铝塑","浙江华海药业股份有限公司","1416.00","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1422","XJ01XXK140A001010204647","2","康替唑胺片","","限对本品敏感的金黄色葡萄球菌(甲氧西林敏感和耐药的菌株)、化脓性链球菌或无乳链球菌引起的复杂性皮肤和软组织感染。","173244","康替唑胺片","优喜泰","薄膜衣片","0.4g","盒","20","铝塑","浙江华海药业股份有限公司","2360.00","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1423","XD11AHK139F001010182999","2","克立硼罗软膏","","限2岁及以上轻度至中度特应性皮炎患者。","171287","克立硼罗软膏","舒坦明","软膏剂","30g:0.6g(2%)","支","1","空","美国Pharmacia & Upjohn Company LLC","158.80","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1424","XG01AFK079D009010103649","2","克霉唑阴道膨胀栓","","限念珠菌性外阴阴道病。","128456","克霉唑阴道膨胀栓","无","栓剂","0.15g","盒","2","塑料壳","哈尔滨田美药业股份有限公司","15.96","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1425","XG01AFK079D009010403649","2","克霉唑阴道膨胀栓","","限念珠菌性外阴阴道病。","174248","克霉唑阴道膨胀栓","无","栓剂","0.15g","盒","4","塑料壳","哈尔滨田美药业股份有限公司","31.92","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1426","XG01AFK079D009010903649","2","克霉唑阴道膨胀栓","","限念珠菌性外阴阴道病。","174604","克霉唑阴道膨胀栓","无","栓剂","0.15g","盒","10","塑料壳","哈尔滨田美药业股份有限公司","79.80","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1427","XJ05ARL390A001010183338","2","拉米夫定多替拉韦片","","限艾滋病病毒感染。","173363","拉米夫定多替拉韦片","无","薄膜衣片","拉米夫定0.3g,多替拉韦钠(以多替拉韦计)50mg","瓶","30","塑料瓶","美国GlaxoSmithKline  LLC","749.40","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1428","XJ05APL372A001010182157","2","来迪派韦索磷布韦片","","限成人和12至<18岁青少年的慢性丙型肝炎病毒(HCV)感染。","165504","来迪派韦索磷布韦片","夏帆宁","薄膜衣片","来迪派韦90mg,索磷布韦0.4g","瓶","28","塑料瓶","爱尔兰Gilead Sciences Ireland UC","2114.00","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1429","XS01LAL328B002010178679","2","雷珠单抗注射液","","限：1.50岁以上的湿性年龄相关性黄斑变性(AMD)；2.糖尿病性黄斑水肿(DME)引起的视力损害；3.脉络膜新生血管(CNV)导致的视力损害；4.继发于视网膜静脉阻塞(RVO)的黄斑水肿引起的视力损害。/n应同时符合以下条件：1.需三级综合医院眼科或二级及以上眼科专科医院医师处方；2.首次处方时病眼基线矫正视力0.05-0.5；3.事前审查后方可用，初次申请需有血管造影或OCT(全身情况不允许的患者可以提供OCT血管成像)证据；4.每眼累计最多支付9支，第1年度最多支付5支。阿柏西普、雷珠单抗和康柏西普的药品支数合并计算。","162662","雷珠单抗注射液","诺适得","注射液","0.165ml:1.65mg","盒","1","预充式(预灌封)注射器","德国Vetter Pharma-Fertigung GmbH & Co.KG","3673.50","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1430","XS01LAL328B002020178679","2","雷珠单抗注射液","","限：1.50岁以上的湿性年龄相关性黄斑变性(AMD)；2.糖尿病性黄斑水肿(DME)引起的视力损害；3.脉络膜新生血管(CNV)导致的视力损害；4.继发于视网膜静脉阻塞(RVO)的黄斑水肿引起的视力损害。/n应同时符合以下条件：1.需三级综合医院眼科或二级及以上眼科专科医院医师处方；2.首次处方时病眼基线矫正视力0.05-0.5；3.事前审查后方可用，初次申请需有血管造影或OCT(全身情况不允许的患者可以提供OCT血管成像)证据；4.每眼累计最多支付9支，第1年度最多支付5支。阿柏西普、雷珠单抗和康柏西普的药品支数合并计算。","147710","雷珠单抗注射液","诺适得","注射液","0.2ml:2mg","盒","1","内附2个针头与1支注射器","瑞士Novartis Pharma Stein AG","3673.50","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1431","XL01XEL356A001010278672","2","磷酸芦可替尼片","","限：1.中危或高危的原发性骨髓纤维化(PMF)(亦称为慢性特发性骨髓纤维化)、真性红细胞增多症继发的骨髓纤维化(PPV-MF)或原发性血小板增多症继发的骨髓纤维化(PET-MF)的成年患者；2.对糖皮质激素或其他系统治疗应答不充分的12岁及以上急性移植物抗宿主病(急性GVHD，aGVHD)患者。","163085","磷酸芦可替尼片","捷恪卫","片剂","5mg","盒","60","PVC/PCTFE-铝泡罩包装","Novartis Pharma Stein AG","3112.20","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1432","XJ05APY326E001010180955","2","磷酸依米他韦胶囊","","限与索磷布韦片联合，用于治疗成人基因1型非肝硬化慢性丙型肝炎。","174257","磷酸依米他韦胶囊","东卫恩","硬胶囊剂","0.1g(以C49H58N8O6计)","盒","28","铝塑","宜昌东阳光长江药业股份有限公司","1736.00","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1433","XL03AAL367B002010101445","2","硫培非格司亭注射液","","限前次化疗曾发生重度中性粒细胞减少的患者。","163442","硫培非格司亭注射液","艾多","注射液","0.6ml:6mg","盒","1","预灌封注射器灌装,氯化丁基橡胶活塞封口","江苏恒瑞医药股份有限公司","2547.78","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1434","XB03XAL373E001010180523","2","罗沙司他胶囊","","限慢性肾脏病(CKD)引起的贫血。","165682","罗沙司他胶囊","爱瑞卓","胶囊剂","20mg","盒","3","铝/铝泡罩","珐博进(中国)医药技术开发有限公司","74.70","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1435","XB03XAL373E001020180523","2","罗沙司他胶囊","","限慢性肾脏病(CKD)引起的贫血。","165671","罗沙司他胶囊","爱瑞卓","胶囊剂","50mg","盒","3","铝/铝泡罩","珐博进(中国)医药技术开发有限公司","150.66","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1436","XN07XXL384E002010183053","2","氯苯唑酸软胶囊","","限成人野生型或遗传型转甲状腺素蛋白淀粉样变性心肌病(ATTR-CM)。","172323","氯苯唑酸软胶囊","维万心","软胶囊(胶丸)","61mg","盒","30","铝塑","美国Catalent Pharma Solutions,LLC.","16260.00","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1437","XL01XEB228A001010101445","2","吡咯替尼","口服常释剂型","限表皮生长因子受体2（HER2）阳性的复发或转移性乳腺癌患者的二线治疗。","163667","马来酸吡咯替尼片","艾瑞妮","薄膜衣片","0.16g","瓶","28","塑料瓶","江苏恒瑞医药股份有限公司","3397.80","停用","招采国码变更","国谈药品"]
["1438","XL01EHB228A001020101445","2","马来酸吡咯替尼片","","限：1.表皮生长因子受体2(HER2)阳性的复发或转移性乳腺癌患者；2.表皮生长因子受体2(HER2)阳性早期或局部晚期乳腺癌患者的新辅助治疗。","163667","马来酸吡咯替尼片","艾瑞妮","薄膜衣片","160mg(按C32H31ClN6O3计)","瓶","28","组合干燥剂塑料瓶","江苏恒瑞医药股份有限公司","3108.84","启用","招采国码变更","国谈药品"]
["1439","XL01XEB228A001020101445","2","吡咯替尼","口服常释剂型","限表皮生长因子受体2（HER2）阳性的复发或转移性乳腺癌患者的二线治疗。","163666","马来酸吡咯替尼片","艾瑞妮","薄膜衣片","80mg","瓶","14","塑料瓶","江苏恒瑞医药股份有限公司","999.32","停用","招采国码变更","国谈药品"]
["1440","XL01EHB228A001010101445","2","马来酸吡咯替尼片","","限：1.表皮生长因子受体2(HER2)阳性的复发或转移性乳腺癌患者；2.表皮生长因子受体2(HER2)阳性早期或局部晚期乳腺癌患者的新辅助治疗。","163666","马来酸吡咯替尼片","艾瑞妮","薄膜衣片","80mg(按C32H31ClN6O3计)","瓶","14","组合干燥剂塑料瓶","江苏恒瑞医药股份有限公司","914.34","启用","招采国码变更","国谈药品"]
["1441","XL01XEB228A001030101445","2","吡咯替尼","口服常释剂型","限表皮生长因子受体2（HER2）阳性的复发或转移性乳腺癌患者的二线治疗。","168994","马来酸吡咯替尼片","艾瑞妮","薄膜衣片","80mg","瓶","100","塑料瓶","江苏恒瑞医药股份有限公司","7138.00","停用","招采国码变更","国谈药品"]
["1442","XL01EHB228A001010201445","2","马来酸吡咯替尼片","","限：1.表皮生长因子受体2(HER2)阳性的复发或转移性乳腺癌患者；2.表皮生长因子受体2(HER2)阳性早期或局部晚期乳腺癌患者的新辅助治疗。","168994","马来酸吡咯替尼片","艾瑞妮","薄膜衣片","80mg(按C32H31ClN6O3计)","瓶","100","组合干燥剂塑料瓶","江苏恒瑞医药股份有限公司","6531.00","启用","招采国码变更","国谈药品"]
["1443","XL01XEN120A001010182949","2","马来酸奈拉替尼片","","限人类表皮生长因子受体2(HER2)阳性的早期乳腺癌成年患者，在接受含曲妥珠单抗辅助治疗之后的强化辅助治疗。","173246","马来酸奈拉替尼片","贺俪安","薄膜衣片","40mg(按C30H29ClN6O3计)","瓶","180","高密度聚乙烯","德国Excella GmbH & Co.KG","6660.00","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1444","XA05BAM076N001010101957","2","门冬氨酸鸟氨酸颗粒","","限因急、慢性肝病如肝硬化、脂肪肝、肝炎所致的高血氨症。","127366","门冬氨酸鸟氨酸颗粒","瑞甘","颗粒剂","3.0g","盒","10","复合膜","武汉启瑞药业有限公司","39.50","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1445","XN05CDM084X001010102000","2","咪达唑仑口服溶液","","限：1.儿童诊断或治疗性操作前以及操作过程中的镇静/抗焦虑/遗忘；2.儿童术前镇静/抗焦虑/遗忘。","174256","咪达唑仑口服溶液","无","口服溶液剂","0.2%(10ml:20mg)","瓶","1","棕色低硼硅玻璃管制口服液体瓶＋口服液体药用氯化丁基橡胶塞","宜昌人福药业有限责任公司","31.00","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1446","XN05CDM084X001010202000","2","咪达唑仑口服溶液","","限：1.儿童诊断或治疗性操作前以及操作过程中的镇静/抗焦虑/遗忘；2.儿童术前镇静/抗焦虑/遗忘。","174278","咪达唑仑口服溶液","无","口服溶液剂","0.2%(10ml:20mg)","瓶","10","棕色低硼硅玻璃管制口服液体瓶＋口服液体药用氯化丁基橡胶塞","宜昌人福药业有限责任公司","310.00","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1447","XL01XCN048B002010107857","2","尼妥珠单抗注射液","","限与放疗联合治疗表皮生长因子受体(EGFR)表达阳性的Ⅲ/Ⅳ期鼻咽癌。","122606","尼妥珠单抗注射液","泰欣生","注射液","50mg/瓶(10mL)","盒","1","硼硅玻璃管制注射剂瓶","百泰生物药业有限公司","1230.00","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1448","XM09AXN115B002010182617","2","诺西那生钠注射液","","限5q脊髓性肌萎缩症。","169446","诺西那生钠注射液","无","注射液","5ml:12mg","瓶","1","玻璃瓶","意大利培森药厂Patheon Italia S.p.A","33180.00","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1449","XL01XKP142E001010182282","2","帕米帕利胶囊","","限既往经过二线及以上化疗的伴有胚系BRCA(gBRCA)突变的复发性晚期卵巢癌、输卵管癌或原发性腹膜癌患者。","172936","帕米帕利胶囊","百汇泽","硬胶囊剂","20mg","瓶","60","塑料瓶","百济神州(苏州)生物科技有限公司","3216.00","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1450","XJ01MBN122B002010107968","2","苹果酸奈诺沙星氯化钠注射液","","限对奈诺沙星呈现敏感的肺炎链球菌、金黄色葡萄球菌、流感嗜血杆菌、副流感嗜血杆菌、卡他莫拉菌、肺炎克雷伯菌、铜绿假单胞菌以及肺炎支原体、肺炎衣原体和嗜肺军团菌所致的成人(≥18岁)社区获得性肺炎。","173436","苹果酸奈诺沙星氯化钠注射液","无","注射液","250ml:苹果酸奈诺沙星(按C20H25N3O4计)0.5g和氯化钠2.25g","袋","1","多层共挤输液袋","浙江医药股份有限公司新昌制药厂","84.80","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1451","XL04AXB245E001010301523","2","泊马度胺胶囊","","限既往接受过至少两种治疗(包括来那度胺和一种蛋白酶体抑制剂)，且在最后一次治疗期间或治疗结束后60天内发生疾病进展的成年多发性骨髓瘤患者。","171494","泊马度胺胶囊","无","硬胶囊剂","1.0mg","盒","21","双铝","正大天晴药业集团股份有限公司","1620.36","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1452","XL04AXB245E001020301523","2","泊马度胺胶囊","","限既往接受过至少两种治疗(包括来那度胺和一种蛋白酶体抑制剂)，且在最后一次治疗期间或治疗结束后60天内发生疾病进展的成年多发性骨髓瘤患者。","171495","泊马度胺胶囊","无","硬胶囊剂","4mg","盒","21","双铝","正大天晴药业集团股份有限公司","4683.00","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1453","XC09DXS255A001010100100","2","沙库巴曲缬沙坦钠片","","限：1.射血分数降低的慢性心力衰竭(NYHA Ⅱ-Ⅳ级，LVEF ≤ 40%)成人患者；2.原发性高血压。","162954","沙库巴曲缬沙坦钠片","诺欣妥","片剂","100mg(49mg/51mg)","盒","14","PVC/PVDC包装","Novartis Pharma Stein AG","42.56","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1454","XC09DXS255A001010181522","2","沙库巴曲缬沙坦钠片","","限：1.射血分数降低的慢性心力衰竭(NYHA Ⅱ-Ⅳ级，LVEF ≤ 40%)成人患者；2.原发性高血压。","205571","沙库巴曲缬沙坦钠片","无","薄膜衣片","100mg(沙库巴曲49mg/缬沙坦51mg)","盒","12","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药品包装用铝箔","江苏宣泰药业有限公司","33.60","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1455","XC09DXS255A001020100100","2","沙库巴曲缬沙坦钠片","","限：1.射血分数降低的慢性心力衰竭(NYHA Ⅱ-Ⅳ级，LVEF ≤ 40%)成人患者；2.原发性高血压。","166621","沙库巴曲缬沙坦钠片","诺欣妥","片剂","50mg(24mg/26mg)","盒","28","PVC/PVDC包装","Novartis Singapore Pharmaceutical Manufacturing Private.Ltd.","50.12","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1456","XC09DXS255A001020181522","2","沙库巴曲缬沙坦钠片","","限：1.射血分数降低的慢性心力衰竭(NYHA Ⅱ-Ⅳ级，LVEF ≤ 40%)成人患者；2.原发性高血压。","205572","沙库巴曲缬沙坦钠片","无","薄膜衣片","200mg(沙库巴曲97mg/缬沙坦103mg)","盒","12","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药品包装用铝箔","江苏宣泰药业有限公司","57.12","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1457","XC09DXS255A001030378679","2","沙库巴曲缬沙坦钠片","","限：1.射血分数降低的慢性心力衰竭(NYHA Ⅱ-Ⅳ级，LVEF ≤ 40%)成人患者；2.原发性高血压。","171728","沙库巴曲缬沙坦钠片","诺欣妥","片剂","以沙库巴曲缬沙坦计200mg(沙库巴曲97mg/缬沙坦103mg)","盒","7","PVC/PVDC包装","Novartis Farma S.p.A","36.12","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1458","XC09DXS255A001050178679","2","沙库巴曲缬沙坦钠片","","限：1.射血分数降低的慢性心力衰竭(NYHA Ⅱ-Ⅳ级，LVEF ≤ 40%)成人患者；2.原发性高血压。","310161","沙库巴曲缬沙坦钠片","诺欣妥","片剂","以沙库巴曲缬沙坦计200mg(沙库巴曲97mg/缬沙坦103mg)","盒","28","PVC/PVDC包装","Novartis Farma S.p.A","144.48","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1459","XN05CCS278K001010201587","2","水合氯醛/糖浆组合包装","","限儿童检查、操作前的镇静、催眠。","174199","水合氯醛/糖浆组合包装","无","糖浆剂","水合氯醛浓缩液1.342g:1.0g/糖浆(稀释液)9ml","瓶","1","玻璃瓶","特丰制药有限公司","42.68","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1460","XB01ACS270A001010178189","2","司来帕格片","","限WHO功能分级II级-III级的肺动脉高压(WHO第1组)的患者。","166535","司来帕格片","优拓比","薄膜衣片","0.2mg","盒","60","聚酰胺/铝/高密度聚乙烯/聚乙烯加嵌入式干燥剂/以铝箔密封的高密度聚乙烯泡罩包装","Excella GmbH & Co. KG","2821.80","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1461","XB01ACS270A001010278189","2","司来帕格片","","限WHO功能分级II级-III级的肺动脉高压(WHO第1组)的患者。","166534","司来帕格片","优拓比","薄膜衣片","0.2mg","盒","140","聚酰胺/铝/高密度聚乙烯/聚乙烯加嵌入式干燥剂/以铝箔密封的高密度聚乙烯泡罩包装","Excella GmbH & Co. KG","6584.20","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1462","XB01ACS270A001020178189","2","司来帕格片","","限WHO功能分级II级-III级的肺动脉高压(WHO第1组)的患者。","166536","司来帕格片","优拓比","薄膜衣片","0.6mg","盒","60","聚酰胺/铝/高密度聚乙烯/聚乙烯加嵌入式干燥剂/以铝箔密封的高密度聚乙烯泡罩包装","Excella GmbH & Co. KG","6542.40","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1463","XB01ACS270A001030178189","2","司来帕格片","","限WHO功能分级II级-III级的肺动脉高压(WHO第1组)的患者。","166537","司来帕格片","优拓比","薄膜衣片","0.8mg","盒","60","聚酰胺/铝/高密度聚乙烯/聚乙烯加嵌入式干燥剂/以铝箔密封的高密度聚乙烯泡罩包装","Excella GmbH & Co. KG","8154.00","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1464","XA10BJS279B002010283568","2","司美格鲁肽注射液","","限：1.成人2型糖尿病患者的血糖控制：在饮食控制和运动基础上，接受二甲双胍和/或磺脲类药物治疗血糖仍控制不佳的成人2型糖尿病患者；2.降低伴有心血管疾病的2型糖尿病成人患者的主要心血管不良事件(心血管死亡、非致死性心肌梗死或非致死性卒中)风险。","173852","司美格鲁肽注射液","诺和泰","注射剂","1.34mg/ml,1.5ml(预填充注射笔)","盒","1","笔芯由1型玻璃制成,橡胶活塞(氯化丁基橡胶)、橡胶垫片(溴化丁基/聚异戊二烯)铝盖组成。注射笔由聚丙烯、聚甲醛、聚碳酸酯和丙烯腈-丁二烯苯乙烯组成","Novo Nordisk A/S","421.34","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1465","XA10BJS279B002020283568","2","司美格鲁肽注射液","","限：1.成人2型糖尿病患者的血糖控制：在饮食控制和运动基础上，接受二甲双胍和/或磺脲类药物治疗血糖仍控制不佳的成人2型糖尿病患者；2.降低伴有心血管疾病的2型糖尿病成人患者的主要心血管不良事件(心血管死亡、非致死性心肌梗死或非致死性卒中)风险。","174129","司美格鲁肽注射液","诺和泰","注射剂","1.34mg/ml,3ml(预填充注射笔)","盒","1","笔芯由1型玻璃制成,笔芯的一端由橡胶活塞(氯化丁基橡胶)封闭,另一端插入带有橡胶垫片(溴化丁基/聚异戊二烯)的铝盖。该注射笔由聚丙烯、聚甲醛、聚碳酸酯和丙烯腈-丁二烯苯乙烯组成","Novo Nordisk A/S","716.28","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1466","XL01EKS277E001010110171","2","索凡替尼胶囊","","限无法手术切除的局部晚期或转移性、进展期非功能性、分化良好(G1、G2)的胰腺和非胰腺来源的神经内分泌瘤。","171949","索凡替尼胶囊","苏泰达/SULANDA","胶囊剂","50mg","盒","42","铝塑","和记黄埔医药(苏州)有限公司","2035.32","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1467","XJ05APS268A001010182157","2","索磷布韦维帕他韦片","","限成人慢性丙型肝炎病毒(HCV)感染。","163520","索磷布韦维帕他韦片","丙通沙","薄膜衣片","索磷布韦0.4g,维帕他韦0.1g","瓶","28","塑料瓶","爱尔兰Gilead Sciences Ireland UC","3290.00","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1468","XJ05APS275A001010182156","2","索磷维伏片","","限既往接受过含直接抗病毒药物(DAA)方案、无肝硬化或伴代偿性肝硬化(Child-Pugh A)的成人慢性丙型肝炎病毒(HCV)感染。","171285","索磷维伏片","沃士韦","薄膜衣片","索磷布韦0.4g,维帕他韦0.1g和伏西瑞韦0.1g","瓶","28","塑料瓶","爱尔兰Gilead Sciences Ireland UC","7252.00","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1469","XL01XCT181B002010181823","2","特瑞普利单抗注射液","","限：1.既往接受全身系统治疗失败的不可切除或转移性黑色素瘤的治疗；2.含铂化疗失败包括新辅助或辅助化疗12个月内进展的局部晚期或转移性尿路上皮癌的治疗；3.既往接受过二线及以上系统治疗失败的复发/转移性鼻咽癌患者的治疗；4.局部复发或转移性鼻咽癌患者的一线治疗；5.不可切除局部晚期/复发或转移性食管鳞癌的一线治疗；6.表皮生长因子受体(EGFR)基因突变阴性和间变性淋巴瘤激酶(ALK)阴性、不可手术切除的局部晚期或转移性非鳞状非小细胞肺癌(NSCLC)的一线治疗。","165280","特瑞普利单抗注射液","拓益","注射液","240mg(6ml)/瓶","盒","1","中硼硅玻璃管制注射剂瓶,注射液用覆聚乙烯-四氟乙烯膜氯化丁基橡胶塞","上海君实生物工程有限公司","1884.86","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1470","XL01XCT181B002020181823","2","特瑞普利单抗注射液","","限：1.既往接受全身系统治疗失败的不可切除或转移性黑色素瘤的治疗；2.含铂化疗失败包括新辅助或辅助化疗12个月内进展的局部晚期或转移性尿路上皮癌的治疗；3.既往接受过二线及以上系统治疗失败的复发/转移性鼻咽癌患者的治疗；4.局部复发或转移性鼻咽癌患者的一线治疗；5.不可切除局部晚期/复发或转移性食管鳞癌的一线治疗；6.表皮生长因子受体(EGFR)基因突变阴性和间变性淋巴瘤激酶(ALK)阴性、不可手术切除的局部晚期或转移性非鳞状非小细胞肺癌(NSCLC)的一线治疗。","171735","特瑞普利单抗注射液","拓益","注射液","80mg(2ml)/瓶","盒","1","中硼硅玻璃管制注射剂瓶,注射液用覆聚乙烯-四氟乙烯膜氯化丁基橡胶塞","上海君实生物工程有限公司","812.88","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1471","XL01XCT190B002010182097","2","替雷利珠单抗注射液","","限：1.至少经过二线系统化疗的复发或难治性经典型霍奇金淋巴瘤的治疗；2.PD-L1高表达的含铂化疗失败包括新辅助或辅助化疗12个月内进展的局部晚期或转移性尿路上皮癌的治疗；3.不可手术切除的局部晚期或转移性鳞状非小细胞肺癌的一线治疗；4.表皮生长因子受体(EGFR)基因突变阴性和间变性淋巴瘤激酶(ALK)阴性、不可手术切除的局部晚期或转移性非鳞状非小细胞肺癌的一线治疗；5.表皮生长因子受体(EGFR)基因突变阴性和间变性淋巴瘤激酶(ALK)阴性、既往接受过含铂方案化疗后疾病进展或不可耐受的局部晚期或转移性非鳞状非小细胞肺癌(NSCLC)成人患者，以及EGFR和ALK阴性或未知的，既往接受过含铂方案化疗后疾病进展或不可耐受的局部晚期或转移性鳞状NSCLC成人患者；6.至少经过一种全身治疗的肝细胞癌的治疗；7.不可切除或转移性微卫星高度不稳定型(MSI-H) 或错配修复基因缺陷型(dMMR)的成人晚期实体瘤患者：既往经过氟尿嘧啶类、奥沙利铂和伊立替康治疗后出现疾病进展的晚期结直肠癌患者；既往治疗后出现疾病进展且无满意替代治疗方案的其他晚期实体瘤患者；8.既往接受过一线标准化疗后进展或不可耐受的局部晚期或转移性食管鳞状细胞癌的治疗；9.复发或转移性鼻咽癌的一线治疗；10.PD-L1高表达的局部晚期不可切除的或转移性的胃或胃食管结合部腺癌的一线治疗；11.不可切除的局部晚期、复发或转移性食管鳞状细胞癌的一线治疗。","169149","替雷利珠单抗注射液","百泽安","注射剂","10ml:100mg","盒","1","西林瓶","广州百济神州生物制药有限公司","1253.53","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1472","XR03ALW115L031010178453","2","乌美溴铵维兰特罗吸入粉雾剂","","限慢性阻塞性肺病(COPD)。","163516","乌美溴铵维兰特罗吸入粉雾剂","欧乐欣","吸入粉雾剂","62.5μg(以乌美铵计),25μg(以维兰特罗计),30吸","盒","1","空","英国Glaxo 0perations UK Ltd","219.00","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1473","XL04ACW114B002010178537","2","乌司奴单抗注射液","","限：1.对环孢素、甲氨喋呤(MTX)等其他系统性治疗或PUVA(补骨脂素和紫外线A)不应答、有禁忌或无法耐受的成年中重度斑块状银屑病患者；2.对其他系统性治疗或光疗应答不足或无法耐受的6岁及以上儿童和青少年(体重60公斤至100公斤)中重度斑块状银屑病患者；3.对传统治疗或肿瘤坏死因子α(TNFα)拮抗剂应答不足、失应答或无法耐受的成年中重度活动性克罗恩病患者。","165659","乌司奴单抗注射液","喜达诺","注射剂","45mg/0.5ml/支","盒","1","本品存放于 1ml 的 I 型玻璃注射器内,并配备固定的不锈钢针头,以及含 干燥天然橡胶(一种乳胶衍生物)的针头保护帽。此注射器配备有被动防护装 置。本品每个包装中含有 1 支预充式注射器。","Cilag AG","4015.74","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1474","XL04ACW114B002020178537","2","乌司奴单抗注射液","","限：1.对环孢素、甲氨喋呤(MTX)等其他系统性治疗或PUVA(补骨脂素和紫外线A)不应答、有禁忌或无法耐受的成年中重度斑块状银屑病患者；2.对其他系统性治疗或光疗应答不足或无法耐受的6岁及以上儿童和青少年(体重60公斤至100公斤)中重度斑块状银屑病患者；3.对传统治疗或肿瘤坏死因子α(TNFα)拮抗剂应答不足、失应答或无法耐受的成年中重度活动性克罗恩病患者。","170012","乌司奴单抗注射液","喜达诺","注射液","90mg/1.0ml/支","盒","1","本品存放于 1ml 的 I 型玻璃注射器内,并配备固定的不锈钢针头,以及含 干燥天然橡胶(一种乳胶衍生物)的针头保护帽。此注射器配备有被动防护装 置。本品每个包装中含有 1 支预充式注射器。","Cilag AG","6826.76","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1475","XL04ACW114B002030178537","2","乌司奴单抗注射液(静脉输注)","","限对传统治疗或肿瘤坏死因子α(TNF-α)拮抗剂应答不足、失应答或无法耐受的成年中重度活动性克罗恩病患者。","169645","乌司奴单抗注射液(静脉输注)","喜达诺","注射剂","130mg/26ml/瓶","盒","1","一次性（I型）玻璃瓶装","Cilag AG","2151.55","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1476","XL01XXX228A001010109758","2","西达本胺片","","限既往至少接受过一次全身化疗的复发或难治的外周T细胞淋巴瘤(PTCL)患者。","162910","西达本胺片","爱谱沙","片剂","5mg","盒","24","双铝泡罩包装","深圳微芯生物科技股份有限公司","7738.08","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1477","XL01FFX242B002010181451","2","信迪利单抗注射液","","限：1.至少经过二线系统化疗的复发或难治性经典型霍奇金淋巴瘤的治疗；2.非鳞状非小细胞肺癌：(1)表皮生长因子受体(EGFR)基因突变阴性和间变性淋巴瘤激酶(ALK)阴性、不可手术切除的局部晚期或转移性非鳞状非小细胞肺癌(NSCLC)的一线治疗；(2)表皮生长因子受体酪氨酸激酶抑制剂(EGFR-TKI)治疗失败的EGFR 基因突变阳性的局部晚期或转移性非鳞状非小细胞肺癌(NSCLC)患者的治疗；3.不可手术切除的局部晚期或转移性鳞状非小细胞肺癌(NSCLC)的一线治疗；4.既往未接受过系统治疗的不可切除或转移性肝细胞癌的一线治疗；5.不可切除的局部晚期、复发或转移性食管鳞癌的一线治疗；6.不可切除的局部晚期、复发或转移性胃及胃食管交界处腺癌的一线治疗。","165207","信迪利单抗注射液","达伯舒","注射液","100mg(10ml)","盒","1","玻璃瓶","信达生物制药(苏州)有限公司","1080.00","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1478","XL01XEA314E001010182435","2","盐酸阿来替尼胶囊","","限间变性淋巴瘤激酶(ALK)阳性的局部晚期或转移性非小细胞肺癌患者。","165183","盐酸阿来替尼胶囊","安圣莎","胶囊剂","150mg(按C30H34N4O2计)","盒","224","双铝泡罩包装","Excella GmbH & Co. KG,Chugai Pharma Manufacturing Co., Ltd.","12745.60","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1479","XL01XEA274A001010104611","2","盐酸埃克替尼片","","限：1.表皮生长因子受体(EGFR)基因具有敏感突变的局部晚期或转移性非小细胞肺癌(NSCLC)患者的一线治疗；2.既往接受过至少一个化疗方案失败后的局部晚期或转移性非小细胞肺癌(NSCLC)；3.II-IIIA期伴有表皮生长因子受体(EGFR)基因敏感突变非小细胞肺癌(NSCLC)术后辅助治疗。","135644","盐酸埃克替尼片","凯美纳","片剂","125mg","盒","21","铝塑铝包装","贝达药业股份有限公司","760.62","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1480","XL01XEA309E001010101523","2","盐酸安罗替尼胶囊","","限：1.用于既往至少接受过2种系统化疗后出现进展或复发的局部晚期或转移性非小细胞肺癌患者的治疗；对于存在表皮生长因子受体(EGFR)基因突变或间变性淋巴瘤激酶(ALK)阳性的患者，在开始盐酸安罗替尼胶囊治疗前应接受相应的标准靶向药物治疗后进展、且至少接受过2种系统化疗后出现进展或复发；2.用于腺泡状软组织肉瘤、透明细胞肉瘤以及既往至少接受过含蒽环类化疗方案治疗后进展或复发的其他晚期软组织肉瘤患者的治疗；3.用于既往至少接受过2种化疗方案治疗后进展或复发的小细胞肺癌患者的治疗；4.用于具有临床症状或明确疾病进展的、不可切除的局部晚期或转移性甲状腺髓样癌患者的治疗。","163301","盐酸安罗替尼胶囊","福可维","硬胶囊剂","10mg","盒","7","铝箔","正大天晴药业集团股份有限公司","1785.00","停用","招采国码变更","国谈药品"]
["1481","XL01EKA309E001020101523","2","盐酸安罗替尼胶囊","","限：1.既往至少接受过2种系统化疗后出现进展或复发的局部晚期或转移性非小细胞肺癌患者的治疗。对于存在表皮生长因子受体(EGFR)基因突变或间变性淋巴瘤激酶(ALK)阳性的患者，在开始本品治疗前应接受相应的标准靶向药物治疗后进展、且至少接受过2种系统化疗后出现进展或复发；2.腺泡状软组织肉瘤、透明细胞肉瘤以及既往至少接受过含蒽环类化疗方案治疗后进展或复发的其他晚期软组织肉瘤患者的治疗；3.既往至少接受过2种化疗方案治疗后进展或复发的小细胞肺癌患者的治疗；4.具有临床症状或明确疾病进展的、不可切除的局部晚期或转移性甲状腺髓样癌患者的治疗；5.进展性、局部晚期或转移性放射性碘难治性分化型甲状腺癌患者。","163301","盐酸安罗替尼胶囊","福可维","胶囊剂","10mg","盒","7","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药用铝箔包装","正大天晴药业集团股份有限公司","1725.99","启用","招采国码变更","国谈药品"]
["1482","XL01XEA309E001010201523","2","盐酸安罗替尼胶囊","","限：1.用于既往至少接受过2种系统化疗后出现进展或复发的局部晚期或转移性非小细胞肺癌患者的治疗；对于存在表皮生长因子受体(EGFR)基因突变或间变性淋巴瘤激酶(ALK)阳性的患者，在开始盐酸安罗替尼胶囊治疗前应接受相应的标准靶向药物治疗后进展、且至少接受过2种系统化疗后出现进展或复发；2.用于腺泡状软组织肉瘤、透明细胞肉瘤以及既往至少接受过含蒽环类化疗方案治疗后进展或复发的其他晚期软组织肉瘤患者的治疗；3.用于既往至少接受过2种化疗方案治疗后进展或复发的小细胞肺癌患者的治疗；4.用于具有临床症状或明确疾病进展的、不可切除的局部晚期或转移性甲状腺髓样癌患者的治疗。","310025","盐酸安罗替尼胶囊","福可维","胶囊剂","10mg","盒","14","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药用铝箔包装","正大天晴药业集团股份有限公司","3570.00","停用","招采国码变更","国谈药品"]
["1483","XL01EKA309E001020201523","2","盐酸安罗替尼胶囊","","限：1.既往至少接受过2种系统化疗后出现进展或复发的局部晚期或转移性非小细胞肺癌患者的治疗。对于存在表皮生长因子受体(EGFR)基因突变或间变性淋巴瘤激酶(ALK)阳性的患者，在开始本品治疗前应接受相应的标准靶向药物治疗后进展、且至少接受过2种系统化疗后出现进展或复发；2.腺泡状软组织肉瘤、透明细胞肉瘤以及既往至少接受过含蒽环类化疗方案治疗后进展或复发的其他晚期软组织肉瘤患者的治疗；3.既往至少接受过2种化疗方案治疗后进展或复发的小细胞肺癌患者的治疗；4.具有临床症状或明确疾病进展的、不可切除的局部晚期或转移性甲状腺髓样癌患者的治疗；5.进展性、局部晚期或转移性放射性碘难治性分化型甲状腺癌患者。","310025","盐酸安罗替尼胶囊","福可维","胶囊剂","10mg","盒","14","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药用铝箔包装","正大天晴药业集团股份有限公司","3451.98","启用","招采国码变更","国谈药品"]
["1484","XL01XEA309E001010301523","2","盐酸安罗替尼胶囊","","限：1.用于既往至少接受过2种系统化疗后出现进展或复发的局部晚期或转移性非小细胞肺癌患者的治疗；对于存在表皮生长因子受体(EGFR)基因突变或间变性淋巴瘤激酶(ALK)阳性的患者，在开始盐酸安罗替尼胶囊治疗前应接受相应的标准靶向药物治疗后进展、且至少接受过2种系统化疗后出现进展或复发；2.用于腺泡状软组织肉瘤、透明细胞肉瘤以及既往至少接受过含蒽环类化疗方案治疗后进展或复发的其他晚期软组织肉瘤患者的治疗；3.用于既往至少接受过2种化疗方案治疗后进展或复发的小细胞肺癌患者的治疗；4.用于具有临床症状或明确疾病进展的、不可切除的局部晚期或转移性甲状腺髓样癌患者的治疗。","310026","盐酸安罗替尼胶囊","福可维","胶囊剂","10mg","盒","28","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药用铝箔包装","正大天晴药业集团股份有限公司","7140.00","停用","招采国码变更","国谈药品"]
["1485","XL01EKA309E001020301523","2","盐酸安罗替尼胶囊","","限：1.既往至少接受过2种系统化疗后出现进展或复发的局部晚期或转移性非小细胞肺癌患者的治疗。对于存在表皮生长因子受体(EGFR)基因突变或间变性淋巴瘤激酶(ALK)阳性的患者，在开始本品治疗前应接受相应的标准靶向药物治疗后进展、且至少接受过2种系统化疗后出现进展或复发；2.腺泡状软组织肉瘤、透明细胞肉瘤以及既往至少接受过含蒽环类化疗方案治疗后进展或复发的其他晚期软组织肉瘤患者的治疗；3.既往至少接受过2种化疗方案治疗后进展或复发的小细胞肺癌患者的治疗；4.具有临床症状或明确疾病进展的、不可切除的局部晚期或转移性甲状腺髓样癌患者的治疗；5.进展性、局部晚期或转移性放射性碘难治性分化型甲状腺癌患者。","310026","盐酸安罗替尼胶囊","福可维","胶囊剂","10mg","盒","28","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药用铝箔包装","正大天晴药业集团股份有限公司","6903.96","启用","招采国码变更","国谈药品"]
["1486","XL01XEA309E001020101523","2","安罗替尼","口服常释剂型","限：1.用于既往至少接受过2种系统化疗后出现进展或复发的局部晚期或转移性非小细胞肺癌患者的治疗。对于存在表皮生长因子受体（EGFR）基因突变或间变性淋巴瘤激酶（ALK）阳性的患者，在开始盐酸安罗替尼胶囊治疗前应接受相应的标准靶向药物治疗后进展、且至少接受过2种系统化疗后出现进展或复发。2.用于腺泡状软组织肉瘤、透明细胞肉瘤以及既往至少接受过含蒽环类化疗方案治疗后进展或复发的其他晚期软组织肉瘤患者的治疗。3.用于既往至少接受过2种化疗方案治疗后进展或复发的小细胞肺癌患者的治疗。该适应症是基于一项包括119例既往至少接受过2种化疗方案资料后进展或复发的小细胞肺癌患者的II期临床试验的结果给予的附条件批准。该适应症的完全批准将取决于正在进行的确证性试验证实本品在该人群的临床获益。4.用于具有临床症状或明确疾病进展的、不可切除的局部晚期或转移性甲状腺髓样癌患者的治疗。该适应症是基于一项包括91例晚期甲状腺髓样癌的IIB期临床试验结果给予的附条件批准。该适应症的完全批准将取决于正在进行的确证性试验证实本品在该人群的临床获益。","163302","盐酸安罗替尼胶囊","福可维","硬胶囊剂","12mg","盒","7","铝箔","正大天晴药业集团股份有限公司","2052.40","停用","招采国码变更","国谈药品"]
["1487","XL01EKA309E001030101523","2","盐酸安罗替尼胶囊","","限：1.既往至少接受过2种系统化疗后出现进展或复发的局部晚期或转移性非小细胞肺癌患者的治疗。对于存在表皮生长因子受体(EGFR)基因突变或间变性淋巴瘤激酶(ALK)阳性的患者，在开始本品治疗前应接受相应的标准靶向药物治疗后进展、且至少接受过2种系统化疗后出现进展或复发；2.腺泡状软组织肉瘤、透明细胞肉瘤以及既往至少接受过含蒽环类化疗方案治疗后进展或复发的其他晚期软组织肉瘤患者的治疗；3.既往至少接受过2种化疗方案治疗后进展或复发的小细胞肺癌患者的治疗；4.具有临床症状或明确疾病进展的、不可切除的局部晚期或转移性甲状腺髓样癌患者的治疗；5.进展性、局部晚期或转移性放射性碘难治性分化型甲状腺癌患者。","163302","盐酸安罗替尼胶囊","福可维","胶囊剂","12mg","盒","7","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药用铝箔包装","正大天晴药业集团股份有限公司","1984.50","启用","招采国码变更","国谈药品"]
["1488","XL01XEA309E001020201523","2","盐酸安罗替尼胶囊","","限：1.用于既往至少接受过2种系统化疗后出现进展或复发的局部晚期或转移性非小细胞肺癌患者的治疗；对于存在表皮生长因子受体(EGFR)基因突变或间变性淋巴瘤激酶(ALK)阳性的患者，在开始盐酸安罗替尼胶囊治疗前应接受相应的标准靶向药物治疗后进展、且至少接受过2种系统化疗后出现进展或复发；2.用于腺泡状软组织肉瘤、透明细胞肉瘤以及既往至少接受过含蒽环类化疗方案治疗后进展或复发的其他晚期软组织肉瘤患者的治疗；3.用于既往至少接受过2种化疗方案治疗后进展或复发的小细胞肺癌患者的治疗；4.用于具有临床症状或明确疾病进展的、不可切除的局部晚期或转移性甲状腺髓样癌患者的治疗。","310027","盐酸安罗替尼胶囊","福可维","胶囊剂","12mg","盒","14","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药用铝箔包装","正大天晴药业集团股份有限公司","4104.80","停用","招采国码变更","国谈药品"]
["1489","XL01EKA309E001030201523","2","盐酸安罗替尼胶囊","","限：1.既往至少接受过2种系统化疗后出现进展或复发的局部晚期或转移性非小细胞肺癌患者的治疗。对于存在表皮生长因子受体(EGFR)基因突变或间变性淋巴瘤激酶(ALK)阳性的患者，在开始本品治疗前应接受相应的标准靶向药物治疗后进展、且至少接受过2种系统化疗后出现进展或复发；2.腺泡状软组织肉瘤、透明细胞肉瘤以及既往至少接受过含蒽环类化疗方案治疗后进展或复发的其他晚期软组织肉瘤患者的治疗；3.既往至少接受过2种化疗方案治疗后进展或复发的小细胞肺癌患者的治疗；4.具有临床症状或明确疾病进展的、不可切除的局部晚期或转移性甲状腺髓样癌患者的治疗；5.进展性、局部晚期或转移性放射性碘难治性分化型甲状腺癌患者。","310027","盐酸安罗替尼胶囊","福可维","胶囊剂","12mg","盒","14","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药用铝箔包装","正大天晴药业集团股份有限公司","3969.00","启用","招采国码变更","国谈药品"]
["1490","XL01XEA309E001020301523","2","盐酸安罗替尼胶囊","","限：1.用于既往至少接受过2种系统化疗后出现进展或复发的局部晚期或转移性非小细胞肺癌患者的治疗；对于存在表皮生长因子受体(EGFR)基因突变或间变性淋巴瘤激酶(ALK)阳性的患者，在开始盐酸安罗替尼胶囊治疗前应接受相应的标准靶向药物治疗后进展、且至少接受过2种系统化疗后出现进展或复发；2.用于腺泡状软组织肉瘤、透明细胞肉瘤以及既往至少接受过含蒽环类化疗方案治疗后进展或复发的其他晚期软组织肉瘤患者的治疗；3.用于既往至少接受过2种化疗方案治疗后进展或复发的小细胞肺癌患者的治疗；4.用于具有临床症状或明确疾病进展的、不可切除的局部晚期或转移性甲状腺髓样癌患者的治疗。","310028","盐酸安罗替尼胶囊","福可维","胶囊剂","12mg","盒","28","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药用铝箔包装","正大天晴药业集团股份有限公司","8209.60","停用","招采国码变更","国谈药品"]
["1491","XL01EKA309E001030301523","2","盐酸安罗替尼胶囊","","限：1.既往至少接受过2种系统化疗后出现进展或复发的局部晚期或转移性非小细胞肺癌患者的治疗。对于存在表皮生长因子受体(EGFR)基因突变或间变性淋巴瘤激酶(ALK)阳性的患者，在开始本品治疗前应接受相应的标准靶向药物治疗后进展、且至少接受过2种系统化疗后出现进展或复发；2.腺泡状软组织肉瘤、透明细胞肉瘤以及既往至少接受过含蒽环类化疗方案治疗后进展或复发的其他晚期软组织肉瘤患者的治疗；3.既往至少接受过2种化疗方案治疗后进展或复发的小细胞肺癌患者的治疗；4.具有临床症状或明确疾病进展的、不可切除的局部晚期或转移性甲状腺髓样癌患者的治疗；5.进展性、局部晚期或转移性放射性碘难治性分化型甲状腺癌患者。","310028","盐酸安罗替尼胶囊","福可维","胶囊剂","12mg","盒","28","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药用铝箔包装","正大天晴药业集团股份有限公司","7938.00","启用","招采国码变更","国谈药品"]
["1492","XL01XEA309E001030101523","2","安罗替尼","口服常释剂型","限：1.用于既往至少接受过2种系统化疗后出现进展或复发的局部晚期或转移性非小细胞肺癌患者的治疗。对于存在表皮生长因子受体（EGFR）基因突变或间变性淋巴瘤激酶（ALK）阳性的患者，在开始盐酸安罗替尼胶囊治疗前应接受相应的标准靶向药物治疗后进展、且至少接受过2种系统化疗后出现进展或复发。2.用于腺泡状软组织肉瘤、透明细胞肉瘤以及既往至少接受过含蒽环类化疗方案治疗后进展或复发的其他晚期软组织肉瘤患者的治疗。3.用于既往至少接受过2种化疗方案治疗后进展或复发的小细胞肺癌患者的治疗。该适应症是基于一项包括119例既往至少接受过2种化疗方案资料后进展或复发的小细胞肺癌患者的II期临床试验的结果给予的附条件批准。该适应症的完全批准将取决于正在进行的确证性试验证实本品在该人群的临床获益。4.用于具有临床症状或明确疾病进展的、不可切除的局部晚期或转移性甲状腺髓样癌患者的治疗。该适应症是基于一项包括91例晚期甲状腺髓样癌的IIB期临床试验结果给予的附条件批准。该适应症的完全批准将取决于正在进行的确证性试验证实本品在该人群的临床获益。","163300","盐酸安罗替尼胶囊","福可维","硬胶囊剂","8mg","盒","7","铝箔","正大天晴药业集团股份有限公司","1504.72","停用","招采国码变更","国谈药品"]
["1493","XL01EKA309E001010101523","2","盐酸安罗替尼胶囊","","限：1.既往至少接受过2种系统化疗后出现进展或复发的局部晚期或转移性非小细胞肺癌患者的治疗。对于存在表皮生长因子受体(EGFR)基因突变或间变性淋巴瘤激酶(ALK)阳性的患者，在开始本品治疗前应接受相应的标准靶向药物治疗后进展、且至少接受过2种系统化疗后出现进展或复发；2.腺泡状软组织肉瘤、透明细胞肉瘤以及既往至少接受过含蒽环类化疗方案治疗后进展或复发的其他晚期软组织肉瘤患者的治疗；3.既往至少接受过2种化疗方案治疗后进展或复发的小细胞肺癌患者的治疗；4.具有临床症状或明确疾病进展的、不可切除的局部晚期或转移性甲状腺髓样癌患者的治疗；5.进展性、局部晚期或转移性放射性碘难治性分化型甲状腺癌患者。","163300","盐酸安罗替尼胶囊","福可维","胶囊剂","8mg","盒","7","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药用铝箔包装","正大天晴药业集团股份有限公司","1454.95","启用","招采国码变更","国谈药品"]
["1494","XL01XEA309E001030201523","2","盐酸安罗替尼胶囊","","限：1.用于既往至少接受过2种系统化疗后出现进展或复发的局部晚期或转移性非小细胞肺癌患者的治疗；对于存在表皮生长因子受体(EGFR)基因突变或间变性淋巴瘤激酶(ALK)阳性的患者，在开始盐酸安罗替尼胶囊治疗前应接受相应的标准靶向药物治疗后进展、且至少接受过2种系统化疗后出现进展或复发；2.用于腺泡状软组织肉瘤、透明细胞肉瘤以及既往至少接受过含蒽环类化疗方案治疗后进展或复发的其他晚期软组织肉瘤患者的治疗；3.用于既往至少接受过2种化疗方案治疗后进展或复发的小细胞肺癌患者的治疗；4.用于具有临床症状或明确疾病进展的、不可切除的局部晚期或转移性甲状腺髓样癌患者的治疗。","310030","盐酸安罗替尼胶囊","福可维","胶囊剂","8mg","盒","14","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药用铝箔包装","正大天晴药业集团股份有限公司","3009.44","停用","招采国码变更","国谈药品"]
["1495","XL01EKA309E001010201523","2","盐酸安罗替尼胶囊","","限：1.既往至少接受过2种系统化疗后出现进展或复发的局部晚期或转移性非小细胞肺癌患者的治疗。对于存在表皮生长因子受体(EGFR)基因突变或间变性淋巴瘤激酶(ALK)阳性的患者，在开始本品治疗前应接受相应的标准靶向药物治疗后进展、且至少接受过2种系统化疗后出现进展或复发；2.腺泡状软组织肉瘤、透明细胞肉瘤以及既往至少接受过含蒽环类化疗方案治疗后进展或复发的其他晚期软组织肉瘤患者的治疗；3.既往至少接受过2种化疗方案治疗后进展或复发的小细胞肺癌患者的治疗；4.具有临床症状或明确疾病进展的、不可切除的局部晚期或转移性甲状腺髓样癌患者的治疗；5.进展性、局部晚期或转移性放射性碘难治性分化型甲状腺癌患者。","310030","盐酸安罗替尼胶囊","福可维","胶囊剂","8mg","盒","14","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药用铝箔包装","正大天晴药业集团股份有限公司","2909.90","启用","招采国码变更","国谈药品"]
["1496","XL01XEA309E001030301523","2","盐酸安罗替尼胶囊","","限：1.用于既往至少接受过2种系统化疗后出现进展或复发的局部晚期或转移性非小细胞肺癌患者的治疗；对于存在表皮生长因子受体(EGFR)基因突变或间变性淋巴瘤激酶(ALK)阳性的患者，在开始盐酸安罗替尼胶囊治疗前应接受相应的标准靶向药物治疗后进展、且至少接受过2种系统化疗后出现进展或复发；2.用于腺泡状软组织肉瘤、透明细胞肉瘤以及既往至少接受过含蒽环类化疗方案治疗后进展或复发的其他晚期软组织肉瘤患者的治疗；3.用于既往至少接受过2种化疗方案治疗后进展或复发的小细胞肺癌患者的治疗；4.用于具有临床症状或明确疾病进展的、不可切除的局部晚期或转移性甲状腺髓样癌患者的治疗。","310024","盐酸安罗替尼胶囊","福可维","胶囊剂","8mg","盒","28","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药用铝箔包装","正大天晴药业集团股份有限公司","6018.88","停用","招采国码变更","国谈药品"]
["1497","XL01EKA309E001010301523","2","盐酸安罗替尼胶囊","","限：1.既往至少接受过2种系统化疗后出现进展或复发的局部晚期或转移性非小细胞肺癌患者的治疗。对于存在表皮生长因子受体(EGFR)基因突变或间变性淋巴瘤激酶(ALK)阳性的患者，在开始本品治疗前应接受相应的标准靶向药物治疗后进展、且至少接受过2种系统化疗后出现进展或复发；2.腺泡状软组织肉瘤、透明细胞肉瘤以及既往至少接受过含蒽环类化疗方案治疗后进展或复发的其他晚期软组织肉瘤患者的治疗；3.既往至少接受过2种化疗方案治疗后进展或复发的小细胞肺癌患者的治疗；4.具有临床症状或明确疾病进展的、不可切除的局部晚期或转移性甲状腺髓样癌患者的治疗；5.进展性、局部晚期或转移性放射性碘难治性分化型甲状腺癌患者。","310024","盐酸安罗替尼胶囊","福可维","胶囊剂","8mg","盒","28","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药用铝箔包装","正大天晴药业集团股份有限公司","5819.80","启用","招采国码变更","国谈药品"]
["1498","XJ05APL382A001010181008","2","盐酸拉维达韦片","","限初治的基因1b型慢性丙型肝炎病毒感染的非肝硬化成人患者。","171051","盐酸拉维达韦片","新力莱","薄膜衣片","0.2g","瓶","14","塑料瓶","歌礼药业(浙江)有限公司","715.68","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1499","XC10AXY310B002010178217","2","依洛尤单抗注射液","","限：1.降低心血管事件的风险：在已有动脉粥样硬化性心血管疾病的成人患者中，降低心肌梗死、卒中以及冠脉血运重建的风险。通过：与最大耐受剂量的他汀类药物联合用药，伴随或不伴随其他降脂疗法，或者在他汀类药物不耐受或禁忌使用的患者中，单独用药或与其他降脂疗法联合用药；2.原发性高胆固醇血症(包括杂合子型家族性高胆固醇血症)和混合型血脂异常：可作为饮食的辅助疗法，用于成人原发性高胆固醇血症(杂合子家族性和非家族性)或混合型血脂异常患者的治疗，以降低低密度脂蛋白胆固醇(LDL-C)水平：在接受最大耐受剂量的他汀类药物治疗仍无法达到LDL-C目标的患者中，与他汀类药物、或者与他汀类药物及其他降脂疗法联合用药，或者在他汀类药物不耐受或禁忌使用的患者中，单独用药或与其他降脂疗法联合用药；3.纯合子型家族性高胆固醇血症：用于成人或12岁以上青少年的纯合子型家族性高胆固醇血症。可与饮食疗法和其他降低密度脂蛋白胆固醇(LDL-C)治疗(例如他汀类药物、依折麦布、LDL分离术)合用，用于患有纯合子型家族性高胆固醇血症(HoFH)且需要进一步降低LDL-C的患者。","164993","依洛尤单抗注射液","瑞百安","注射液","1ml:0.14g","支","1","预充式(预灌封)注射器","美国Amgen Manufacturing Limited (AML)","283.80","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1500","XC10AXY310B002020178217","2","依洛尤单抗注射液","","限：1.降低心血管事件的风险：在已有动脉粥样硬化性心血管疾病的成人患者中，降低心肌梗死、卒中以及冠脉血运重建的风险。通过：与最大耐受剂量的他汀类药物联合用药，伴随或不伴随其他降脂疗法，或者在他汀类药物不耐受或禁忌使用的患者中，单独用药或与其他降脂疗法联合用药；2.原发性高胆固醇血症(包括杂合子型家族性高胆固醇血症)和混合型血脂异常：可作为饮食的辅助疗法，用于成人原发性高胆固醇血症(杂合子家族性和非家族性)或混合型血脂异常患者的治疗，以降低低密度脂蛋白胆固醇(LDL-C)水平：在接受最大耐受剂量的他汀类药物治疗仍无法达到LDL-C目标的患者中，与他汀类药物、或者与他汀类药物及其他降脂疗法联合用药，或者在他汀类药物不耐受或禁忌使用的患者中，单独用药或与其他降脂疗法联合用药；3.纯合子型家族性高胆固醇血症：用于成人或12岁以上青少年的纯合子型家族性高胆固醇血症。可与饮食疗法和其他降低密度脂蛋白胆固醇(LDL-C)治疗(例如他汀类药物、依折麦布、LDL分离术)合用，用于患有纯合子型家族性高胆固醇血症(HoFH)且需要进一步降低LDL-C的患者。","177091","依洛尤单抗注射液","瑞百安","注射剂","1mL:140mg","盒","2","预填充式注射笔","美国Amgen Manufacturing Limited (AML)","567.60","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1501","XL04ACY317B002010178396","2","依奇珠单抗注射液","","限：1.适合系统治疗或光疗的中度至重度斑块型银屑病成人患者；2.常规治疗疗效欠佳的活动性强直性脊柱炎成人患者。","165930","依奇珠单抗注射液","拓咨","注射液","1ml:80mg","支","1","玻璃瓶","美国Eli Lilly and Company","1218.00","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1502","XL04AAY270A001010178679","2","依维莫司片","","限：1.既往接受舒尼替尼或索拉非尼治疗失败的晚期肾细胞癌成人患者；2.不可切除的、局部晚期或转移性的、分化良好的(中度分化或高度分化)进展期胰腺神经内分泌瘤成人患者；3.无法手术切除的、局部晚期或转移性的、分化良好的、进展期非功能性胃肠道或肺源神经内分泌肿瘤(NET)成人患者；4.需要治疗干预但不适于手术切除的结节性硬化症(TSC)相关的室管膜下巨细胞星形细胞瘤(SEGA)成人和儿童患者；5.不需立即手术治疗的结节性硬化症相关的肾血管平滑肌脂肪瘤(TSC-AML)成人患者；6.来曲唑或阿那曲唑治疗失败后的激素受体阳性、表皮生长因子受体-2阴性、绝经后晚期女性乳腺癌患者。","162916","依维莫司片","飞尼妥","素片","2.5mg","盒","30","铝塑","瑞士Novartis Pharma Stein AG","2064.60","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1503","XL04AAY270A001020178679","2","依维莫司片","","限：1.既往接受舒尼替尼或索拉非尼治疗失败的晚期肾细胞癌成人患者；2.不可切除的、局部晚期或转移性的、分化良好的(中度分化或高度分化)进展期胰腺神经内分泌瘤成人患者；3.无法手术切除的、局部晚期或转移性的、分化良好的、进展期非功能性胃肠道或肺源神经内分泌肿瘤(NET)成人患者；4.需要治疗干预但不适于手术切除的结节性硬化症(TSC)相关的室管膜下巨细胞星形细胞瘤(SEGA)成人和儿童患者；5.不需立即手术治疗的结节性硬化症相关的肾血管平滑肌脂肪瘤(TSC-AML)成人患者；6.来曲唑或阿那曲唑治疗失败后的激素受体阳性、表皮生长因子受体-2阴性、绝经后晚期女性乳腺癌患者。","153764","依维莫司片","飞尼妥","素片","5mg","盒","30","铝塑","瑞士Novartis Pharma Stein AG","3510.00","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1504","XR03ALY302L031010678672","2","茚达特罗格隆溴铵吸入粉雾剂用胶囊(茚达特罗格隆溴铵吸入粉雾剂)","","限成人慢性阻塞性肺疾病(COPD)。","165213","茚达特罗格隆溴铵吸入粉雾剂","杰润","吸入粉雾剂","含马来酸茚达特罗0.11mg(以C24H28N2O3计)和格隆溴铵50μg(以C19H28NO3计)","盒","30","附吸入器","西班牙Novartis Farmaceutica S.A.","229.50","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1505","XL01XEZ104E001010182282","2","泽布替尼胶囊","","限：1.既往至少接受过一种治疗的成人套细胞淋巴瘤(MCL)患者；2.成人慢性淋巴细胞白血病(CLL)/小淋巴细胞淋巴瘤(SLL)患者；3.成人华氏巨球蛋白血症(WM)患者。","170843","泽布替尼胶囊","百悦泽","胶囊剂","80mg","盒","64","高密度聚乙烯瓶","百济神州(苏州)生物科技有限公司","5336.96","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1506","XL01XXC116B002010104184","2","重组人血管内皮抑制素注射液","","限晚期非小细胞肺癌患者。","103095","重组人血管内皮抑制素注射液","恩度","注射液","15mg/2.4×105U/3ml/支","盒","1","3.0 ml预灌封注射器包装,PVC吸塑泡罩密封包装","山东先声生物制药有限公司","472.85","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1507","XA02BCA084B001010100453","2","注射用艾普拉唑钠","","限：1.预防重症患者应激性溃疡出血；2.消化性溃疡出血。","163411","注射用艾普拉唑钠","壹丽安","注射剂","10mg(按C19H18N4O2S计)","盒","1","中硼硅玻璃管制注射剂瓶和覆聚四氟乙烯/乙烯共聚物氯化丁基橡胶塞","丽珠集团丽珠制药厂","63.00","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1508","XR03DXA305B001010178672","2","注射用奥马珠单抗","","限：1.经吸入型糖皮质激素和长效吸入型β2-肾上腺素受体激动剂治疗后，仍不能有效控制症状的中至重度持续性过敏性哮喘的6岁及以上患者，并需IgE(免疫球蛋白E)介导确诊证据；2.H1抗组胺药治疗后仍有症状的成人和青少年(12岁及以上)慢性自发性荨麻疹患者。","163185","注射用奥马珠单抗","茁乐","注射剂","每盒装奥马珠单抗150mg/瓶和灭菌注射用水2ml/瓶各1瓶。","盒","1","瓶装冻干粉:I类玻璃瓶。  稀释液安瓿:I型玻璃安瓿.","Novartis Pharma Stein AG","1198.00","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1509","XL04AAB235B001010178453","2","注射用贝利尤单抗","","限：1.在常规治疗基础上仍具有高疾病活动(例如：抗ds-DNA抗体阳性及低补体、SELENA-SLEDAI评分≥8)的活动性、自身抗体阳性的系统性红斑狼疮(SLE)5岁及以上患者；2.与常规治疗联合用于活动性狼疮肾炎成人患者。","165885","注射用贝利尤单抗","倍力腾","粉针剂","0.12g","瓶","1","玻璃瓶","意大利GlaxoSmithKline Manufacturing S.p.A","700.00","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1510","XN05CDR099B001010202000","2","注射用苯磺酸瑞马唑仑","","限：1.结肠镜检查；2.全身麻醉诱导与维持。","174254","注射用苯磺酸瑞马唑仑","锐马","注射剂","25mg(按C21H19BrN4O2计)","支","1","中硼硅玻璃管制注射剂瓶","宜昌人福药业有限责任公司","40.50","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1511","XN05CDR099B001010101445","2","注射用甲苯磺酸瑞马唑仑","","限：1.非气管插管手术/操作中的镇静和麻醉；2.全身麻醉的诱导和维持。","174253","注射用甲苯磺酸瑞马唑仑","瑞倍宁","冻干粉针剂","36mg［按瑞马唑仑(C21H19BrN4O2)计］","瓶","1","玻璃瓶","江苏恒瑞医药股份有限公司","56.19","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1512","XN05CDR099B001020101445","2","注射用甲苯磺酸瑞马唑仑","","限：1.非气管插管手术/操作中的镇静和麻醉；2.全身麻醉的诱导和维持。","174273","注射用甲苯磺酸瑞马唑仑","瑞倍宁","冻干粉针剂","25mg［按瑞马唑仑(C21H19BrN4O2)计］","瓶","1","玻璃瓶","江苏恒瑞医药股份有限公司","42.50","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1513","XN05AXL386B015010104139","2","注射用利培酮微球(Ⅱ)","","限急性和慢性精神分裂症以及其他各种精神病性状态的明显的阳性症状和明显的阴性症状。","172096","注射用利培酮微球(Ⅱ)","无","粉针剂","25mg","瓶","1","玻璃瓶","山东绿叶制药有限公司","678.00","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1514","XN05AXL386B015020104139","2","注射用利培酮微球(Ⅱ)","","限急性和慢性精神分裂症以及其他各种精神病性状态的明显的阳性症状和明显的阴性症状。","174202","注射用利培酮微球(Ⅱ)","无","粉针剂","37.5mg","瓶","1","玻璃瓶","山东绿叶制药有限公司","924.77","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1515","XN05AXL386B015030104139","2","注射用利培酮微球(Ⅱ)","","限急性和慢性精神分裂症以及其他各种精神病性状态的明显的阳性症状和明显的阴性症状。","174258","注射用利培酮微球(Ⅱ)","无","粉针剂","50mg","瓶","1","玻璃瓶","山东绿叶制药有限公司","1152.60","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1516","XJ02AAL387B001010102770","2","注射用两性霉素B胆固醇硫酸酯复合物","","限患有深部真菌感染的患者；因肾损伤或药物毒性而不能使用有效剂量的两性霉素B的患者，或已经接受过两性霉素B治疗无效的患者均可使用。","172094","注射用两性霉素B胆固醇硫酸酯复合物","无","冻干粉针剂","50mg","瓶","1","玻璃瓶","石药集团欧意药业有限公司","396.00","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1517","XJ01XDZ105B001010182147","2","注射用磷酸左奥硝唑酯二钠","","限：1.肠道和肝脏严重的阿米巴病；2.奥硝唑敏感厌氧菌引起的手术后感染；3.预防外科手术导致的敏感厌氧菌感染。","202452","注射用磷酸左奥硝唑酯二钠","新锐","注射剂","0.5g(按C？H？？ClN？O？计)","瓶","1","中硼硅玻璃管制注射剂瓶、注射用冷冻干燥用卤化丁基橡胶塞(溴化)","扬子江药业集团江苏紫龙药业有限公司","72.77","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1518","XJ01XDZ105B001020182147","2","注射用磷酸左奥硝唑酯二钠","","限：1.肠道和肝脏严重的阿米巴病；2.奥硝唑敏感厌氧菌引起的手术后感染；3.预防外科手术导致的敏感厌氧菌感染。","202608","注射用磷酸左奥硝唑酯二钠","新锐","注射剂","1.0g(按C？H？？ClN？O？计)","瓶","1","中硼硅玻璃管制注射剂瓶、注射用冷冻干燥用卤化丁基橡胶塞(溴化))","扬子江药业集团江苏紫龙药业有限公司","123.71","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1519","XV08DAQ134B015010104859","2","注射用全氟丙烷人血白蛋白微球","","","170810","注射用全氟丙烷人血白蛋白微球","无","冻干粉针剂","0.5g","瓶","1","玻璃瓶","厦门力卓药业有限公司","558.00","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1520","XV08DAQ173B015010178446","2","注射用全氟丁烷微球","","限肝脏局灶性病变血管相和Kupffer相的超声成像。","165460","注射用全氟丁烷微球","示卓安","粉针剂","16μl","盒","1","配溶媒(灭菌注射用水)+无菌加药输液器","挪威GE HEALTHCARE AS","511.00","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1521","XC07ABL385B001010201563","2","注射用盐酸兰地洛尔","","限：1.手术过程中发生的下列快速性心律失常的紧急治疗：心房纤颤、心房扑动、窦性心动过速；2.手术后循环系统动态监护时发生的快速性心律失常的紧急治疗：心房纤颤、心房扑动、窦性心动过速；3.心功能不全患者发生下列快速性心律失常的治疗：心房纤颤、心房扑动。","172481","注射用盐酸兰地洛尔","无","冻干粉针剂","50mg","瓶","1","玻璃瓶","南京海辰药业股份有限公司","168.00","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1522","XN07XXY184B001010100344","2","注射用尤瑞克林","","限轻-中度急性血栓性脑梗死，应在发作48小时内开始使用，支付不超过21天。","112748","注射用尤瑞克林","凯力康","冻干粉针剂","0.15PNA单位","瓶","1","玻璃瓶","广东天普生化医药股份有限公司","100.00","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1523","XB02BDC110B001010178997","2","注射用重组人凝血因子Ⅶa","","限下列患者群体出血的治疗，以及外科手术或有创操作出血的防治：1.凝血因子VIII或IX的抑制物>5个Bethesda单位(BU)的先天性血友病患者；预计对注射凝血因子VIII或凝血因子IX，具有高记忆应答的先天性血友病患者；2.获得性血友病患者；3.先天性凝血因子VII(FVII)缺乏症患者；4.具有血小板膜糖蛋白IIb－IIIa(GPIIb－IIIa)和/或人白细胞抗原(HLA)抗体和既往或现在对血小板输注无效或不佳的血小板无力症患者。","163368","注射用重组人凝血因子Ⅶa","诺其","注射剂","1mg(50KIU)/支","盒","1","氯化丁基橡胶塞密封的I型玻璃瓶,塞子上盖有铝盖。密封 瓶上带有聚丙烯制备的螺旋易拉封盖。","Novo Nordisk A/S","3903.50","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1524","XB02BDC110B001020178997","2","注射用重组人凝血因子Ⅶa","","限下列患者群体出血的治疗，以及外科手术或有创操作出血的防治：1.凝血因子VIII或IX的抑制物>5个Bethesda单位(BU)的先天性血友病患者；预计对注射凝血因子VIII或凝血因子IX，具有高记忆应答的先天性血友病患者；2.获得性血友病患者；3.先天性凝血因子VII(FVII)缺乏症患者；4.具有血小板膜糖蛋白IIb－IIIa(GPIIb－IIIa)和/或人白细胞抗原(HLA)抗体和既往或现在对血小板输注无效或不佳的血小板无力症患者。","166569","注射用重组人凝血因子Ⅶa","诺其","注射剂","2mg(100KIU)/支","盒","1","氯化丁基橡胶塞密封的I型玻璃瓶,塞子上盖有铝盖。密封瓶上带有聚丙烯制备的螺旋易拉封盖","Novo Nordisk A/S","6635.95","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1525","ZA04BAD0406010103014","2","冬凌草滴丸","","清热解毒,消肿散结,利咽止痛。用于热毒壅盛所致的咽喉肿痛、声音嘶哑； 急性扁桃体炎、急性咽炎轻症见上述证候者。","162801","冬凌草滴丸","无","滴丸","40mg","瓶","270","塑料瓶","河南百年康鑫药业有限公司","48.60","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1526","ZA12AAD0362010103357","2","杜蛭丸","","","153540","杜蛭丸(浓缩水蜜丸)","无","浓缩丸","5g/25粒","盒","100","铝箔","吉林敖东延边药业股份有限公司","25.32","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1527","ZA12AAD0362010303357","2","杜蛭丸","","","146550","杜蛭丸(浓缩水蜜丸)","无","浓缩丸","5g/25粒","盒","200","铝箔","吉林敖东延边药业股份有限公司","50.64","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1528","ZA12AAD0362020103357","2","杜蛭丸","","","170515","杜蛭丸(浓缩水蜜丸)","无","浓缩丸","5g/25粒","盒","350","铝箔","吉林敖东延边药业股份有限公司","88.62","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1529","ZA12CAD0087010103962","2","丹红注射液","","限二级及以上医疗机构。","116250","丹红注射液","无","注射液","10ml","支","1","安瓿","山东丹红制药有限公司","16.92","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1530","ZA12CAD0087020103962","2","丹红注射液","","限二级及以上医疗机构。","116261","丹红注射液","无","注射液","20ml","支","1","安瓿","山东丹红制药有限公司","28.76","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1531","ZA12HAX0829010100864","2","血必净注射液","","限二级及以上医疗机构。","132443","血必净注射液","无","注射液","10ml","支","1","安瓿","天津红日药业股份有限公司","22.08","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1532","XL01XCK131B001010181825","2","注射用卡瑞利珠单抗","","限：1.至少经过二线系统化疗的复发或难治性经典型霍奇金淋巴瘤患者的治疗；2.既往接受过索拉非尼治疗和/或含奥沙利铂系统化疗的晚期肝细胞癌患者的治疗；3.表皮生长因子受体(EGFR)基因突变阴性和间变性淋巴瘤激酶(ALK)阴性的、不可手术切除的局部晚期或转移性非鳞状非小细胞肺癌(NSCLC)的一线治疗；4.既往接受过一线化疗后疾病进展或不可耐受的局部晚期或转移性食管鳞癌患者的治疗；5.既往接受过二线及以上化疗后疾病进展或不可耐受的晚期鼻咽癌患者的治疗； 6.局部复发或转移性鼻咽癌患者的一线治疗；7.不可切除局部晚期/复发或转移性食管鳞癌患者的一线治疗；8.局部晚期或转移性鳞状非小细胞肺癌患者的一线治疗；9.不可切除或转移性肝细胞癌患者的一线治疗。","165683","注射用卡瑞利珠单抗","艾瑞卡","冻干粉针剂","0.2g","瓶","1","玻璃瓶","苏州盛迪亚生物医药有限公司","2576.64","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1533","XL01XEA298A001020279096","2","甲磺酸奥希替尼片","","限：1.IB-IIIA期存在表皮生长因子受体(EGFR)外显子19缺失或外显子21(L858R)置换突变的非小细胞肺癌(NSCLC)患者的治疗，患者须既往接受过手术切除治疗，并由医生决定接受或不接受辅助化疗；2.具有表皮生长因子受体(EGFR)外显子19缺失或外显子21(L858R)置换突变的局部晚期或转移性非小细胞肺癌(NSCLC)成人患者的一线治疗；3.既往经EGFR酪氨酸激酶抑制剂(TKI)治疗时或治疗后出现疾病进展，并且经检测确认存在EGFR T790M突变阳性的局部晚期或转移性NSCLC成人患者的治疗。","164539","甲磺酸奥希替尼片","泰瑞沙","薄膜衣片","80mg","盒","30","双铝","瑞典AstraZeneca AB","4966.20","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1534","XL01EFD357A001010101445","2","羟乙磺酸达尔西利片","","限：1.激素受体(HR)阳性、人表皮生长因子受体2(HER2)阴性局部晚期或转移性乳腺癌患者：2.与芳香化酶抑制剂联合使用作为初始内分泌治疗；3.与氟维司群联合用于既往曾接受内分泌治疗后出现疾病进展的患者。","174729","羟乙磺酸达尔西利片","艾瑞康","片剂","50mg(按C25H30N6O2计)","盒","42","聚氯乙烯固体药用硬片加药用铝箔热合密封包装。","江苏恒瑞医药股份有限公司","3713.22","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1535","XL01EFD357A001020101445","2","羟乙磺酸达尔西利片","","限：1.激素受体(HR)阳性、人表皮生长因子受体2(HER2)阴性局部晚期或转移性乳腺癌患者：2.与芳香化酶抑制剂联合使用作为初始内分泌治疗；3.与氟维司群联合用于既往曾接受内分泌治疗后出现疾病进展的患者。","174728","羟乙磺酸达尔西利片","艾瑞康","片剂","125mg(按C25H30N6O2计)","盒","21","聚氯乙烯固体药用硬片加药用铝箔热合密封包装。","江苏恒瑞医药股份有限公司","3744.09","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1536","XL01EFD357A001020201445","2","羟乙磺酸达尔西利片","","限：1.激素受体(HR)阳性、人表皮生长因子受体2(HER2)阴性局部晚期或转移性乳腺癌患者：2.与芳香化酶抑制剂联合使用作为初始内分泌治疗；3.与氟维司群联合用于既往曾接受内分泌治疗后出现疾病进展的患者。","177141","羟乙磺酸达尔西利片","艾瑞康","片剂","125mg(按C25H30N6O2计)","盒","7","聚氯乙烯固体药用硬片加药用铝箔热合密封包装。","江苏恒瑞医药股份有限公司","1248.03","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1537","XL01EFD357A001030101445","2","羟乙磺酸达尔西利片","","限：1.激素受体(HR)阳性、人表皮生长因子受体2(HER2)阴性局部晚期或转移性乳腺癌患者：2.与芳香化酶抑制剂联合使用作为初始内分泌治疗；3.与氟维司群联合用于既往曾接受内分泌治疗后出现疾病进展的患者。","174727","羟乙磺酸达尔西利片","艾瑞康","片剂","150mg(按C25H30N6O2计)","盒","21","聚氯乙烯固体药用硬片加药用铝箔热合密封包装。","江苏恒瑞医药股份有限公司","4305.00","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1538","XL01EFD357A001030201445","2","羟乙磺酸达尔西利片","","限：1.激素受体(HR)阳性、人表皮生长因子受体2(HER2)阴性局部晚期或转移性乳腺癌患者：2.与芳香化酶抑制剂联合使用作为初始内分泌治疗；3.与氟维司群联合用于既往曾接受内分泌治疗后出现疾病进展的患者。","177140","羟乙磺酸达尔西利片","艾瑞康","片剂","150mg(按C25H30N6O2计)","盒","7","聚氯乙烯固体药用硬片加药用铝箔热合密封包装。","江苏恒瑞医药股份有限公司","1435.00","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1539","XL04AAW126A010010282925","2","乌帕替尼缓释片","","限：1.12岁及以上患者难治性、中重度特应性皮炎的二线治疗；2.活动性银屑病关节炎成人患者的二线治疗；3.中重度活动性类风湿关节炎成人患者的二线治疗；4.对一种或多种TNF抑制剂应答不佳或不耐受或禁忌的中度至重度活动性溃疡性结肠炎成人患者；5.对一种或多种TNF抑制剂应答不佳或不耐受或禁忌的中度至重度活动性克罗恩病成人患者。","176881","乌帕替尼缓释片","瑞福","片剂","15mg（按C17H19F3N6O计）","盒","28","PVC/PE/PCTFE铝塑泡罩包装","AbbVie Ireland NL B.V.","2086.00","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1540","XL04AAW126A010020182925","2","乌帕替尼缓释片","","限：1.12岁及以上患者难治性、中重度特应性皮炎的二线治疗；2.活动性银屑病关节炎成人患者的二线治疗；3.中重度活动性类风湿关节炎成人患者的二线治疗；4.对一种或多种TNF抑制剂应答不佳或不耐受或禁忌的中度至重度活动性溃疡性结肠炎成人患者；5.对一种或多种TNF抑制剂应答不佳或不耐受或禁忌的中度至重度活动性克罗恩病成人患者。","310076","乌帕替尼缓释片","瑞福","片剂","30mg（按C17H19F3N6O计）","盒","28","PVC/PE/PCTFE铝塑泡罩包装","AbbVie Ireland NL B.V.","3546.20","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1541","XM09AXL393P001010182529","2","利司扑兰口服溶液用散","","限治疗16日龄及以上患者的脊髓性肌萎缩症(SMA)。","173947","利司扑兰口服溶液用散","艾满欣","口服溶液用散","每瓶含利司扑兰60 mg","盒","1","琥珀色玻璃瓶装","F.Hoffmann-La Roche AG","3780.00","修改（医保信息）","医保发〔2023〕30号","国谈药品"]
["1542","XJ01XXK134B001010100792","2","硫酸黏菌素","注射剂","","133970","注射用硫酸黏菌素","无","注射剂","50万IU","瓶","10","玻璃瓶","上海上药新亚药业有限公司","10350.00","修改（医保信息）","医保发〔2023〕30号",""]
["1543","XL01EXA350A001010183503","2","阿伐替尼片","","限携带血小板衍生生长因子受体α(PDGFRA)外显子18突变(包括PDGFRA D842V突变)的不可切除或转移性胃肠道间质瘤(GIST)成人患者。","173568","阿伐替尼片","泰吉华","片剂","100mg","瓶","30","高密度聚乙烯(HDPE)瓶包装","Catalent Nottingham Limited","6840.00","启用","医保发〔2023〕30号","国谈药品"]
["1544","XL01EXA350A001020183503","2","阿伐替尼片","","限携带血小板衍生生长因子受体α(PDGFRA)外显子18突变(包括PDGFRA D842V突变)的不可切除或转移性胃肠道间质瘤(GIST)成人患者。","173569","阿伐替尼片","泰吉华","片剂","300mg","瓶","30","高密度聚乙烯(HDPE)瓶包装","Catalent Nottingham Limited","15860.40","启用","医保发〔2023〕30号","国谈药品"]
["1545","XL01ELA387E001010184513","2","阿可替尼胶囊","","限既往至少接受过一种治疗的成人套细胞淋巴瘤(MCL)患者。","203674","阿可替尼胶囊","康可期","胶囊剂","100mg","盒","56","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片＋药用铝箔的泡罩包装。","AstraZeneca AB","10006.08","启用","医保发〔2023〕30号","国谈药品"]
["1546","XN05AXA028M002010104021","2","阿立哌唑口溶膜","","","206374","阿立哌唑口溶膜","无","膜剂","10mg","盒","14","聚酯/铝/流延聚乙烯药用复合膜","齐鲁制药有限公司","64.54","启用","医保发〔2023〕30号","国谈药品"]
["1547","XA04ADA285B002010104021","2","阿瑞匹坦注射液","","限放化疗且吞咽困难的患者。","176649","阿瑞匹坦注射液","无","注射剂","18ml:130mg","瓶","1","中硼硅玻璃管制注射剂瓶、注射液用覆聚四氟乙烯/六氟丙烯的共聚物膜氯化丁基橡胶塞和抗生素瓶用铝塑组合盖","齐鲁制药有限公司","139.13","启用","医保发〔2023〕30号","国谈药品"]
["1548","XL03AAA390B002010183514","2","艾贝格司亭α注射液","","限前次化疗曾发生重度中性粒细胞减少的患者。","204059","艾贝格司亭α注射液","亿立舒","注射剂","20mg(1.0ml)/支(预充式注射器)","盒","1","预充式注射器","亿一生物制药(北京)有限公司","2388.00","启用","医保发〔2023〕30号","国谈药品"]
["1549","XL04AAA395B002010184816","2","艾加莫德α注射液","","限乙酰胆碱受体(AChR)抗体阳性的成人全身型重症肌无力(gMG)患者。","205194","艾加莫德α注射液","卫伟迦","注射剂","400mg/20ml/瓶","盒","1","I型玻璃瓶,用橡胶塞、铝制品封圈和聚丙烯易掀盖密封","Vetter Pharma-Fertigung GmbH & Co. KG","5608.00","启用","医保发〔2023〕30号","国谈药品"]
["1550","XJ05ARA383A001010181452","2","艾诺米替片","","限艾滋病病毒感染。","200231","艾诺米替片","复邦德","片剂","每片含艾诺韦林0.15g,拉米夫定0.3g,富马酸替诺福韦二吡呋酯0.3g","瓶","30","口服固体药用高密度聚乙烯瓶装","江苏艾迪药业股份有限公司","724.50","启用","医保发〔2023〕30号","国谈药品"]
["1551","XA02BCA081X006010179537","2","艾司奥美拉唑镁肠溶干混悬剂","","限：1.胃食管反流病；2.与幽门螺杆菌相关的十二指肠溃疡；3.需要持续非甾体抗炎药(NSAID)治疗，且与使用NSAID治疗相关的胃溃疡。","206129","艾司奥美拉唑镁肠溶干混悬剂","无","口服混悬剂","40mg(按C？？H？？N？O？S计)","盒","7","四层药用复合膜","Cipla Ltd.","52.94","启用","医保发〔2023〕30号",""]
["1552","XA02BCA081X006010379537","2","艾司奥美拉唑镁肠溶干混悬剂","","限：1.胃食管反流病；2.与幽门螺杆菌相关的十二指肠溃疡；3.需要持续非甾体抗炎药(NSAID)治疗，且与使用NSAID治疗相关的胃溃疡。","206253","艾司奥美拉唑镁肠溶干混悬剂","无","口服混悬剂","40mg(按C？？H？？N？O？S计)","盒","14","四层药用复合膜","Cipla Ltd.","105.88","启用","医保发〔2023〕30号",""]
["1553","XA02BCA081X006020379537","2","艾司奥美拉唑镁肠溶干混悬剂","","限：1.胃食管反流病；2.与幽门螺杆菌相关的十二指肠溃疡；3.需要持续非甾体抗炎药(NSAID)治疗，且与使用NSAID治疗相关的胃溃疡。","206128","艾司奥美拉唑镁肠溶干混悬剂","无","口服混悬剂","10mg(按C？？H？？N？O？S计)","盒","14","四层药用复合膜","Cipla Ltd.","36.64","启用","医保发〔2023〕30号",""]
["1554","XA02BCA081X006030179537","2","艾司奥美拉唑镁肠溶干混悬剂","","限：1.胃食管反流病；2.与幽门螺杆菌相关的十二指肠溃疡；3.需要持续非甾体抗炎药(NSAID)治疗，且与使用NSAID治疗相关的胃溃疡。","206254","艾司奥美拉唑镁肠溶干混悬剂","无","口服混悬剂","20mg(按C？？H？？N？O？S计)","盒","7","四层药用复合膜","Cipla Ltd.","31.14","启用","医保发〔2023〕30号",""]
["1555","XA02BCA081X006030279537","2","艾司奥美拉唑镁肠溶干混悬剂","","限：1.胃食管反流病；2.与幽门螺杆菌相关的十二指肠溃疡；3.需要持续非甾体抗炎药(NSAID)治疗，且与使用NSAID治疗相关的胃溃疡。","206255","艾司奥美拉唑镁肠溶干混悬剂","无","口服混悬剂","20mg(按C？？H？？N？O？S计)","盒","14","四层药用复合膜","Cipla Ltd.","62.28","启用","医保发〔2023〕30号",""]
["1556","XA02BCA081X006010202181","2","艾司奥美拉唑镁肠溶干混悬剂","","限：1.胃食管反流病；2.与幽门螺杆菌相关的十二指肠溃疡；3.需要持续非甾体抗炎药(NSAID)治疗，且与使用NSAID治疗相关的胃溃疡。","206606","艾司奥美拉唑镁肠溶干混悬剂","无","口服混悬剂","20mg(按C？？H？？N？O？S计)","盒","14","聚酯/铝/聚乙烯药用复合膜包装","成都苑东生物制药股份有限公司","60.68","启用","医保发〔2023〕30号",""]
["1557","XA02BCA081X006020202181","2","艾司奥美拉唑镁肠溶干混悬剂","","限：1.胃食管反流病；2.与幽门螺杆菌相关的十二指肠溃疡；3.需要持续非甾体抗炎药(NSAID)治疗，且与使用NSAID治疗相关的胃溃疡。","206607","艾司奥美拉唑镁肠溶干混悬剂","无","口服混悬剂","40mg(按C？？H？？N？O？S计)","盒","14","聚酯/铝/聚乙烯药用复合膜包装","成都苑东生物制药股份有限公司","103.16","启用","医保发〔2023〕30号",""]
["1558","XA02BCA393A012010183696","2","安奈拉唑钠肠溶片","","限十二指肠溃疡。","206485","安奈拉唑钠肠溶片","安久卫","片剂","20mg(按C？？H？？N？O？S计)","盒","7","聚氯乙烯固体药用硬片及药用铝箔包装,袋内3g固体药用纸/聚乙烯复合袋装硅胶干燥剂。","北京京丰制药集团有限公司","77.00","启用","医保发〔2023〕30号","国谈药品"]
["1559","XA02BCA393A012010283696","2","安奈拉唑钠肠溶片","","限十二指肠溃疡。","206486","安奈拉唑钠肠溶片","安久卫","片剂","20mg(按C？？H？？N？O？S计)","盒","14","聚氯乙烯固体药用硬片及药用铝箔包装,袋内3g固体药用纸/聚乙烯复合袋装硅胶干燥剂。","北京京丰制药集团有限公司","154.00","启用","医保发〔2023〕30号","国谈药品"]
["1560","XA02BCA393A012010383696","2","安奈拉唑钠肠溶片","","限十二指肠溃疡。","205879","安奈拉唑钠肠溶片","安久卫","片剂","20mg(按C？？H？？N？O？S计)","盒","6","聚氯乙烯固体药用硬片及药用铝箔包装,袋内3g固体药用纸/聚乙烯复合袋装硅胶干燥剂","北京京丰制药集团有限公司","66.00","启用","医保发〔2023〕30号","国谈药品"]
["1561","XN05ALA161X001010181979","2","氨磺必利口服溶液","","","206487","氨磺必利口服溶液","无","口服溶液剂","60ml:6g","盒","1","钠钙玻璃模制药瓶和口服药用聚烯烃安全盖,本品附带口服液体药用聚丙烯量杯。","浙江康恩贝制药股份有限公司","136.00","启用","医保发〔2023〕30号","国谈药品"]
["1562","XN03AGA357P001010202181","2","氨己烯酸口服溶液用散","","限婴儿痉挛症。","206488","氨己烯酸口服溶液用散","无","散剂","500mg","盒","50","聚酯/铝/聚乙烯药用复合膜","成都苑东生物制药股份有限公司","1450.00","启用","医保发〔2023〕30号","竞价药品"]
["1563","XN03AGA357P001010102181","2","氨己烯酸口服溶液用散","","限婴儿痉挛症。","176760","氨己烯酸口服溶液用散","无","散剂","500mg","盒","30","聚酯/铝/聚乙烯药用复合膜","成都苑东生物制药股份有限公司","870.00","启用","医保发〔2023〕30号","竞价药品"]
["1564","XJ05APA391A001010101583","2","奥磷布韦片","","限基因 1、2、3、6 型成人慢性丙型肝炎。","205189","奥磷布韦片","圣诺迪","片剂","100mg","瓶","42","口服固体药用高密度聚乙烯瓶、口服药用聚丙烯压旋盖(含药用聚酯/铝/聚乙烯封口垫片)","南京圣和药业股份有限公司","787.50","启用","医保发〔2023〕30号","国谈药品"]
["1565","XR03DXA305B002010178672","2","奥马珠单抗注射液","","限：1.经吸入型糖皮质激素和长效吸入型β2-肾上腺素受体激动剂治疗后，仍不能有效控制症状的中至重度持续性过敏性哮喘的6岁及以上患者，并需IgE(免疫球蛋白E)介导确诊证据；2.H1抗组胺药治疗后仍有症状的成人和青少年(12岁及以上)慢性自发性荨麻疹患者。","203516","奥马珠单抗注射液","茁乐","注射剂","预充式注射器装:1.0ml:150mg","盒","1","包装于由 1ml 带有不锈钢针头的 I 型玻璃注射器针筒,橡胶活塞,丁苯橡胶刚性针帽组装的预灌封注射器中,并配有被动安全装置。","Vetter Pharma-Fertigung GmbH & Co. KG","1204.00","启用","医保发〔2023〕30号","国谈药品"]
["1566","XV08DAB253B030010184494","2","八氟丙烷脂质微球注射液","","","60035","八氟丙烷脂质微球注射液","无","注射剂","活化前每1ml上层气体中含八氟 丙烷6.52mg, 活化后每瓶1.5ml乳 液中含八氟丙烷225μl","支","1","高硼硅玻璃管制注射剂瓶和注射用冻干粉末用ETFE层压氯化丁基橡胶塞","JUBILANT HOLLISTERSTIER LLC","535.00","启用","医保发〔2023〕30号","国谈药品"]
["1567","XV08DAB253B030010284494","2","八氟丙烷脂质微球注射液","","","60036","八氟丙烷脂质微球注射液","无","注射剂","活化前每1ml上层气体中含八氟 丙烷6.52mg, 活化后每瓶1.5ml乳 液中含八氟丙烷225μl","盒","4","高硼硅玻璃管制注射剂瓶和注射用冻干粉末用ETFE层压氯化丁基橡胶塞","JUBILANT HOLLISTERSTIER LLC","2140.00","启用","医保发〔2023〕30号","国谈药品"]
["1568","XV08DAB253B030010384494","2","八氟丙烷脂质微球注射液","","","60037","八氟丙烷脂质微球注射液","无","注射剂","活化前每1ml上层气体中含八氟 丙烷6.52mg, 活化后每瓶1.5ml乳 液中含八氟丙烷225μl","盒","16","高硼硅玻璃管制注射剂瓶和注射用冻干粉末用ETFE层压氯化丁基橡胶塞","JUBILANT HOLLISTERSTIER LLC","8560.00","启用","医保发〔2023〕30号","国谈药品"]
["1569","XB01ABB210B002010179579","2","贝米肝素钠注射液","","","165246","贝米肝素钠注射液","稀保","注射液","0.2ml:2500IU(抗Xa)","支","1","预充式注射器包装","ROVI PHARMA INDUSTRIAL SERVICES, S.A.","35.90","启用","医保发〔2023〕30号","国谈药品"]
["1570","XB01ABB210B002020179579","2","贝米肝素钠注射液","","","165245","贝米肝素钠注射液","稀保","注射液","0.2ml:3500IU(抗Xa)","支","1","预充式注射器包装","ROVI PHARMA INDUSTRIAL SERVICES, S.A.","46.45","启用","医保发〔2023〕30号","国谈药品"]
["1571","XB01ABB210B002030179579","2","贝米肝素钠注射液","","","206490","贝米肝素钠注射液","稀保","注射液","0.2ml:3500IU(抗Xa )","盒","10","预充式注射器包装","ROVI PHARMA INDUSTRIAL SERVICES, S.A.","464.50","启用","医保发〔2023〕30号","国谈药品"]
["1572","XB01ABB210B002030279579","2","贝米肝素钠注射液","","","206489","贝米肝素钠注射液","稀保","注射液","0.2ml:2500IU(抗Xa )","盒","10","预充式注射器包装","ROVI PHARMA INDUSTRIAL SERVICES, S.A.","359.00","启用","医保发〔2023〕30号","国谈药品"]
["1573","XC02KXB144A001010178189","2","波生坦片","","限WHO功能分级II级-IV级的肺动脉高压(WHO第1组)的患者。","147425","波生坦片","全可利","薄膜衣片","0.125g","盒","56","铝塑","加拿大Patheon Inc.","1334.48","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1574","XN01BBB164B018010201445","2","布比卡因脂质体注射液","","限：1.12岁及以上的患者单剂量浸润产生术后局部镇痛；2. 成人肌间沟臂丛神经阻滞产生术后区域镇痛。","206491","布比卡因脂质体注射液","无","注射剂","20ml:266mg","盒","10","采用中硼硅玻璃管制注射剂瓶、注射制剂用溴化丁基橡胶塞及抗生素瓶用铝塑组合盖包装","江苏恒瑞医药股份有限公司","3820.00","启用","医保发〔2023〕30号","国谈药品"]
["1575","XN01BBB164B018010101445","2","布比卡因脂质体注射液","","限：1.12岁及以上的患者单剂量浸润产生术后局部镇痛；2. 成人肌间沟臂丛神经阻滞产生术后区域镇痛。","310033","布比卡因脂质体注射液","无","注射剂","20ml:266mg","盒","1","采用中硼硅玻璃管制注射剂瓶、注射制剂用溴化丁基橡胶塞及抗生素瓶用铝塑组合盖包装","江苏恒瑞医药股份有限公司","382.00","启用","医保发〔2023〕30号","国谈药品"]
["1576","ZA10DAS1085010200255","2","参葛补肾胶囊","","益气、养阴、补肾。适用于轻、中度抑郁症中医辨证属气阴两虚、肾气不足证，症见情绪低落、多思善虑、言语动作减少、目光迟滞、健忘、食少、心悸胆怯、少寐多梦、心烦，舌质淡红或偏红、舌苔白或花剥，脉细弱等。","206493","参葛补肾胶囊","无","胶囊剂","每粒装0.32g(相当于饮片3.6g)","盒","24","聚氯乙烯固体药用硬片 、药用铝箔。","国药集团德众(佛山)药业有限公司","104.40","启用","医保发〔2023〕30号","国谈药品"]
["1577","ZA10DAS1085010300255","2","参葛补肾胶囊","","益气、养阴、补肾。适用于轻、中度抑郁症中医辨证属气阴两虚、肾气不足证，症见情绪低落、多思善虑、言语动作减少、目光迟滞、健忘、食少、心悸胆怯、少寐多梦、心烦，舌质淡红或偏红、舌苔白或花剥，脉细弱等。","206492","参葛补肾胶囊","无","胶囊剂","每粒装0.32g(相当于饮片3.6g)","盒","16","聚氯乙烯固体药用硬片 、药用铝箔。","国药集团德众(佛山)药业有限公司","69.60","启用","医保发〔2023〕30号","国谈药品"]
["1578","ZA10DAS1085010400255","2","参葛补肾胶囊","","益气、养阴、补肾。适用于轻、中度抑郁症中医辨证属气阴两虚、肾气不足证，症见情绪低落、多思善虑、言语动作减少、目光迟滞、健忘、食少、心悸胆怯、少寐多梦、心烦，舌质淡红或偏红、舌苔白或花剥，脉细弱等。","206494","参葛补肾胶囊","无","胶囊剂","每粒装0.32g(相当于饮片3.6g)","盒","32","聚氯乙烯固体药用硬片 、药用铝箔。","国药集团德众(佛山)药业有限公司","139.20","启用","医保发〔2023〕30号","国谈药品"]
["1579","ZA10DAS1085010100255","2","参葛补肾胶囊","","益气、养阴、补肾。适用于轻、中度抑郁症中医辨证属气阴两虚、肾气不足证，症见情绪低落、多思善虑、言语动作减少、目光迟滞、健忘、食少、心悸胆怯、少寐多梦、心烦，舌质淡红或偏红、舌苔白或花剥，脉细弱等。","202914","参葛补肾胶囊","无","胶囊剂","每粒装0.32g(相当于饮片3.6g)","瓶","56","口服固体药用高密度聚乙烯瓶。","国药集团德众(佛山)药业有限公司","243.60","启用","医保发〔2023〕30号","国谈药品"]
["1580","ZA09GAC0544010101463","2","参乌益肾片","","限慢性肾衰竭患者。","166635","参乌益肾片","无","薄膜衣片","0.4g","瓶","36","塑料瓶","江苏康缘药业股份有限公司","45.72","修改（支付标准）","医保发〔2023〕30号","国谈药品"]
["1581","ZA09GAC0544010201463","2","参乌益肾片","","限慢性肾衰竭患者。","112862","参乌益肾片","无","薄膜衣片","0.4g","瓶","100","塑料瓶","江苏康缘药业股份有限公司","127.00","修改（支付标准）","医保发〔2023〕30号","国谈药品"]
["1582","XN06ABA225X001010104634","2","草酸艾司西酞普兰口服溶液","","","205285","草酸艾司西酞普兰口服溶液","无","口服溶液剂","按C？？H？？FN？O计:5ml:5mg","盒","10","钠钙玻璃管制口服液体瓶＋口服液瓶用铝塑组合盖","浙江国镜药业有限公司","31.80","启用","医保发〔2023〕30号","竞价药品"]
["1583","XN06ABA225X001020104634","2","草酸艾司西酞普兰口服溶液","","","205286","草酸艾司西酞普兰口服溶液","无","口服溶液剂","按C？？H？？FN？O计:10ml:10mg","盒","10","钠钙玻璃管制口服液体瓶＋口服液瓶用铝塑组合盖","浙江国镜药业有限公司","54.00","启用","医保发〔2023〕30号","竞价药品"]
["1584","XA10BDD366A010020179096","2","达格列净二甲双胍缓释片(Ⅰ)","","","205517","达格列净二甲双胍缓释片( Ⅰ)","无","片剂","达格列净10mg( 以C？？H？？ClO？ 计)和盐酸二甲双胍1000mg","盒","28","铝/铝泡罩包装","AstraZeneca Pharmaceuticals LP","116.48","启用","医保发〔2023〕30号","国谈药品"]
["1585","XA10BDD366A010020279096","2","达格列净二甲双胍缓释片(Ⅰ)","","","206495","达格列净二甲双胍缓释片( Ⅰ)","无","片剂","达格列净10mg( 以C？？H？？ClO？ 计)和盐酸二甲双胍1000mg","盒","56","铝/铝泡罩包装","AstraZeneca Pharmaceuticals LP","232.96","启用","医保发〔2023〕30号","国谈药品"]
["1586","XA10BDD366A010020379096","2","达格列净二甲双胍缓释片(Ⅰ)","","","205313","达格列净二甲双胍缓释片( Ⅰ)","无","片剂","达格列净10mg( 以C？？H？？ClO？ 计)和盐酸二甲双胍1000mg","盒","14","铝/铝泡罩包装","AstraZeneca Pharmaceuticals LP","58.24","启用","医保发〔2023〕30号","国谈药品"]
["1587","XR01ACD361L025010181450","2","氮？斯汀氟替卡松鼻喷雾剂","","限12岁及以上单一鼻用抗组胺药或糖皮质激素治疗效果不佳的中至重度季节性过敏性鼻炎和常年性过敏性鼻炎患者。","310143","氮？斯汀氟替卡松鼻喷雾剂","无","鼻用制剂","每瓶120喷,每喷含盐酸氮？斯汀137μg和丙酸氟替卡松50μg","盒","1","中硼硅玻璃管制注射剂瓶(棕色)和药用喷雾剂泵。","长风药业股份有限公司","89.60","启用","医保发〔2023〕30号","竞价药品"]
["1588","XN05BAD088L025010184797","2","地西泮鼻喷雾剂","","限6岁及以上儿童和成人癫痫患者的丛集性癫痫发作/急性反复性癫痫发作的急性治疗。","206422","地西泮鼻喷雾剂","无","鼻用喷雾剂","0.1ml:10mg","盒","2","吸入剂用中硼硅玻璃管制玻璃瓶及氯化丁基橡胶塞,配备单剂量药用喷雾剂泵。","Renaissance Lakewood LLC","741.20","启用","医保发〔2023〕30号","国谈药品"]
["1589","XN05BAD088L025010284797","2","地西泮鼻喷雾剂","","限6岁及以上儿童和成人癫痫患者的丛集性癫痫发作/急性反复性癫痫发作的急性治疗。","60028","地西泮鼻喷雾剂","无","鼻用喷雾剂","0.1ml:10mg","盒","4","吸入剂用中硼硅玻璃管制玻璃瓶及氯化丁基橡胶塞,配备单剂量药用喷雾剂泵。","Renaissance Lakewood LLC","1482.40","启用","医保发〔2023〕30号","国谈药品"]
["1590","XN05BAD088L025020184797","2","地西泮鼻喷雾剂","","限6岁及以上儿童和成人癫痫患者的丛集性癫痫发作/急性反复性癫痫发作的急性治疗。","60029","地西泮鼻喷雾剂","无","鼻用喷雾剂","0.1ml:7.5mg","盒","4","吸入剂用中硼硅玻璃管制玻璃瓶及氯化丁基橡胶塞,配备单剂量药用喷雾剂泵。","Renaissance Lakewood LLC","1189.36","启用","医保发〔2023〕30号","国谈药品"]
["1591","XN05BAD088L025030184797","2","地西泮鼻喷雾剂","","限6岁及以上儿童和成人癫痫患者的丛集性癫痫发作/急性反复性癫痫发作的急性治疗。","60030","地西泮鼻喷雾剂","无","鼻用喷雾剂","0.1ml:5mg","盒","2","吸入剂用中硼硅玻璃管制玻璃瓶及氯化丁基橡胶塞,配备单剂量药用喷雾剂泵。","Renaissance Lakewood LLC","436.00","启用","医保发〔2023〕30号","国谈药品"]
["1592","XN07XXD353A001010179179","2","丁苯那嗪片","","限亨廷顿病相关的舞蹈症。","60022","丁苯那嗪片","无","片剂","12.5mg","瓶","112","高密度聚乙烯瓶,带儿童安全阻开盖。","Sun Pharmaceutical Industries Ltd.","850.08","启用","医保发〔2023〕30号","竞价药品"]
["1593","XN07XXD353A001020179179","2","丁苯那嗪片","","限亨廷顿病相关的舞蹈症。","60023","丁苯那嗪片","无","片剂","25mg","瓶","112","高密度聚乙烯瓶,带儿童安全阻开盖。","Sun Pharmaceutical Industries Ltd.","1444.80","启用","医保发〔2023〕30号","竞价药品"]
["1594","XM09AXD370B002010181788","2","丁甘交联玻璃酸钠注射液","","限对非药物保守治疗及单纯止痛药物治疗(如对乙酰氨基酚)疼痛缓解效果欠佳的膝骨关节炎(OA)成人患者。","60027","丁甘交联玻璃酸钠注射液","无","注射剂","3ml: 60mg(按玻璃酸钠计)","盒","1","采用3ml COC预灌封注射器组合件和预灌封注射器用涂层溴化丁基橡胶活塞","LG Chem, Ltd.","980.00","启用","医保发〔2023〕30号","国谈药品"]
["1595","XL01EMD359E001020184089","2","度维利塞胶囊","","限既往接受过至少两种系统性治疗的复发或难治性滤泡性淋巴瘤成人患者。","203880","度维利塞胶囊","克必妥","胶囊剂","25mg","盒","56","铝塑泡罩","Catalent CTS, LLC","5012.00","启用","医保发〔2023〕30号","国谈药品"]
["1596","XA10BXD360A001010100648","2","多格列艾汀片","","限2型糖尿病患者。","202461","多格列艾汀片","华堂宁","片剂","75mg","盒","28","聚氯乙烯/聚乙烯/聚偏二氯乙烯固体药用复合硬片和药用铝箔包装","上海迪赛诺生物医药有限公司","150.92","启用","医保发〔2023〕30号","国谈药品"]
["1597","XV02DXD352B002010178432","2","多种微量元素注射液(Ⅲ)","","限与肠外营养药物配合使用时支付，单独使用不予支付。","206599","多种微量元素注射液(Ⅲ)","无","注射剂","10ml/支","支","1","聚丙烯安瓿","Fresenius Kabi Norge AS","34.50","启用","医保发〔2023〕30号","国谈药品"]
["1598","XV02DXD352B002010278432","2","多种微量元素注射液(Ⅲ)","","限与肠外营养药物配合使用时支付，单独使用不予支付。","206598","多种微量元素注射液(Ⅲ)","无","注射剂","10ml","盒","20","聚丙烯安瓿","Fresenius Kabi Norge AS","690.00","启用","医保发〔2023〕30号","国谈药品"]
["1599","XB03XAE097A001010200553","2","恩那度司他片","","限非透析的成人慢性肾脏病(CKD)患者。","206501","恩那度司他片","无","薄膜衣片","4mg","盒","14","聚氯乙烯固体药用硬片和药用铝箔包装","深圳信立泰药业股份有限公司","363.02","启用","医保发〔2023〕30号","国谈药品"]
["1600","XB03XAE097A001010300553","2","恩那度司他片","","限非透析的成人慢性肾脏病(CKD)患者。","206502","恩那度司他片","无","薄膜衣片","4mg","盒","28","聚氯乙烯固体药用硬片和药用铝箔包装","深圳信立泰药业股份有限公司","726.04","启用","医保发〔2023〕30号","国谈药品"]
["1601","XB03XAE097A001010400553","2","恩那度司他片","","限非透析的成人慢性肾脏病(CKD)患者。","206503","恩那度司他片","无","薄膜衣片","4mg","盒","56","聚氯乙烯固体药用硬片和药用铝箔包装","深圳信立泰药业股份有限公司","1452.08","启用","医保发〔2023〕30号","国谈药品"]
["1602","XB03XAE097A001020100553","2","恩那度司他片","","限非透析的成人慢性肾脏病(CKD)患者。","206498","恩那度司他片","无","薄膜衣片","2mg","盒","7","聚氯乙烯固体药用硬片和药用铝箔包装","深圳信立泰药业股份有限公司","106.75","启用","医保发〔2023〕30号","国谈药品"]
["1603","XB03XAE097A001020200553","2","恩那度司他片","","限非透析的成人慢性肾脏病(CKD)患者。","206499","恩那度司他片","无","薄膜衣片","2mg","盒","14","聚氯乙烯固体药用硬片和药用铝箔包装","深圳信立泰药业股份有限公司","213.50","启用","医保发〔2023〕30号","国谈药品"]
["1604","XB03XAE097A001020300553","2","恩那度司他片","","限非透析的成人慢性肾脏病(CKD)患者。","206500","恩那度司他片","无","薄膜衣片","2mg","盒","28","聚氯乙烯固体药用硬片和药用铝箔包装","深圳信立泰药业股份有限公司","427.00","启用","医保发〔2023〕30号","国谈药品"]
["1605","XB03XAE097A001030100553","2","恩那度司他片","","限非透析的成人慢性肾脏病(CKD)患者。","206496","恩那度司他片","无","薄膜衣片","1mg","盒","7","聚氯乙烯固体药用硬片和药用铝箔包装","深圳信立泰药业股份有限公司","62.79","启用","医保发〔2023〕30号","国谈药品"]
["1606","XB03XAE097A001030200553","2","恩那度司他片","","限非透析的成人慢性肾脏病(CKD)患者。","206497","恩那度司他片","无","薄膜衣片","1mg","盒","14","聚氯乙烯固体药用硬片和药用铝箔包装","深圳信立泰药业股份有限公司","125.58","启用","医保发〔2023〕30号","国谈药品"]
["1607","XB03XAE097A001010100553","2","恩那度司他片","","限非透析的成人慢性肾脏病(CKD)患者。","204307","恩那度司他片","无","薄膜衣片","4mg","盒","7","聚氯乙烯固体药用硬片和药用铝箔包装","深圳信立泰药业股份有限公司","181.51","启用","医保发〔2023〕30号","国谈药品"]
["1608","XL01EXE094E001010181735","2","恩曲替尼胶囊","","限：1.12岁及以上，经充分验证的检测方法诊断为携带神经营养酪氨酸受体激酶(NTRK)融合基因且不包括已知获得性耐药突变的实体瘤：患有局部晚期、转移性疾病或手术切除可能导致严重并发症的患者，或无满意替代治疗或既往治疗失败的患者；2. ROS1阳性的局部晚期或转移性非小细胞肺癌(NSCLC)成人患者。","206423","恩曲替尼胶囊","罗圣全","胶囊剂","100mg","盒","30","口服固体药用高密度聚乙烯瓶及口服固体药用防潮组合瓶盖包装","Mayne Pharma Inc.","2964.60","启用","医保发〔2023〕30号","国谈药品"]
["1609","XL01EXE094E001020181735","2","恩曲替尼胶囊","","限：1.12岁及以上，经充分验证的检测方法诊断为携带神经营养酪氨酸受体激酶(NTRK)融合基因且不包括已知获得性耐药突变的实体瘤：患有局部晚期、转移性疾病或手术切除可能导致严重并发症的患者，或无满意替代治疗或既往治疗失败的患者；2. ROS1阳性的局部晚期或转移性非小细胞肺癌(NSCLC)成人患者。","177124","恩曲替尼胶囊","罗圣全","胶囊剂","200mg","盒","90","口服固体药用高密度聚乙烯瓶及口服固体药用防潮组合瓶盖包装。","Mayne Pharma Inc.","15120.00","启用","医保发〔2023〕30号","国谈药品"]
["1610","XL01EKF736A001010104611","2","伏罗尼布片","","限与依维莫司联合，用于既往接受过酪氨酸激酶抑制剂治疗失败的晚期肾细胞癌(RCC)患者。","204780","伏罗尼布片","伏美纳","薄膜衣片","100mg","盒","20","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药品包装用铝箔包装。","贝达药业股份有限公司","2510.00","启用","医保发〔2023〕30号","国谈药品"]
["1611","XS01BAF091J005010184257","2","氟轻松玻璃体内植入剂","","限累及眼后段的慢性非感染性葡萄膜炎。","205290","氟轻松玻璃体内植入剂","无","眼用制剂","0.18mg","盒","1","植入剂预装于无菌单剂量注射器中并配备 25ga 针头,装入无菌铝箔袋密封,再装入 Tyvek 袋密封,外加纸盒包装","EyePoint Pharmaceuticals US, Inc.","27888.00","启用","医保发〔2023〕30号","国谈药品"]
["1612","XB05BAF737B002010178433","2","复方氨基酸(16AA)/葡萄糖(12.6%)电解质注射液","","需经营养风险筛查，明确具有营养风险，且不能经饮食或“肠内营养剂”补充足够营养的住院患者方予支付。","206504","复方氨基酸(16AA)/葡萄糖(12.6%)电解质注射液","无","注射剂","1000ml[复方氨基酸(16AA)电解质注射液500ml；葡萄糖注射液(12.6%)500ml]","袋","1","三层共挤两腔输液袋装","Fresenius Kabi Austria GmbH","109.00","启用","医保发〔2023〕30号","国谈药品"]
["1613","XB05BAF737B002010278433","2","复方氨基酸(16AA)/葡萄糖(12.6%)电解质注射液","","需经营养风险筛查，明确具有营养风险，且不能经饮食或“肠内营养剂”补充足够营养的住院患者方予支付。","206505","复方氨基酸(16AA)/葡萄糖(12.6%)电解质注射液","无","注射剂","1000ml[复方氨基酸(16AA)电解质注射液500ml；葡萄糖注射液(12.6%)500ml]","箱","6","三层共挤两腔输液袋装","Fresenius Kabi Austria GmbH","654.00","启用","医保发〔2023〕30号","国谈药品"]
["1614","XB05BAF737B002020178433","2","复方氨基酸(16AA)/葡萄糖(12.6%)电解质注射液","","需经营养风险筛查，明确具有营养风险，且不能经饮食或“肠内营养剂”补充足够营养的住院患者方予支付。","206506","复方氨基酸(16AA)/葡萄糖(12.6%)电解质注射液","无","注射剂","1500ml[复方氨基酸(16AA)电解质注射液750ml；葡萄糖注射液(12.6%)750ml]","袋","1","三层共挤两腔输液袋装","Fresenius Kabi Austria GmbH","148.67","启用","医保发〔2023〕30号","国谈药品"]
["1615","XB05BAF737B002020278433","2","复方氨基酸(16AA)/葡萄糖(12.6%)电解质注射液","","需经营养风险筛查，明确具有营养风险，且不能经饮食或“肠内营养剂”补充足够营养的住院患者方予支付。","206507","复方氨基酸(16AA)/葡萄糖(12.6%)电解质注射液","无","注射剂","1500ml[复方氨基酸(16AA)电解质注射液750ml；葡萄糖注射液(12.6%)750ml]","箱","4","三层共挤两腔输液袋装","Fresenius Kabi Austria GmbH","594.68","启用","医保发〔2023〕30号","国谈药品"]
["1616","XB05BAF737B002030178433","2","复方氨基酸(16AA)/葡萄糖(12.6%)电解质注射液","","需经营养风险筛查，明确具有营养风险，且不能经饮食或“肠内营养剂”补充足够营养的住院患者方予支付。","206508","复方氨基酸(16AA)/葡萄糖(12.6%)电解质注射液","无","注射剂","2000ml[复方氨基酸(16AA)电解质注射液1000ml；葡萄糖注射液(12.6%)1000ml]","袋","1","三层共挤两腔输液袋装","Fresenius Kabi Austria GmbH","185.30","启用","医保发〔2023〕30号","国谈药品"]
["1617","XB05BAF737B002030278433","2","复方氨基酸(16AA)/葡萄糖(12.6%)电解质注射液","","需经营养风险筛查，明确具有营养风险，且不能经饮食或“肠内营养剂”补充足够营养的住院患者方予支付。","206509","复方氨基酸(16AA)/葡萄糖(12.6%)电解质注射液","无","注射剂","2000ml[复方氨基酸(16AA)电解质注射液1000ml；葡萄糖注射液(12.6%)1000ml]","箱","4","三层共挤两腔输液袋装","Fresenius Kabi Austria GmbH","741.20","启用","医保发〔2023〕30号","国谈药品"]
["1618","XB05BBF735B002010283607","2","复方电解质醋酸钠葡萄糖注射液","","","206510","复方电解质醋酸钠葡萄糖注射液","无","注射剂","250ml","箱","40","五层共挤输液用袋","江苏大红鹰恒顺药业有限公司","1230.00","启用","医保发〔2023〕30号","竞价药品"]
["1619","XB05BBF735B002020283607","2","复方电解质醋酸钠葡萄糖注射液","","","206511","复方电解质醋酸钠葡萄糖注射液","无","注射剂","500ml","箱","30","五层共挤输液用袋","江苏大红鹰恒顺药业有限公司","1568.40","启用","医保发〔2023〕30号","竞价药品"]
["1620","XB05BBF735B002010183607","2","复方电解质醋酸钠葡萄糖注射液","","","202793","复方电解质醋酸钠葡萄糖注射液","无","注射剂","250ml","袋","1","五层共挤输液用袋","江苏大红鹰恒顺药业有限公司","30.75","启用","医保发〔2023〕30号","竞价药品"]
["1621","XB05BBF735B002020183607","2","复方电解质醋酸钠葡萄糖注射液","","","202795","复方电解质醋酸钠葡萄糖注射液","无","注射剂","500ml","袋","1","五层共挤输液用袋","江苏大红鹰恒顺药业有限公司","52.28","启用","医保发〔2023〕30号","竞价药品"]
["1622","XB05BBF735B002010102525","2","复方电解质醋酸钠葡萄糖注射液","","","205212","复方电解质醋酸钠葡萄糖注射液","无","注射剂","500ml","袋","1","五层共挤输液用袋","西安万隆制药股份有限公司","37.80","启用","医保发〔2023〕30号","竞价药品"]
["1623","ZC01AAF0817010104336","2","复方黄黛片","","限初治的急性早幼粒细胞白血病。","143243","复方黄黛片","无","薄膜衣片","0.27g","瓶","100","塑料瓶","天长亿帆制药有限公司","994.00","修改（支付标准）","医保发〔2023〕30号","国谈药品"]
["1624","XA06ADF336P001010100233","2","复方聚乙二醇(3350)电解质散","","限2岁至11岁儿童慢性便秘。","176988","复方聚乙二醇(3350)电解质散","无","散剂","6.9g/袋","盒","10","聚酯/铝/聚乙烯药用复合膜","舒泰神(北京)生物制药股份有限公司","37.20","启用","医保发〔2023〕30号","国谈药品"]
["1625","XN02AXA389B002010101435","2","富马酸奥赛利定注射液","","","206515","富马酸奥赛利定注射液","无","注射剂","1ml:1mg(按C？？H？？N？O？S计)","盒","5","中硼硅玻璃管制注射剂瓶,注射液用局部覆聚四氟乙烯膜氯化丁基橡胶塞,抗生素瓶用铝塑组合盖。","江苏恩华药业股份有限公司","119.25","启用","医保发〔2023〕30号","国谈药品"]
["1626","XN02AXA389B002010201435","2","富马酸奥赛利定注射液","","","206514","富马酸奥赛利定注射液","无","注射剂","1ml:1mg(按C？？H？？N？O？S计)","支","1","中硼硅玻璃管制注射剂瓶,注射液用局部覆聚四氟乙烯膜氯化丁基橡胶塞,抗生素瓶用铝塑组合盖。","江苏恩华药业股份有限公司","23.85","启用","医保发〔2023〕30号","国谈药品"]
["1627","XN02AXA389B002020101435","2","富马酸奥赛利定注射液","","","206513","富马酸奥赛利定注射液","无","注射剂","10ml:10mg(按C？？H？？N？O？S计)","盒","5","中硼硅玻璃管制注射剂瓶,注射液用局部覆聚四氟乙烯膜氯化丁基橡胶塞,抗生素瓶用铝塑组合盖。","江苏恩华药业股份有限公司","695.00","启用","医保发〔2023〕30号","国谈药品"]
["1628","XN02AXA389B002020201435","2","富马酸奥赛利定注射液","","","206512","富马酸奥赛利定注射液","无","注射剂","10ml:10mg(按C？？H？？N？O？S计)","支","1","中硼硅玻璃管制注射剂瓶,注射液用局部覆聚四氟乙烯膜氯化丁基橡胶塞,抗生素瓶用铝塑组合盖。","江苏恩华药业股份有限公司","139.00","启用","医保发〔2023〕30号","国谈药品"]
["1629","XN02AXA389B002030101435","2","富马酸奥赛利定注射液","","","206517","富马酸奥赛利定注射液","无","注射剂","2ml:2mg(按C？？H？？N？O？S计)","盒","5","中硼硅玻璃管制注射剂瓶,注射液用局部覆聚四氟乙烯膜氯化丁基橡胶塞,抗生素瓶用铝塑组合盖。","江苏恩华药业股份有限公司","202.70","启用","医保发〔2023〕30号","国谈药品"]
["1630","XN02AXA389B002030201435","2","富马酸奥赛利定注射液","","","206516","富马酸奥赛利定注射液","无","注射剂","2ml:2mg(按C？？H？？N？O？S计)","支","1","中硼硅玻璃管制注射剂瓶,注射液用局部覆聚四氟乙烯膜氯化丁基橡胶塞,抗生素瓶用铝塑组合盖。","江苏恩华药业股份有限公司","40.54","启用","医保发〔2023〕30号","国谈药品"]
["1631","XN02AXA389B002040101435","2","富马酸奥赛利定注射液","","","206519","富马酸奥赛利定注射液","无","注射剂","30ml:30mg(按C？？H？？N？O？S计)","盒","5","中硼硅玻璃管制注射剂瓶,注射液用局部覆聚四氟乙烯膜氯化丁基橡胶塞,抗生素瓶用铝塑组合盖。","江苏恩华药业股份有限公司","1611.55","启用","医保发〔2023〕30号","国谈药品"]
["1632","XN02AXA389B002040201435","2","富马酸奥赛利定注射液","","","206518","富马酸奥赛利定注射液","无","注射剂","30ml:30mg(按C？？H？？N？O？S计)","支","1","中硼硅玻璃管制注射剂瓶,注射液用局部覆聚四氟乙烯膜氯化丁基橡胶塞,抗生素瓶用铝塑组合盖。","江苏恩华药业股份有限公司","322.31","启用","医保发〔2023〕30号","国谈药品"]
["1633","XA10AEG191B002010183807","2","甘精胰岛素利司那肽注射液(Ⅰ)","","限血糖控制不佳的成人2型糖尿病患者。","203617","甘精胰岛素利司那肽注射液(Ⅰ)","赛益宁","注射剂","预填充笔,3ml:300单位甘精胰岛素 ＋ 300 μg利司那肽","盒","1","笔芯(I型无色玻璃)带有一个黑色的活塞(溴化丁基橡胶)和一个含垫片(异戊二烯层压和溴化丁基橡胶)的凸缘铝盖。笔芯密封在一个用完即弃的笔式注射器内。每个笔芯内装有3 ml药液。","Sanofi-Aventis Deutschland GmbH","226.58","启用","医保发〔2023〕30号","国谈药品"]
["1634","XA10AEG192B002010182160","2","甘精胰岛素利司那肽注射液(Ⅱ)","","限血糖控制不佳的成人2型糖尿病患者。","204316","甘精胰岛素利司那肽注射液(Ⅱ)","无","注射剂","预填充笔, 3ml: 300单位甘 精胰岛素 ＋ 150 μg利司那肽","盒","1","笔芯(I型无色玻璃)带有一个黑色的活塞(溴化丁基橡胶)和一个含垫片(异戊二烯层压和溴化丁基橡胶)的凸缘铝盖。笔芯密封在一个用完即弃的笔式注射器内。每个笔芯内装有3 ml药液。","Sanofi-Aventis Deutschland GmbH","160.00","启用","医保发〔2023〕30号","国谈药品"]
["1635","XB05ZBJ252B001010183618","2","枸橼酸钠血滤置换液","","","60024","枸橼酸钠血滤置换液","无","注射剂","5000ml","袋","1","非PVC内包装袋由三层共挤输液用膜和三层共挤输液用管制成,配有加药口组合件和鲁尔接头组合件。次级包装为外包装袋。","Bieffe Medital S.p.A.","155.00","启用","医保发〔2023〕30号","国谈药品"]
["1636","XL01EXG193A001010183970","2","谷美替尼片","","限具有间质-上皮转化因子(MET)外显子14跳变的局部晚期或转移性非小细胞肺癌。","203512","谷美替尼片","海益坦","片剂","50mg(按 C21H17N9O2S 计)","盒","24","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药用铝箔的泡罩包装。","江苏宣泰药业有限公司","2400.00","启用","医保发〔2023〕30号","国谈药品"]
["1637","XA11CCG111X001010105999","2","骨化三醇口服溶液","","限：1.绝经后骨质疏松；2.慢性肾功能衰竭，尤其是接受血液透析患者之肾性骨营养不良症；3.术后甲状旁腺功能低下；4.特发性甲状旁腺功能低下；5.假性甲状旁腺功能低下；6.维生素D依赖性佝偻病；7.低血磷性维生素D抵抗型佝偻病等。","206352","骨化三醇口服溶液","无","口服溶液剂","10ml:10μg","盒","1","棕色低硼硅玻璃管制口服液体瓶和注射液用覆乙烯-四氯乙烯共聚物膜丁基橡胶塞","新疆特丰药业股份有限公司","48.90","启用","医保发〔2023〕30号","竞价药品"]
["1638","XA11CCG111X001010104036","2","骨化三醇口服溶液","","限：1.绝经后骨质疏松；2.慢性肾功能衰竭，尤其是接受血液透析患者之肾性骨营养不良症；3.术后甲状旁腺功能低下；4.特发性甲状旁腺功能低下；5.假性甲状旁腺功能低下；6.维生素D依赖性佝偻病；7.低血磷性维生素D抵抗型佝偻病等。","205716","骨化三醇口服溶液","无","口服溶液剂","15ml:15μg","盒","1","棕色低硼硅玻璃管制螺口瓶、口服药用聚丙烯压旋盖,附带一次性使用注射器。","正大制药(青岛)有限公司","66.70","启用","医保发〔2023〕30号","竞价药品"]
["1639","ZB01DAG0513010201951","2","广金钱草总黄酮胶囊","","清热祛湿，利尿排石。用于输尿管结石中医辨证属湿热蕴结证者。","206520","广金钱草总黄酮胶囊","无","胶囊剂","每粒装0.2g(含广金钱草总黄酮提取物133mg)","盒","18","铝塑泡罩,外加聚酯/铝/流延聚丙烯药品包装用复合膜袋包装","武汉康乐药业股份有限公司","85.68","启用","医保发〔2023〕30号","国谈药品"]
["1640","ZB01DAG0513010101951","2","广金钱草总黄酮胶囊","","清热祛湿，利尿排石。用于输尿管结石中医辨证属湿热蕴结证者。","200110","广金钱草总黄酮胶囊","无","胶囊剂","每粒装0.2g(含广金钱草总黄酮提取物133mg)","盒","24","铝塑泡罩,外加聚酯/铝/流延聚丙烯药品包装用复合膜袋包装","武汉康乐药业股份有限公司","114.24","启用","医保发〔2023〕30号","国谈药品"]
["1641","XN06AXD371A010010102770","2","琥珀酸地文拉法辛缓释片","","","205623","琥珀酸地文拉法辛缓释片","无","片剂","50mg(按C？？H？？NO？计)","盒","14","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药品包装用铝箔包装","石药集团欧意药业有限公司","94.08","启用","医保发〔2023〕30号","国谈药品"]
["1642","XL01EFR125A001010178679","2","琥珀酸瑞波西利片","","限激素受体(HR)阳性、人表皮生长因子受体2(HER2)阴性局部晚期或转移性乳腺癌，与芳香化酶抑制剂联合用药作为女性患者的初始内分泌治疗。","206600","琥珀酸瑞波西利片","凯丽隆","片剂","200mg(按C？？H？？N？O计)","盒","21","聚氯乙烯/聚三氟氯乙烯固体药用复合硬片和药用铝箔包装","Novartis Singapore Pharmaceutical Manufacturing Pte. Ltd.","1488.90","启用","医保发〔2023〕30号","国谈药品"]
["1643","XL01EFR125A001010278679","2","琥珀酸瑞波西利片","","限激素受体(HR)阳性、人表皮生长因子受体2(HER2)阴性局部晚期或转移性乳腺癌，与芳香化酶抑制剂联合用药作为女性患者的初始内分泌治疗。","206601","琥珀酸瑞波西利片","凯丽隆","片剂","200mg(按C？？H？？N？O计)","盒","42","聚氯乙烯/聚三氟氯乙烯固体药用复合硬片和药用铝箔包装","Novartis Singapore Pharmaceutical Manufacturing Pte. Ltd.","2977.80","启用","医保发〔2023〕30号","国谈药品"]
["1644","XL01EFR125A001010378679","2","琥珀酸瑞波西利片","","限激素受体(HR)阳性、人表皮生长因子受体2(HER2)阴性局部晚期或转移性乳腺癌，与芳香化酶抑制剂联合用药作为女性患者的初始内分泌治疗。","300418","琥珀酸瑞波西利片","凯丽隆","片剂","200mg(按C？？H？？N？O计)","盒","63","聚氯乙烯/聚三氟氯乙烯固体药用复合硬片和药用铝箔包装","Novartis Singapore Pharmaceutical Manufacturing Pte. Ltd.","4466.70","启用","医保发〔2023〕30号","国谈药品"]
["1645","XB05AAH119B002010179246","2","琥珀酰明胶电解质醋酸钠注射液","","限低血容量性休克或手术创伤、烧伤等引起的显著低血容量患者。","175850","琥珀酰明胶电解质醋酸钠注射液","无","注射剂","500ml:20g","袋","1","五层共挤输液用膜制袋","贝朗医疗(苏州)有限公司","100.00","启用","医保发〔2023〕30号","国谈药品"]
["1646","ZA16BAH0471010200359","2","虎贞清风胶囊","","清热利湿，化瘀利浊，滋补肝肾。用于轻中度急性痛风性关节炎。中医辨证属湿热蕴结证，症见关节疼痛、肿胀、发热、活动受限、口渴、烦闷不安，舌红、苔黄或黄腻、脉滑数。","206522","虎贞清风胶囊","无","胶囊剂","每粒装0.40ｇ（相当于饮片2.33ｇ）","瓶","48","口服固体药用高密度聚乙烯瓶","一力制药股份有限公司","143.52","启用","医保发〔2023〕30号","国谈药品"]
["1647","ZA16BAH0471010100359","2","虎贞清风胶囊","","清热利湿，化瘀利浊，滋补肝肾。用于轻中度急性痛风性关节炎。中医辨证属湿热蕴结证，症见关节疼痛、肿胀、发热、活动受限、口渴、烦闷不安，舌红、苔黄或黄腻、脉滑数。","174853","虎贞清风胶囊","无","胶囊剂","每粒装0.40ｇ（相当于饮片2.33ｇ）","瓶","36","口服固体药用高密度聚乙烯瓶","一力制药股份有限公司","107.64","启用","医保发〔2023〕30号","国谈药品"]
["1648","ZF05AAH0475010104489","2","黄蜀葵花总黄酮口腔贴片","","清心泄热。用于心脾积热所致轻型复发性口腔溃疡(轻型复发性阿弗他溃疡)，症见口腔黏膜溃疡局部红肿、灼热疼痛等。","206524","黄蜀葵花总黄酮口腔贴片","无","片剂","每片重75mg(含黄蜀葵花总黄酮提取物20mg)","盒","15","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药用铝箔","杭州康恩贝制药有限公司","26.25","启用","医保发〔2023〕30号","国谈药品"]
["1649","ZF05AAH0475010204489","2","黄蜀葵花总黄酮口腔贴片","","清心泄热。用于心脾积热所致轻型复发性口腔溃疡(轻型复发性阿弗他溃疡)，症见口腔黏膜溃疡局部红肿、灼热疼痛等。","206525","黄蜀葵花总黄酮口腔贴片","无","片剂","每片重75mg(含黄蜀葵花总黄酮提取物20mg)","盒","20","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药用铝箔","杭州康恩贝制药有限公司","35.00","启用","医保发〔2023〕30号","国谈药品"]
["1650","ZF05AAH0475010304489","2","黄蜀葵花总黄酮口腔贴片","","清心泄热。用于心脾积热所致轻型复发性口腔溃疡(轻型复发性阿弗他溃疡)，症见口腔黏膜溃疡局部红肿、灼热疼痛等。","206523","黄蜀葵花总黄酮口腔贴片","无","片剂","每片重75mg(含黄蜀葵花总黄酮提取物20mg)","盒","10","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药用铝箔","杭州康恩贝制药有限公司","17.50","启用","医保发〔2023〕30号","国谈药品"]
["1651","ZF05AAH0475010404489","2","黄蜀葵花总黄酮口腔贴片","","清心泄热。用于心脾积热所致轻型复发性口腔溃疡(轻型复发性阿弗他溃疡)，症见口腔黏膜溃疡局部红肿、灼热疼痛等。","206526","黄蜀葵花总黄酮口腔贴片","无","片剂","每片重75mg(含黄蜀葵花总黄酮提取物20mg)","盒","30","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药用铝箔","杭州康恩贝制药有限公司","52.50","启用","医保发〔2023〕30号","国谈药品"]
["1652","XJ01AAA367A001010181522","2","甲苯磺酸奥马环素片","","","176070","甲苯磺酸奥马环素片","纽再乐","片剂","0.15g（按C29H40N4O7计）","瓶","14","口服固体药用高密度聚乙烯瓶,内置干燥剂","江苏宣泰药业有限公司","1968.40","启用","医保发〔2023〕30号","国谈药品"]
["1653","XL01EBB256E001010104611","2","甲磺酸贝福替尼胶囊","","限既往经表皮生长因子受体(EGFR)酪氨酸激酶抑制剂(TKI)治疗时或治疗后出现疾病进展，并且经检测确认存在EGFR T790M 突变阳性的局部晚期或转移性非小细胞肺癌(NSCLC)成人患者。","204779","甲磺酸贝福替尼胶囊","赛美纳","胶囊剂","25mg( 按C29H32F3N7O2计)","盒","40","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片、药品包装用铝箔包装","贝达药业股份有限公司","2862.40","启用","医保发〔2023〕30号","国谈药品"]
["1654","XL01XEF727A001010110103","2","甲磺酸伏美替尼片","","限：1.表皮生长因子受体(EGFR)外显子19缺失或外显子21(L858R)置换突变的局部晚期或转移性非小细胞肺癌(NSCLC)成人患者的一线治疗；2.既往因表皮生长因子受体(EGFR)酪氨酸激酶抑制剂(TKI)治疗时或治疗后出现疾病进展，并且经检验确认存在EGFR T790M 突变阳性的局部晚期或转移性非小细胞肺癌成人患者的治疗。","172467","甲磺酸伏美替尼片","艾弗沙","素片","40mg","盒","28","铝箔","江苏艾力斯生物医药有限公司","2494.52","修改（支付标准）","医保发〔2023〕30号","国谈药品"]
["1655","XA16AXA384E001010102807","2","酒石酸艾格司他胶囊","","限经CYP2D6基因型检测为弱代谢型(PMs)、中间代谢型(IMs)或快代谢型(EMs)的Ⅰ型戈谢病(GD1)成年患者。","206396","酒石酸艾格司他胶囊","无","硬胶囊剂","84mg(按C23H36N2O4计)","盒","20","药用铝箔和聚氯乙烯固体药用硬片泡罩包装","纽哈伯药业有限公司","7620.00","启用","医保发〔2023〕30号","国谈药品"]
["1656","XN03AXL371X001010179426","2","拉考沙胺口服溶液","","","206252","拉考沙胺口服溶液","无","口服溶液剂","200ml:2g","盒","1","聚对苯二甲酸乙二醇酯瓶和聚丙烯儿童安全盖(含衬垫),配备口服液体药用短式给药器(带适配器)","Hetero Labs Limited","44.75","启用","医保发〔2023〕30号",""]
["1657","XJ05AXL410A001010100290","2","来瑞特韦片","","限轻中度新型冠状病毒感染(COVID-19)的成年患者。","300419","来瑞特韦片","乐睿灵","片剂","0.2g","盒","30","聚氯乙烯/聚偏二氯乙烯固体药用复合硬片、药用铝箔包装,外套聚酯/铝/聚乙烯药品包装用复合膜。","广东华南药业集团有限公司","470.00","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1658","XN01BBL054V006010100156","2","利多卡因凝胶贴膏","","限带状疱疹患者。","163570","利多卡因凝胶贴膏","无","贴膏剂","每贴(14.0cm×10.0cm)含膏量14g,含利多卡因700mg","袋","4","纸/聚乙烯/铝/聚乙烯药品包装用复合袋","北京泰德制药股份有限公司","70.40","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1659","ZB01BAL0467010101749","2","连榆烧伤膏","","清热解毒，生肌止痛。用于浅Ⅱ°、深Ⅱ°烧烫伤创面的治疗，用药面积不宜超出体表面积的1%。","206424","连榆烧伤膏","无","软膏剂","每1g相当于饮片0.73g,每支装25g","盒","1","聚乙烯/铝/聚乙烯复合药用软膏管","扬子江药业集团江苏制药股份有限公司","100.00","启用","医保发〔2023〕30号","国谈药品"]
["1660","XL01EML407A001010181522","2","林普利塞片","","限既往接受过至少两种系统性治疗的复发或难治性滤泡性淋巴瘤成人患者。","310002","林普利塞片","因他瑞","片剂","20mg","瓶","120","口服固体药用高密度聚乙烯瓶及聚丙烯儿童安全组合瓶盖系统包装","江苏宣泰药业有限公司","11040.00","启用","医保发〔2023〕30号","国谈药品"]
["1661","XA10BHR126A001010101445","2","磷酸瑞格列汀片","","","204817","磷酸瑞格列汀片","瑞泽唐","薄膜衣片","50mg(按C？？H？？F？N？O？计 )","盒","7","本品采用聚氯乙烯固体药用硬片及药用铝箔包装,外加铝箔袋。","江苏恒瑞医药股份有限公司","17.29","启用","医保发〔2023〕30号","国谈药品"]
["1662","XA10BHR126A001020101445","2","磷酸瑞格列汀片","","","204820","磷酸瑞格列汀片","瑞泽唐","薄膜衣片","100mg(按C？？H？？F？N？O？计)","盒","7","本品采用聚氯乙烯固体药用硬片及药用铝箔包装,外加铝箔袋。","江苏恒瑞医药股份有限公司","29.40","启用","医保发〔2023〕30号","国谈药品"]
["1663","XL01XJS283E001010183691","2","磷酸索立德吉胶囊","","限不宜手术或放疗，以及手术或放疗后复发的局部晚期基底细胞癌(BCC)成年患者。","60026","磷酸索立德吉胶囊","奥昔朵","胶囊剂","200mg（按C26H26F3N3O3计）","盒","10","铝塑泡罩包装","Patheon Inc.","2880.00","启用","医保发〔2023〕30号","国谈药品"]
["1664","XL01XJS283E001010283691","2","磷酸索立德吉胶囊","","限不宜手术或放疗，以及手术或放疗后复发的局部晚期基底细胞癌(BCC)成年患者。","176938","磷酸索立德吉胶囊","奥昔朵","胶囊剂","200mg（按C26H26F3N3O3计）","盒","30","铝塑泡罩包装","Patheon Inc.","8640.00","启用","医保发〔2023〕30号","国谈药品"]
["1665","XJ01XXT182A001010201606","2","磷酸特地唑胺片","","限急性细菌性皮肤及皮肤软组织感染。","206527","磷酸特地唑胺片","无","薄膜衣片","200mg","盒","12","铝塑泡罩包装(药用铝箔和聚氯乙烯/聚偏二氯乙烯固体药用复合硬片)","南京正大天晴制药有限公司","1272.00","启用","医保发〔2023〕30号","竞价药品"]
["1666","XJ01XXT182A001010101606","2","磷酸特地唑胺片","","限急性细菌性皮肤及皮肤软组织感染。","202537","磷酸特地唑胺片","无","薄膜衣片","200mg","盒","6","铝塑泡罩包装(药用铝箔和聚氯乙烯/聚偏二氯乙烯固体药用复合硬片)","南京正大天晴制药有限公司","636.00","启用","医保发〔2023〕30号","竞价药品"]
["1667","XJ01XXT182A001010301606","2","磷酸特地唑胺片","","限急性细菌性皮肤及皮肤软组织感染。","205196","磷酸特地唑胺片","无","薄膜衣片","200mg","盒","3","铝塑泡罩包装(药用铝箔和聚氯乙烯/聚偏二氯乙烯固体药用复合硬片)","南京正大天晴制药有限公司","318.00","启用","医保发〔2023〕30号","竞价药品"]
["1668","ZA09AAL0469010101463","2","苓桂术甘颗粒","","温阳化饮，健脾利湿。用于中阳不足之痰饮。症见胸胁支满，目眩心悸，短气而咳，舌苔白滑，脉弦滑。","206528","苓桂术甘颗粒","无","颗粒剂","每袋装16g(相当于饮片55.2g)","盒","9","聚酯/铝/聚乙烯药用复合膜","江苏康缘药业股份有限公司","169.20","启用","医保发〔2023〕30号","国谈药品"]
["1669","XJ02ACA370E001010183103","2","硫酸艾沙康唑胶囊","","限侵袭性曲霉病或侵袭性毛霉病的成人患者。","175879","硫酸艾沙康唑胶囊","康新博","胶囊剂","100 mg(按C22H17F2N5OS计)","盒","14","铝塑/铝泡罩包装,包装中有干燥剂","SwissCo Services AG","2940.00","启用","医保发〔2023〕30号","国谈药品"]
["1670","XL01EEQ180E001010178241","2","硫酸氢司美替尼胶囊","","限3岁及3岁以上伴有症状、无法手术的丛状神经纤维瘤(PN)的I型神经纤维瘤病(NF1)儿童患者。","204128","硫酸氢司美替尼胶囊","科赛优","胶囊剂","10mg( 按C？？H？？BrClFN？O？ 计)","盒","60","口服固体药用高密度聚乙烯白瓶＋口服固体药用儿童安全塑料CR-III盖(由聚合物组成)包装,内置1袋口服固体药用高密度聚乙烯柱状干燥剂","PATHEON PHARMACEUTICALS INCORPORATED","11187.00","启用","医保发〔2023〕30号","国谈药品"]
["1671","XL01EEQ180E001020178241","2","硫酸氢司美替尼胶囊","","限3岁及3岁以上伴有症状、无法手术的丛状神经纤维瘤(PN)的I型神经纤维瘤病(NF1)儿童患者。","204979","硫酸氢司美替尼胶囊","科赛优","胶囊剂","25mg( 按C？？H？？BrClFN？O？ 计)","盒","60","口服固体药用高密度聚乙烯白瓶＋口服固体药用儿童安全塑料CR-III盖(由聚合物组成)包装,内置1袋口服固体药用高密度聚乙烯柱状干燥剂","PATHEON PHARMACEUTICALS INCORPORATED","22560.00","启用","医保发〔2023〕30号","国谈药品"]
["1672","XA06AXL415E002010301606","2","芦比前列酮软胶囊","","限成人慢性特发性便秘的治疗。","206529","芦比前列酮软胶囊","无","胶囊剂","24μg","盒","10","口服固体药用高密度聚乙烯瓶","南京正大天晴制药有限公司","45.20","启用","医保发〔2023〕30号","国谈药品"]
["1673","XA06AXL415E002010401606","2","芦比前列酮软胶囊","","限成人慢性特发性便秘的治疗。","206090","芦比前列酮软胶囊","无","胶囊剂","24μg","盒","28","口服固体药用高密度聚乙烯瓶","南京正大天晴制药有限公司","126.56","启用","医保发〔2023〕30号","国谈药品"]
["1674","XA06AXL415E002010101606","2","芦比前列酮软胶囊","","限成人慢性特发性便秘的治疗。","204882","芦比前列酮软胶囊","无","胶囊剂","24μg","盒","14","口服固体药用高密度聚乙烯瓶","南京正大天晴制药有限公司","63.28","启用","医保发〔2023〕30号","国谈药品"]
["1675","XA06AXL415E002010201606","2","芦比前列酮软胶囊","","限成人慢性特发性便秘的治疗。","205193","芦比前列酮软胶囊","无","胶囊剂","24μg","盒","60","口服固体药用高密度聚乙烯瓶","南京正大天晴制药有限公司","271.20","启用","医保发〔2023〕30号","国谈药品"]
["1676","XB02BXL417A001010184813","2","芦曲泊帕片","","限计划接受手术(含诊断性操作)的慢性肝病伴血小板减少症的成年患者。","206079","芦曲泊帕片","稳可达","片剂","3mg","盒","7","聚酰胺/铝/聚氯乙烯冷冲压成型药用复合硬片及药用铝箔泡罩包装","Quotient Sciences-Philadelphia LLC","4053.00","启用","医保发〔2023〕30号","国谈药品"]
["1677","XA12BAL208X001010104670","2","氯化钾口服溶液","","","204918","氯化钾口服溶液","无","口服溶液","100ml:10g","盒","1","口服液体药用高密度聚乙烯压旋式安全瓶","浙江康恩贝制药股份有限公司","16.88","启用","医保发〔2023〕30号","国谈药品"]
["1678","XC02KXM170A001010178189","2","马昔腾坦片","","限WHO功能分级II级-III级的肺动脉高压(WHO第1组)的患者。","163217","马昔腾坦片","傲朴舒","片剂","10mg","盒","30","铝塑包装","Excella GmbH & Co. KG","4036.50","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1679","XA16AXM157E001010181328","2","麦格司他胶囊","","限C型尼曼匹克病患者。","163505","麦格司他胶囊","泽维可","胶囊剂","100mg","盒","84","铝塑包装","Almac Pharma Services Limited","9903.60","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1680","XA07ECM053E013010105815","2","美沙拉秦肠溶缓释胶囊","","","206530","美沙拉秦肠溶缓释胶囊","无","肠溶缓释胶囊","0.375g","盒","14","聚氯乙烯固体药用硬片、药用铝箔。","海南合瑞制药股份有限公司","70.42","启用","医保发〔2023〕30号","国谈药品"]
["1681","XA07ECM053E013010205815","2","美沙拉秦肠溶缓释胶囊","","","206531","美沙拉秦肠溶缓释胶囊","无","肠溶缓释胶囊","0.375g","盒","28","聚氯乙烯固体药用硬片、药用铝箔。","海南合瑞制药股份有限公司","140.84","启用","医保发〔2023〕30号","国谈药品"]
["1682","XA07ECM053E013010305815","2","美沙拉秦肠溶缓释胶囊","","","203297","美沙拉秦肠溶缓释胶囊","无","肠溶缓释胶囊","0.375g","盒","16","聚氯乙烯固体药用硬片、药用铝箔。","海南合瑞制药股份有限公司","80.48","启用","医保发〔2023〕30号","国谈药品"]
["1683","XA07ECM053E013010405815","2","美沙拉秦肠溶缓释胶囊","","","203298","美沙拉秦肠溶缓释胶囊","无","肠溶缓释胶囊","0.375g","盒","8","聚氯乙烯固体药用硬片、药用铝箔。","海南合瑞制药股份有限公司","40.24","启用","医保发〔2023〕30号","国谈药品"]
["1684","XR03DCM082M002010104021","2","孟鲁司特钠口溶膜","","限：1.1岁至14岁儿童哮喘的预防和长期治疗；2.2岁至14岁儿童季节性过敏性鼻炎和常年性过敏性鼻炎。","206532","孟鲁司特钠口溶膜","无","膜剂","按C35H36ClNO3S计 4mg","盒","7","聚酯/铝/流延聚乙烯药用复合膜包装","齐鲁制药有限公司","29.82","启用","医保发〔2023〕30号","国谈药品"]
["1685","XR03DCM082M002010204021","2","孟鲁司特钠口溶膜","","限：1.1岁至14岁儿童哮喘的预防和长期治疗；2.2岁至14岁儿童季节性过敏性鼻炎和常年性过敏性鼻炎。","206533","孟鲁司特钠口溶膜","无","膜剂","按C35H36ClNO3S计 5mg","盒","7","聚酯/铝/流延聚乙烯药用复合膜包装","齐鲁制药有限公司","35.35","启用","医保发〔2023〕30号","国谈药品"]
["1686","XR03DCM082M002010304021","2","孟鲁司特钠口溶膜","","限：1.1岁至14岁儿童哮喘的预防和长期治疗；2.2岁至14岁儿童季节性过敏性鼻炎和常年性过敏性鼻炎。","206375","孟鲁司特钠口溶膜","无","膜剂","按C35H36ClNO3S计 5mg","盒","14","聚酯/铝/流延聚乙烯药用复合膜包装","齐鲁制药有限公司","70.70","启用","医保发〔2023〕30号","国谈药品"]
["1687","XR03DCM082M002010404021","2","孟鲁司特钠口溶膜","","限：1.1岁至14岁儿童哮喘的预防和长期治疗；2.2岁至14岁儿童季节性过敏性鼻炎和常年性过敏性鼻炎。","206376","孟鲁司特钠口溶膜","无","膜剂","按C35H36ClNO3S计 4mg","盒","14","聚酯/铝/流延聚乙烯药用复合膜包装","齐鲁制药有限公司","59.64","启用","医保发〔2023〕30号","国谈药品"]
["1688","XA16AXN123E001010183654","2","尼替西农胶囊","","限成人和儿童酪氨酸血症Ⅰ型(HT-1)。","60020","尼替西农胶囊","无","胶囊剂","2mg","瓶","60","白色高密度聚乙烯瓶及低密度聚乙烯盖","LABORATOIRES K.A.B.S. INC.","2187.60","启用","医保发〔2023〕30号","竞价药品"]
["1689","XA16AXN123E001030183654","2","尼替西农胶囊","","限成人和儿童酪氨酸血症Ⅰ型(HT-1)。","60021","尼替西农胶囊","无","胶囊剂","10mg","瓶","60","白色高密度聚乙烯瓶及低密度聚乙烯盖","LABORATOIRES K.A.B.S. INC.","7500.00","启用","医保发〔2023〕30号","竞价药品"]
["1690","XA16AXN123E001020183654","2","尼替西农胶囊","","限成人和儿童酪氨酸血症Ⅰ型(HT-1)。","174744","尼替西农胶囊","无","胶囊剂","5mg","瓶","60","白色高密度聚乙烯瓶及低密度聚乙烯盖","LABORATOIRES K.A.B.S. INC.","4411.80","启用","医保发〔2023〕30号","竞价药品"]
["1691","XB03XAP149B002030101444","2","培莫沙肽注射液","","限因慢性肾脏病引起的贫血，包括：1.未接受红细胞生成刺激剂(ESA)治疗的成人非透析患者；2.正在接受短效促红细胞生成素治疗的成人透析患者。","206534","培莫沙肽注射液","圣罗莱","注射剂","1.5ml∶6.0mg","盒","1","预灌封注射器组合件(带注射针)包装","江苏豪森药业集团有限公司","1062.53","启用","医保发〔2023〕30号","国谈药品"]
["1692","XB03XAP149B002010101444","2","培莫沙肽注射液","","限因慢性肾脏病引起的贫血，包括：1.未接受红细胞生成刺激剂(ESA)治疗的成人非透析患者；2.正在接受短效促红细胞生成素治疗的成人透析患者。","204964","培莫沙肽注射液","圣罗莱","注射剂","0.5ml∶2.0mg","盒","1","预灌封注射器组合件(带注射针)包装","江苏豪森药业集团有限公司","458.24","启用","医保发〔2023〕30号","国谈药品"]
["1693","XB03XAP149B002020101444","2","培莫沙肽注射液","","限因慢性肾脏病引起的贫血，包括：1.未接受红细胞生成刺激剂(ESA)治疗的成人非透析患者；2.正在接受短效促红细胞生成素治疗的成人透析患者。","204965","培莫沙肽注射液","圣罗莱","注射剂","1ml∶4.0mg","盒","1","预灌封注射器组合件(带注射针)包装","江苏豪森药业集团有限公司","779.00","启用","医保发〔2023〕30号","国谈药品"]
["1694","XL04ACP147B002010280023","2","佩索利单抗注射液","","限成人泛发性脓疱型银屑病(GPP)。","206313","佩索利单抗注射液","圣利卓","注射剂","450mg(7.5 mL)/瓶","盒","2","中硼硅玻璃管制注射剂瓶和注射制剂用覆聚乙烯-四氟乙烯膜丁基橡胶塞","Boehringer Ingelheim Pharma GmbH & Co. KG","26436.00","启用","医保发〔2023〕30号","国谈药品"]
["1695","XL04ACP147B002010380023","2","佩索利单抗注射液","","限成人泛发性脓疱型银屑病(GPP)。","206297","佩索利单抗注射液","圣利卓","注射剂","450mg(7.5 mL)/瓶","盒","2","中硼硅玻璃管制注射剂瓶和注射制剂用覆聚乙烯-四氟乙烯膜丁基橡胶塞","Boehringer Ingelheim Pharma GmbH & Co. KG","26436.00","启用","医保发〔2023〕30号","国谈药品"]
["1696","XL04ACP147B002010480023","2","佩索利单抗注射液","","限成人泛发性脓疱型银屑病(GPP)。","206224","佩索利单抗注射液","圣利卓","注射剂","450mg(7.5 mL)/瓶","瓶","1","中硼硅玻璃管制注射剂瓶和注射制剂用覆聚乙烯-四氟乙烯膜丁基橡胶塞","Boehringer Ingelheim Pharma GmbH & Co. KG","13218.00","启用","医保发〔2023〕30号","国谈药品"]
["1697","XL04ACP147B002010180023","2","佩索利单抗注射液","","限成人泛发性脓疱型银屑病(GPP)。","204136","佩索利单抗注射液","圣利卓","注射剂","450mg(7.5 mL)/瓶","瓶","1","中硼硅玻璃管制注射剂瓶和注射制剂用覆聚乙烯-四氟乙烯膜丁基橡胶塞","Boehringer Ingelheim Pharma GmbH & Co. KG","13218.00","启用","医保发〔2023〕30号","国谈药品"]
["1698","ZD01AAQ0645010104904","2","芪胶调经颗粒","","益气补血、止血调经。用于上环所致经期延长中医辨证属气血两虚证，症见经血过期不净，月经色淡，神疲乏力，头晕眼花，少腹坠胀，舌淡苔薄白、脉细弱。","206536","芪胶调经颗粒","无","颗粒剂","每袋装8g(相当于饮片14.08g)","盒","10","聚酯/铝/聚乙烯药品包装用复合膜包装。","湖南安邦制药股份有限公司","200.00","启用","医保发〔2023〕30号","国谈药品"]
["1699","ZD01AAQ0645010204904","2","芪胶调经颗粒","","益气补血、止血调经。用于上环所致经期延长中医辨证属气血两虚证，症见经血过期不净，月经色淡，神疲乏力，头晕眼花，少腹坠胀，舌淡苔薄白、脉细弱。","206535","芪胶调经颗粒","无","颗粒剂","每袋装8g(相当于饮片14.08g)","盒","5","聚酯/铝/聚乙烯药品包装用复合膜包装。","湖南安邦制药股份有限公司","100.00","启用","医保发〔2023〕30号","国谈药品"]
["1700","XJ05AXD362A001010184134","2","氢溴酸氘瑞米德韦片","","限轻中度新型冠状病毒感染(COVID-19)的成年患者。","300403","氢溴酸氘瑞米德韦片","民得维","片剂","0.1g","盒","20","塑瓶包装:口服固体药用高密度聚乙烯瓶-圆形瓶、口服固体药用聚丙烯瓶盖-儿童安全塑料Argus Loc盖、药用固体纸袋装硅胶干燥剂。","上海迪赛诺医药集团股份有限公司","263.89","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1701","XJ05AXD362A001010284134","2","氢溴酸氘瑞米德韦片","","限轻中度新型冠状病毒感染(COVID-19)的成年患者。","300404","氢溴酸氘瑞米德韦片","民得维","片剂","0.1g","盒","36","塑瓶包装:口服固体药用高密度聚乙烯瓶-圆形瓶、口服固体药用聚丙烯瓶盖-儿童安全塑料Argus Loc盖、药用固体纸袋装硅胶干燥剂。","上海迪赛诺医药集团股份有限公司","475.00","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1702","XA10BHT196A001010179327","2","氢溴酸替格列汀片","","","200829","氢溴酸替格列汀片","泰里安","片剂","20mg（按C22H30N6OS计）","盒","7","铝塑板包装","Mitsubishi Tanabe Pharma Factory Ltd., Yoshitomi Plant","24.50","启用","医保发〔2023〕30号","竞价药品"]
["1703","XA10BHT196A001010102180","2","氢溴酸替格列汀片","","","204254","氢溴酸替格列汀片","无","片剂","20mg(按C？？H？？N？OS计)","盒","20","聚氯乙烯固体药用硬片/药用铝箔","四川科伦药业股份有限公司","70.00","启用","医保发〔2023〕30号","竞价药品"]
["1704","XL01BCQ174A001010182736","2","曲氟尿苷替匹嘧啶片","","限：既往接受过氟嘧啶类、奥沙利铂和伊立替康为基础的化疗，以及既往接受过或不适合接受抗血管内皮生长因子(VEGF)治疗、抗表皮生长因子受体(EGFR)治疗(RAS野生型)的转移性结直肠癌(mCRC)患者 。","171067","曲氟尿苷替匹嘧啶片","无","片剂","曲氟尿苷15mg,盐酸替匹嘧啶7.065mg相当于替匹嘧啶6.14mg","盒","20","聚丙烯泡罩包装","Taiho Pharmaceutical Co.,Ltd.Kitajima Plant","1107.20","启用","医保发〔2023〕30号","竞价药品"]
["1705","XL01BCQ174A001010282736","2","曲氟尿苷替匹嘧啶片","","限：既往接受过氟嘧啶类、奥沙利铂和伊立替康为基础的化疗，以及既往接受过或不适合接受抗血管内皮生长因子(VEGF)治疗、抗表皮生长因子受体(EGFR)治疗(RAS野生型)的转移性结直肠癌(mCRC)患者 。","171068","曲氟尿苷替匹嘧啶片","无","片剂","曲氟尿苷20mg,盐酸替匹嘧啶9.420mg相当于替匹嘧啶8.19mg","盒","20","聚丙烯泡罩包装","Taiho Pharmaceutical Co.,Ltd.Kitajima Plant","1380.00","启用","医保发〔2023〕30号","竞价药品"]
["1706","XL01BCQ174A001010104021","2","曲氟尿苷替匹嘧啶片","","限：既往接受过氟嘧啶类、奥沙利铂和伊立替康为基础的化疗，以及既往接受过或不适合接受抗血管内皮生长因子(VEGF)治疗、抗表皮生长因子受体(EGFR)治疗(RAS野生型)的转移性结直肠癌(mCRC)患者 。","171802","曲氟尿苷替匹嘧啶片","无","片剂","15 mg规格:曲氟尿苷15 mg,盐酸替匹嘧啶7.065 mg(相当于替匹嘧啶6.14 mg)","盒","20","聚氯乙烯泡罩包装,密封于聚酯/铝/聚乙烯复合袋内,内置固体药用纸袋装硅胶干燥剂","齐鲁制药有限公司","1098.39","启用","医保发〔2023〕30号","竞价药品"]
["1707","XL01BCQ174A001020104021","2","曲氟尿苷替匹嘧啶片","","限：既往接受过氟嘧啶类、奥沙利铂和伊立替康为基础的化疗，以及既往接受过或不适合接受抗血管内皮生长因子(VEGF)治疗、抗表皮生长因子受体(EGFR)治疗(RAS野生型)的转移性结直肠癌(mCRC)患者 。","171800","曲氟尿苷替匹嘧啶片","无","片剂","20mg规格:曲氟尿苷20mg,盐酸替匹嘧啶9.42mg(相当于替匹嘧啶8.19mg)","盒","20","聚氯乙烯泡罩包装,密封于聚酯/铝/聚乙烯复合袋内,内置固体药用纸袋装硅胶干燥剂","齐鲁制药有限公司","1369.00","启用","医保发〔2023〕30号","竞价药品"]
["1708","XL01BCQ174A001010101523","2","曲氟尿苷替匹嘧啶片","","限：既往接受过氟嘧啶类、奥沙利铂和伊立替康为基础的化疗，以及既往接受过或不适合接受抗血管内皮生长因子(VEGF)治疗、抗表皮生长因子受体(EGFR)治疗(RAS野生型)的转移性结直肠癌(mCRC)患者 。","206538","曲氟尿苷替匹嘧啶片","无","片剂","曲氟尿苷20mg与盐酸替匹嘧啶9.420mg","盒","14","双铝泡罩包装,外套聚酯/聚乙烯/铝/聚乙烯药用复合袋密封,每袋内置固体药用纸袋装硅胶干燥剂。","正大天晴药业集团股份有限公司","966.00","启用","医保发〔2023〕30号","竞价药品"]
["1709","XL01BCQ174A001010201523","2","曲氟尿苷替匹嘧啶片","","限：既往接受过氟嘧啶类、奥沙利铂和伊立替康为基础的化疗，以及既往接受过或不适合接受抗血管内皮生长因子(VEGF)治疗、抗表皮生长因子受体(EGFR)治疗(RAS野生型)的转移性结直肠癌(mCRC)患者 。","206537","曲氟尿苷替匹嘧啶片","无","片剂","曲氟尿苷15mg与盐酸替匹嘧啶7.065mg","盒","14","双铝泡罩包装,外套聚酯/聚乙烯/铝/聚乙烯药用复合袋密封,每袋内置固体药用纸袋装硅胶干燥剂。","正大天晴药业集团股份有限公司","775.04","启用","医保发〔2023〕30号","竞价药品"]
["1710","XL01BCQ174A001010301523","2","曲氟尿苷替匹嘧啶片","","限：既往接受过氟嘧啶类、奥沙利铂和伊立替康为基础的化疗，以及既往接受过或不适合接受抗血管内皮生长因子(VEGF)治疗、抗表皮生长因子受体(EGFR)治疗(RAS野生型)的转移性结直肠癌(mCRC)患者 。","173876","曲氟尿苷替匹嘧啶片","无","片剂","曲氟尿苷15mg与盐酸替匹嘧啶7.065mg","盒","20","双铝泡罩包装,外套聚酯/聚乙烯/铝/聚乙烯药用复合袋密封,每袋内置固体药用纸袋装硅胶干燥剂。","正大天晴药业集团股份有限公司","1099.20","启用","医保发〔2023〕30号","竞价药品"]
["1711","XL01BCQ174A001010401523","2","曲氟尿苷替匹嘧啶片","","限：既往接受过氟嘧啶类、奥沙利铂和伊立替康为基础的化疗，以及既往接受过或不适合接受抗血管内皮生长因子(VEGF)治疗、抗表皮生长因子受体(EGFR)治疗(RAS野生型)的转移性结直肠癌(mCRC)患者 。","173877","曲氟尿苷替匹嘧啶片","无","片剂","曲氟尿苷20mg与盐酸替匹嘧啶9.420mg","盒","20","双铝泡罩包装,外套聚酯/聚乙烯/铝/聚乙烯药用复合袋密封,每袋内置固体药用纸袋装硅胶干燥剂。","正大天晴药业集团股份有限公司","1370.00","启用","医保发〔2023〕30号","竞价药品"]
["1712","XL01XCQ110B002010181735","2","曲妥珠单抗注射液(皮下注射)","","限：1.HER2阳性的早期乳腺癌患者的辅助和新辅助治疗，支付不超过12个月；2.HER2阳性的转移性乳腺癌。","202565","曲妥珠单抗注射液(皮下注射)","无","注射剂","600mg(5ml)/瓶","盒","1","西林瓶","F. Hoffmann-La Roche Ltd","4800.00","启用","医保发〔2023〕30号","国谈药品"]
["1713","XH01BAQ117X001010184206","2","去氨加压素口服溶液","","","206539","去氨加压素口服溶液","无","口服溶液剂","15ml:5.4mg( 按C？？H？？N？？O？？S？ 计)","盒","1","钠钙玻璃模制药瓶、药用低密度聚乙烯瓶盖和口服液体药用高密度聚乙烯瓶盖包装","浙江康恩贝制药股份有限公司","299.00","启用","医保发〔2023〕30号","国谈药品"]
["1714","XL01FAR123B002010182454","2","瑞帕妥单抗注射液","","限国际预后指数(IPI)为0～2分的新诊断CD20阳性弥漫大B细胞性非霍奇金淋巴瘤(DLBCL)成人患者。","206540","瑞帕妥单抗注射液","安平希","注射剂","50mg(5ml)/瓶","瓶","1","西林瓶装","神州细胞工程有限公司","792.94","启用","医保发〔2023〕30号","国谈药品"]
["1715","XL01FAR123B002020182454","2","瑞帕妥单抗注射液","","限国际预后指数(IPI)为0～2分的新诊断CD20阳性弥漫大B细胞性非霍奇金淋巴瘤(DLBCL)成人患者。","201323","瑞帕妥单抗注射液","安平希","注射剂","100mg(10ml)/瓶","瓶","1","西林瓶装","神州细胞工程有限公司","1348.00","启用","医保发〔2023〕30号","国谈药品"]
["1716","XL01FAR123B002030182454","2","瑞帕妥单抗注射液","","限国际预后指数(IPI)为0～2分的新诊断CD20阳性弥漫大B细胞性非霍奇金淋巴瘤(DLBCL)成人患者。","201324","瑞帕妥单抗注射液","安平希","注射剂","500mg(50ml)/瓶","瓶","1","西林瓶装","神州细胞工程有限公司","4621.42","启用","医保发〔2023〕30号","国谈药品"]
["1717","XL04ACS281B002010182529","2","萨特利珠单抗注射液","","限≥12岁青少年及成人患者水通道蛋白4(AQP4)抗体阳性的视神经脊髓炎谱系疾病(NMOSD)。","204500","萨特利珠单抗注射液","安适平","注射液","120 mg (1ml)/支","盒","1","预充式注射器(PFS)","Utsunomiya Plant of Chugai Pharma Manufacturing Co., Ltd.","11318.00","启用","医保发〔2023〕30号","国谈药品"]
["1718","XL01XXS286A001010183951","2","塞利尼索片","","限既往接受过治疗且对至少一种蛋白酶体抑制剂，一种免疫调节剂以及一种抗CD38单抗难治的复发或难治性多发性骨髓瘤成人患者。","176749","塞利尼索片","希维奥","片剂","20mg","盒","12","聚氯乙烯/聚三氟氯乙烯/聚氯乙烯固体药用复合硬片和药用铝箔包装","Catalent CTS, LLC","4656.00","启用","医保发〔2023〕30号","国谈药品"]
["1719","XL01XXS286A001010283951","2","塞利尼索片","","限既往接受过治疗且对至少一种蛋白酶体抑制剂，一种免疫调节剂以及一种抗CD38单抗难治的复发或难治性多发性骨髓瘤成人患者。","206541","塞利尼索片","希维奥","片剂","20mg","盒","16","聚氯乙烯/聚三氟氯乙烯/聚氯乙烯固体药用复合硬片和药用铝箔包装","Catalent CTS, LLC","6208.00","启用","医保发〔2023〕30号","国谈药品"]
["1720","ZA16AAS1084010101463","2","散寒化湿颗粒","","散寒化湿、宣肺透邪、辟秽化浊、解毒通络。用于寒湿郁肺所致疫病，症见发热，乏力，周身酸痛，咳嗽，咯痰，胸闷憋气，纳呆，恶心，呕吐，腹泻，大便粘腻不爽；舌质淡胖齿痕或淡红，舌苔白厚腻或腐腻，脉滑或濡。","177097","散寒化湿颗粒","无","颗粒剂","每袋装10g(相当于饮片48g)","盒","10","聚酯/铝/聚乙烯药用复合膜","江苏康缘药业股份有限公司","82.80","启用","医保发〔2023〕30号","国谈药品"]
["1721","XB05CXS291S002010102763","2","山梨醇甘露醇冲洗剂","","限经尿道前列腺切除术及其他泌尿外科手术的术中冲洗。","203188","山梨醇甘露醇冲洗剂","无","冲洗剂","3000ml","袋","1","三层共挤输液用袋","石家庄四药有限公司","168.16","启用","医保发〔2023〕30号","竞价药品"]
["1722","XB03ACS292B002010178941","2","羧基麦芽糖铁注射液","","限口服铁剂无效或无法口服补铁；或临床上需要快速补充铁。","206604","羧基麦芽糖铁注射液","菲新捷","注射剂","按Fe计 2mL:100mg","瓶","1","本品采用 I 型玻璃管型瓶、注射液和注射用无菌粉末用涂膜溴化丁基橡胶塞、抗生素 瓶和输液瓶用铝塑组合盖包装。","IDT Biologika GmbH","85.34","启用","医保发〔2023〕30号","国谈药品"]
["1723","XB03ACS292B002010278941","2","羧基麦芽糖铁注射液","","限口服铁剂无效或无法口服补铁；或临床上需要快速补充铁。","206605","羧基麦芽糖铁注射液","菲新捷","注射剂","按Fe计 2mL:100mg","盒","5","本品采用 I 型玻璃管型瓶、注射液和注射用无菌粉末用涂膜溴化丁基橡胶塞、抗生素 瓶和输液瓶用铝塑组合盖包装。","IDT Biologika GmbH","426.70","启用","医保发〔2023〕30号","国谈药品"]
["1724","XB03ACS292B002020178941","2","羧基麦芽糖铁注射液","","限口服铁剂无效或无法口服补铁；或临床上需要快速补充铁。","206602","羧基麦芽糖铁注射液","菲新捷","注射剂","按Fe计 10mL:500mg","瓶","1","本品采用 I 型玻璃管型瓶、注射液和注射用无菌粉末用涂膜溴化丁基橡胶塞、抗生素瓶和输液瓶用铝塑组合盖包装。","IDT Biologika GmbH","292.56","启用","医保发〔2023〕30号","国谈药品"]
["1725","XB03ACS292B002020278941","2","羧基麦芽糖铁注射液","","限口服铁剂无效或无法口服补铁；或临床上需要快速补充铁。","206603","羧基麦芽糖铁注射液","菲新捷","注射剂","按Fe计 10mL:500mg","盒","5","本品采用 I 型玻璃管型瓶、注射液和注射用无菌粉末用涂膜溴化丁基橡胶塞、抗生素瓶和输液瓶用铝塑组合盖包装。","IDT Biologika GmbH","1462.80","启用","医保发〔2023〕30号","国谈药品"]
["1726","XL03AAT208B002010104870","2","拓培非格司亭注射液","","限前次化疗曾发生重度中性粒细胞减少的患者。","206542","拓培非格司亭注射液","珮金","注射剂","1.0mg(4.0×10^7U)/0.5mL/支(西林瓶式)","盒","1","西林瓶","厦门特宝生物工程股份有限公司","1427.65","启用","医保发〔2023〕30号","国谈药品"]
["1727","XL03AAT208B002040104870","2","拓培非格司亭注射液","","限前次化疗曾发生重度中性粒细胞减少的患者。","206543","拓培非格司亭注射液","珮金","注射剂","2.0mg(8.0×10^7U)/1.0mL/支(西林瓶式)","盒","1","西林瓶","厦门特宝生物工程股份有限公司","2427.00","启用","医保发〔2023〕30号","国谈药品"]
["1728","XL03AAT208B002020104870","2","拓培非格司亭注射液","","限前次化疗曾发生重度中性粒细胞减少的患者。","204708","拓培非格司亭注射液","珮金","注射剂","1.0mg(4.0×10^7U)/0.5mL/支(预充式)","盒","1","预充注射器","厦门特宝生物工程股份有限公司","1437.65","启用","医保发〔2023〕30号","国谈药品"]
["1729","XL03AAT208B002030104870","2","拓培非格司亭注射液","","限前次化疗曾发生重度中性粒细胞减少的患者。","205080","拓培非格司亭注射液","珮金","注射剂","2.0mg(8.0×10^7U)/1.0mL/支(预充式)","盒","1","预充注射器","厦门特宝生物工程股份有限公司","2437.00","启用","医保发〔2023〕30号","国谈药品"]
["1730","XL04ACT207B002010179179","2","替瑞奇珠单抗注射液","","限适合系统治疗或光疗的中度至重度斑块状银屑病成人患者。","206391","替瑞奇珠单抗注射液","益路取","注射剂","100mg(1 ml)/支","盒","1","单次给药预充式注射器,配固定针头和针头盖,装有自动针头护罩","Vetter Pharma-Fertigung GmbH & Co. KG","4360.00","启用","医保发〔2023〕30号","国谈药品"]
["1731","XM01AET056V006010104942","2","酮洛芬凝胶贴膏","","限骨关节炎。","203190","酮洛芬凝胶贴膏","无","贴膏剂","每贴(14×10cm)含膏体13g,含酮洛芬30mg","盒","2","聚酯/铝/流延聚丙烯药用复合膜","湖南九典制药股份有限公司","17.36","启用","医保发〔2023〕30号","国谈药品"]
["1732","XJ01GBT125L020010100545","2","妥布霉素吸入溶液","","限成人伴肺部铜绿假单胞菌感染的支气管扩张症。","206544","妥布霉素吸入溶液","无","吸入制剂","5ml:300mg","支","1","内包装为吸入溶液用低密度聚乙烯瓶,外包装为聚酯/铝/聚乙烯药品包装用复合袋","健康元海滨药业有限公司","253.60","启用","医保发〔2023〕30号","国谈药品"]
["1733","XJ01GBT125L020010200545","2","妥布霉素吸入溶液","","限成人伴肺部铜绿假单胞菌感染的支气管扩张症。","200676","妥布霉素吸入溶液","无","吸入制剂","5ml:300mg","盒","4","内包装为吸入溶液用低密度聚乙烯瓶,外包装为聚酯/铝/聚乙烯药品包装用复合袋","健康元海滨药业有限公司","1014.40","启用","医保发〔2023〕30号","国谈药品"]
["1734","XJ01GBT125L020010300545","2","妥布霉素吸入溶液","","限成人伴肺部铜绿假单胞菌感染的支气管扩张症。","206545","妥布霉素吸入溶液","无","吸入制剂","5ml:300mg","盒","8","内包装为吸入溶液用低密度聚乙烯瓶,外包装为聚酯/铝/聚乙烯药品包装用复合袋","健康元海滨药业有限公司","2028.80","启用","医保发〔2023〕30号","国谈药品"]
["1735","XJ01GBT125L020010400545","2","妥布霉素吸入溶液","","限成人伴肺部铜绿假单胞菌感染的支气管扩张症。","206546","妥布霉素吸入溶液","无","吸入制剂","5ml:300mg","盒","12","内包装为吸入溶液用低密度聚乙烯瓶,外包装为聚酯/铝/聚乙烯药品包装用复合袋","健康元海滨药业有限公司","3043.20","启用","医保发〔2023〕30号","国谈药品"]
["1736","XJ01GBT125L020010500545","2","妥布霉素吸入溶液","","限成人伴肺部铜绿假单胞菌感染的支气管扩张症。","206547","妥布霉素吸入溶液","无","吸入制剂","5ml:300mg","盒","28","内包装为吸入溶液用低密度聚乙烯瓶,外包装为聚酯/铝/聚乙烯药品包装用复合袋","健康元海滨药业有限公司","7100.80","启用","医保发〔2023〕30号","国谈药品"]
["1737","XC01DXW128A001030178262","2","维立西呱片","","限心力衰竭失代偿经静脉治疗后病情稳定的射血分数降低(射血分数<45%)的症状性慢性心力衰竭成人患者。","206548","维立西呱片","唯可同","片剂","10mg","盒","7","铝塑泡罩","Bayer AG","66.15","启用","医保发〔2023〕30号","国谈药品"]
["1738","XC01DXW128A001040178262","2","维立西呱片","","限心力衰竭失代偿经静脉治疗后病情稳定的射血分数降低(射血分数<45%)的症状性慢性心力衰竭成人患者。","206552","维立西呱片","唯可同","片剂","2.5mg","盒","14","铝塑泡罩","Bayer AG","45.78","启用","医保发〔2023〕30号","国谈药品"]
["1739","XC01DXW128A001040278262","2","维立西呱片","","限心力衰竭失代偿经静脉治疗后病情稳定的射血分数降低(射血分数<45%)的症状性慢性心力衰竭成人患者。","206553","维立西呱片","唯可同","片剂","2.5mg","盒","28","铝塑泡罩","Bayer AG","91.56","启用","医保发〔2023〕30号","国谈药品"]
["1740","XC01DXW128A001040378262","2","维立西呱片","","限心力衰竭失代偿经静脉治疗后病情稳定的射血分数降低(射血分数<45%)的症状性慢性心力衰竭成人患者。","206554","维立西呱片","唯可同","片剂","2.5mg","盒","98","铝塑泡罩","Bayer AG","320.46","启用","医保发〔2023〕30号","国谈药品"]
["1741","XC01DXW128A001050178262","2","维立西呱片","","限心力衰竭失代偿经静脉治疗后病情稳定的射血分数降低(射血分数<45%)的症状性慢性心力衰竭成人患者。","206555","维立西呱片","唯可同","片剂","5mg","盒","14","铝塑泡罩","Bayer AG","77.84","启用","医保发〔2023〕30号","国谈药品"]
["1742","XC01DXW128A001050278262","2","维立西呱片","","限心力衰竭失代偿经静脉治疗后病情稳定的射血分数降低(射血分数<45%)的症状性慢性心力衰竭成人患者。","206556","维立西呱片","唯可同","片剂","5mg","盒","28","铝塑泡罩","Bayer AG","155.68","启用","医保发〔2023〕30号","国谈药品"]
["1743","XC01DXW128A001050378262","2","维立西呱片","","限心力衰竭失代偿经静脉治疗后病情稳定的射血分数降低(射血分数<45%)的症状性慢性心力衰竭成人患者。","206557","维立西呱片","唯可同","片剂","5mg","盒","98","铝塑泡罩","Bayer AG","544.88","启用","医保发〔2023〕30号","国谈药品"]
["1744","XC01DXW128A001060178262","2","维立西呱片","","限心力衰竭失代偿经静脉治疗后病情稳定的射血分数降低(射血分数<45%)的症状性慢性心力衰竭成人患者。","206549","维立西呱片","唯可同","片剂","10mg","盒","14","铝塑泡罩","Bayer AG","132.30","启用","医保发〔2023〕30号","国谈药品"]
["1745","XC01DXW128A001060278262","2","维立西呱片","","限心力衰竭失代偿经静脉治疗后病情稳定的射血分数降低(射血分数<45%)的症状性慢性心力衰竭成人患者。","206550","维立西呱片","唯可同","片剂","10mg","盒","28","铝塑泡罩","Bayer AG","264.60","启用","医保发〔2023〕30号","国谈药品"]
["1746","XC01DXW128A001060378262","2","维立西呱片","","限心力衰竭失代偿经静脉治疗后病情稳定的射血分数降低(射血分数<45%)的症状性慢性心力衰竭成人患者。","206551","维立西呱片","唯可同","片剂","10mg","盒","98","铝塑泡罩","Bayer AG","926.10","启用","医保发〔2023〕30号","国谈药品"]
["1747","XC01DXW128A001010178262","2","维立西呱片","","限心力衰竭失代偿经静脉治疗后病情稳定的射血分数降低(射血分数<45%)的症状性慢性心力衰竭成人患者。","176672","维立西呱片","唯可同","片剂","2.5mg","盒","7","铝塑泡罩","Bayer AG","22.89","启用","医保发〔2023〕30号","国谈药品"]
["1748","XC01DXW128A001020178262","2","维立西呱片","","限心力衰竭失代偿经静脉治疗后病情稳定的射血分数降低(射血分数<45%)的症状性慢性心力衰竭成人患者。","176673","维立西呱片","唯可同","片剂","5mg","盒","7","铝塑泡罩","Bayer AG","38.92","启用","医保发〔2023〕30号","国谈药品"]
["1749","XR05CBA198L019020100041","2","吸入用盐酸氨溴索溶液","","","206558","吸入用盐酸氨溴索溶液","无","吸入制剂","2ml:15mg","支","1","低密度聚乙烯瓶,外置铝复合膜袋枕式包装","Hanmi Pharm.Co.,Ltd.","8.50","启用","医保发〔2023〕30号","竞价药品"]
["1750","XR05CBA198L019020179031","2","吸入用盐酸氨溴索溶液","","","206559","吸入用盐酸氨溴索溶液","无","吸入制剂","2ml:15mg","支","1","低密度聚乙烯瓶,外置铝复合膜袋枕式包装","Hanmi Pharm.Co.,Ltd.","8.50","启用","医保发〔2023〕30号","竞价药品"]
["1751","XR05CBA198L019020279031","2","吸入用盐酸氨溴索溶液","","","206561","吸入用盐酸氨溴索溶液","无","吸入制剂","2ml:15mg","盒","24","低密度聚乙烯瓶,外置铝复合膜袋枕式包装","Hanmi Pharm.Co.,Ltd.","204.00","启用","医保发〔2023〕30号","竞价药品"]
["1752","XR05CBA198L019020379031","2","吸入用盐酸氨溴索溶液","","","206560","吸入用盐酸氨溴索溶液","无","吸入制剂","2ml:15mg","盒","12","低密度聚乙烯瓶,外置铝复合膜袋枕式包装","Hanmi Pharm.Co.,Ltd.","102.00","启用","医保发〔2023〕30号","竞价药品"]
["1753","XR05CBA198L019010100041","2","吸入用盐酸氨溴索溶液","","","168605","吸入用盐酸氨溴索溶液","无","吸入制剂","2ml:15mg","盒","24","低密度聚乙烯瓶,外置铝复合膜袋枕式包装。","Hanmi Pharm.Co.,Ltd.","204.00","启用","医保发〔2023〕30号","竞价药品"]
["1754","XA10BDX252A010010101523","2","西格列汀二甲双胍缓释片","","","204217","西格列汀二甲双胍缓释片","无","片剂","磷酸西格列汀50mg(以C？？H？？F？N？O计)和盐酸二甲双胍500mg","盒","60","口服固体药用高密度聚乙烯瓶、固体药用聚乙烯瓶装硅胶干燥剂包装","正大天晴药业集团股份有限公司","209.40","启用","医保发〔2023〕30号","竞价药品"]
["1755","XA10BDX223A010010183135","2","西格列汀二甲双胍缓释片(Ⅱ)","","","206562","西格列汀二甲双胍缓释片( Ⅱ)","无","片剂","每片含磷酸西格列汀50mg(以C？？H？？F？N？O计)和盐酸二甲双胍1000mg","瓶","60","口服固体药用高密度聚乙烯瓶、固体药用纸袋装干燥剂包装","江苏宣泰药业有限公司","208.20","启用","医保发〔2023〕30号","国谈药品"]
["1756","XL01EGX009U001010184516","2","西罗莫司凝胶","","限成人和6岁及以上儿童患者的结节性硬化症相关面部血管纤维瘤。","60025","西罗莫司凝胶","无","凝胶剂","0.2％(10g:20mg)","盒","1","铝管包装","Joto Plant, TOYO Pharmaceutical Co., Ltd.","1788.00","启用","医保发〔2023〕30号","国谈药品"]
["1757","XL01XCX020B002010178635","2","西妥昔单抗注射液","","限：1.RAS基因野生型的转移性结直肠癌；2.头颈部鳞状细胞癌。","176237","西妥昔单抗注射液","爱必妥","注射剂","100mg/20ml/瓶","盒","1","20毫升玻璃瓶(I型玻璃),特氟隆涂层的溴丁橡胶瓶塞及密封件。","Merck Healthcare KGaA","1072.62","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1758","XJ05AXX253A001010105849","2","先诺特韦片/利托那韦片组合包装","","限轻中度新型冠状病毒感染(COVID-19)成年患者。","300394","先诺特韦片/利托那韦片组合包装","先诺欣","片剂","先诺特韦片0.375g/利托那韦片0.1g","盒","30","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药用铝箔包装","海南先声药业有限公司","479.00","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1759","XR01ACA210N001010100151","2","盐酸奥洛他定颗粒","","","206567","盐酸奥洛他定颗粒","无","颗粒剂","2.5mg","盒","10","双向拉伸聚酯/聚乙烯药用复合膜为内包装,聚酯/铝/聚乙烯药用复合袋为外包装","北京四环科宝制药股份有限公司","20.80","启用","医保发〔2023〕30号","国谈药品"]
["1760","XR01ACA210N001010200151","2","盐酸奥洛他定颗粒","","","206569","盐酸奥洛他定颗粒","无","颗粒剂","2.5mg","盒","12","双向拉伸聚酯/聚乙烯药用复合膜为内包装,聚酯/铝/聚乙烯药用复合袋为外包装","北京四环科宝制药股份有限公司","24.96","启用","医保发〔2023〕30号","国谈药品"]
["1761","XR01ACA210N001010300151","2","盐酸奥洛他定颗粒","","","206564","盐酸奥洛他定颗粒","无","颗粒剂","2.5mg","盒","6","双向拉伸聚酯/聚乙烯药用复合膜为内包装,聚酯/铝/聚乙烯药用复合袋为外包装","北京四环科宝制药股份有限公司","12.48","启用","医保发〔2023〕30号","国谈药品"]
["1762","XR01ACA210N001010201503","2","盐酸奥洛他定颗粒","","","206563","盐酸奥洛他定颗粒","无","颗粒剂","2.5mg","盒","2","纸/铝/聚乙烯药用复合膜内包装,聚酯/铝/聚乙烯药用复合膜外包装","江苏万高药业股份有限公司","4.16","启用","医保发〔2023〕30号","国谈药品"]
["1763","XR01ACA210N001010301503","2","盐酸奥洛他定颗粒","","","206565","盐酸奥洛他定颗粒","无","颗粒剂","2.5mg","盒","6","纸/铝/聚乙烯药用复合膜内包装,聚酯/铝/聚乙烯药用复合膜外包装","江苏万高药业股份有限公司","12.48","启用","医保发〔2023〕30号","国谈药品"]
["1764","XR01ACA210N001010401503","2","盐酸奥洛他定颗粒","","","206566","盐酸奥洛他定颗粒","无","颗粒剂","2.5mg","盒","8","纸/铝/聚乙烯药用复合膜内包装,聚酯/铝/聚乙烯药用复合膜外包装","江苏万高药业股份有限公司","16.64","启用","医保发〔2023〕30号","国谈药品"]
["1765","XR01ACA210N001010501503","2","盐酸奥洛他定颗粒","","","206568","盐酸奥洛他定颗粒","无","颗粒剂","2.5mg","盒","10","纸/铝/聚乙烯药用复合膜内包装,聚酯/铝/聚乙烯药用复合膜外包装","江苏万高药业股份有限公司","20.80","启用","医保发〔2023〕30号","国谈药品"]
["1766","XR01ACA210N001010601503","2","盐酸奥洛他定颗粒","","","206570","盐酸奥洛他定颗粒","无","颗粒剂","2.5mg","盒","12","纸/铝/聚乙烯药用复合膜内包装,聚酯/铝/聚乙烯药用复合膜外包装","江苏万高药业股份有限公司","24.96","启用","医保发〔2023〕30号","国谈药品"]
["1767","XR01ACA210N001010101503","2","盐酸奥洛他定颗粒","","","203763","盐酸奥洛他定颗粒","无","颗粒剂","2.5mg","盒","4","纸/铝/聚乙烯药用复合膜内包装,聚酯/铝/聚乙烯药用复合膜外包装","江苏万高药业股份有限公司","8.32","启用","医保发〔2023〕30号","国谈药品"]
["1768","XL04AAA385E001010179518","2","盐酸奥扎莫德胶囊","","限成人复发型多发性硬化。","205282","盐酸奥扎莫德胶囊","热珀西亚","胶囊剂","0.92mg(按C？？H？？N？O？计)","盒","28","聚氯乙烯/聚三氟氯乙烯固体药用复合硬片、泡罩箔(Blisterfoil)包装。","Celgene International Sarl","6006.00","启用","医保发〔2023〕30号","国谈药品"]
["1769","XL04AAA385E001020179518","2","盐酸奥扎莫德胶囊","","限成人复发型多发性硬化。","205283","盐酸奥扎莫德胶囊","热珀西亚","胶囊剂","0.23mg(按C？？H？？N？O？计)/0.46mg(按C？？H？？N？O？计)","盒","7","聚氯乙烯/聚三氟氯乙烯固体药用复合硬片、泡罩箔(Blisterfoil)包装。","Celgene International Sarl","675.42","启用","医保发〔2023〕30号","国谈药品"]
["1770","XR03ACB127L020010182770","2","盐酸丙卡特罗吸入溶液","","","205429","盐酸丙卡特罗吸入溶液","无","吸入用溶液剂","0.5ml:50μg( 按C？？H？？N？O？· HCl·？H？O计)","盒","10","吸入溶液用低密度聚乙烯瓶,密封于聚酯/铝/聚乙烯药品包装用复合袋。","南京华盖制药有限公司","154.00","启用","医保发〔2023〕30号","国谈药品"]
["1771","XR05CBX169X001010104293","2","盐酸溴己新口服溶液","","","200882","盐酸溴己新口服溶液","无","口服溶液剂","40ml:80mg","盒","1","钠钙玻璃药瓶＋口服液瓶用扭断式防盗铝盖,配备有带刻度的量杯","精诚徽药药业股份有限公司","17.76","启用","医保发〔2023〕30号","国谈药品"]
["1772","XR05CBX169X001010204293","2","盐酸溴己新口服溶液","","","60038","盐酸溴己新口服溶液","无","口服溶液剂","40ml:80mg","盒","2","钠钙玻璃模制药瓶＋口服液瓶用扭断式防盗铝盖,配备有带刻度的量杯","精诚徽药药业股份有限公司","35.52","启用","医保发〔2023〕30号","国谈药品"]
["1773","XR05CBX169X001010304293","2","盐酸溴己新口服溶液","","","60039","盐酸溴己新口服溶液","无","口服溶液剂","40ml:80mg","盒","3","钠钙玻璃模制药瓶＋口服液瓶用扭断式防盗铝盖,配备有带刻度的量杯","精诚徽药药业股份有限公司","53.28","启用","医保发〔2023〕30号","国谈药品"]
["1774","XN06ABF098X001010104360","2","盐酸氟西汀口服溶液","","","205043","盐酸氟西汀口服溶液","无","口服溶液剂","70ml:0.28g","盒","1","棕色钠钙玻璃模制药瓶,附带5ml聚乙烯口服给药器","安徽新世纪药业有限公司","62.80","启用","医保发〔2023〕30号","国谈药品"]
["1775","XA02BCK145A001010183061","2","盐酸凯普拉生片","","限：1.十二指肠溃疡；2.反流性食管炎。","202965","盐酸凯普拉生片","无","片剂","10mg(按C？？H？？FN？O？S计)","盒","8","铝塑泡罩包装(聚氯乙烯固体药用硬片、药品包装用铝塑)","南京柯菲平盛辉制药有限公司","45.44","启用","医保发〔2023〕30号","国谈药品"]
["1776","XC02ACK062A010010280923","2","盐酸可乐定缓释片","","限6-17岁儿童和青少年的注意缺陷多动障碍(ADHD)。","206571","盐酸可乐定缓释片","无","片剂","0.1mg","瓶","60","口服固体药用高密度聚乙烯热封垫片瓶","力品药业(厦门)股份有限公司","592.80","启用","医保发〔2023〕30号","国谈药品"]
["1777","XC02ACK062A010010180923","2","盐酸可乐定缓释片","","限6-17岁儿童和青少年的注意缺陷多动障碍(ADHD)。","176710","盐酸可乐定缓释片","无","片剂","0.1mg","瓶","21","口服固体药用高密度聚乙烯热封垫片瓶","力品药业(厦门)股份有限公司","207.48","启用","医保发〔2023〕30号","国谈药品"]
["1778","XS01HAL054G006010181567","2","盐酸利多卡因眼用凝胶","","","206572","盐酸利多卡因眼用凝胶","无","眼用制剂","5ml:0.175g（按C14H22N2O·HCl计）","盒","1","低密度聚乙烯药用滴眼剂瓶装","四川禾亿制药有限公司","33.90","启用","医保发〔2023〕30号","国谈药品"]
["1779","XL01DBM109B018010102777","2","盐酸米托蒽醌脂质体注射液","","限既往至少经过一线标准治疗的复发或难治的外周T细胞淋巴瘤(PTCL)成人患者。","174737","盐酸米托蒽醌脂质体注射液","无","注射剂","10ml:10mg（按C22H28N4O6计）","盒","1","中硼硅玻璃管制注射剂瓶、注射制剂用氯化丁基橡胶塞包装","石药集团中诺药业(石家庄)有限公司","2970.00","启用","医保发〔2023〕30号","国谈药品"]
["1780","XD01ACN126F002010100568","2","盐酸奈康唑乳膏","","","203528","盐酸奈康唑乳膏","无","乳膏剂","1%(10g:0.1g)","盒","1","铝质药用软膏管包装","扬子江药业集团江苏制药股份有限公司","22.50","启用","医保发〔2023〕30号","国谈药品"]
["1781","XN07XXT211A001020184820","2","盐酸替洛利生片","","限发作性睡病成人患者。","60032","盐酸替洛利生片","无","薄膜衣片","18mg","盒","30","口服固体药用高密度聚乙烯瓶,聚丙烯盖和低密度乙烯盖(含干燥剂)包装。","Inpharmasci","1317.00","启用","医保发〔2023〕30号","国谈药品"]
["1782","XN07XXT211A001010184820","2","盐酸替洛利生片","","限发作性睡病成人患者。","60031","盐酸替洛利生片","无","薄膜衣片","4.5mg","盒","30","口服固体药用高密度聚乙烯瓶,聚丙烯盖和低密度乙烯盖(含干燥剂)包装。","Patheon","455.70","启用","医保发〔2023〕30号","国谈药品"]
["1783","XN05CMY189L025010100675","2","盐酸右美托咪定鼻喷雾剂","","限成人术前镇静/抗焦虑。","203185","盐酸右美托咪定鼻喷雾剂","无","鼻用制剂","1ml:500μg,8喷,每喷25μg(按C？？H？？N？计)","盒","1","硼硅玻璃模制药瓶,药用聚丙烯瓶盖和低密度聚乙烯密封垫片。配备药用喷雾剂定量泵。","上海恒瑞医药有限公司","110.80","启用","医保发〔2023〕30号","国谈药品"]
["1784","XN05CMY323B002010202013","2","盐酸右美托咪定氯化钠注射液","","限：1.重症监护患者插管和机械通气时的镇静；2.非插管患者术前和/或术中以及其他程序镇静。","206573","盐酸右美托咪定氯化钠注射液","无","注射剂","20ml︰盐酸右美托咪定80μg(按C13H16N2计)与氯化钠0.18g","盒","2","中硼硅玻璃安瓿","成都倍特药业股份有限公司","54.54","启用","医保发〔2023〕30号","竞价药品"]
["1785","XN05CMY323B002010302013","2","盐酸右美托咪定氯化钠注射液","","限：1.重症监护患者插管和机械通气时的镇静；2.非插管患者术前和/或术中以及其他程序镇静。","206574","盐酸右美托咪定氯化钠注射液","无","注射剂","20ml︰盐酸右美托咪定80μg(按C13H16N2计)与氯化钠0.18g","盒","5","中硼硅玻璃安瓿","成都倍特药业股份有限公司","136.35","启用","医保发〔2023〕30号","竞价药品"]
["1786","XN05CMY323B002010102013","2","盐酸右美托咪定氯化钠注射液","","限：1.重症监护患者插管和机械通气时的镇静；2.非插管患者术前和/或术中以及其他程序镇静。","174040","盐酸右美托咪定氯化钠注射液","无","注射剂","20ml︰盐酸右美托咪定80μg(按C13H16N2计)与氯化钠0.18g","支","1","中硼硅玻璃安瓿","成都倍特药业股份有限公司","27.27","启用","医保发〔2023〕30号","竞价药品"]
["1787","XN05CMY323B002020102013","2","盐酸右美托咪定氯化钠注射液","","限：1.重症监护患者插管和机械通气时的镇静；2.非插管患者术前和/或术中以及其他程序镇静。","174005","盐酸右美托咪定氯化钠注射液","无","注射剂","50ml:盐酸右美托咪定0.2mg(按C13H16N2计)与氯化钠0.45g","盒","1","中硼硅玻璃模制注射剂瓶、注射液用局部覆聚四氟乙烯膜氯化丁基橡胶塞、输液瓶用铝塑组合盖","成都倍特药业股份有限公司","55.00","启用","医保发〔2023〕30号","竞价药品"]
["1788","XN05CMY323B002030102013","2","盐酸右美托咪定氯化钠注射液","","限：1.重症监护患者插管和机械通气时的镇静；2.非插管患者术前和/或术中以及其他程序镇静。","174006","盐酸右美托咪定氯化钠注射液","无","注射剂","100ml︰盐酸右美托咪定0.4mg(按C13H16N2计)与氯化钠0.9g","盒","1","中硼硅玻璃模制注射剂瓶、注射液用局部覆聚四氟乙烯膜氯化丁基橡胶塞、输液瓶用铝塑组合盖。1瓶/盒","成都倍特药业股份有限公司","93.50","启用","医保发〔2023〕30号","竞价药品"]
["1789","XN05CMY323B002010101445","2","盐酸右美托咪定氯化钠注射液","","限：1.重症监护患者插管和机械通气时的镇静；2.非插管患者术前和/或术中以及其他程序镇静。","171868","盐酸右美托咪定氯化钠注射液","无","注射剂","50ml:200μg(按C13H16N2计)","瓶","1","中性硼硅玻璃输液瓶,胶塞,铝塑组合盖","江苏恒瑞医药股份有限公司","55.00","启用","医保发〔2023〕30号","竞价药品"]
["1790","XN05CMY323B002020101445","2","盐酸右美托咪定氯化钠注射液","","限：1.重症监护患者插管和机械通气时的镇静；2.非插管患者术前和/或术中以及其他程序镇静。","171869","盐酸右美托咪定氯化钠注射液","无","注射剂","100ml:400μg(按C13H16N2计)","瓶","1","中性硼硅玻璃输液瓶,胶塞,铝塑组合盖","江苏恒瑞医药股份有限公司","93.50","启用","医保发〔2023〕30号","竞价药品"]
["1791","XN05CMY323B002010101749","2","盐酸右美托咪定氯化钠注射液","","限：1.重症监护患者插管和机械通气时的镇静；2.非插管患者术前和/或术中以及其他程序镇静。","174862","盐酸右美托咪定氯化钠注射液","无","注射剂","50ml:盐酸右美托咪定0.2mg（按C13H16N2计）与氯化钠0.45g","瓶","1","中硼硅玻璃输液瓶","扬子江药业集团有限公司","55.00","启用","医保发〔2023〕30号","竞价药品"]
["1792","XL01EDY342A001020104021","2","伊鲁阿克片","","限既往接受过克唑替尼治疗后疾病进展或对克唑替尼不耐受的间变性淋巴瘤激酶(ALK)阳性的局部晚期或转移性非小细胞肺癌(NSCLC)患者。","206575","伊鲁阿克片","启欣可","薄膜衣片","30mg","盒","30","口服固体药用高密度聚乙烯瓶包装(内含固体药用纸袋装硅胶干燥剂)","齐鲁制药有限公司","2558.70","启用","医保发〔2023〕30号","国谈药品"]
["1793","XL01EDY342A001020204021","2","伊鲁阿克片","","限既往接受过克唑替尼治疗后疾病进展或对克唑替尼不耐受的间变性淋巴瘤激酶(ALK)阳性的局部晚期或转移性非小细胞肺癌(NSCLC)患者。","206576","伊鲁阿克片","启欣可","薄膜衣片","30mg","盒","90","口服固体药用高密度聚乙烯瓶包装(内含固体药用纸袋装硅胶干燥剂)","齐鲁制药有限公司","7676.10","启用","医保发〔2023〕30号","国谈药品"]
["1794","XL01EDY342A001010104021","2","伊鲁阿克片","","限既往接受过克唑替尼治疗后疾病进展或对克唑替尼不耐受的间变性淋巴瘤激酶(ALK)阳性的局部晚期或转移性非小细胞肺癌(NSCLC)患者。","204556","伊鲁阿克片","启欣可","薄膜衣片","60mg","盒","90","口服固体药用高密度聚乙烯瓶包装(内含固体药用纸袋装硅胶干燥剂)","齐鲁制药有限公司","13050.00","启用","医保发〔2023〕30号","国谈药品"]
["1795","XL01EDY342A001010204021","2","伊鲁阿克片","","限既往接受过克唑替尼治疗后疾病进展或对克唑替尼不耐受的间变性淋巴瘤激酶(ALK)阳性的局部晚期或转移性非小细胞肺癌(NSCLC)患者。","204569","伊鲁阿克片","启欣可","薄膜衣片","60mg","盒","30","口服固体药用高密度聚乙烯瓶包装(内含固体药用纸袋装硅胶干燥剂)","齐鲁制药有限公司","4350.00","启用","医保发〔2023〕30号","国谈药品"]
["1796","XL04AAY311B002010182467","2","依库珠单抗注射液","","限：1.阵发性睡眠性血红蛋白尿症(PNH)的患者；2.非典型溶血性尿毒症综合征(aHUS)的患者；3.抗乙酰胆碱受体(AChR)抗体阳性的难治性全身型重症肌无力(gMG)成人患者。","176973","依库珠单抗注射液","舒立瑞","注射液","300mg/30mL","盒","1","玻璃瓶(I类玻璃),附瓶塞(丁基硅胶)和带钳口瓶帽(聚丙烯)的封壳(铝)","Alexion Athlone Manufacturing Facility (AAMF)","2518.00","启用","医保发〔2023〕30号","国谈药品"]
["1797","ZC01AAY0788010100074","2","淫羊藿素软胶囊","","限不适合或患者拒绝接受标准治疗,且既往未接受过全身系统性治疗的、不可切除的肝细胞癌，患者外周血复合标志物满足以下检测指标的至少两项：AFP≥400 ng/mL；TNF-α<2.5 pg/mL；IFN-γ≥7.0 pg/mL。","175953","淫羊藿素软胶囊","无","胶囊剂","每粒装0.4g（含淫羊藿素100mg）","瓶","60","口服固体药用高密度聚乙烯瓶、药用聚酯/铝/聚乙烯封口垫片","北京康而福药业有限责任公司","1020.00","启用","医保发〔2023〕30号","国谈药品"]
["1798","XM01AEY320B002010101599","2","右酮洛芬氨丁三醇注射液","","限成人不适合口服给药的急性中度至重度术后疼痛。","206577","右酮洛芬氨丁三醇注射液","无","注射剂","2ml:50mg","盒","1","中硼硅玻璃安瓿(棕色)","南京正科医药股份有限公司","39.65","启用","医保发〔2023〕30号","国谈药品"]
["1799","XM01AEY320B002010201599","2","右酮洛芬氨丁三醇注射液","","限成人不适合口服给药的急性中度至重度术后疼痛。","204542","右酮洛芬氨丁三醇注射液","无","注射剂","2ml:50mg","盒","6","中硼硅玻璃安瓿(棕色)","南京正科医药股份有限公司","237.90","启用","医保发〔2023〕30号","国谈药品"]
["1800","XL01FAZ111B002010184297","2","泽贝妥单抗注射液","","限CD20阳性弥漫大B细胞淋巴瘤，非特指性(DLBCL，NOS)成人患者。","204164","泽贝妥单抗注射液","安瑞昔","注射剂","100mg(10ml)/瓶","盒","1","中硼硅玻璃管制注射剂瓶装","海正生物制药有限公司","1408.98","启用","医保发〔2023〕30号","国谈药品"]
["1801","XV03AEZ110A005010184511","2","蔗糖羟基氧化铁咀嚼片","","限：1.接受血液透析(HD)或腹膜透析(PD)的成人慢性肾脏病(CKD)患者；2.12岁及以上CKD4-5期(定义为肾小球滤过率<30 mL/min/1.73 m2)或接受透析的CKD儿科患者。","60033","蔗糖羟基氧化铁咀嚼片","维福瑞","片剂","0.5g(按Fe计)","瓶","30","高密度聚乙烯瓶包装,配有聚丙烯儿童安全盖和铝箔感应密封垫片,内有干燥剂和药用棉卷。","Vifor SA","362.40","启用","医保发〔2023〕30号","国谈药品"]
["1802","XV03AEZ110A005010284511","2","蔗糖羟基氧化铁咀嚼片","","限：1.接受血液透析(HD)或腹膜透析(PD)的成人慢性肾脏病(CKD)患者；2.12岁及以上CKD4-5期(定义为肾小球滤过率<30 mL/min/1.73 m2)或接受透析的CKD儿科患者。","60034","蔗糖羟基氧化铁咀嚼片","维福瑞","片剂","0.5g(按Fe计)","瓶","90","高密度聚乙烯瓶包装,配有聚丙烯儿童安全盖和铝箔感应密封垫片,内有干燥剂和药用棉卷。","Vifor SA","1087.20","启用","医保发〔2023〕30号","国谈药品"]
["1803","XB05BAZ097B002040402180","2","中长链脂肪乳/氨基酸(16)/葡萄糖(30%)注射液","","需经营养风险筛查，明确具有营养风险，且不能经饮食或“肠内营养剂”补充足够营养的住院患者方予支付。","206578","中长链脂肪乳/氨基酸（16）/葡萄糖（30%）注射液","无","注射剂","1250ml［中长链脂肪乳注射液250ml；复方氨基酸（16）注射液500ml；复方葡萄糖（30％）注射液500ml］","箱","6","本品采用外阻隔袋三层共挤输液用三室袋装,内外袋间含脱氧剂。","四川科伦药业股份有限公司","1108.08","启用","医保发〔2023〕30号","国谈药品"]
["1804","XB05BAZ097B002050202180","2","中长链脂肪乳/氨基酸(16)/葡萄糖(30%)注射液","","需经营养风险筛查，明确具有营养风险，且不能经饮食或“肠内营养剂”补充足够营养的住院患者方予支付。","206579","中长链脂肪乳/氨基酸（16）/葡萄糖（30%）注射液","无","注射剂","1875ml［中长链脂肪乳注射液375ml；复方氨基酸（16）注射液750ml；复方葡萄糖（30％）注射液750ml］","箱","3","本品采用外阻隔袋三层共挤输液用三室袋装,内外袋间含脱氧剂。","四川科伦药业股份有限公司","755.70","启用","医保发〔2023〕30号","国谈药品"]
["1805","XB05BAZ097B002040202180","2","中长链脂肪乳/氨基酸(16)/葡萄糖(30%)注射液","","需经营养风险筛查，明确具有营养风险，且不能经饮食或“肠内营养剂”补充足够营养的住院患者方予支付。","175872","中长链脂肪乳/氨基酸（16）/葡萄糖（30%）注射液","无","注射剂","1250ml［中长链脂肪乳注射液250ml；复方氨基酸（16）注射液500ml；复方葡萄糖（30％）注射液500ml］","袋","1","本品采用外阻隔袋三层共挤输液用三室袋装,内外袋间含脱氧剂。","四川科伦药业股份有限公司","184.68","启用","医保发〔2023〕30号","国谈药品"]
["1806","XB05BAZ097B002050102180","2","中长链脂肪乳/氨基酸(16)/葡萄糖(30%)注射液","","需经营养风险筛查，明确具有营养风险，且不能经饮食或“肠内营养剂”补充足够营养的住院患者方予支付。","175871","中长链脂肪乳/氨基酸（16）/葡萄糖（30%）注射液","无","注射剂","1875ml［中长链脂肪乳注射液375ml；复方氨基酸（16）注射液750ml；复方葡萄糖（30％）注射液750ml］","袋","1","本品采用外阻隔袋三层共挤输液用三室袋装,内外袋间含脱氧剂。","四川科伦药业股份有限公司","251.90","启用","医保发〔2023〕30号","国谈药品"]
["1807","XR03DXA392B001010181463","2","注射用奥马珠单抗α","","限经吸入型糖皮质激素和长效吸入型β2-肾上腺素受体激动剂治疗后，仍不能有效控制症状的中至重度持续性过敏性哮喘的15岁及以上患者，并需IgE(免疫球蛋白E)介导确诊证据。","204856","注射用奥马珠单抗α","无","注射剂","75mg/瓶","盒","1","西林瓶装","泰州迈博太科药业有限公司","656.47","启用","医保发〔2023〕30号","国谈药品"]
["1808","XR03DXA392B001020181463","2","注射用奥马珠单抗α","","限经吸入型糖皮质激素和长效吸入型β2-肾上腺素受体激动剂治疗后，仍不能有效控制症状的中至重度持续性过敏性哮喘的15岁及以上患者，并需IgE(免疫球蛋白E)介导确诊证据。","204857","注射用奥马珠单抗α","无","注射剂","150mg/瓶","盒","1","西林瓶装","泰州迈博太科药业有限公司","1116.00","启用","医保发〔2023〕30号","国谈药品"]
["1809","XL02AEQ108B015010183253","2","注射用醋酸曲普瑞林微球","","限需要雄激素去势治疗的前列腺癌患者。","206580","注射用醋酸曲普瑞林微球","无","注射剂","3.75mg(按C64H82N18O13计)","盒","1","中硼硅玻璃管制注射剂瓶＋注射用无 菌粉末用卤化丁基橡胶塞(氯化)","上海丽珠制药有限公司","1000.00","启用","医保发〔2023〕30号","国谈药品"]
["1810","XB05BAD346B001010200294","2","注射用多种维生素(13)","","限与肠外营养药物配合使用时支付，单独使用不予支付。","206581","注射用多种维生素(13)","无","注射剂","5ml/瓶","盒","2","低硼硅玻璃管制注射剂瓶、注射用冷冻干燥用氯化丁基橡胶塞、抗生素瓶用铝塑组合盖。","国药集团广东环球制药有限公司","168.00","启用","医保发〔2023〕30号","国谈药品"]
["1811","XB05BAD346B001010300294","2","注射用多种维生素(13)","","限与肠外营养药物配合使用时支付，单独使用不予支付。","206582","注射用多种维生素(13)","无","注射剂","5ml/瓶","盒","5","低硼硅玻璃管制注射剂瓶、注射用冷冻干燥用氯化丁基橡胶塞、抗生素瓶用铝塑组合盖。","国药集团广东环球制药有限公司","420.00","启用","医保发〔2023〕30号","国谈药品"]
["1812","XB05BAD346B001010400294","2","注射用多种维生素(13)","","限与肠外营养药物配合使用时支付，单独使用不予支付。","206583","注射用多种维生素(13)","无","注射剂","5ml/瓶","盒","10","低硼硅玻璃管制注射剂瓶、注射用冷冻干燥用氯化丁基橡胶塞、抗生素瓶用铝塑组合盖。","国药集团广东环球制药有限公司","840.00","启用","医保发〔2023〕30号","国谈药品"]
["1813","XB05BAD346B001010500294","2","注射用多种维生素(13)","","限与肠外营养药物配合使用时支付，单独使用不予支付。","201705","注射用多种维生素(13)","无","注射剂","5ml/瓶","瓶","1","低硼硅玻璃管制注射剂瓶、注射用冷冻干燥用氯化丁基橡胶塞、抗生素瓶用铝塑组合盖。","国药集团广东环球制药有限公司","84.00","启用","医保发〔2023〕30号","国谈药品"]
["1814","XL02AEG063B015010104139","2","注射用戈舍瑞林微球","","限需要雄激素去势治疗的前列腺癌患者。","206584","注射用戈舍瑞林微球","无","注射剂","3.6mg","盒","1","注射用戈舍瑞林微球:中性硼硅玻璃管制注射剂瓶＋注射制剂用氯化丁基橡胶塞包装。 注射用微球专用溶剂:预灌封注射器组合件＋预灌封注射器用溴化丁基橡胶活塞包装。","山东绿叶制药有限公司","1028.00","启用","医保发〔2023〕30号","国谈药品"]
["1815","ZC02AAZ0407010100869","2","注射用黄芪多糖","","限二级及以上医疗机构肿瘤患者，单次住院最多支付14天。","111863","注射用黄芪多糖","无","注射剂","250mg","盒","1","西林瓶","天津赛诺制药有限公司","171.18","修改（招标信息）","招采变更","国谈药品"]
["1816","XJ01XXT182B001010102763","2","注射用磷酸特地唑胺","","限急性细菌性皮肤及皮肤软组织感染。","204197","注射用磷酸特地唑胺","无","注射剂","200mg","支","1","中硼硅玻璃管制注射剂瓶、注射用冷冻干燥用卤化丁基橡胶塞 (氯化)和抗生素瓶用铝塑组合盖包装","河北爱尔海泰制药有限公司","136.00","启用","医保发〔2023〕30号",""]
["1817","XL04ACS287B001010183716","2","注射用司妥昔单抗","","限人体免疫缺陷病毒(HIV)阴性和人疱疹病毒8型(HHV-8)阴性的多中心Castleman病(MCD)成人患者。","176078","注射用司妥昔单抗","萨温珂","注射剂","100mg/瓶","盒","1","玻璃瓶","Cilag AG","1905.88","启用","医保发〔2023〕30号","国谈药品"]
["1818","XL04ACS287B001020183716","2","注射用司妥昔单抗","","限人体免疫缺陷病毒(HIV)阴性和人疱疹病毒8型(HHV-8)阴性的多中心Castleman病(MCD)成人患者。","176079","注射用司妥昔单抗","萨温珂","注射剂","400mg/瓶","盒","1","玻璃瓶","Cilag AG","5508.00","启用","医保发〔2023〕30号","国谈药品"]
["1819","XJ01DDT185B002010100108","2","注射用头孢地嗪钠/5%葡萄糖注射液","","","206585","注射用头孢地嗪钠/5%葡萄糖注射液","无","注射剂","粉体室:1.0g(按C20H20N6O7S4计)；液体室:40ml:葡萄糖2g","袋","1","三层共挤输液用双室袋","北京锐业制药有限公司","24.20","启用","医保发〔2023〕30号","国谈药品"]
["1820","XJ01DDT185B002020100108","2","注射用头孢地嗪钠/5%葡萄糖注射液","","","206586","注射用头孢地嗪钠/5%葡萄糖注射液","无","注射剂","粉体室:2.0g (按C20H20N6O7S4计)；液体室:40ml∶葡萄糖2g","袋","1","三层共挤输液用双室袋","北京锐业制药有限公司","30.64","启用","医保发〔2023〕30号","国谈药品"]
["1821","XJ01DDT186B002010100108","2","注射用头孢地嗪钠/5%葡萄糖注射液","","","166512","注射用头孢地嗪钠/氯化钠注射液","无","注射剂","粉体室:1.0g(按C20H20N6O7S4计)；液体室:40ml:氯化钠0.36g","袋","1","三层共挤输液用双室袋","北京锐业制药有限公司","23.90","启用","医保发〔2023〕30号","国谈药品"]
["1822","XJ01DDT186B002020100108","2","注射用头孢地嗪钠/5%葡萄糖注射液","","","166513","注射用头孢地嗪钠/氯化钠注射液","无","注射剂","粉体室:2.0g(按C20H20N6O7S4计)；液体室:40ml:氯化钠0.36g","袋","1","三层共挤输液用双室袋","北京锐业制药有限公司","30.13","启用","医保发〔2023〕30号","国谈药品"]
["1823","XJ01DDT203B002010100108","2","注射用头孢曲松钠/氯化钠注射液","","","206587","注射用头孢曲松钠/氯化钠注射液","无","注射剂","粉体室:按头孢曲松(C18H18N8O7S3)计1.0g；液体室:氯化钠注射液100ml∶0.9g","袋","1","三层共挤输液用双室袋","北京锐业制药有限公司","20.00","启用","医保发〔2023〕30号","竞价药品"]
["1824","XJ01DDT203B002020100108","2","注射用头孢曲松钠/氯化钠注射液","","","206588","注射用头孢曲松钠/氯化钠注射液","无","注射剂","粉体室:按头孢曲松(C18H18N8O7S3)计2.0g；液体室:氯化钠注射液100ml:0.9g","袋","1","三层共挤输液用双室袋","北京锐业制药有限公司","23.50","启用","医保发〔2023〕30号","竞价药品"]
["1825","XJ01DDT203B002010204948","2","注射用头孢曲松钠/氯化钠注射液","","","206589","注射用头孢曲松钠/氯化钠注射液","无","即配型粉液双室袋注射剂","粉体室:按头孢曲松(C？？H？？N？O？S？)计1.0g；液体室:氯化钠注射液 100ml:0.9g","盒","10","三层共挤(粉-液)输液用袋","湖南科伦制药有限公司","200.00","启用","医保发〔2023〕30号","竞价药品"]
["1826","XJ01DDT203B002010304948","2","注射用头孢曲松钠/氯化钠注射液","","","206590","注射用头孢曲松钠/氯化钠注射液","无","即配型粉液双室袋注射剂","粉体室:按头孢曲松(C？？H？？N？O？S？)计1.0g；液体室:氯化钠注射液 100ml:0.9g","箱","60","三层共挤(粉-液)输液用袋","湖南科伦制药有限公司","1200.00","启用","医保发〔2023〕30号","竞价药品"]
["1827","XJ01DDT203B002010104948","2","注射用头孢曲松钠/氯化钠注射液","","","202371","注射用头孢曲松钠/氯化钠注射液","无","即配型粉液双室袋注射剂","粉体室:按头孢曲松(C？？H？？N？O？S？)计1.0g；液体室:氯化钠注射液 100ml:0.9g","袋","1","三层共挤(粉-液)输液用袋","湖南科伦制药有限公司","20.00","启用","医保发〔2023〕30号","竞价药品"]
["1828","XJ01DDT199B001010180542","2","注射用头孢噻肟钠他唑巴坦钠","","","206591","注射用头孢噻肟钠他唑巴坦钠","无","注射剂","1.17g(C16H17N5O7S2 1.0g与C10H12N4O5S 0.17g)","盒","1","低硼硅玻璃管制注射剂瓶、注射用无菌粉末用卤化丁基橡胶塞和抗生素瓶用铝塑组合盖。","南京优科制药有限公司","61.18","启用","医保发〔2023〕30号","国谈药品"]
["1829","XJ01DDT199B001020180542","2","注射用头孢噻肟钠他唑巴坦钠","","","206592","注射用头孢噻肟钠他唑巴坦钠","无","注射剂","2.34g(C16H17N5O7S2 2.0g与C10H12N4O5S 0.34g)","盒","1","低硼硅玻璃管制注射剂瓶、注射用无菌粉末用卤化丁基橡胶塞和抗生素瓶用铝塑组合盖。","南京优科制药有限公司","104.00","启用","医保发〔2023〕30号","国谈药品"]
["1830","XJ01DDT188B001010104021","2","注射用头孢他啶阿维巴坦钠","","","310041","注射用头孢他啶阿维巴坦钠","无","注射剂","2.5g(C22H22N6O7S2 2.0g与C7H11N3O6S 0.5g)","瓶","1","采用20ml中硼硅玻璃模制注射剂瓶、注射用无菌粉末用覆聚酯膜溴化丁基橡胶塞和铝塑组合盖","齐鲁制药有限公司","340.00","启用","医保发〔2023〕30号","竞价药品"]
["1831","XJ01DCT210B001010100108","2","注射用头孢西丁钠/氯化钠注射液","","","206593","注射用头孢西丁钠/氯化钠注射液","无","注射剂","本品为即配型粉液双室袋注射剂。 粉体室:按头孢西丁(C？？H？？N？O？S？)计1.0g；液体室:氯化钠注射液100ml:0.9g","袋","1","三层共挤输液用双室袋","北京锐业制药有限公司","21.50","启用","医保发〔2023〕30号","国谈药品"]
["1832","XJ01DCT210B001020100108","2","注射用头孢西丁钠/氯化钠注射液","","","206594","注射用头孢西丁钠/氯化钠注射液","无","注射剂","本品为即配型粉液双室袋注射剂。粉体室:按头孢西丁(C？？H？？N？O？S？)计2.0g；液体室:氯化钠注射液100ml:0.9g","袋","1","三层共挤输液用双室袋","北京锐业制药有限公司","26.05","启用","医保发〔2023〕30号","国谈药品"]
["1833","ZA09HAZ0413010100940","2","注射用益气复脉(冻干)","","限二级及以上医疗机构冠心病心绞痛及冠心病所致左心功能不全II-III级的患者，单次住院最多支付14天。","102878","注射用益气复脉","无","注射剂","每瓶装0.65g(相当于含红参0.5g、五味子0.75g和麦冬1.5g)","瓶","1","低硼硅玻璃管制注射剂瓶包装","天津天士力之骄药业有限公司","15.92","修改（招标信息）","招采变更","国谈药品"]
["1834","XA02BCY338B001010182416","2","注射用右兰索拉唑","","限伴有出血的胃、十二指肠溃疡。","206595","注射用右兰索拉唑","无","注射剂","20mg","盒","1","中性硼硅玻璃管制镀聚二甲基硅氧烷膜注射剂瓶＋冷冻干燥注射用局部覆聚 四氟乙烯膜卤化丁基橡胶塞(溴化) ＋抗生素瓶用铝塑组合盖","盛禾(中国)生物制药有限公司","35.48","启用","医保发〔2023〕30号","国谈药品"]
["1835","XC01EBC109B001010102049","2","注射用重组人脑利钠肽","","限二级及以上医疗机构用于规范治疗效果不佳的急性失代偿性心力衰竭短期治疗，单次住院支付不超过3天。","118223","注射用重组人脑利钠肽","新活素","注射剂","0.5mg/ 500U/瓶","支","1","玻璃管制注射剂瓶","成都诺迪康生物制药有限公司","424.98","修改（医保和招标信息）","医保发〔2023〕30号","国谈药品"]
["1836","XC01EBC109B001020102049","2","注射用重组人脑利钠肽","","限二级及以上医疗机构用于规范治疗效果不佳的急性失代偿性心力衰竭短期治疗，单次住院支付不超过3天。","204390","注射用重组人脑利钠肽","新活素","注射剂","0.5mg/ 500U/瓶","盒","2","玻璃管制注射剂瓶","成都诺迪康生物制药有限公司","849.96","修改（支付标准）","医保发〔2023〕30号","国谈药品"]
["1837","XB05BAU012B002010102180","2","ω-3甘油三酯(2%)中/长链脂肪乳/氨基酸(16)/葡萄糖(36%)注射液","","需经营养风险筛查，明确具有营养风险，且不能经饮食或“肠内营养剂”补充足够营养的住院患者方予支付。","206596","ω-3甘油三酯(2%)中/长链脂肪乳/氨基酸(16)/葡萄糖(36%)注射液","无","注射剂","1250ml[250ml:ω-3甘油三酯(2%)中/长链脂肪乳注射液,500ml:复方葡萄糖(36%)注射液,500ml:复方氨基酸(16)注射液]","箱","4","外阻隔袋三层共挤输液用三室袋","四川科伦药业股份有限公司","1168.00","启用","医保发〔2023〕30号","国谈药品"]
["1838","XB05BAU012B002010202180","2","ω-3甘油三酯(2%)中/长链脂肪乳/氨基酸(16)/葡萄糖(36%)注射液","","需经营养风险筛查，明确具有营养风险，且不能经饮食或“肠内营养剂”补充足够营养的住院患者方予支付。","205377","ω-3甘油三酯(2%)中/长链脂肪乳/氨基酸(16)/葡萄糖(36%)注射液","无","注射剂","1250ml[250ml:ω-3甘油三酯(2%)中/长链脂肪乳注射液,500ml:复方葡萄糖(36%)注射液,500ml:复方氨基酸(16)注射液]","袋","1","外阻隔袋三层共挤输液用三室袋","四川科伦药业股份有限公司","292.00","启用","医保发〔2023〕30号","国谈药品"]
["1839","XB05BAU012B002020102180","2","ω-3甘油三酯(2%)中/长链脂肪乳/氨基酸(16)/葡萄糖(36%)注射液","","需经营养风险筛查，明确具有营养风险，且不能经饮食或“肠内营养剂”补充足够营养的住院患者方予支付。","206597","ω-3甘油三酯(2%)中/长链脂肪乳/氨基酸(16)/葡萄糖(36%)注射液","无","注射剂","625ml[125ml:ω-3甘油三酯(2%)中/长链脂肪乳注射液,250ml:复方葡萄糖(36%)注射液,250ml:复方氨基酸(16)注射液]","箱","6","外阻隔袋三层共挤输液用三室袋","四川科伦药业股份有限公司","1030.56","启用","医保发〔2023〕30号","国谈药品"]
["1840","XB05BAU012B002020202180","2","ω-3甘油三酯(2%)中/长链脂肪乳/氨基酸(16)/葡萄糖(36%)注射液","","需经营养风险筛查，明确具有营养风险，且不能经饮食或“肠内营养剂”补充足够营养的住院患者方予支付。","205378","ω-3甘油三酯(2%)中/长链脂肪乳/氨基酸(16)/葡萄糖(36%)注射液","无","注射剂","625ml[125ml:ω-3甘油三酯(2%)中/长链脂肪乳注射液,250ml:复方葡萄糖(36%)注射液,250ml:复方氨基酸(16)注射液]","袋","1","外阻隔袋三层共挤输液用三室袋","四川科伦药业股份有限公司","171.76","启用","医保发〔2023〕30号","国谈药品"]
["1841","XB03XAJ236B002010179436","2","甲氧聚二醇重组人促红素注射液","","限因慢性肾脏病引起的贫血，且正在接受红细胞生成刺激剂类药品治疗的患者。","60040","甲氧聚二醇重组人促红素注射液","美信罗","注射剂","75μg/0.3ml/支:每支预充式注射器内含75μg甲氧聚二醇重组人促红素,装量为0.3ml","盒","1","预充式注射器包装","F.Hoffmann-La Roche AG","367.47","启用","医保发〔2023〕30号","国谈药品"]
["1842","XB03XAJ236B002020179436","2","甲氧聚二醇重组人促红素注射液","","限因慢性肾脏病引起的贫血，且正在接受红细胞生成刺激剂类药品治疗的患者。","60041","甲氧聚二醇重组人促红素注射液","美信罗","注射剂","100μg/0.3ml/支:每支预充式注射器内含100μg甲氧聚二醇重组人促红素,装量为0.3ml","盒","1","预充式注射器包装","F.Hoffmann-La Roche AG","458.00","启用","医保发〔2023〕30号","国谈药品"]
["1843","XB03XAJ236B002030179436","2","甲氧聚二醇重组人促红素注射液","","限因慢性肾脏病引起的贫血，且正在接受红细胞生成刺激剂类药品治疗的患者。","60042","甲氧聚二醇重组人促红素注射液","美信罗","注射液","50μg/0.3ml/支:每支预充式注射器内含50μg甲氧聚二醇重组人促红素,装量为0.3ml","盒","1","预充式注射器包装","F.Hoffmann-La Roche AG","269.41","启用","医保发〔2023〕30号","国谈药品"]